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Emerging evidence shows vascular resident pericytes are multifunctional, with 
involvement in inflammation and immune cell infiltration in addition to their well 
characterised functions in angiogenesis and the regulation of vascular stability and 
perfusion. Similar to pericytes from animal models, cultured human pericytes are able 
to produce inflammatory mediators, and renal pericytes show active involvement in the 
recruitment and direction of immune cells. This has big implications for the treatment 
of renal disease, where loss of pericytes and marked inflammation are associated with 
poor patient outcomes. However, the nature of this pericyte-mediated inflammation 
varies between animals and humans, and tissue culture does not always accurately 
reflect in vivo behaviour. Further still, the means by which inflammatory involvement if 
pericytes is identified may be misattributed; with a known overlap in cell-surface 
molecule expression between pericytes and macrophage (MΦ). Proper identification 
of pericytes and thus their multifunctionality is imperative.  
The hypothesis behind this investigation is that renal pericytes in in situ kidney slices 
reflect in vivo physiology and are multifunctional, distinguishable from MΦ, and 
involved in renal inflammation. The utilisation of both rodent and murine in situ “live” 
kidney slices will enable investigations into this phenomenon by enabling use of co-
labelling with overlapping pericyte (NG2 and PDGFR-β) and MΦ (CD163 and F4/80) 
markers, maintaining in vivo cellular communications, and visualisation of notable cell 
morphology. Overall, this thesis presents data to support kidney slices accurately 
modelling in vivo vascular physiology and thus other pericyte-mediated functions. 
Furthermore, this data supports renal pericytes exhibiting multifunctionality, notably in 
a cell-surface molecule-specific manner that is conserved across species. While not 
investigated in this thesis it is hoped these findings may translate to human physiology 




I certify that this work has not been accepted in substance for any degree and is 
not concurrently being submitted for any degree other than that of Doctor of 
Philosophy being studied at Universities of Greenwich and Kent. I also declare that 
this work is the result of my own investigations except where otherwise identified 







   Rebecca Lilley 
July 2020 
 
   Word Count: 64 568  
 4 
Acknowledgements 
Thanks pals, we crushed it.  
 5 
Table of Contents 
Abstract ................................................................................................................... 2 
Declaration .............................................................................................................. 3 
Acknowledgements ................................................................................................ 4 
Table of Contents .................................................................................................... 5 
List of Figures ....................................................................................................... 11 
List of Tables ......................................................................................................... 14 
1 General Introduction. .................................................................................. 15 
1.1 The kidney. ............................................................................................ 15 
1.1.1 The tubular compartment ................................................................ 16 
1.1.2 The vascular compartment .............................................................. 17 
1.1.3 Regional regulation of renal blood flow is needed to facilitate urine 
concentration. ............................................................................................... 19 
1.1.3.1 Generation of the corticomedullary concentration gradient results in 
a low medullary oxygen tension. ................................................................ 22 
1.1.3.2 Autoregulation of MBF. ............................................................... 23 
1.2 Pericytes. ............................................................................................... 26 
1.2.1 Pericytes are a highly heterogenous population of cell. ................... 27 
1.2.1.1 NG2 and PDGFR-β expression varies along the capillary network.
 28 
1.2.1.2 Pericyte morphology correlates with NG2 and PDGFR-β 
expression. ................................................................................................ 29 
1.2.1.1.1 NG2 and PDGFR-β are more suitable identifying markers than 
others. ....................................................................................................... 30 
1.2.2 Novel pericyte-mediated activities can be organ specific, yet there 
remain conserved behaviours across tissues. ............................................... 32 
1.2.3 Inconsistent experimental methods in identifying pericytes may 
confound findings. ........................................................................................ 33 
1.2.3.1 There is a highly varied regional distribution of renal pericytes. .. 34 
1.3 A novel emerging conserved behaviour of NG2+ and PDGFR-β+ pericytes 
involves coordination and involvement in the immune response. ...................... 36 
1.3.1 Pericytes as coordinators of immune function. ................................ 37 
1.3.2 Angiogenesis and vessel stability require macrophages and pericytes.
 38 
 6 
1.3.2.1 A subset of NG2+ pericytes are derived from macrophages ........ 40 
1.3.3 Pericytes as non-professional immune cells. ................................... 40 
1.3.3.1 Are these pericytes acting as immune cells or perivascular 
macrophages? ........................................................................................... 41 
1.4 Pericytes and macrophage converge on the renal medulla. ................... 42 
1.4.1 Renal Pericytes co-ordinate inflammation in the kidney. .................. 43 
1.4.1.1 NG2 and PDGFR-β, though not other pericyte markers are 
reportedly expressed by immune cells ....................................................... 47 
1.5 Species specific differences in behaviour can influence translatability. .. 47 
1.5.1 Cross-species and Cross-organ pericyte immune functionality is 
conserved, in a species dependent manner. ................................................. 49 
1.6 Summary and aims. ............................................................................... 49 
2 General Methodology. ................................................................................ 51 
2.1 Tissue preparation and slicing ................................................................ 51 
2.2 Viability of C57BL/6J live kidney slices ................................................... 51 
2.3 C57BL/6J pericyte characteristics. ......................................................... 52 
2.4 Functional experiments and video analysis. ........................................... 54 
2.5 Immunohistochemical staining of Sprague-Dawley and C57BL/6J kidney 
slices with pericyte and macrophage markers. ................................................. 56 
2.6 Statistics ................................................................................................ 61 
3 A rodent live kidney slice model to investigate the multifunctional nature 
of renal pericytes. .............................................................................................. 62 
3.1 Introduction ............................................................................................ 62 
3.2 Methods: ................................................................................................ 64 
3.2.1 Immunohistochemical staining of Sprague-Dawley kidney slices. .... 64 
3.2.2 Statistics. ........................................................................................ 65 
3.3 Results: .................................................................................................. 65 
3.3.1 Vasa recta pericytes are identifiable via immunohistochemical 
staining with PDGFR-β. ................................................................................ 65 
3.3.2 CD68 and CD163 expression is regionally specific in rodent kidney 
slices. 66 
3.3.3 PDGFR-β+ pericytes are larger and more abundant than NG2+ 
pericytes. ...................................................................................................... 70 
3.3.4 In control tissue, few CD163+ macrophages are present spatially close 
to vasa recta NG2+ and PDGFR-β+ pericytes. ............................................... 72 
3.3.5 Pericytes in contact with CD163+ macrophages are constricted in 
healthy tissue. .............................................................................................. 75 
 7 
3.3.6 Exposure of live tissue to cytokines, and duration of incubation in 
control tissue sections, influences CD163+ macrophage presence in the renal 
medulla. 76 
3.3.6.1 Cytokine stimulation did not influence contact between CD163+ 
macrophage and NG2+ pericytes. .............................................................. 78 
3.3.7 Cytokine stimulation differentially altered PDGFR-β+ and NG2+-
labelled pericyte densities. ............................................................................ 80 
3.3.8 Cytokine stimulation differentially altered PDGFR-β+-labelled and 
NG2+-labelled pericyte covered vasa recta diameters. .................................. 82 
3.3.9 Cytokine stimulation, but not CD163+ macrophage cellular contact, 
influenced NG2+ pericyte soma size. ............................................................ 85 
3.3.10 Stimulation of kidney slices with pro-inflammatory cytokines TNF-α 
and IL-1β does not induce CD163 expression in NG2+ pericytes but does in 
few PDGFR-β+ pericytes. .............................................................................. 86 
3.4 Discussion: ............................................................................................ 89 
3.4.1 PDGFR-β+ pericyte covered vasa recta have larger diameters and are 
more numerous than those covered by NG2+ pericytes. ................................ 90 
3.4.1.1 Vasa recta PDGFR-β+ pericytes bear morphological differences to 
NG2+ pericytes. ......................................................................................... 92 
3.4.2 In control kidney tissue there are few CD163+ macrophages, which 
primarily reside in the medulla. ..................................................................... 93 
3.4.3 CD163+ macrophage and pericytes may actively communicate to 
regulate vasa recta diameter. ....................................................................... 94 
3.4.4 Stimulation of tissue with TNF-α and IL-1β increase the number of 
CD163+ macrophages in the medulla. ........................................................... 95 
3.4.5 TNF-α and IL-1β stimulation significantly reduce NG2+ pericyte 
density in both medullary regions. ................................................................. 96 
3.4.6 TNF-α and IL-1β differentially affect PDGFR-β+ and NG2+ pericyte 
contractility and morphology. ........................................................................ 97 
3.4.7 A small number of PDGFR-β+ pericytes were co-labelled with anti-
CD163. 98 
4 Establishment of a murine live kidney slice model. ................................ 100 
4.1 Introduction. .......................................................................................... 100 
4.2 Methods. ............................................................................................... 101 
4.2.1 C57BL/6J tissue slicing. ................................................................. 101 
4.2.2 Viability of C57BL/6J live kidney slices. .......................................... 102 
4.2.3 Determination of C57BL/6J NG2+ pericyte density and pericyte 
characteristics. ............................................................................................ 102 
 8 
4.2.4 Functional experiments and video analysis .................................... 103 
4.2.5 Statistics ........................................................................................ 103 
4.3 Results .................................................................................................. 104 
4.3.1 C57BL/6J kidney slices are viable, with pericytes clearly identifiable.
 104 
4.3.2 NG2+ pericytes are clearly labelled in C57BL/6J kidney slices. ....... 105 
4.3.3 C57BL/6J renal pericytes are functionally responsive, and vasoactive 
agents affect vasa recta diameter in situ. ..................................................... 107 
4.3.3.1 Responsiveness of murine pericytes in situ to endogenous 
vasoactive compounds varies from those in the rat. ................................. 109 
4.3.3.1.1 Angiotensin-II ...................................................................... 109 
4.3.3.1.2 Adenosine-5’-triphosphate and noradrenaline. ..................... 111 
4.3.3.1.3 Endothelin-1 ........................................................................ 113 
4.3.3.1.4 Prostaglandin E2 and bradykinin .......................................... 114 
4.3.3.2 Superfusion of C57BL/6J slices with exogenous compounds 
demonstrates pericyte-mediated vasoactivity. .......................................... 115 
4.4 Discussion. ........................................................................................... 118 
4.4.1 C57BL/6J kidney slices are viable. ................................................. 118 
4.4.2 C57BL/6J NG2+ pericyte morphology is comparable to the rat whilst 
vasa recta capillaries are smaller. ................................................................ 119 
4.4.3 C57BL/6J renal pericyte-mediated responsiveness is less frequent 
than the SD model. ...................................................................................... 120 
4.4.4 C57BL/6J renal pericytes are vasoactive, and contractility reflects 
known species differences in vascular reactivity .......................................... 121 
4.4.4.1 Angiotensin II-mediated constriction of DVR-pericytes is conserved 
across species. ........................................................................................ 122 
4.4.4.2 Bradykinin is contractile at high concentrations at C57 DVR 
pericytes. .................................................................................................. 123 
4.4.4.3 Adenosine-5’-triphosphate and BzATP suggest DVR pericytes-
contractility is mediated at least in part by P2X7. ...................................... 124 
4.4.4.4 The activity of noradrenaline (NA) and tyramine in the mouse 
further suggest species-related differences to both NA and ATP .............. 125 
4.4.4.5 In the mouse, the DVR pericyte responsiveness to endothelin-1 
differs from that described in the literature. ............................................... 127 
4.4.4.6 Prostaglandin E2, and associated exogenous drugs, have 
comparable pericyte-mediated activity in both species. ............................ 128 
4.4.5 There is benefit to developing and characterising a cross-species 
model. 130 
 9 
5 The use of a murine live slice model to investigate the multifunctional 
nature of renal pericytes. ................................................................................. 132 
5.1 Introduction ........................................................................................... 132 
5.2 5.2 Methods: ......................................................................................... 134 
5.2.1 5.2.1 DIC video analysis. ................................................................ 134 
5.2.2 5.2.2 Immunohistochemical experiments. ....................................... 134 
5.2.3 Statistics ........................................................................................ 135 
5.3 Results: ................................................................................................. 136 
5.3.1 TNF-α, but not IL-1β induces a significant pericyte-mediated 
vasoconstriction of vasa recta. ..................................................................... 136 
5.3.2 PDGFR-β and CD68 expression in the C57BL/6J mouse kidney is 
similar to that observed in the Sprague-Dawley rat model. ........................... 136 
5.3.3 Vasa recta capillaries where pericytes are in contact with F4/80+ 
macrophages are constricted. ...................................................................... 139 
5.3.4 NG2+-labelled pericytes and F4/80+-labelled macrophages have a 
close spatial relationship in the OM. ............................................................ 143 
5.3.5 A small population of cells were positive for both F4/80 and either 
PDGFR-β or NG2. ....................................................................................... 146 
5.3.6 Incubations with cytokines increased the outer medullary (OM) F4/80+ 
macrophages presence and reduced both PDGFR-β+ and NG2+ pericyte 
density. 147 
5.3.7 IL-1β, not TNF-α, retained F4/80+ macrophages near NG2+ pericytes 
in both the OM and IM. ................................................................................ 152 
5.3.8 ............................................................................................................ 154 
5.3.9 TNF-α- and IL-1β-induced, pericyte-mediated vasoconstriction, is 
potentiated by macrophage contact in NG2+, but not PDGFR-β+ pericytes ... 154 
5.3.10 Presence of F4/80+ macrophages, not cytokine stimulation has 
potential to influence PDGFR-β+ pericyte morphology ................................. 157 
5.3.11 Pro-inflammatory cytokine stimulation does not appear to encourage 
cellular co-expression of F4/80 and NG2+, but does for F4/80 and PDGFR-β.
 159 
5.4 Discussion ............................................................................................ 163 
5.4.1 5.4.1 Murine PDGFR-β+ pericyte covered vasa recta have larger 
diameters and are more numerous than those covered by NG2+ pericytes. . 163 
5.4.2 5.4.2 F4/80+ macrophages and pericytes may actively communicate 
to regulate vasa recta diameter. ................................................................... 164 
5.4.3 The differential acute activity of TNF-α and IL-1β appears to be 
conserved between mice and rats, whilst reflecting species differences. ..... 165 
 10 
5.4.3.1 In the mouse, TNF-α and IL-1β differentially affect PDGFR-β+ and 
NG2+ pericyte contractility, whilst not affecting the morphology of either. . 165 
5.4.4 Dormant monocytes when activated migrate towards NG2+ pericytes 
in the outer medulla. .................................................................................... 166 
5.4.5 IL-1β, but not TNF-α, significantly influences distances between NG2+ 
pericytes and F4/80+ macrophages. ............................................................. 168 
5.4.6 The pericyte-mediated constriction of vasa recta capillaries induced 
by macrophages may be orchestrated by NG2+ not NG2- pericytes. ............ 168 
5.4.7 A small population of cells co-label with anti-PDGFR-β and anti-
F4/80, with both pericyte and macrophage morphology ............................... 170 
Interestingly in the kidney it has ...................................................................... 170 
6 General Discussion ................................................................................... 172 
6.1 Pericytes as a multifunctional class of cell? .......................................... 172 
6.2 Renal pericytes are contractile in a species-specific manner. ................ 173 
6.3 The kidney slice models can be used to further investigate the 
multifunctionality of renal pericytes. ................................................................ 174 
6.4 PDGFR-β+ and NG2+ pericytes represent different renal populations of 
pericytes, likely correlating to AVR and DVR coverage. .................................. 175 
6.5 Renal pericytes and macrophages seemingly communicate. ................. 176 
6.6 Macrophages and NG2+ pericytes may communicate via RhoA/ROCK 
signalling. ........................................................................................................ 177 
6.7 PDGFR-β co-labels with CD163 and F4/80. .......................................... 178 
6.8 Expression of NG2 by macrophage-derived pericytes may occur at a later 
stage of investment into the endothelial wall. .................................................. 179 
6.9 Future work. .......................................................................................... 180 
References ........................................................................................................... 185 




List of Figures 
Figure 1.1 Schematic showing the gross architecture of the mammalian kidney. .... 16 
Figure 1.2 Anatomy of the renal vasculature. .......................................................... 18 
Figure 1.3 A schematic illustrating counter-current multiplication and counter-current 
exchange. ............................................................................................................... 20 
Figure 1.4 A schematic showing the effect Tubulo-vascular crosstalk and medullary 
blood flow on solute excretion and local oxygenation. ............................................. 22 
Figure 1.5 Known markers for renal pericyte identification. ..................................... 26 
Figure 1.6 Schematic showing the diversity of pericytes around the microvasculature 
network of the renal medulla. .................................................................................. 28 
Figure 1.7 A schematic illustrating cell type pericytes reportedly differentiate into. .. 33 
Figure 1.8 Renal NG2+/PDGFR-β+ pericyte distribution in the cortex and outer medulla 
of healthy young adult mice. ................................................................................... 35 
Figure 1.9 NG2-dependent extravasation of polymorphonuclear leukocytes (PMN). 38 
Figure 1.10 . In healthy mammalian kidneys immune cells have preponderance in the 
medulla. .................................................................................................................. 44 
Figure 1.11 Proposed co-ordination of the immune response at the vasa recta 
capillaries by pericytes. ........................................................................................... 46 
Figure 2.1 Distribution of NG2+ pericytes in a region of interest (ROI) from mouse 
tissue. ..................................................................................................................... 59 
Figure 3.1 Platelet derived growth factor receptor-β (PDGFR-β)+, CD68+, and CD163+ 
positive staining in the Sprague-Dawley rat. ........................................................... 67 
Figure 3.2 Morphologies of CD163+ macrophage (MΦ). .......................................... 69 
Figure 3.3 Features of neural-glial-2 (NG2)+ pericyte and CD163+ macrophage (MΦ) 
distribution. ............................................................................................................. 70 
Figure 3.4 Both platelet derived growth factor receptor-β (PDGFR-β)+ vessel diameter, 
and fluorescent staining is significantly greater than neural-glial-2 (NG2)+ staining in 
the outer and inner medulla. ................................................................................... 73 
Figure 3.5 The effect of pro-inflammatory cytokines TNF-α and IL-1β on the spatial 
arrangement of neural-glial-2 (NG2)+ pericytes and CD163+ macrophages (MΦ). ... 78 
Figure 3.6 Effects of pro-inflammatory cytokine stimulation on CD163+ macrophage 
(MΦ) and neural-glial-2 (NG2)+ pericyte density in the outer (OM) and inner (IM) 
medulla. .................................................................................................................. 81 
Figure 3.7 Effects of pro-inflammatory cytokine stimulation on CD163+ macrophage 
(MΦ) and platelet derived growth factor receptor-β (PDGFR-β)+ pericyte density in the 
outer (OM) and inner (IM) medulla. ......................................................................... 82 
 12 
Figure 3.8 The effect of pro-inflammatory cytokines TNF-α and IL-1β and CD163+ 
macrophage (MΦ) presence on neural-glial-2 (NG2)+ or platelet derived growth factor 
receptor-β  (PDGFR-β)+ pericyte-regulated vasa recta diameter. ............................ 84 
Figure 3.9 Co-expression of platelet derived growth factor receptor-β (PDGFR-β)+ with 
CD163+ on vascular resident cells in the renal medulla bearing morphological 
similarities to PDGFR-β+ pericytes. ......................................................................... 88 
Figure 4.1 Viability of kidney slices from C57BL/6J mice ........................................ 104 
Figure 4.2 Identification of NG2+ pericytes in the C57BL/6J renal medulla. ............ 105 
Figure 4.3 Pericytes in the C57BL/6J preparation only constrict in the presence of an 
agonist. .................................................................................................................. 108 
Figure 4.4  Angiotensin-II (Ang-II) evoked constriction of in situ vasa recta is of a lower 
magnitude than in the Sprague-Dawley (SD) model. .............................................. 110 
Figure 4.5  Adenosine-5’-triphosphate (ATP) and noradrenaline (NA) needed marked 
increase in concentration to stimulate vasoactivity of C57BL/6J in situ vasa recta 
capillaries. ............................................................................................................. 112 
Figure 4.6 Endothelin-1 (ET-1) evoked a significantly greater, pericyte-mediate, 
constriction in the C57BL/6J mouse. ...................................................................... 113 
Figure 4.7 Prostaglandin E2 (PGE2) and Bradykinin (BK) needed marked increase in 
concentration to stimulate vasoactivity of C57BL/6J in situ vasa recta capillaries. . 115 
Figure 4.8 Simulating or attenuating the release of endogenous compounds in 
C57BL/6J kidney slices. ......................................................................................... 117 
Figure 4.9 Interspecies differences between SD (a) and C57 (b) pericyte density. . 120 
Figure 5.1 Superfusion of C57BL/6J murine kidney slices with TNF-α, but not IL-1β, 
caused a pericyte-mediated constriction of vasa recta capillaries. ......................... 137 
Figure 5.2 Platelet derived growth factor receptor-β (PDGFR-β)+ and CD68+ positive 
staining in the C57BL/6J mouse. ............................................................................ 138 
Figure 5.3 The regional densities of pericytes and macrophage (MΦ) in the outer (OM) 
and inner medulla (IM). .......................................................................................... 140 
Figure 5.4 The effect of F4/80
+
 MΦ on vasa recta diameter and their spatial relationship 
with neural-glial-2 (NG2)
+
 pericytes. ....................................................................... 142 
Figure 5.5 Features of neural-glial 2 (NG2)
+
 pericyte and F4/80
+
 macrophage (MΦ) 
morphology ............................................................................................................ 144 





 macrophage (MΦ) morphology. ........................................................... 145 
Figure 5.7 Co-expression of neural-glial-2 (NG2) and F4/80 on perivascular cells. 147 
Figure 5.8 Co-expression of platelet derived growth factor receptor-β (PDGFR-β) and 
F4/80 on perivascular cells. ................................................................................... 148 
 13 
Figure 5.9 Effects of pro-inflammatory cytokine stimulation on F4/80+ macrophage 
(MΦ) and neural-glial 2 (NG2)+-labelled pericyte density in the outer (OM) and inner 
(IM) medulla ........................................................................................................... 150 
Figure 5.10 Effects of pro-inflammatory cytokine stimulation on F4/80+ macrophage 
(MΦ) and platelet derived growth factor receptor-β (PDGFR-β)+-labelled pericyte 
density in the outer (OM) and inner (IM) medulla. .................................................. 151 
Figure 5.11 The effect of pro-inflammatory cytokines TNF-α and IL-1β on the spatial 
arrangement between neural-glial-2 (NG2)+ pericytes and F4/80+ macrophage (MΦ).
 .............................................................................................................................. 153 
Figure 5.12 The effect of pro-inflammatory cytokines TNF-α and IL-1β and MΦ 
presence on vasa recta diameter. .......................................................................... 156 
Figure 5.13 Differential effect of F4/80+ macrophage (MΦ) presence on neural-glial-2 
(NG2)+ or platelet derived growth factor receptor-β  (PDGFR-β)+  pericytes in the outer 
medulla (OM). ........................................................................................................ 158 
Figure 5.14 Morphology of perivascular neural-glial-2 (NG2)-, F4/80+ cells is 
comparable to NG2+ pericytes, irrespective of cytokine treatment in the renal medulla.
 .............................................................................................................................. 160 
Figure 5.15 Co-expression of platelet derived growth factor receptor-β (PDGFR-β) and 
F4/80 on non-vascular resident cells in the renal medulla. ..................................... 161 
Figure 5.16 Co-expression of platelet derived growth factor receptor-β (PDGFR-β)+ 
with F4/80+ on vascular resident cells in the renal medulla bearing morphological 
similarities to PDGFR-β+ pericytes. ........................................................................ 162 
Figure 6.1 Proposed co-ordination of the immune response at the vasa recta capillaries 




List of Tables 
Table 1.1 Vasoactive agonists that evoke a pericyte-mediated change in DVR 
diameter. ................................................................................................................. 25 
Table 2.1 Concentration of agonists used for functional experiments. ..................... 53 
Table 2.2 Antibody dilutions table. .......................................................................... 57 
Table 3.1 Characteristics of platelet derived growth factor receptor-β (PDGFR-β)+ and 
neural-glial 2 (NG2)+ pericytes in the renal medulla. ................................................ 71 
Table 3.2 Characteristics of renal platelet derived growth factor receptor-β (PDGFR-
β)+ and neural-glial 2 (NG2)+ pericytes in contact with CD163+ macrophages (MΦ). 74 
Table 3.3 CD163+ Macrophage (MΦ), platelet derived growth factor receptor-β 
(PDGFR-β)+, and neural-glial-2 (NG2)+ pericyte quantification after TNF-α and IL-1β 
stimulation. ............................................................................................................. 77 
Table 3.4 Effect of TNF-α and IL-1β stimulation, and CD163+ macrophage (MΦ) 
presence on vasa recta diameter encircled by neural-glial-2 (NG2)+ or platelet derived 
growth factor receptor-β  (PDGFR-β)+ pericytes. ..................................................... 83 
Table 3.5 Effect of TNF-α and IL-1β stimulation, and CD163+ macrophage (MΦ) 
presence neural-glial-2 (NG2)+ or platelet derived growth factor receptor-β  (PDGFR-
β)+ pericyte soma size. ............................................................................................ 85 
Table 4.1 Summary of C57BL/6J NG2+ pericyte characteristics. ............................ 106 
Table 5.1 Characteristics of platelet derived growth factor receptor-β (PDGFR-β)+ and 
neural-glial 2 (NG2)+ pericytes in the renal medulla. .............................................. 139 
Table 5.2 Characteristics of renal platelet derived growth factor receptor-β (PDGFR-
β)+ and neural-glial 2 (NG2)+ pericytes in contact with F4/80+ macrophages (MΦ). 141 
Table 5.3 F4/80+ Macrophage (MΦ), platelet derived growth factor receptor-β (PDGFR-
β)+, and neural-glial-2 (NG2)+ pericyte quantification after TNF-α and IL-1β stimulation
 .............................................................................................................................. 149 
Table 5.4 The spatial relationship between F4/80+ Macrophage (MΦ) and neural-glial-
2 (NG2)+ pericytes after TNF-α and IL-1β stimulation ............................................. 152 
Table 5.5 Effect of TNF-α and IL-1β stimulation, and F4/80+ macrophage (MΦ) 
presence on vasa recta diameter encircled by neural-glial-2 (NG2)+ or platelet derived 
growth factor receptor-β  (PDGFR-β)+ pericytes. .................................................... 155 
Table 5.6 Effect of TNF-α and IL-1β stimulation, and F4/80+ macrophage (MΦ) 
presence on neural-glial-2 (NG2)+ or platelet derived growth factor receptor-β  
(PDGFR-β)+ pericyte soma size. ............................................................................ 157 
  
 15 
1 GENERAL INTRODUCTION. 
 
1.1 The kidney. 
The kidneys are highly-specialised organs located outside the peritoneal cavity, 
responsible for a multitude of homeostatic processes in the body including: regulation 
of body fluid, glucose, pH, and electrolytes; the regulation of local and systemic blood 
pressure (BP) via the production of an array of vasoactive agents; the filtration and 
purification of blood; the activation of vitamin D; and the removal of waste products via 
the production of urine (Martini et al., 2012).  In humans to efficiently perform these 
duties kidneys receive approximately 20% of the cardiac output and handling 
approximately 170 L of blood per day (Epstein, 1997). Consequently, kidneys are 
highly vascularised, with a diverse regional vascular structure to perform its many 
tasks.  
Mammalian kidneys consist of 2 major regions; the cortex and the medulla. The 
medulla is further subdivided into: the outer medulla (OM), having both outer (OSOM) 
and inner stripes (ISOM); and the inner medulla (IM) (Shaw et al., 2018) (Figure 1.1). 
Filtration begins in the cortex via the passage of blood into the nephrons. Each nephron 
is comprised of a renal corpuscle (a Bowman’s Capsule and a glomerulus) with an 
associated tubule. Adult human kidneys have approximately 800,000-1 million 
nephrons each, which constitute the tubular compartment of the kidney. These 
nephrons are either cortical, who’s Loop of Henle (LoH) is confined to the OM, or 
juxtamedullary, who’s LoH extend deep into the medulla. Juxtamedullary nephrons are 
the predominant type and all nephrons are perfused by an extensive vascular network 
to meet their metabolic requirements (Am et al., 2013; Kriz, and Kaissling, 2013), 
described in more detail below in section 1.1.2. 
The glomerulus is where the filtration process is initiated in the nephron, before entry 
of filtrate into the Bowman’s space. Glomeruli are small looping bundles of capillaries 
or “capillary tufts”, that are surrounded by podocytes, supported by contractile 
mesangial cells, and work together with endothelial cells to form a functional unit 
(Schlondorff, and Banas, 2009). These tufts are permeable to water and small or 
uncharged molecules, such as glucose, NaCl and urea, with both the hydrostatic and 
osmotic pressure differential providing the force behind the ultrafiltration of blood. The 
rate at which this filtration occurs is known as the glomerular filtration rate (GFR) and 
is highly dependent upon upstream blood flow (BF) through the afferent arteriole (AA; 
described in more detail in section 1.1.2). 
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Figure 1.1 Schematic showing the gross architecture of the mammalian kidney. 
Kidneys are comprised of the outer fibrous capsule layer externally. Internally, there is a 
peripheral region called the cortex and internal pyramidal regions called the medulla (red box). 
The medulla can be further divided into the outer stripe of the outer medulla, the inner stripe of 
the outer medulla, and the inner medulla. Nephrons, and their various segments, are found 
within the cortex and medulla, and are comprised of a glomerulus and associated tubule. Blood 
flows through the glomerular capillaries, with the filtrate collecting in the Bowman’s capsule 
and subsequently passing through all tubule segments, being modified as it passes. Urine 
drains from the collecting duct at the papillary tip of the medulla into the calices and 
subsequently flows through the renal pelvis, transmitting urine to the bladder via the ureter. 
Nephrons can be classified as either: juxtamedullary, descending deep into the medulla; or 
cortical, with only the descending thin limb of Henle (DTL), ascending thin limb of Henle (ATL), 
and mTAL present in the medulla. The tubule is subdivided into proximal segments, the Loop 
of Henle, and distal segments (see colour key). The black box highlights the juxtaglomerular 
apparatus which is involved in tubuloglomerular feedback (Davidson, 2009). 
 
1.1.1  The tubular compartment  
 
Once in the Bowman’s Space, the glomerular filtrate begins its passage along the 
tubule. The tubular segments consist of; the proximal tubule (convoluted; PCT, and 
straight; PST/ S3) immediately post Bowman’s Capsule, the Loop of Henle, the distal 
tubule (convoluted; DCT, and straight; DST or medullar thick ascending limb (mTAL)), 
and finally a connecting tubule (CT) passing filtrate into the collecting duct (CD; Figure 
1.1). As filtrate passes along the nephron it is continuously being altered. Overall the 
solute secretion remains fairly constant (Hall, 2010), it is the reabsorption of water that 
influences urine concentration. The DCT and the CD are impermeable to water except 
in the presence of anti-diuretic hormone (ADH), which stimulates the translocation of 
aquaporin-2 (AQP-2) to the cell membrane and subsequent movement of tubular fluid 
into the hyperosmotic medullary interstitium to be collected taken up by the ascending 
vasa recta (AVR) and producing a concentrated urine output (Sands, and Layton, 
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2014). Each section of the nephron, and the subsequent cell types present, are 
adapted for the filtration, reabsorption and secretion of solutes or waste products to 
produce a concentrated urine (Martini et al., 2012). 
Perfusion of the glomerulus is autoregulated by the juxtaglomerulr apparatus (JGA). 
The JGA consists of the juxtaglomerular cells, the mesangium, and the macula densa, 
residing between the terminal pole of the AA and the mTAL and form a feedback unit 
(Peti-Peterdi, and Harris, 2010).  The mTAL segment of the nephron communicates to 
the AA via purinergic signalling through the JGA in response to fluctuations in tubular 
NaCl concentration. This autoregulatory mechanism, known as tubuloglomerular 
feedback (TGF), modulates AA perfusion and the GFR (Peti-Peterdi, and Harris, 2010; 
Marsh et al., 2019). TGF exists to regulate glomerular perfusion (Palmer et al., 2013), 
to both protect the glomerular capillaries from excessive pressure, and preserve flow 
rate through the nephron and regulate solute excretion. These are autoregulatory 
processes confined to the microvasculature, with possibilities for further cortical 
nephron-to-vascular crosstalk to occur (Pallone, and Cao, 2013). This highlights the 
importance of communication between the tubular and vascular network for renal 
function. 
 
1.1.2  The vascular compartment 
 
In order to efficiently filter the blood, as well meeting the metabolic needs of the 
tubules, the structure of the vascular compartment is highly complex and varied. Blood 
enters the kidney through the renal artery, which undergoes several structural divisions 
before blood passes through the glomerular tuft. It is at the corticomedullary border 
where the vascular network begins to then change quite drastically comparative to 
other tissues. The divisions of the renal artery that arise at this border are known as 
arcuate arteries. These give rise to the interlobular arteries, which ascend radially 
within the cortex, and diverge into numerous afferent arterioles (AA; Figure 1.2(a)). 
Individual AA split into the glomerular tuft inside the Bowman’s capsule. These 
glomerular capillaries subsequently coalesce into the efferent arteriole (EA), as 
opposed to a venule, leaving the Bowman’s Space (Pallone et al., 2003b). Cortical EA 
become the cortical capillary plexus and perfuse the tubular segments in this region 
before ultimately re-joining with the arcuate vein, juxtamedullary EA descend into the 
renal medulla. It is important to note tubules are not perfused by capillaries that arise 
from the EA of their parent glomerulus (Chou et al., 1990). 
Comparative to the cortex that is rich in arteries, the medulla is perfused solely by the 
microvasculature arising from juxtamedullary EA. These EA split into descending vasa 
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recta (DVR) capillaries in the OSOM. DVR coalesce to form cone-shaped vascular 
bundles in the ISOM. In these bundles, few central DVR descend into the IM (Pallone 
et al., 1990), whilst peripheral DVR branch of and give rise to the interbundle capillary 
plexus which perfuse the highly metabolically active tubular segments in the OM 
(Pallone et al., 2003b). Most DVR join the capillary plexus within the ISOM and as such 
perfusion of the IM by DVR is very limited (Figure 1.2(a)). In the IM DVR become 
dispersed with nephron segments, with few reaching the papillary tip. All DVR 
ultimately join a capillary plexus, but that of the IM is less dense than that in the ISOM, 
converging to become AVR, which run in parallel and counterflow to the DVR (Figure 
1.2(b)).  
 
Figure 1.2 Anatomy of the renal vasculature. 
(a) The renal artery divides into the arcuate arteries along the corticomedullary border; the 
border of the cortex and the outer stripe of the outer medulla (OSOM). These give rise to 
interlobular arteries that feed the glomeruli and subsequently branch into the peritubular 
capillary network. Individual afferent arterioles (AA) split into the glomerular tuft (black box), 
which then coalesce into the efferent arterioles (EA). Cortical EA (C-EA) become the cortical 
capillary plexus before ultimately re-joining with the arcuate vein. Juxtamedullary EA (J-EA) 
provide the medullary blood flow, branching into the descending vasa recta (DVR) in the 
OSOM, forming cone-shaped bundles in the inner stripe of the outer medulla (ISOM). DVR on 
the periphery of the vascular bundles branch off in the ISOM to form the interbundle capillary 
plexus which perfuse the metabolically active tubular segments in this region. Most DVR leave 
the vascular bundles in the ISOM, the remaining DVR in the centre of the bundle descend into 
the inner medulla (IM) with few reaching the papillary tip (Figure 1). These IM-DVR form a 
sparser IM-capillary plexus, which converge to become the ascending vasa recta (AVR). AVR 
drain the medulla and ascend to ultimately re-join the arcuate vein and ultimately the remaining 
renal venous architecture.  The dashed box highlights a vascular bundle (b) demonstrating a 
longitudinal view. DVR (red, solid border) have a continuous endothelium and are covered with 
NG2+ pericytes. AVR (blue, dashed border) are fenestrated, slightly larger and more abundant, 









































AVR are the draining vessels of the medulla, reabsorbing water, whilst also being a 
primary source of oxygenated blood to the tubules due to O2 shunting (Pallone et al., 
2003b). AVR are fenestrated, larger in diameter, and covered in neural-glial 2 (NG2)- 
pericytes, whereas the DVR have a narrower continuous endothelium, and encircled 
by NG2+ pericytes (Figure 1.2(b)). Once the AVR breach the IM, some join the centre 
of the vascular bundles whilst the remaining AVR do not and ascend straight to the 
OSOM. At the corticomedullary border, AVR empty deoxygenated blood into the 
arcuate veins and the remaining venous architecture to leave the kidney. The overall 
structure and regional variation of the microcirculation arising from the arcuate artery 
can be seen in Figure 1.2(a). Helping maintain renal homeostasis and effective urine 
concentration is highly dependent on the microvascular architecture and subsequent 
regional regulation of BF. 
 
1.1.3  Regional regulation of renal blood flow is needed to facilitate urine 
concentration. 
 
Even as total RBF remains constant, within the kidney there is marked regional variation in 
perfusion. Given the size and function of the cortex, the distribution of blood flow is significantly 
higher in this region; cortical nephrons comprise ~85% of nephrons (Martini et al., 2012) and 
thus the majority of the blood that enters the kidney remains within the cortical vasculature. 
Blood flow in the cortex (CBF), and thus the GFR, is regulated by TGF and the myogenic 
response (MR) (Just, 2007). The MR is a Ca2+-dependent contractile response of smooth 
muscle to the stretch induced by an increase in perfusion pressure to maintain GFR. TGF 
occurs due to reasons described above (section 1.1.1), with fluctuations in tubular [NaCl] or 
perfusion activating this mechanism.  TGF acts to increase parent glomerular capillary pressure 
and thus GFR in response to low tubular perfusion and [NaCl] via renin release from 
juxtaglomerular cells and PGE2-mediated AA dilation (Peti-Peterdi, and Harris, 2010). TGF acts 
to decrease GFR in response to increased tubular perfusion and [NaCl] via ATP release from 
the macula densa eliciting an A1 receptor dependent vasoconstriction of AA, and a reduction 
in renin release (Peti-Peterdi, and Harris, 2010). TGF is a slower mechanism than the MR 
(Mitrou, and Cupples, 2014) but both act to regulate CBF and maintain the GFR.  
The medulla receives a small percentage of RBF, equating to less than 10% of the cortical BF 
(Cowley, 2008). The medullary BF (MBF) has to satisfy the conflicting demands of preserving 
the microenvironment, whilst maintaining adequate O2 and nutrient delivery to the metabolically 
active mTAL (Sands, and Layton, 2009; Mattson, 2003). As filtrate flows through the medullary 
LoH to the CD, the exchange of NaCl, urea and water with the medullary interstitium and vasa 
recta generates a corticomedullary NaCl and urea concentration gradient; a progressive  
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Figure 1.3 A schematic illustrating counter-current multiplication and counter-current 
exchange.  
The mTAL actively reabsorbs NaCl (orange) through the apical Na-K-2Cl cotransporter. Flow 
is constant through the tubule, and the DTL reaches equilibrium with the interstitium via 
aquaporin (AQP)-1-mediated water (blue) efflux. The OMCD is impermeable to urea (green), 
whilst the IMCD express vasopressin-regulated urea transporter (UT)-A1 (dashed border) and 
UT-A3, enabling passive movement of urea out of the CD. This increases the IMCD NaCl 
concentration and thus NaCl passively diffuses from the CD into the interstitium. Water is 
reabsorbed across the CD by regionally expressed AQP-3-4, and vasopressin regulated-AQP-
2. Resultantly, the NaCl concentration of the ATL is higher, and the urea concentration is lower 
than the interstitium, urea will passively diffuse into the ATL and NaCl will be passively 
reabsorbed from the ATL. Reabsorbed NaCl keeps adding to new inflow into the DTL thus 
multiplying the concentration. DVR reach equilibrium with the interstitium via passive and AQP-
1-mediated water efflux and NaCl diffusion, with UT-B facilitated urea reabsorption in the IM. 
The solute concentration of the AVR is higher than the DVR and the interstitium and as such 
NaCl and urea are passively shunted from the AVR to the DVR or DTL (UT-A2), and water is 
collected by the AVR, effectively trapping NaCl and urea in the interstitium. Increasing 
concentration of blood (red), tubular (yellow), or interstitial fluid (light-dark blue) is indicated by 
the darkening gradient in structures. Segments are numbered according to key. Direction of 






































1 Descending vasa recta (DVR)
2 Ascending vasa recta (AVR)
3 Proximal straight tubule (PST)
4 Descending thin limb (DTL)
5 Ascending thin limb (ATL)
6 Medullary thick ascending limb (mTAL)
7 Outer medullary collecting duct (OMCD)
4 Inner medullary collecting duct (IMCD)
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increase in osmolality from the cortex to the innermost IM and papillary tip (Shaw et al., 2018), 
summarised in Figure 1.3.   
NaCl exchange of the LoH is facilitated by its hair pin arrangement, and the variable 
permeability of tubular segments. The mTAL is impermeable to water and actively reabsorbs 
NaCl via the apical Na-K-2Cl cotransporter. As the DTL is permeable to water, filtrate here 
quickly reaches osmotic equilibrium, with water drained by the AVR. As flow is continuous 
through the tubule, hyperosmotic fluid from the DTL flows into the mTAL, where again NaCl is 
actively reabsorbed, concentrating the medullary interstitium further. NaCl reabsorbed from 
mTAL is addititive to the new inflow of NaCl into the DTL thereby “multiplying” the concentration 
as this process repeats itself (Hall, 2010). 
Unlike NaCl, urea cycles between the IMCD and the IM LoH in the presence of antidiuretic 
hormone (ADH), with cortical and OM tubular segments always poorly permeable to urea. High 
concentrations of ADH upregulates expression of aquaporin (AQP)-2 water channels and the 
rapid reabsorption of water from the cortical connecting tubule, as well as the entirety 
of the CD, resulting in a concentrated tubular fluid. Urea can only diffuse out of the 
IMCD with ADH-induced expression of urea transporter (UT)-A1 and UT-A3, passing 
into the interstitium and cycles back into the IM LoH, which are always permeable to 
this solute, thus creating a corticomedullary urea concentration gradient. 
Together these processes result in a urea concentration in the interstitium that is higher 
than in the ATL and mTAL, and a NaCl concentration in the ATL and mTAL higher than 
in the interstitium, with the AVR draining away water. NaCl will then tend to diffuse out 
whilst urea will tend to diffuse into the corresponding tubular segments. If the 
permeability of the ATL and mTAL to NaCl is sufficiently high and to urea sufficiently 
low, the interstitium will be concentrated (Sands, and Layton, 2014), with counter-
current exchange between the vasa recta preserving this concentration gradient.  
The osmolality of the blood within the DVR equilibrates with that of the medullary 
interstitium; solutes diffuse passively down their concentration gradient into the blood, 
with urea transport facilitated by UTB on the IM. Some, but not all, DVR are poorly 
permeable to NaCl, so equilibrium here is reached via AQP-1-mediated water efflux in 
these DVR (Pallone et al., 2003a). The AVR, with a greater flow rate and osmolality, 
collects the water and deposits solutes into the interstitium, maintaining the osmolality 
of the blood and trapping NaCl and urea in the interstitium (Evans, and Cowley, 2015), 
whilst preserving perfusion of the IM albeit at the cost of low O2 tensions (Figure 1.3). 
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1.1.3.1 Generation of the corticomedullary concentration gradient results in a 
low medullary oxygen tension. 
Overall, the hairpin arrangements of the LoH and the vasa recta effectively trap solutes 
in the interstitium and enable the production of a concentrated urine (Figure 1.3) 
(Pallone et al., 2003a). However, this structural arrangement results in low O2 
availability in the medulla. The partial pressure of O2 (PO2) in the medulla is between 
10-20 mmHg (Brezis et al., 1991), and whilst not low for capillaries, the OM is a highly 
metabolically active region and O2 is not evenly released from the capillaries 
(Leonhardt, and Landes, 1963). O2 is shunted from the DVR to the AVR, resultantly 
delivering O2 poor blood to the medulla (Leonhardt, and Landes, 1963; Brezis, 2005). 
This O2 delivery would be influenced by changes in MBF. 
 
Figure 1.4 A schematic showing the effect Tubulo-vascular crosstalk and medullary 
blood flow on solute excretion and local oxygenation. 
Signalling molecules released from the medullary thick ascending limb(mTAL; yellow tubes) 
directly (white arrows) or by other renal cells directly (grey boxes boxes) can act at pericytes 
to either increase (↑) or decrease (↓) medullary blood flow (MBF) in response to (↓)  low or high 
(↑) oxygen tension (pO2).  High concentration adenosine 5’-triphosphate (ATP, bold) or 
superoxide (O2.-) produced by the mTAL can diffuse across to the pericytes (blue cells) on the 
descending vasa recta DVR) to cause a pericyte-mediated constriction and thereby reduce 
MBF to reabsorb more solute (Na+). Circulating angiotensin-II (Ang-II), antidiuretic hormone 
(ADH), noradrenaline (NA), and endothelin-1 (ET-1) from vascular or other renal sources can 
also constrict pericytes to reduce MBF. The increased metabolic activity of the mTAL and 
reduced MBF reduces the pO2. Hypoxia induced adenosine, or compensatory production of 
prostaglandin E2 (PGE2), nitric oxide (NO), or low concentration ATP from the mTAL can buffer 
the vasoconstrictor effects, dilate pericytes and thus increase MBF. This reduces reabsorption 
of Na+, reducing the metabolic demand of the mTAL. Bradykinin (BK), NO, and PGE2 from 
other renal sources can also increase MBF to the same effect. This in turn increases the pO2. 
This increase in pO2 can also increase Na+ reabsorption by enabling mTAL metabolically and 
thus continued communication between the pericytes on the DVR and mTAL are necessary to 
maintain pO2 and Na+ balance (Cowley, 2008; Kriz, and Kaissling, 2013; Dickhout et al., 2002; 


























ADH acts via vasopressin receptor 2 (V2) to regulate the permeability of the tubular 
segments to NaCl and urea. Interestingly, ADH CAN also influence MBF  via  V1a 
activity (Evans, and Cowley, 2015; Davenport, 2008; Nakanishi et al., 1995; Turner, 
and Pallone, 1997), but with potentially different outcomes.  ADH contracting central 
DVR would reduce IMBF, provide more time for the AVR to reach equilibrium with the 
interstitium, enhancing counter-current exchange and reabsorption of water, whilst 
increasing perfusion of peripheral DVR and therefore O2 supply to the mTAL. 
Constriction of peripheral DVR  would encourage blood flow to the IM via the central 
DVR, inducing pressure-natriuresis and NaCl excretion (Cowley, 2008). Increasing 
IMBF comes at the risk of reducing counter-current exchange interstitial solute 
washout, whereas reducing IMBF enhances counter-current exchange at the risk of 
reduced nutrient supply and waste clearance from this IM (Sands, and Layton, 2014). 
Interestingly, a regional difference of ADH activity has been noted; ADH, reduces IMBF 
to a greater extent that OMBF or CBF (Neuhofer, and Beck, 2005; Nakanishi et al., 
1995), suggesting ADH preferentially constricts central DVR to increase the 
reabsorption of water. 
Preservation of the corticomedullary gradient, whilst meeting the metabolic needs of 
the parenchyma, demonstrates importance of regionally regulated BF in the kidney. 
As stated in section 1.1.1, nephrons are not perfused by their parent glomerulus-
derived capillaries (Chou et al., 1990); thus if regulation of MBF was controlled by the 
AA, nephrons and the surrounding microenvironment are at risk of a metabolism-
perfusion mismatch. Summarily,  it is the DVR that provide BF to the medulla (Figure 
1.2) and therefore within the DVR potential exists to regulate MBF (Evans, and Cowley, 
2015), and such control must exist outside of upstream autoregulatory mechanisms. 
The evidence would suggest that MBF is autoregulated by tubule-vascular feedback 
between mTAL and pericytes on the DVR (Figure 1.4).  
 
1.1.3.2 Autoregulation of MBF. 
 
Mechanisms behind the autoregulation of CBF are well characterised (Section 1.1.3), 
yet autoregulatory mechanisms for MBF remain controversial despite data illustrating 
this process (Kennedy-Lydon et al., 2013). A recent study, using an in vivo Microfil 
technique to visualise the renal vascular architecture demonstrated angiotensin-II 
(Ang-II) differentially effects cortical and medullary BF, with preferential reduction of 
IMBF (Fan et al., 2019). Much like the data for ADH (Evans, and Cowley, 2015), this 
illustrates autoregulation at the level of the OM DVR. As there are no arteries present 
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in the medulla, all BF is provided by the extensive capillary network. In place of 
vascular smooth muscle, capillaries are enwrapped by spatially separated contractile 
pericytes (Shaw et al., 2018; Peppiatt-Wildman, 2013). Evidence in the rodent brain 
(Hall et al., 2014; Peppiatt et al., 2006), retina (Peppiatt et al., 2006), lungs (Kerkar et 
al., 2006; Speyer et al., 1999), kidneys (Silldorff et al., 1995; Crawford et al., 2012; 
Crawford et al., 2011; Zhang et al., 2005; Cowley Jr, and O’connor, 2013) and murine 
pancreas (Almaça et al., 2018) demonstrate regulation of  the microcirculation by 
pericytes. 
Human and rodent kidney sections show contractile filaments α-smooth muscle actin 
(α-SMA) and desmin localised around the vascular bundles (Colvin, 2019; Wei et al., 
2015; Park et al., 1997a). From the late 1980’s studies have demonstrated that 
endogenously synthesised vasoactive substances and their corresponding receptors 
converge around the medullary vasculature, modulating medullary blood flow and 
therefore O2 supply (Neuhofer, and Beck, 2005; Pallone, and Silldorff, 2001; Cowley 
et al., 1995; Brezis et al., 1991), with key agonists and receptors summarised in Table 
1.1. These agents also act specifically at contractile DVR pericytes with no 
downstream arteriolar signalling  feasible due to vivisection (Silldorff et al., 1995; 
Zhang et al., 2004; Zhang et al., 2005; Sendeski et al., 2013; Crawford et al., 2012; 
Crawford et al., 2011; Cowley Jr, and O’connor, 2013) 
Not only are renal pericytes contractile, but data supports their role in autoregulation 
via communications with the other cell types present. In DVR that have been isolated 
with the adjacent mTAL segment, the tubular epithelium buffers Ang-II-evoked 
pericyte-mediated vasoconstriction via NO-crosstalk (Cowley Jr, and O’connor, 2013). 
Further still Crawford et al, have shown that manipulation of live kidney slices with 
exogenous manipulators of endogenous BF exert their vasoactivity specifically via 
pericytes, further demonstrating communications between renal parenchyma and 
pericytes (Crawford et al., 2011; Crawford et al., 2012). The activity of specific agonists 




Table 1.1 Vasoactive agonists that evoke a pericyte-mediated change in DVR diameter. 
Agonist Source of agonist Receptor location References 
Adenosine mTAL 
A1: DVR, LoH and CD. 
A2a: CD. 
A2b: LoH 
(Billet et al., 2007; Pallone et 
al., 1998b; Crawford et al., 
2011) 
Ang-II EdC 
AT1: OMDVR, interstitial 
cells and CD (constrict) 
AT2: renal arteries (dilate) 
(Weinstein, 2013; Crawford et 
al., 2012; Zhang et al., 2004; 
Ruan et al., 1999; Sasamura et 
al., 1994) 
ADH hypothalamus 
V1a: vSM, glomerulus, 
pericytes, medullary 
vasculature, ATL and 
OMCD 
V2: CD 
(Davenport, 2008; Cowley, 
2008; Nakanishi et al., 1995; 
Turner, and Pallone, 1997) 
 
ATP mTAL, CD, EdC, RBCs P2: DVR, LoH and CD 
(Crawford et al., 2011; Menzies 
et al., 2015; Crawford et al., 
2013; Shirley et al., 2013) 
 
Bradykinin CD, Interstitial fluid 
B2R: vSM, EdC, CT, CCD, 
pericytes 
(Rhinehart et al., 2002; Ma et 
al., 1994; Staruschenko, 2012; 
Pallone et al., 1998a) 
ET-1 EdC and CD 
ET-1a: EdC, OM vasa recta 
ET-1b: EA 
 (Crawford et al., 2012; Silldorff 
et al., 1995; Schildroth et al., 
2011) 
 
NA sympathetic nerves α1: OM vasa recta 
(Crawford et al., 2012; 
Crawford et al., 2013) 
NO PST, mTAL, CD, MΦ (medulla) 
diffuses through biological 
membranes 
(Mohaupt et al., 1994; 
Crawford et al., 2012; Dickhout 
et al., 2002; Cowley Jr, and 
O’connor, 2013) 
 
PGE2 mTAL, CD, ISC, MΦ 
EP2: PST and OM vasa 
recta, IM. 
EP3: OM>IM 
EP4: CD, OM vasa recta 
(Hume, and Gordon, 1983; 
Meurer et al., 2018; Silldorff et 
al., 1995; Crawford et al., 
2012) 
 
Ang-II; Angiotensin II, ADH; Antidiuretic Hormone, ATL; Ascending Thin Limb,  
ATP: Adenosine-5’-triphosphate, CD; Collecting Duct, CCD; Cortical Collecting Duct, CT; 
Connecting Tubule, DVR; Descending Vasa Recta, EA; Efferent Arteriole, EdC; Endothelial 
cells, ET-1; Endothelin-1, ISC; Interstitial Cells. LoH; Loop of Henle, MΦ; Macrophage, 
mTAL; Medullary Thick Ascending Limb, NA; noradrenaline, NO; nitric oxide, OMCD; Outer 
Medullary Collecting Duct, OM; Outer Medulla, PGE2; prostaglandin E2, PST; Proximal 





Pericytes embody a multifunctional population of perivascular cells present in every 
capillary bed in the body (Harrell et al., 2018). These are spatially separated cells, 
embedded in the basement membrane on the abluminal side of the endothelium (Díaz-
Flores et al., 2009) that are notable for their characteristic “bump-on-a-log” cellular 
morphology (Attwell et al., 2016), with numerous claw-like processes that are 
circumferential around and longitudinal along the capillary wall (Bergers, and Song, 
2005). Pericytes are primarily defined by this proximity to endothelial cells (EdC), their 
characteristic morphology, their cell-surface molecule expression, and their 
functionality  (Shaw et al., 2018).   
 
Figure 1.5 Known markers for renal pericyte identification. 
Pericytes are a known heterogeneic cell-type and as such multiple markers, although no pan-
specific marker, has been found, pericytes in the kidney are identified by expression of cell-
surface protein expression such as platelet-derived growth factor receptor β (PDGFRβ): a 
widely used marker, receptor with tyrosin kinase activity, involved in pericytes proliferation, 
recruitment investment, and maturation of the vasculature ; neural-glial antigen-2 (NG2): 
membrane chondroitin sulfate proteoglycan, another commonly used pericyte marker, NG2 is 
involved in pericyte recruitment to tumour vasculature as well as angiogenesis; α-smooth 
muscle actin (α-SMA) and desmin: structural proteins providing the contractile machinery and 
thereby enabling regulation of vessel diameter; CD248: a Type I transmembrane protein 
important for PDGFR-β-mediated signalling and is upregulated in disease; Gli1: zinc finger 
protein, involved in pericyte-mediated modulation of fibrosis and vital for maintenance of the 
peritubular capillary; and RSG-5: a GTPase- activating protein, expressed on activated 
angiogenic pericytes (Harrell et al., 2018; Smith et al., 2012; Am et al., 2013). 
 
Organs with high metabolic needs and need for tightly regulated BF have higher 
pericyte densities; in the retina the ratio of EdC:pericytes is approximately 1:1, whereas 
in skeletal muscle it is much closer to 100:1 (Armulik et al., 2011; Smith et al., 2012), 







constituting 30% of the renal tissue population (Ferland-McCollough et al., 2016). 
There is a correspondingly high EdC: pericyte ratio of approximately 2.5:1, with neural-
glial-2 (NG2)+ pericytes covering  62 ± 23% of the renal vasculature (Smith et al., 
2015). However, difficulties arise in identifying pericytes as their morphology and 
receptor expression patterns vary significantly along the capillary bed, expression 
patterns which identify functionally differing sub-populations. A summary of identifying-
markers used for renal pericytes are summarised in Figure 1.5. Further discussion of 
the most commonly used markers platelet derived growth factor receptor-β (PDGFR-
β), the proteoglycan NG2, and α-SMA (Attwell et al., 2016; Shaw et al., 2018; Am et 
al., 2013; Smith et al., 2012) is presented below in Section 1.2.1.1 
 
1.2.1  Pericytes are a highly heterogenous population of cell. 
 
Pericytes are a heterogenous class of cell, yet across tissues there are conserved 
functions. Primarily pericytes; regulate blood flow, provide and maintain the structural 
support and integrity of the endothelium (Lemos et al., 2016), are involved in 
angiogenic processes (Stapor et al., 2014; Betsholtz et al., 2005; Bergers, and Song, 
2005; Díaz-Flores et al., 2009), and have an emerging role in inflammation. Specific 
examples of immune-pathogenic roles of pericytes are discussed further below in 
section 1.3. Further to this, pathogenically pericytes contribute to fibrosis in multiple 
organs (Birbrair et al., 2014) including: the liver (Iwaisako et al., 2014); cardiac and 
skeletal muscle (Murray et al., 2017); and in the kidney (Rojas et al., 2012; Kramann 
et al., 2017); as well as directly contributing to localised ischaemia and vessel 
rarefaction (Hall et al., 2014; Kramann et al., 2017), and tumorogenesis  (Huang et al., 
2011; You et al., 2014; Lu, and Shenoy, 2017). However, as described above (Section 
1.2) there is inherent difficulty in determining behaviours that are pericyte-mediated. 
Pericytes do not have an entirely specific identifying-marker, and not all markers are 
useful as receptor expression is dynamic and there is regional variation in protein 
expression dependent where upon the vascular tree they reside (Murfee et al., 2005) 
and developmental or pathologic states (Armulik et al., 2011).  That considered, the 
best described cell-surface proteins for the identification of pericytes are PDGFR-β, 
NG2, and α-SMA (Attwell et al., 2016; Shaw et al., 2018; Am et al., 2013; Smith et al., 
2012). These, and other known renal-pericyte identifying cell surface proteins are 
shown in Figure 1.5. Further discussion of pericyte distribution and morphology will 




1.2.1.1 NG2 and PDGFR-β expression varies along the capillary network. 
 
PDGFR-β appears to be the broadest pericyte-identifying marker (Winkler et al., 2010; 
Dore-duffy, and Esen, 2018; Crisan et al., 2008), whilst non-specific, (Bergers, and 
Song, 2005; Díaz-Flores et al., 2009), identifying macrophage (Inaba et al., 1993; de 
Parseval et al., 1993), T-cells (Daynes et al., 1991), and NK-cells (Gersuk et al., 1991). 
All NG2+ pericytes are considered to co-express PDGFR-β (Dore-duffy, and Esen, 
2018; Crisan et al., 2008; Castellano et al., 2018), in pericytes cultured from the CNS 
a minimum of 97% of pericytes express PDGFRβ, while 50–80% express the 
proteoglycan NG2. In the lung all pericytes were PDGFR-β+, and 60% of them 
expressed NG2 (Barron et al., 2016). A similar finding has been observed in human 
tissue; in the umbilical cord, all pericytes expressed PDGFR-β, but varied in NG2 and 
α-SMA expression depending on location along the vascular tree (Montemurro et al., 
2011).  This appears consistent with other tissues.  α-SMA expression is restricted to 
the pre/post-capillary pericytes vs “true” mid-capillary pericytes (Nehls, and 
Drenckhahn, 1991). NG2 expression distinguishes three subsets of human pericytes, 
associated with: capillaries (NG2+/α-SMA-), venules (NG2-/α-SMA+) and arterioles 
(NG2+/α-SMA+) (Crisan et al., 2012) (Figure 1.6). This pattern of expression has been 
observed in the rodent ureteric microvascular network (Burdyga, and Borysova, 2014), 
the murine CNS (Grant et al., 2017; Hartmann et al., 2015), and the rodent mesentery 
(Murfee et al., 2005). 
 
 
Figure 1.6 Schematic showing the diversity of pericytes around the microvasculature 
network of the renal medulla. 
Differences presented here are both morphological and in expression of proteins α-SMA, 
PDGFR-β, and NG2. Only the red cells between the arteriolar capillary and venular capillary 




Unlike the use of PDGFR-β to identify renal pericytes, the use of NG2 in adult tissues 
has been contested. Reportedly only 3% of mature pericytes express NG2 in the 
healthy adult rodent renal cortex (Lin et al., 2008; Rojas et al., 2012), yet adult murine 
kidneys show NG2+ pericytes with a marked regional distribution, with an 
approximately 6-fold difference in presence between the cortex and the medulla 
(Stefanska et al., 2015).  Crawford et al reported a density of 12.4±1.2 NG2+ pericytes 
per 100 μm2 in the adult rodent OM (Crawford et al., 2012) and as such it is possible 
a focus in the renal cortex where NG2+ pericytes are demonstrably less populated is a 
confounding factor with the low percentages reported.  
Expression of α-SMA by pericytes is also debated, yet a recent paper has suggested 
this contractile protein is influenced by fixation method used in the tissue (Alarcon-
Martinez et al., 2018). Medullary pericytes of chickens have shown to express 
contractile proteins desmin and vimentin (Fuxe et al., 2011; Fujimoto, and Singer, 
1987), with rodent, chicken, and murine medullary pericytes expressing α-SMA (Park 
et al., 1997a; Stefanska et al., 2015). Interestingly, in the murine renal medulla 
NG2+/PDGFR-β+ pericytes express α-SMA (Stefanska et al., 2015) whereas PDGFR-
β+/NG2- pericytes show minimal expression of this contractile protein (Wang et al., 
2017). This suggests renal NG2- pericytes are  α-SMA-, unlike other tissues such as 
the murine cremaster muscle where venular capillary pericytes are NG2-/α-SMA+ 
(Proebstl et al., 2012). Figure 1.6 illustrates the cell-surface molecule diversity of 
pericytes of the renal microvascular network in light of this finding. Why this difference 
exists in the kidney remains unclear, but possibly pertains to the unique architecture 
of the vasa recta and the counterflow arrangement (Pallone et al., 1998b). Overall, the 
arteriolar-restriction of NG2 expression appears to be a conserved feature of pericytes 
across different tissues and species (Díaz-Flores et al., 2009; Kumar et al., 2017; 
Burdyga, and Borysova, 2014; Murfee et al., 2005; Crisan et al., 2008; Fuxe et al., 
2011), and taken together suggests the pericyte subpopulation which regulate MBF 
are likely PDGFR-β+/NG2+/α-SMA+ encircling the DVR, with PDGFR-β+/NG2-/α-SMA-  
pericytes reside on the AVR, and potentially offers a means of discrimination between 
pericyte subtypes.  
 
1.2.1.2 Pericyte morphology correlates with NG2 and PDGFR-β expression. 
 
Zimmerman was the first to describe pericyte variation according to their location along 
blood vessels as: arteriolar, true-capillary, and venular (Zimmermann, 1923). Along 
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with regional expression of cell-surface molecules discussed above, there also 
appears to be a heterogeneity in morphology along the vascular tree (Figure 1.6) 
(Zimmermann, 1923). Arteriolar pericytes that are NG2+/α-SMA+ have thick cell bodies 
with circular branches that overlap or attach to each other, forming a complicated and 
dense meshwork over the arteriolar capillary. True-capillary pericytes are NG2+/α-
SMA- with highly elongated longitudinal processes and soma, with short 
circumferential processes. Arteriolar contractile pericytes also appear to have a 
smaller soma morphology (Kutcher et al., 2007; Kolyada et al., 2003), with true-
capillary α-SMA- pericytes (soma and processes) 3-4x larger than arteriolar pericytes 
(Borysova et al., 2013). Venular pericytes cover the abluminal surface of 
postcapillaries and are PDGFR-β+/NG2- and stellate shaped (Díaz-Flores et al., 2009; 
Kumar et al., 2017; Burdyga, and Borysova, 2014; Murfee et al., 2005; Crisan et al., 
2008; Fuxe et al., 2011).  
Comparative to the vSMC of arterioles that also express NG2 and PDGFR-β  
(Stefanska et al., 2016), it is the pericytes characteristic morphology that enables their 
identification. Unfortunately, specific measurements of pericyte soma size, despite 
visual morphological differences, are not readily reported. If the contractile population 
of pericytes that consistently express NG2 are determined to have a smaller cellular 
morphology consistently, these characteristics together may enable accurate 
identification of the sub-population of pericytes which reside on the DVR and regulate 
MBF, and consequently any other alternative functions of these NG2+ pericytes. 
 
1.2.1.1.1 NG2 and PDGFR-β are more suitable identifying markers than others.  
 
Pericyte expressed NG2 proteoglycan is involved recruitment of pericytes pericyte-
EdC network formation and mediates communications between them to maintain 
vascular stability (You et al., 2014). As an identifying molecule, NG2 readily identifies 
medullary pericytes in both rat,  mouse, and porcine kidneys (Crawford et al., 2012; 
Stefanska et al., 2015; Castellano et al., 2018). During angiogenesis, sprouting 
endothelial cells express PDGF-B and recruit pericytes via PDGF-B/PDGFR-β  
signalling (Trost et al., 2016) thus pericyte PDGFR-β expression is necessary for the 
investment of pericytes into the endothelial tube to finish angiogenesis and provide 
structural support (Bergers, and Song, 2005). PDGFR-β is expressed by all pericytes 
and has extensively been used for pericyte identification (Section 1.2.1.1). 
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Use of the other proteins presented in Figure 1.5 for identifying renal pericytes belie 
specific functions and distinguish further subpopulations. Regulator of G protein 
signalling protein 5 (RSG-5)-expression is restricted to pericytes and vSMC (Adams et 
al., 2000) and co-labelling with PDGFR-β (Cho et al., 2003; Berger et al., 2005). It is 
an indicator of actively angiogenic renal pericytes for both embryonic vascularisation 
(Cho et al., 2003) and pathological angiogenesis associated with renal cell carcinoma 
(Berger et al., 2005). However, RGS-5 is not expressed in healthy adult renal tissue 
unlike NG2 and PDGFR-β (Stefanska et al., 2015) and as such unlikely to broadly 
identify pericytes. 
Zinc finger protein “Gli1” expression represents a sub-population of PDGFR-β+ 
pericytes (Grgic et al., 2014), and fate tracing  showed their loss induces capillary 
rarefaction and PST injury (Kramann et al., 2017). Gli1 contributes to capillary stability 
and Gli1+ pericytes seemingly contribute to the pathogenesis of fibrosis. Much like 
NG2+ pericytes, Gli1+ pericytes are most abundant in the renal OM (Kramann et al., 
2017). Given the density of pericytes in the OM it would be interesting to further probe 
the expression pattern of renal Gli1+ pericytes, yet Gli1+ pericytes in the lung do not 
co-express NG2 despite over 60% of lung pericytes expressing NG2 (Barron et al., 
2016), and only identifies a very small population of PDGFR-β+ pericytes (Kramann et 
al., 2015) . Further work is needed to characterise Gli1+ pericytes prior to its use in 
identifying pericyte multifunctionality. 
CD248 is expressed by the mesangium and renal pericytes. When assessing the 
degree of co-expression, it was found some, but not all, of cellular CD248 expression 
correlated with PDGFR-β, NG2, and α-SMA expression. The authors concluded 
CD248 identifies a subset of pericytes not commonly identified by the above markers 
based upon the location and morphology (Smith et al., 2015). Functionally, CD248 
appears to modulate fibrosis by enhancing PDGF-signalling. In CD248-/- mice there 
was reduced fibrotic scarring, and reduced numbers of α-SMA+ and NG2+ pericytes 
comparative to wild type controls after unilateral ureteral obstruction. Unlike NG2 and 
PDGFR-β (Tanaka et al., 2017; Proebstl et al., 2012; Alon, and Nourshargh, 2013), 
CD248+ pericytes do not appear to influence the inflammatory response as no 
difference in CD45, CD3, or F4/80 staining was observed (Smith et al., 2015), whilst 
NG2+ and PDGFR-β+ pericytes appear extensively involved in inflammation, discussed 
in greater detail below in section 1.4.1. 
What can be seen here is that these less common pericyte identifying-markers, whilst 
useful for specific subtypes or activation states, are unlikely to identify most pericytes. 
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Comparatively, NG2 and PDGFR-β are more reliably expressed and are regularly used 
to identify renal pericytes. 
 
1.2.2 Novel pericyte-mediated activities can be organ specific, yet there remain 
conserved behaviours across tissues. 
 
It is known that pericytes have organ-specific functions. In skeletal muscle, type-2 
nestin+/NG2+ pericytes contribute to muscle formation and regeneration (Birbrair et al., 
2015), and in both the skin and skeletal muscle,”type-1” nestin-/NG2+ pericytes 
contribute to fat accumulation (Birbrair et al., 2015). In the liver, pericytes store 80% 
of the body’s total vitamin A (Sato et al., 2003). In a mouse model of skin-regeneration, 
NG2+/PDGFR-β+ pericytes promote epithelial proliferation, differentiation, and tissue 
regeneration without any angiogenic behaviours, by modifying the surrounding ECM, 
demonstrating a role for co-ordinating wound healing (Paquet-Fifield et al., 2009). α-
SMA+/NG2+/PDGFR-β+ pericytes are involved in adipogenesis during murine 
development (Tang et al., 2008), and in the rodent inguinal fat pad in response to 
thermal lesion (Richardson et al., 1982). This is also true for the kidney; PDGFR-β+ 
pericytes contribute to the production of erythropoietin (Shih et al., 2018), and human 
NG2+ foetal renal pericytes produce renin (Stefanska et al., 2016). Summarily, duties 
enacted by different organs are often conducted, in part, by pericytes. Yet the 
expression of cell-surface proteins PDGFR-β and NG2 remain consistent suggesting 
it is the organs the pericytes reside which influences some behaviours, whilst other 
features remain conserved. 
This describes organ-specific behaviours of pericytes, yet pericytes do exhibit 
conserved behaviours. Along with regulation of BF (section 1.2.1.2.1), pericytes also 
seemingly possess conserved progenitor properties. Vascular cells have a slow 
turnover, and secondary colonies of single-sorted CD34+/CD31- pericytes conserve a 
mesenchymal phenotype in vitro (Campagnolo et al., 2010). NG2+/PDGFR-β+/CD146+ 
human pericytes isolated from various tissues including the placenta, skeletal muscle, 
pancreas, retina, and adipose tissue, show multipotency in vivo (Crisan et al., 2009). 
Adult pericytes are reportedly able to differentiate into ECs, vSMC, neural cells, and 
Macrophages (MΦ) (Orekhov et al., 2014; Dore-duffy, and Esen, 2018; Díaz-Flores et 
al., 2009). A summary of the multipotency of pericytes can be seen in Figure 1.7, but 
further comment is beyond the scope of this study. 
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What is to be taken away is that receptor expression, the varied morphology of 
pericytes, and the tissues in which they reside together can indicate what the 
functionality of the particular subpopulations of pericytes (Attwell et al., 2016), yet in 
all tissues pericytes multifunctionality appears consistently, primarily when identifying 
pericytes with NG2 and PDGFR-β. 
 
Figure 1.7 A schematic illustrating cell type pericytes reportedly differentiate into.  
Cell types and the key identifying cell-surface markers used to determine the multipotency of 
pericytes have been highlighted. MΦ = macrophage. (Orekhov et al., 2014) 
 
1.2.3 Inconsistent experimental methods in identifying pericytes may confound 
findings. 
 
One of the most extensively investigated, and controversial, multipotent behaviours of 
pericytes is that they are considered a source of myofibroblasts. Data has shown 
communications between the endothelium and PDGFR-β+ pericytes encourages 
fibrosis; inhibiting PDGF-signalling and vascular endothelial growth factor (VEGF)-
signalling attenuates fibrosis and vessel rarefaction (Lin et al., 2011). How pericytes 
are involved does seem to vary. Birbriar et al, found nestin- pericytes contribute to 
collagen production in fibrosis (Birbrair et al., 2014) whilst NG2+ pericyte contribution 


















around the fibrotic area (Birbrair et al., 2014; Dulauroy et al., 2012; Soderblom et al., 
2013) These studies suggest two potential mechanisms by which pericytes may 
contribute to fibrosis: by directly producing collagen  (Grgic et al., 2014), or by first 
differentiating into α-SMA+ myofibroblasts that are responsible for the expansion of 
fibrotic tissue via the production of collagen  (Kisseleva, and Brenner, 2008). What 
these studies show is subtype-dependent involvement of pericytes in fibrosis. 
Consistent use of well characterised pericyte-identifying markers here has been key 
for elucidating their fibrotic involvement. 
This is highlighted by a recent study, which suggested pericytes do not contribute to 
fibrosis.  However, the marker used for tracing pericytes and their subsequent fibrotic 
involvement, Tbx18 (Guimarães-Camboa et al., 2017) was not the most suitable 
choice. Whilst Tbx18 co-labels with PDGFR-β+ perivascular cells in the heart, brain, 
skeletal muscle, and adipose tissue it does not label any pericytes in the liver, 
intestines, or the kidney (Campagnolo et al., 2018). Given the high pericyte density of 
the kidney (Crawford et al., 2012; Lin et al., 2008), the fact Tbx18 does not identify 
pericytes in this organ would suggest Tbx18 is not a pan-pericyte marker. consistent 
use of pericyte-identification necessary and accumulating evidence points at pericytes 
as a source of myofibroblast progenitors (Lin et al., 2011; Grgic et al., 2014; Kisseleva, 
and Brenner, 2008; Birbrair et al., 2014; Dulauroy et al., 2012; Soderblom et al., 2013; 
Iwaisako et al., 2014). With respect to renal pericytes, another key consideration is 
their regional distribution in the kidney. 
 
1.2.3.1 There is a highly varied regional distribution of renal pericytes. 
 
Renal pericytes are present throughout the microvasculature of the kidney with the 
greatest density in the OM (Figure 1.8). As described above (Section 1.2.1) the cell-
surface protein expression pattern varies along the vascular bed. However, a focus in 
the cortex may not best represent the activities of all renal pericytes. 
In a unilateral ureteric obstruction (UUO) injury model LeBleu et al, found 5% of renal 
myofibroblasts were sourced via the epithelial-mesenchymal transition, 10% came 
from EdC-mesenchymal transition, and 50% came from residential fibroblasts (LeBleu 
et al., 2013), with an accumulation but no active involvement of PDGFR-β+ or NG2+ 
pericytes in the cortex. However, another lab using a different method to induce UUO 
(Duffield et al., 2005), coll1a1 expressing  PDGFR-β+/ α-SMA+ cortical pericytes are 
the primary source of fibrosis in the renal cortex (Lin et al., 2008).  Whilst the different 
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methods to induce renal injury might influence cell types responsible for fibrosis, as 
observed in the liver (Iwaisako et al., 2014), the limited pericyte involvement measured 
above may have also resulted from a focus in the renal cortex. 
 
Figure 1.8 Renal NG2+/PDGFR-β+ pericyte distribution in the cortex and outer medulla 
of healthy young adult mice. 
Young adult C57BL/6J kidney slices were triple stained with NG2 (blue), PDGFR-β (green), 
and CD31 (red) to identify pericytes and the endothelium. (A-B) Double positive cells that are 
indicated with white arrows are pericytes, whilst double-positive cells that are highlighted only 
with a hatched box in (A) are afferent arteriolar vascular smooth muscle cells. Cells indicated 
with an arrow and box show the pericyte soma. Pericytes in the outer medulla were far more 
numerous than in the cortex. (C) the white arrow highlights a glomerular tuft, with hatched box 
regions highlighting pericytes. These pericytes are shown in higher power images (a-c), 
showing pericytes supporting peritubular capillaries. (D) in the outer medulla, vasa recta can 




 pericytes. (g-i) show high power images of 
hatched boxed in (D). (C-D) also show pericytes are more numerous in the outer medulla than 
the cortex. Arrow heads highlight pericyte soma. PDGFR-β
+ 
staining is more abundant than 
NG2
+ 
staining. Scale bars are 200 μM. Data taken from (Stefanska et al., 2015). 
 
When the renal medulla has been investigated, fibrotic scarring is most abundant at 
the corticomedullary junction and around the vascular bundles in the ISOM (Strupler 
et al., 2008; Shaw et al., 2018). Further still, studies that include the medulla in 






















involvement in the progression of fibrosis. Fate tracing in vivo that renal pericytes 
(FoxD1+/ PDGFR-β+/ CD73+) demonstrated differentiation into myofibroblasts 
(Humphreys et al., 2010) and found collagen producing col1α1-eGFP-L10a+ pericytes 
actually have the highest density in the OM (Grgic et al., 2014). Using flow cytometry 
with digestion of the whole kidney, another lab who used both UUO and a folic acid-
induced kidney injury model found that PDGFR-β+ pericytes secrete complement and 
contribute to the progression of fibrosis via upregulation of α-SMA, fibronectin, and 
col1α1 in both disease models  (Xavier et al., 2017) although potential difference 
between models are not discussed. Consistency in the identification of pericytes and 
their microanatomical location are clearly important considerations in elucidating 
conserved pericyte-mediated activities. 
 
1.3 A novel emerging conserved behaviour of NG2+ and PDGFR-β+ pericytes 
involves coordination and involvement in the immune response. 
  
The lack of a specific pan-pericyte marker makes investigations into the multifunctional 
nature of pericytes difficult and makes data analysis complicated. From the literature 
PDGFR-β and NG2 are optimal for use in identifying pericytes, although expression of 
these proteins is influenced by different factors (Morita et al., 2014). A more complete 
profile of pericytes might aid in their identification, such as objective metrics like soma 
size, as discussed above (Section 1.2.1.2). However, it is also important to determine 
whether it is pericytes responsible as opposed to a pericyte-derived cell type. Much of 
the data relating to the multifunctionality of pericytes derives from tissue culture 
(section 1.3.3) , which do not belie the complexity of the functions or distribution of 
cells in vivo  (Vickers, and Fisher, 2005; Bach et al., 1996). Further still,  ex vivo or in 
vitro analysis of extracted cell suspensions can oversimplify both MΦ and pericyte 
populations (Gordon, and Plüddemann, 2017), with a varied morphology and stark 
microheterogeneity, and therefore not wholly reflect the cellular distribution (Gordon et 
al., 2014) or functionality (Stapor et al., 2014) in situ or in vivo.  Cultured cells can 
dedifferentiate and lose functionality leading to variation in data generated 
comparative to in vivo observations (Elberg et al., 2008)). In vitro work also does not 
offer the advantage of maintaining cell-cell interactions and the complex structural 
integrity that better mimic in vivo behaviours, whilst tissues slices, like the rodent 
kidney slice model (Crawford et al., 2012), maintain these communications. 
Studies in the kidney in vivo have shown that both pericytes and immune cells 
contribute to tubulointerstitial fibrosis, and are heavily implicated in its progression 
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(Xavier et al., 2017; Kurts et al., 2013). Inflammation is a key feature in the 
pathogenesis of renal disease, regardless of whether the insult is primarily induced by 
the immune response, the innate immune system is involved in injury (Weisheit et al., 
2015). However, with recent evidence suggesting that an emerging conserved 
pericyte-mediated activity is co-ordination of the immune response and may 
themselves act as immune cells, with the overlap of protein expression between 
pericytes and immune cells shown in Figure 1.7, the question becomes which cell 
populations are actually responsible for propagating and directing the innate immune 
response. 
 
1.3.1 Pericytes as coordinators of immune function. 
 
As potential mediators of inflammation, not only do pericytes occupy an optimal 
physical location between the interstitium and the blood stream residing along the 
capillary wall (Stark et al., 2018; Lapenna et al., 2018; Navarro et al., 2016), there is 
evidence demonstrating pericyte presence is necessary for inflammation. Pericytes of 
the kidney (PDGFR-β+) and in tumour models (NG2+) can directly recruit inflammatory 
MΦ via VEGFR2 and PDGF-β signalling, and cytokines IL-33, macrophage migration-
inhibitory factor (MIF) and CCL2 (Lin et al., 2011; Yang et al., 2016). It is NG2+ 
pericytes on arteriolar capillaries of the cremaster muscle and ear that express and 
store the chemoattractant MIF to recruit polymorphonuclear leukocytes (PMN; Ly6G+) 
and mediate PMN transmigration and activity post extravasation via ICAM-1, MAC-1 
and LFA-1 (Stark et al., 2012; Proebstl et al., 2012) interactions with the NG2 
proteoglycan (Alon, and Nourshargh, 2013). 
However, PMN migrate out into the interstitium via NG2- pericytes on the venular 
capillaries. This venular extravasation was observed with microspheres in the murine 
trachea, where they only extravasate out via venular specific PECAM-1,  with no 
capillary involvement (Fuxe et al., 2011), and has been experimentally demonstrated 
in vivo (Proebstl et al., 2012; Wang et al., 2012). PMN migrate out through the low 
expression regions where there are reduced matrix proteins α-SMA and Collagen IV, 
with direct contact between PMN and pericytes causing a α-SMA+/NG2-  pericyte-
mediated relaxation (Wang et al., 2012), creating sites for further PMN to extravasate 
(Proebstl et al., 2012). Some of  these extravasated PMN are then further “instructed” 
by arteriolar NG2+ pericytes to migrate towards the inflammatory stimulus via ICAM-1, 
MAC-1 and LFA-1 (Alon, and Nourshargh, 2013) (Figure 1.9).  This data suggests 
subpopulations of pericytes co-ordinate differing stages of immune cell infiltration; with 
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arteriolar NG2+ pericytes necessary for recruitment, whilst venular NG2- pericyte 
involvement in PMN extravasation. However, data shows perivascular MΦ (PVM) are 
also involved in this process (discussed in section 1.3.3.1). 
 
Figure 1.9 NG2-dependent extravasation of polymorphonuclear leukocytes (PMN). 
Pericyte cell surface protein expression varies dependent upon where along the capillary 
network they reside.  Along the arteriolar capillary, NG2+/PDGFR-β+ pericytes (blue) attract 
circulating Ly6G+ PMN via MIF, IL-33, IL-6, and CCL2 (grey arrow). These PMN travel along 
the capillary network and extravasate via venular capillary NG2-/PDGFR-β+ pericytes 
(turquoise). Direct cell-cell contact between PMN and NG2-/PDGFR-β+ encourages these 
pericytes to dilate, express PECAM-1 (dark green bars), and thereby enable PMN to 
extravasate out of low expression regions where there are reduced matrix proteins (shown as 
less pericyte coverage).  After migrating into the interstitial space and crawling on NG2-
/PDGFR-β+ pericytes, some PMN migrate directly to the inflammatory foci (dashed arrow) 
whilst a fraction of PMN are attracted by NG2+/PDGFR-β+ pericytes. Secretion of MIF, ICAM-
1, MAC-1 and LFA-1 by these pericytes (yellow bars) render the recruited leukocytes highly 
sensitized (light green bars) and “instruct” these PMN, which then have the capacity for highly 
directional migration through the interstitial space toward the inflammatory foci. DAMP, 
damage-associated molecular pattern. (Alon, and Nourshargh, 2013). 
 
1.3.2 Angiogenesis and vessel stability require macrophages and pericytes. 
 
Angiogenesis is a well characterised pericyte-mediated activity (Stapor et al., 2014). 
EdC from pre-existing vessels secrete proteases like matrix metalloproteinases-9 
(MMP-9) to degrade basement membrane and invade the surrounding extracellular 












proleratory and migratory cells that assemble into a simple capillary network , guided 
by tip EdC (Bergers, and Song, 2005) and pericytes (Kang et al., 2019; Nicosia, 2009). 
As the new capillary sprout is formed, the EdC adhere to one another and cease 
proliferating. EdC secrete PDGF-BB to recruit PDGFR-β+ pericytes to stabilise this new 
endothelial tube (Tanaka, and Nangaku, 2013).  This pericyte-EdC contact is required 
for tissue inhibitor of matrix metalloproteinases-3 (TIMP-3)-mediated stabilisation of 
new vessels, dependent on pericyte-expressed NG2 (Hesp et al., 2017; Cuervo et al., 
2017; You et al., 2014).  TIMP-3 inhibits pro-angiogenic molecules MMP-9, MMP-2, 
and VEGF-A activity at the VEGF receptor-2 (Saunders et al., 2006), inducing matrix-
bridging protein production to stabilise the newly formed basement membrane 
(Stratman et al., 2009), arresting EdC growth (Durham et al., 2014).  Investment of 
pericytes resolves angiogenesis, achieving EdC quiescence and maturation of the 
vessel in a GTPase-dependent manner (Kutcher et al., 2007). To maintain 
homeostasis in adult vascular beds, pericytes are constantly secreting potent pro- and 
anti-angiogenic factors to maintain stability of the capillary (Schrimpf et al., 2012). 
Interestingly in vivo data suggests pericyte-MΦ interaction is necessary for 
angiogenesis to occur, with MΦ-pericyte interactions occurring well before vessel 
maturation (Rajantie et al., 2004). 
Developmentally renal MΦ promote endothelial connections and proliferation 
frequently associating with the capillaries developing PTC (Munro et al., 2019; Puranik 
et al., 2018). Direct adherence of MΦ to EdC directs EdC tube and neovessel formation 
(Munro, and Hughes, 2017). In an aortic ring model, at atmospheric O2 neovessels 
formed of EdC tubes were coated with pericytes and surrounded by MΦ (Aplin, and 
Nicosia, 2016). subsequent depletion of these MΦ inhibited neovessel formation 
(Nicosia, 2009). This, in line with the above ex vivo data suggest pericytes and MΦ 
together are required for angiogenesis. In adult tissues, perivascular macrophage 
(PVM; Mrc1+) are frequently associated with the capillary, interacting with pericytes to 
regulate the endothelial barrier and permeability (He et al., 2016).  In the cochlear duct, 
communication of residential MΦ (F4/80+) with NG2+ pericytes is essential to maintain 
vascular integrity, regulating the tight junctions proteins VE-cadherin and ZO-1 (Neng 
et al., 2013). What can be seen is that pericytes and MΦ communicate and collaborate 
to maintain the microvasculature, therefore it is feasible they may communicate to 




1.3.2.1 A subset of NG2+ pericytes are derived from macrophages 
 
As mentioned above (section 1.2.2) pericytes reportedly differentiate into MΦ, but it 
has also been found that some pericytes derive from MΦ. In both the embryonic skin 
and brain genetic fate mapping studies have shown that 27% of NG2+ pericytes were 
derived from MΦ. Although these pericytes did not continue to express CD11b or 
F4/80, around 13% of all pericytes had originated from CD11b+ cells (Yamazaki et al., 
2017), with transforming growth factor (TGF)-β encouraging myeloid progenitors 
differentiation into NG2+ pericytes  (Yamazaki et al., 2017). In the developing midbrain 
CD31+/F4/80+ cells transdifferentiated into pericytes expressing NG2, PDGFR-β or 
desmin (Komuro et al., 2017). This differentiation of MΦ into pericytes has also been 
observed in adult animals.  
In a subcutaneous matrigel plug model, pericyte-MΦ interactions occurred well before 
vessel maturation, with the appearance of CD31+ EdC signifying the onset of perfusion. 
In this study, a small population of NG2+ pericytes were derived from F4/80+ MΦ, and 
when EdC populated blood vessels were perfused, 10% of these cells remained co-
expressing NG2 and F4/80 (Tigges et al., 2008). In the murine ear, subpopulations of 
VEGF-induced angiogenic cells were NG2+,CD11b+, and CD45+, with a small 
population of NG2+ cells co-expressing CD11b or CD45 (Rajantie et al., 2004). Taken 
together this suggests a shared lineage of F4/80+ MΦ and a subpopulation of NG2+ 
pericytes. These MΦ-derived pericytes may not lose their immune-activities, and MΦ 
that adhere to the developing endothelium may become pericytes. 
 
1.3.3  Pericytes as non-professional immune cells. 
 
Outside of the emergent role of pericytes in co-ordinating the immune response 
(Section 1.3.1), data shows pericytes across tissues acting as “non-professional” 
immune cells; non-immune cells which show capacity for immunogenicity and 
phagocytosis (Hamada et al., 2019). In the lung, following LPS-stimulation pericyte-
like PDGFR-β+ cells act as immune sentinels expressing IL-6, chemokine (C-X-C motif) 
ligand-1, chemokine (C-C motif) ligand 2/ monocyte chemotactic protein-1, and ICAM-
1 in vivo (Hung et al., 2017). In the liver, pericytes act as antigen-presenting cells, 
recruiting Natural Killer T-cells (Winau et al., 2007), as well as inactivating T-cells in 
the human and murine kidney by inhibiting antigen-specific activation of chemokine 
recruited cells (Pober, and Tellides, 2012). In disease models, NG2+/PDGFR-β+ 
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tumour pericytes secrete high levels of IL-33, MIF and CCL2 recruiting F4/80+ tumour 
associated MΦ (Yang et al., 2016). CNS PDGFR-β+ pericytes sense inflammation in a 
CCL2 dependent manner(Duan et al., 2018), and secrete a panel of pro- and anti-
inflammatory mediators (Lin et al., 2008; Hung et al., 2017) as well as demonstrating 
phagocytotic capabilities (Balabanov et al., 1996). Pericytes of the kidney (PDGFR-β+) 
directly recruit inflammatory MΦ (Lin et al., 2011). Renal mesangial cells (Schreiner, 
1992) have shown phagocytic potential, co-labelling with CD68; a marker of phagocytic 
cells (Beranek, 2005). However, overlap in receptor expression might also mean that 
PVM may have been mis-identified as pericytes. 
 
1.3.3.1 Are these pericytes acting as immune cells or perivascular 
macrophages? 
 
Described above is pericyte-mediated direction of inflammatory cells (section 1.3.1). 
However, some of the reports of pericyte-mediated immune activity may be 
confounded by their developmental origin and the co-expression of pericyte- and MΦ-
associated markers as evidence shows PVM involvement in these processes. In the 
heart, skin, and intestine  post ischaemia-reperfusion injury (IRI) PVM are necessary 
for PMN recruitment and extravasation, with ICAM-1-mediated  neutrophil adherence 
and extravasation are markedly reduced in their absence (Li et al., 2016; Abtin et al., 
2014; Chen et al., 2004)..PVM are not necessarily solely pro-inflammatory however as 
in the kidney, CD169+ PVM show to be protective post-IRI. CD169+ PVM 
homeostatically suppress basal ICAM-1 expression by EdC,  acting as anti-
inflammatory MΦ population and promoting tissue repair post-IRI (Karasawa et al., 
2015). Much like with pericytes, there appears to be differing roles for subpopulations 
of PVM, but they remain key regulators of the inflammation and tissue homeostasis. 
With reports of the immunoactivity of pericytes – the population of MΦ they may 
overlap with would be PVM given their vascular residence. Clarity over which cell type; 
PVM or pericytes, is important to define. Whilst argued that PVM and pericytes can be 
distinguished on the basis of morphology, location and phenotype (Fabriek et al., 
2005b) the definitions proposed for both are overlapping; PVM-identifying criteria are 
“making direct contact with the abluminal surface of the vasculature, or within 15 μm” 
(Lapenna et al., 2018); somewhat similar to pericytes “spatially isolated cells with a 
bump-on-a-log morphology present on the outside of capillaries, both on straight parts 
of the capillaries and at capillary branch points” (Attwell et al., 2016). However, 
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morphology is not always a key consideration for the primary identification of pericytes, 
instead designating functions based on markers that are co-expressed. 
F4/80 is not the only MΦ-identifying marker to be co-expressed by pericytes (section 
1.3.2.1, Figure 1.7).  Other classic MΦ markers such as CD163 and CD68 in the rodent 
CNS and skeletal muscle are reportedly expressed by pericytes (Graeber et al., 1989; 
Balabanov et al., 1996; Rustenhoven et al., 2016; Pieper et al., 2014; Thomas, 1999). 
And much like PDGFR-β and NG2-expression by pericytes being encourage by 
osmotic stimulation (Morita et al., 2014), MHC-II is expressed by  porcine brain 
pericytes after stimulation with interferon-γ (Pieper et al., 2014). Interestingly, this co-
expression of MΦ markers by pericytes is seemingly further conserved across species 
as both CD68 and MHC-II have reported expression on hepatic pericytes in mice and 
humans (Winau et al., 2007). Human CNS NG2+ pericytes express CD68 and CD11c 
(Pouly et al., 1999), and more recently, Iba1+/NG2+ perivascular cells have been 
(Smirkin et al., 2009; Özen et al., 2014). Whilst these cells were determined by 
investigators to be pericytes, given the definitions above they may well be PVM. As 
NG2 expression by F4/80+ MΦ is dynamic (Moransard et al., 2011), pericyte 
expression of MΦ proteins also appears dynamic (Pieper et al., 2014). NG2 is 
upregulated in response to TGF-β (Moransard et al., 2011), where it encourages MΦ-
pericyte differentiation, or pericyte-MΦ differentiation  (Orekhov et al., 2014; Dore-
duffy, and Esen, 2018; Díaz-Flores et al., 2009; Leaf et al., 2016). PDGFR-β also 
reportedly labels human immune cells (Inaba et al., 1993; de Parseval et al., 1993) so 
boundaries between these cells are blurred. 
Under basal conditions in the kidney, residential MΦ predominate in the OM, much like 
pericyte, in humans and animals (see section 1.4). This abundance of both cell types 
could mean that direct pericyte-immune functions in the kidney could be misattributed 
to pericyte, or that they are interacting.  Experimental evidence suggests 
communication between MΦ and pericytes in the OM. 
 
1.4 Pericytes and macrophage converge on the renal medulla. 
   
With the above sections (1.2-1.3) considered, it is interesting to note that pericytes and 
MΦ are most dense in the OM. Whilst there have been no reports of PVM on the vasa 
recta, there is convergence of MΦ around in OM in humans (CD163+ and CD14+) 
(Colvin, 2019; Berry et al., 2017) and in mice (F4/80+ or CD169+)  (Hume, and Gordon, 
1983; Karasawa et al., 2015; Clements et al., 2013) under basal conditions, primarily 
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around the vascular bundles. In humans and mice, these medullary MΦ are notably 
more active with their phagocytic and secretory behaviour with the hypersalinity 
stimulated MΦ  producing more IL-6, IL-8, and TNF-α (Berry et al., 2017). Tissue 
resident perivascular F4/80+ MΦ in the renal cortex actively patrol the microvascular 
environment located between the endothelium and the basement membrane of 
tubules, (Stamatiades et al., 2016) but ultimately the density of pericytes (Figure 1.8) 
and MΦ (Figure 1.10) are greatest in the OM. 
Both damage to and the low O2 availability in the medulla encourages immune cell 
recruitment; MΦ migrate via CXCR4/ CXCL12 and  CCR2/ CCL2 dependent chemotaxis 
(Berry et al., 2017; Ceradini, and Gurtner, 2005). In various rodent models of AKI, 
immune cell infiltration is present in early observations; residential macrophages (MΦ;  
CX3CR1+) migrate within an hour of ischaemic injury (Basile et al., 2012), and in a 
murine ischaemia reperfusion model of AKI, IL-6 producing residential F4/80+ MΦ are 
specifically located adjacent to the vascular bundles 4-hours post reperfusion (Kielar 
et al., 2005). Furthemore, in rodent models of AKI circulating T-cells (CD28+) and 
infiltrating MΦ (CD68+) are present in this region within 3-4-hours, occluding the AVR 
(Ysebaert et al., 2004). The NG2-expression dependent, pericyte-mediated PMN 
recruitment (section 1.3.1) is seemingly reflected in these findings,;the recruitment of 
PMN is potentially co-ordinated by DVR NG2+ pericytes and residential MΦ, whilst the 
PMN extravasation involves NG2- pericytes on the AVR. The evidence of renal 
pericytes being directly involved in the propagation of the immune response is ever 
growing. 
 
1.4.1 Renal Pericytes co-ordinate inflammation in the kidney.  
 
In the kidney there is a wealth of evidence showing involvement of renal pericytes in 
key stages of inflammation.  In both humans and mice, samples from AKI patients 
show FoxD1+ pericytes activate the NLRP3 inflammasome, leading to IL-1β and IL-18 
secretion, signalling which is both propagated and amplified by pericyte TLR-2/4 and 
MyD88-activation (Leaf et al., 2016). Interestingly, after ischaemic damage, F4/80+ MΦ 
migrate to vascular bundles to recruit inflammatory cells via production of IL-6 (Kielar 
et al., 2005), yet, Leaf et al, have recently found pericytes had significantly higher 
expression of IL-6 compared with EdC, epithelial cells and even MΦ in mouse kidneys 
following IRI (Leaf et al., 2016) suggesting perhaps pericytes recruiting PMN with IL-6 
secretion. Vascular adhesion molecule VAP-1 and the generation of a H2O2 gradient, 
is mediated by PDGFR-β+ pericytes to enhances PMN infiltration (Tanaka et al., 2017),  
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Figure 1.10 . In healthy mammalian kidneys immune cells have preponderance in the 
medulla. 
(A-B) show CD163+ residential MΦ distribution in the (A) cortex and (B) medulla. In both 
regions the MΦ are apposite capillaries, with the greatest density along the vascular bundles 
in the outer medulla. open black arrows show apposition to venules, and black arrows shop 
apposition to vascular bundles. Data Taken from (Colvin, 2019). (C) Shows a low magnification 
image of a healthy C57BL/6J kidney slice showing CD11c(green) and F4/80 (red) in the cortex 
and medulla, with the combined density greatest in the medulla. Scale bar is 300μm on low 
magnification, and 50μm on high magnification images on the right. Data taken from (Berry et 
al., 2017) (D-E) Shows higher magnification of outer medullary F4/80 staining as a healthy 
cross-section (D) through the medullary rays and (E) longitudinally through medullary rays 
highlighting numerous F4/80+ macrophage (MΦ) surrounding the capillaries and tubules in a 
C57BL/6J kidney. Black arrows highlight F4/80+ cells. Scale bar is 10μm. Data taken from 
(Hume, and Gordon, 1983). 
 45 
assisted by CD169+ PVM (Karasawa et al., 2015), further suggesting specific pericyte 
involvement. In addition to this, in the absence of PDGFR-β+ pericytes, early indicators 
of inflammation; the increased presence of F4/80+ MΦ, and expression of IL-6 and 
TNF-α, are not detected (Lemos et al., 2016). 
In a unilateral ureteric obstruction (UUO) murine model PDGFR-β+ pericytes secrete 
complement factor C1q (Xavier et al., 2017), which instructs the progression of innate 
to adaptive immunity (Hosszu et al., 2010).  Recruitment of immune cells is not the 
only reported immune activity of pericytes as further recent data from show aspects of 
pericyte-mediated antigen presentation or inactivation of T-cells in both mice and 
humans (Liu et al., 2018). In acute T-cell mediated rejection of renal allografts in 
humans, INF-γ-stimulated (α-SMA+) pericytes express Indoleamine-pyrrole 2,3- 
dioxygenase (IDO1), a memory T-cell inhibitory protein (Liu et al., 2018). Interestingly, 
as inhibition of T-cells is anti-inflammatory, these studies suggest further pericyte-sub-
population-mediated inflammation, though this requires further study. 
Pericytes are spatially close to residential immune cells in both basal and pathogenic 
settings, and it has been suggested this proximity is indicative of cell-cell 
communication (section 1.3.1). In a rodent model of acute brain injury, PDGFR-β+ 
perivascular cells have a close spatial relationship with allograft inflammatory factor 1 
(Iba1)+ MΦ, with increased cell-to-cell contact post injury encouraging fibrosis (Riew 
et al., 2018). It has been found using knock-in mice with PDGFR-β mutations, that 
genes encoding immune factors are upregulated by increased PDGFR-β signalling 
(Olson, and Soriano, 2011). In the human kidney it has also been proposed that cell-
cell contact between MΦ and pericyte-derived myofibroblasts encourage fibrosis 
(Campanholle et al., 2013), with a close spatial and temporal relationship between 
CD163+ and CD204+ MΦ and fibroblasts during healing (Eardley et al., 2008; Nikolic-
Paterson et al., 2014). It is possible that coupled with the increased density in the OM, 
pericyte-MΦ cell-cell contact is potentially indicative of communication, this is how 
MRP14+ PMN instruct α-SMA+/NG2- pericytes to dilate and thereby extravasate  (Wang 
et al., 2012). An interpretation of this renal data, in line with what was discussed in 
section 1.3.1 is summarised in Figure 11. However, it is important to consider the 
reported co-expression of PDGFR-β, NG2, F4/80, and CD163, amongst other markers 




Figure 1.11 Proposed co-ordination of the immune response at the vasa recta capillaries 
by pericytes. 
The inflammatory foci stimulates both residential macrophage (MΦ; yellow) and NG2+/PDGFR-
β+ pericytes (blue) on the DVR to communicate (dark yellow arrow) secrete pro-inflammatory 
mediators IL-1β, TNF-α, IL-6, MIF, IL-33 and CCL2 (black arrows) to recruit  more immune 
cells including more MΦ, infiltrating MΦ (orange), T-cells (green) and polymorphonuclear 
leukocytes (peach). These immune cells travel along the vasa recta and towards a H2O2 
concentration gradient generated by NG2-/PDGFR-β+ pericytes (turquoise) on the AVR, that 
have detached from the endothelium. PMN can pass through the destabilised endothelial cell 
layer, as well as communicate directly via cell-cell contact with NG2- pericytes to dilate the 
capillary and migrate into the interstitial space via PECAM-1 mediated transmigration (thick 
border), at areas of low matrix protein expression. Infiltrating MΦ and T-cells also extravasate 
via the AVR which can lead to congestion and blockage of the AVR. If the process is the same 
across tissues some immune cells can amble to the inflammatory foci (peach dashed arrows), 
whereas a small population will be instructed by the NG2+ pericytes on the DVR expressing 
ICAM-1, MIF, MAC-1, and LFA-1 (thick border), sensitising them and directing them directly to 
the inflammation (solid peach arrow) in an NG2-dependent manner. MΦ also express ICAM-1 
(thick border) and are necessary for both recruitment (DVR; F4/80+ mouse; CD163+ human) 
and enabling extravasation (AVR; CD169+).Gradients indicates a chemotactic gradient on the 
DVR (red), and  expression of matrix proteins α-SMA and Collagen IV as well as H2O2 



















1.4.1.1 NG2 and PDGFR-β, though not other pericyte markers are reportedly 
expressed by immune cells 
 
Pericyte subpopulations identified with niche markers do not appear to have any 
overlapping expression. Although spatially close, PDGFR-β+/ eGFP- L10a+pericytes, 
do not co-stain with macrophage marker F4/80 or T-cell marker CD3 (Ferland-
McCollough et al., 2016). Gli1+ pericytes often come into close contact with F4/80+ 
MΦ, though co-expression does not occur in the OM (Fabian et al., 2012), and CD248+ 
pericytes do not appear to influence the inflammatory response as no difference in 
CD45, CD3, or F4/80 staining was observed (Smith et al., 2015),  However, both anti-
NG2 and PDGFR-β appear to label MΦ (section 1.3.3.1) so caution is needed, and 
further identifying criteria are necessary to discriminate between pericytes and MΦ. 
The notable characteristic pericyte “bump-on-a-log” morphology (Peppiatt et al., 2006) 
may be useful in this instance concurrently with antibody labelling.   
 
1.5 Species specific differences in behaviour can influence translatability.  
 
Use of a valid model is important when trying to address specific research questions. 
However, equally useful is seeing what is conserved across species, whilst considering 
the species-specific physiology. Despite plentiful data showing species-dependent 
differences in responsiveness (Boswell et al., 2014; Steven et al., 2017), translating 
findings across species can be confounded by such differences (Natoli et al., 2013; 
Ellenbroek, and Youn, 2016) or the use of inconsistent experimental methods (Steven 
et al., 2017), affecting interpretation of the data. For example, in septic shock models 
with multiple different; methods to induce disease, set experimental time-points for 
data acquisition, and different strains and species used, it is difficult to accurately 
characterise the response to disease. However, when these are considered species-
independent pathways can be identified i.e. conserved behaviours across species, 
which aids translatability to humans (Steven et al., 2017). 
Even within the same animal, tissue-variation might confound data; LPS stimulated 
VCAM-1 and ICAM-1 varies between the heart, mesentery, brain and small intestine 
within the same animal (Henninger et al., 1997). Methodology is a key consideration, 
in the kidney not using comparable MΦ marker CD68, and instead opting for F4/80 in 
the mouse,  led to conflicting results over glomerular MΦ infiltration between mice, and 
what was measured in rats and humans (CD68+) (Masaki et al., 2003). Lack of 
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investigations into inter-species heterogeneity, or assuming between species findings 
will be conserved in a “like-for-like”-manner i.e. findings in the rat will be identical to 
findings in the mouse, has likely led to erroneous conclusions.  As such, the use of the 
same methods in different species allows more holistic interpretation of data 
(Vandamme, 2014), and gives better generalisation to the findings.  
If a novel model performs in a way that the literature suggests it should it  demonstrates 
predictive validity of the model and thus data generated (Denayer et al., 2014). Data 
generated in differing rat and mouse models are often used to corroborate findings 
using the assumption that physiology is similar, if not equivalent, between them 
(Downs, 2011), yet evidence demonstrates they are markedly different in vascular 
profiles and responsiveness (Russell, and Watts, 2000; Cholewa et al., 2005; 
Hedemann et al., 2004; Zhao et al., 2009; Boswell et al., 2014), disease pathogenesis  
(Natoli et al., 2013; Ellenbroek, and Youn, 2016), susceptibility to disease (Neuhofer, 
and Beck, 2005; Hartner et al., 2003), inflammatory gene induction (Schroeter et al., 
2003), receptor pharmacology (Sabolic et al., 2011; Schildroth et al., 2011; Russell, 
and Watts, 2000; Wiley, and Davenport, 2004), and enzyme activity (Martignoni et al., 
2006), to name a few examples. This highlights that translation of models between 
species is not straightforward, and why species differences require consideration. 
Data on the physiological response of a mouse or a rat model can only be understood 
in keeping with the frame of reference of the animal’s physiology. However, probing 
such differences can aid in translatability. By acknowledging and understanding these 
differences, they can be used as a frame of reference for  comparative pathophysiology 
(Radermacher, and Haouzi, 2013). For example, use of 2-butoxyethanol in both 
species depleted vitamin E and increased ROS-production. However, rats have a 
significantly higher basal vitamin E level than mice, and as such mice were more 
sensitive to the ROS damage (Siesky et al., 2002). Subsequently, translating these 
findings to humans, it was concluded that humans would be resistant to ROS-induced 
damaged following 2-butoxyethanol given the basal levels of vitamin E are 100x higher 
than that of the mouse (Cunningham, 2002). This allows both insight into the 
pathomechanisms of 2-butoxyethanol and translatability to humans. 
For a better understanding of comparative physiology, it is beneficial to determine 
conserved behaviours whilst considering species differences. Interestingly, 
investigations into pericyte-mediated regulation of DVR have been conducted in both 
humans and rats, and show active regulation of vasa recta diameter by pericytes 
(Sendeski et al., 2013; Zhang et al., 2004; Crawford et al., 2012). In chapter 4, it is 
also demonstrated that murine pericytes, in a species-dependent manner, regulate the 
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DVR; this is a conserved behaviour of renal pericytes (discussed in more detail 
chapter 4, section 4.4.). Immune activity of pericytes is also present across species.  
1.5.1  Cross-species and Cross-organ pericyte immune functionality is 
conserved, in a species dependent manner. 
 
Discussed above in sections 1.3 and 1.4 is the conserved inflammatory 
multifunctionality of pericytes present in human and animal models. Another 
consideration is that the immunogenicity of human pericytes appears to vary from that 
observed in animal models; rodent and porcine in vitro models secrete pro-
inflammatory cytokines TNF-α, IL-1β, and IFNγ, where human pericytes do not 
(Rustenhoven et al., 2017). Yet human CNS pericytes do secrete monocyte 
chemotactic protein-1 (MCP-1) and interferon inducible protein 10 (IP-10/ CXCL10), 
which could increase immune cell recruitment (Jansson et al., 2014). Human placental 
NG2+ pericytes express  CXCL1, CXCL8, MIF, CCL2, forming a structural and 
chemotactic microenvironment to traffic PMN in response to ATP and LPS (Stark et 
al., 2012), much like human renal pericytes (Leaf et al., 2016). As such, the inter-
species nature of pericyte-mediated immune activity may be different in line with 
species-specific physiology i.e. CD8+/CD4+ T-cells express functional GABA-A 
receptors, but the subtype profile varies between mice, rats, and humans (Mendu et 
al., 2012), yet GABA is involved in T-cell modulation in all species (Bjurström et al., 
2009). If immune functionality is conserved across animal models and enables 
elucidation of how pericytes are multifunctional these findings could hopefully translate 
across and inform human physiology and as such provide novel therapeutic targets to 
prevent the associated complications and progression of renal disease. 
 
1.6 Summary and aims. 
 
In the kidney, it has been observed that human DVR pericytes are contractile 
(Sendeski et al., 2013), and that renal MΦ across species congregate around the vasa 
recta (Colvin, 2019; Berry et al., 2017; Hume, and Gordon, 1983; Karasawa et al., 
2015), with both human and mouse pericytes post-AKI showing inflammatory 
activation (Leaf et al., 2016). The trans-species trends in function and cellular 
distribution of both cell types having predominance in the OM is suggestive of a 
conserved cellular dynamics and function. As discussed in section 1.4, it appears 
pericyte-mediated direction of inflammation is conserved across tissues but ultimately 
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the relationships between pericytes and MΦ in the kidney warrants further investigation 
and delineation. However, given that the proteins used to identify MΦ (F4/80, CD68, 
CD163 etc.) in the above studies show spatial overlap (Karasawa et al., 2015), and 
reportedly co-label with markers expressed by pericytes (NG2+ and PDGFR-β+) 
(Graeber et al., 1989; Balabanov et al., 1996; Komuro et al., 2017; Tigges et al., 2008; 
Rajantie et al., 2004), accurate identification of cells is essential in order to support 
this line of investigation. 
The aims are as follows: 
Chapter 3: The overall aim of this chapter is to assess the use of using rodent kidney 
slices in investigating the multifunctional nature of renal medullary pericytes by: 
i. Determining the suitability of anti-PDGFR-β for identifying pericytes the rodent live 
kidney slice model.  
ii. Determining the suitability of anti-CD163 and anti-CD68 for the identification of 
residential macrophage (MΦ) in the rodent live kidney slice model.  
iii. Determining any overlap in cellular expression with MΦ (anti-CD163) and pericyte 
(anti-NG2 and anti-PDGFR-β) markers. 
a) Determine if co-expression can be encouraged in an emulated inflammatory 
environment with cytokines TNF-α and IL-1β.  
iv. Characterise the spatial relationship between MΦ and pericytes.  
a) Characterise any functional consequence of close proximity by measuring vasa 
recta diameter. 
Chapter 4: Given the limitations from the rodent model in chapter 3, the overall aim is 
this chapter is establishing a companion kidney slice model using murine tissue, by: 
i. Characterising NG2+ pericyte density and morphology in murine kidney slices 
ii. Characterising the vasoactive responsiveness of murine pericytes on the vasa 
recta capillaries using endogenously produced vasoactive mediators. 
Chapter 5: With the newly established murine live kidney slice model, the aim here is 
to assess use this tissue in investigating the multifunctional nature of renal medullary 
pericytes by: 
i. Performing acute superfusion experiments on murine kidney slices with TNF-α and 
IL-1β  
ii. Repeating the aims as listed under the chapter 3 subsection above, using anti-
F4/80 in place of anti-CD163. 
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2 GENERAL METHODOLOGY. 
 
2.1 Tissue preparation and slicing 
 
Experiments using either 9-week-old male C57BL/6J mice (C57) or 200-225g male 
Sprague-Dawley rats (SD; Charles River UK Ltd, Margate, UK) were conducted in 
accordance with United Kingdom Home Office Scientific Procedures Act (1968). This 
age of C57 was chosen as an approximate age-match to the weight of the SD used in 
the live rodent kidney slice model (Crawford et al., 2012). Animals were killed by 
cervical dislocation, kidneys isolated, the renal capsule was removed, and kidneys 
were placed in ice cold physiological saline solution (PSS) bubbled with 95% O2/ 5% 
CO2 for preparation for slicing. PSS contained (mM): NaCl (100), KCl (5), NaH2PO4 
(0.24), Na2HPO4 (0.96), Na acetate (10), CaCl2 (1), MgSO4 (1.2), glucose (5), NaHCO3 
(25) and Na pyruvate (5) (Sigma-Aldrich Ltd, Dorset, UK). PSS pH was determined 
using a Hanna bench pH 209 meter (Hanna Instruments, Bedfordshire, UK) and 
adjusted to 7.4 using 0.1 M NaOH or 95% O2/ 5% CO2. Kidneys from either C57 mice 
or SD rats were fixed on an ice-cold slicing block and sliced using a Leica VT 1200 S 
vibrating microtome (Leica, Germany). To expose the renal medulla, the outer cortical 
dome region of the mouse and rat kidney was removed (1.2 cm and 3.5 cm 
respectively, from the exposed surface) after which 200-µm thick slices were cut 
serially. Descriptions of differences between rodent and murine kidney slice properties 
are presented in Chapter 4 section 4.3.1. Post slicing, kidney slices were kept for up 
to 4-hours in a holding chamber containing PSS bubbled with 95% O2/ 5% CO2 at room 
temperature (25°C) before experimentation.  
 
2.2 Viability of C57BL/6J live kidney slices 
 
To ascertain viability of cells within C57 kidney slices, slices were incubated at room 
temperature (25°C) for 20 mins with: 20 µM propidium iodide (PI; Sigma-Aldrich Ltd.), 
a red fluorescent nuclear and chromosome stain only able to permeate dead cells via 
damaged membranes; and 5 µM Hoechst 33342 (Hoechst; Invitrogen Ltd. UK), a blue 
fluorescent nuclear stain that binds to dsDNA in all cells. Both fluorescent compounds 
were made up in PSS bubbled with 95% O2/ 5% CO2 (1). After incubations, slices were 
washed with PSS for 5-minutes three times and then subsequently fixed for 15-minutes 
with 4% PFA (made in 0.1 M phosphate buffered saline, PBS, Sigma-Aldrich Ltd.). 
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Post-fixation slices were washed three times in 0.1 M PBS for 10-minutess each then 
mounted using Citifluor (Agar Scientific Ltd, Stanstead) and stored at 4°C in the dark 
prior to imaging. 
Images were acquired from both the inner (IM) and outer medulla (OM) of stained 
slices, using a Carl Zeiss LSM 800 confocal microscope with a Plan-Apochromat 63x 
oil immersion lens (Carl Zeiss Ltd, Oberkochen, Germany) using immersion oil (#518F, 
Carl Zeiss Ltd, Oberkochen, Germany). At least 6 randomly selected regions of interest 
(ROIs) in the IM and OM were visualized. For visualization: PI was excited at with the 
argon laser line 561 nm, and emission detected by a at 566-697 nm; and Hoechst was 
excited at with the ultraviolet laser line 405 nm, with emission detected at 410-508 nm. 
Differential interference contrast (DIC) images of were also obtained using the 
transmitted light field, to see if the parenchyma was alivereference tubular and 
vascular structures.  Stained (Hoechst alone; all cells) and co-stained (Hoechst and 
PI; dead cells only) cells were quantified using the cell counter plugin in the open-
source image processing FIJI software (2) so the overall percentage of live cells in the 
kidney slices could be calculated with Equation 2.1. 
	𝐿𝑖𝑣𝑒	𝑐𝑒𝑙𝑙𝑠 = *
(#𝐻𝑜𝑒𝑐ℎ𝑠𝑡!	𝑐𝑒𝑙𝑙𝑠	)– (#𝐻𝑜𝑒𝑐ℎ𝑠𝑡!𝑎𝑛𝑑	𝑃𝐼!	𝑐𝑒𝑙𝑙𝑠)	
#𝐻𝑜𝑒𝑐ℎ𝑠𝑡!𝑐𝑒𝑙𝑙𝑠 8 ∗ 100 
Equation 2.1 Calculation for the percentage of live cells in murine kidney slices. 
 
2.3 C57BL/6J pericyte characteristics. 
 
Nerual-glial 2 (NG2)+-positive pericyte density in the SD kidney slice model has 
previously been established (1), so the NG2+ve pericyte density and morphology were 
determined in the C57 model (murine).  For primary identification of NG2-positive 
pericytes on the murine vasa recta (n=4 animals, 2-3 slices per animal), live kidney 
slices were first incubated for 45-minutes with Alexa Fluor 488-conjugated isolectin B4 
(IB4; i21411, Invitrogen Ltd.), prepared using PSS bubbled with 95% O2/ 5% CO2 at a 
concentration of 50 μg/mL at room temperature (25°C). IB4 labels alpha-D-galactosyl 
residues expressed by the endothelial cells of non-primates, selectively staining 
murine renal capillaries (Laitinen, 1987) . After incubation, slices were given a 15-
minute wash in PSS and fixed using 4% PFA. After fixation, three 10-minute washes 
with PBS (0.1 M; Sigma-Aldrich) were performed, then slices were permeabilised using 
0.1% Triton-X 100 (Sigma-Aldrich Ltd, Dorset, UK) solution made in 0.1 M PBS for 10-
minutes. Subsequently, non-selective binding of antibodies to structures in slices was 
blocked with a 2-hour incubation in 10% donkey serum, 90% 0.1% Triton-X 100/ 0.1 
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M PBS solution (DS-Triton) at room temperature before an overnight incubation with 
anti-NG2 primary antibody (rabbit; 1:200; AB5320, Millipore UK Ltd, Watford, UK), 
diluted in 10% DS-Triton, at 4°C.  




A438079 10 µM IL-1β 10 ng/mL 
Ang-II 




50 nM 30 nM 
100 nM 100 nM 





1 mM 10 µM 
2 mM 100 µM 





10 µM 100 µM 
100 µM TNF-α 10 ng/mL 




1 nM 1 µM 
3 nM 10 µM 
5 nM 30 µM 
10 nM 100 µM 
Ang-II; Angiotensin II, ATP: Adenosine-5’-triphosphate, BzATP; 2’(3’)-O-(4-
Benzoylbenzoyl) Adenosine5’-triphosphate ET-1; Endothelin-1, IL-1β; interleukin 1β, NA; 
noradrenaline,PGE2; prostaglandin E2, PSS; Physiological saline solution, SNAP; (S)-
Nitroso-N-acetylpenicillamine, TNF-α; tumour necrosis factor-α. 
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The anti-NG2 primary antibody was probed using donkey-anti-rabbit conjugated with 
Alexa Fluor-555 secondary antibody (donkey, 1:200, A-31572, Invitrogen Ltd.), diluted 
in DS-Triton, via a 2-hour incubation. Post incubation, slices were washed in three 
times in PBS 0.1 M for 10-minutes then mounted using Citifluor (Agar Scientific Ltd, 
Stanstead) and stored at 4°C in the dark. 
For analysis, both the IM and OM of stained slices were imaged using a Carl Zeiss 
LSM 800 confocal microscope with a Plan-Apochromat 63x oil immersion lens (Carl 
Zeiss Ltd, Oberkochen, Germany) using immersion oil (#518F, Carl Zeiss Ltd, 
Oberkochen, Germany). For visualization: Alexa Fluor-488 was excited with the argon 
laser 488 nm line and detected at 490-570 nm and Alexa Fluor-555 was excited with 
the argon laser line 514 nm, excited at 561 nm, and detected at 566-697 nm DIC bright 
field images were acquired alongside the fluorescence. Images were processed in the 
open-source FIJI software (2). For NG2+ pericyte density calculations, ≥4 x 100 μm2 
regions in both the IM and OM of every kidney slice were selected at random for 
comparison with the original rodent model for comparison (Crawford et al., 2012). In 
these regions, NG2+ pericyte soma size was calculated, by: measuring soma height, 
by measuring top-to-bottom from the side of the cell adjacent to the vasa recta wall; 
and soma width, the length of the pericyte running along the vessel. Pericyte process 
length along the IB4-labelled vasculature (longitudinal), and around the vasculature 
(circumferential) were also measured as described previously (Crawford et al., 2012). 
IB4-labelled vasa recta capillary diameter was measured at: a pericyte site, defined as 
the segment of the vessel underneath the pericyte soma and surrounded by 
circumferential processes; and at a non-pericyte site, defined as a segment of the vasa 
recta capillary with no observable pericyte soma. Values obtained were compared 
between the OM and IM as described in Section 2.6. Processes were not used for 
calculating overall pericyte size due to difficulty in discriminating between processes 
from different pericytes. Any subsequent comments of pericyte size relate solely to the 
soma. 
 
2.4 Functional experiments and video analysis. 
 
A single live C57 kidney slice was secured in a 1.25mL bath chamber on the stage of 
an upright Olympus microscope (model BX51WI, Olympus microscopy, Essex, UK) 
using a purpose-built platinum slice anchor. The slice was continuously perfused 
(~2.5mL min-1) with PSS bubbled with 95% O2/ 5% CO2 and maintained at room 
temperature (~25°C). Differential interference contrast (DIC) images of pericytes on 
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subsurface vasa recta capillaries (identified by their ‘bump on a log’ morphology; 
(Peppiatt et al., 2006)) were recorded through an Olympus 60X water immersion 
objective (0.9 NA). Real-time images of changes in the diameter of the vasa recta were 
captured as a video every second by an attached Rolera XR CCD camera (Qimaging, 
Surrey, Canada) and recorded using Image Pro Software (Media Cybernetics Inc., 
Bucks, UK).  To establish a baseline vessel diameter, Slices were superfused with 
PSS alone for ~100s before the following vasoactive compounds were applied: 
A438079 (Tocris, UK) angiotensin II (Ang-II; Sigma-Aldrich, UK); 2’(3’)-O-(4-
Benzoylbenzoyl)Adenosine5’-triphosphate (BzATP; Tocris, UK) endothelin-1 (ET-1; 
Tocris, UK); adenosine 5’-triphosphate (ATP; Sigma-Aldrich, UK); Noradrenaline (NA; 
Sigma-Aldrich, UK); Bradykinin (BRADY; Sigma-Aldrich, UK); prostaglandin E2 (PGE2; 
Tocris, UK); Indomethacin (Sigma-Aldrich, UK); tyramine (Sigma-Aldrich, UK); (S)-
Nitroso-N-acetylpenicillamine (SNAP; Tocris, UK); along with PSS only control 
superfusion experiments. Proinflammatory cytokines tumour necrosis factor-α (TNF-α; 
Bio-Techne Ltd, UK), and interleukin 1β (IL-1β; Bio-Techne Ltd, UK) were also applied 
(see Table 1.1 for concentrations). To demonstrate the responsive potential of the 
slices, PSS control experiments were subsequently followed by perfusion with ET-1; a 
response with ET-1 but not PSS would demonstrate the reason why no change in 
vessel diameter could be measured is due to lack of agonist in PSS. 
Concentrations used were those that had previously been established in the rat live 
slice kidney preparation (Crawford et al., 2011; Crawford et al., 2012; Kennedy-Lydon 
et al., 2015); unpublished data (Data provided by Kirsti Daylor) see Table 2.1 for 
concentrations used. All compounds were made up in PSS, oxygenated with 95% O2/ 
5% CO2, with: Ang-II, ET-1, ATP, NA, Indomethacin, and tyramine used to evoke 
vasoconstriction; and PGE2, BK, SNAP used to evoke vasodilation. Cytokines IL-
1βand TNF-α were also applied to kidney slices to determine how pericytes responded 
to these compounds. Initially slices were superfused for ~100s with PSS alone to 
establish the baseline for the vasa recta capillary, after which kidney slices were 
superfused with vasoactive compounds for ~ 250s, cytokines were superfused for 
~600s, to match exposures times experiments previously performed in the SD model. 
After application of agonist, slices were superfused again with PSS to assess 
reversibility of pericyte-mediated changes in vessel diameter, with at least 10 minutes 
of a washout with PSS in all experiments. Time-series analysis of the change in vasa 
recta diameter was conducted using FIJI public domain software (Schindelin et al., 
2012). For each experiment, a pericyte site and a non-pericyte site were identified 
along vasa recta capillaries, and the diameter at both sites were measured (D) every 
5s for the entirety of the experiment, with each vessel acting as its own control. The 
average of the first 5 measurements of vasa recta width were used as the baseline 
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diameter (Db) and normalised to be 100%. Every subsequent diameter measurement 
was expressed as a percentage change of the original baseline diameter (Equation 
2.2). Due to limitations of resolving very small changes in vessel diameter in the 
images obtained, only changes in vasa recta vessel diameter greater than 5% of the 
baseline value were considered a response to the agonist applied, and only changes 
in vessel diameter greater than 5% were to be included in statistical analysis as 
described in section 2.6. A vessel was considered to have returned to baseline if it 
returned to within 5% of the resting diameter. This threshold was set as there is a limit 
with which the tissue can be resolved by the microscope and the corresponding pixel 
size measurable on-screen for analysis. It was calculated that 10 μm is approximately 
47 pixels (Crawford et al., 2012). At least 3 replicates of experiments where the change 




7 ∗ 100 
𝑫𝒃 −%	𝚫	𝒗𝒆𝒔𝒔𝒆𝒍	𝒅𝒊𝒂𝒎𝒆𝒕𝒆𝒓 = %	𝒄𝒐𝒏𝒔𝒕𝒓𝒊𝒄𝒕𝒊𝒐𝒏	𝒐𝒓	𝒅𝒊𝒍𝒂𝒕𝒊𝒐𝒏 
 
Equation 2.2 Calculation of the percentage change in vessel diameter 
 
2.5 Immunohistochemical staining of Sprague-Dawley and C57BL/6J kidney 
slices with pericyte and macrophage markers. 
 
Prior to use of these antibodies (Ab) in murine and rodent kidney sections for 
quantitative experimentation, the optimised dosage of these Ab needed calculating. 
The dilutions presented in table 2.2 were those found to be ideal for staining the 200-
μm thick kidney sections. After which, initial exploratory experiments were conducted 
to assess suitability of multiple macrophage (MΦ) markers; CD68 (rabbit: 1:100, 
AB125212; Abcam, Cambridge, UK), CD163 (mouse; 1:100, MCA342GA, Bio-Rad 
Laboratories, Oxford, UK) , F4/80 (rat; 1:1000, MCA497R, Bio-Rad Laboratories, 
Oxford, UK, and the pericyte marker platelet derived growth factor receptor-β  
(PDGFR-β; rabbit, 1:500; AB_2783647;  kindly donated by William Stallcup, Sanford-
Burnham Medical Research Institute) for use in the kidney slice preparations. NG2 was 
not included in these exploratory experiments as it has previously been used for renal 
pericytes (Crawford et al., 2012), but staining of PDGFR-β in the renal medulla has not 
yet been visually characterized. NG2 is also considered an identifier of a sub-
population of pericytes (Stark et al., 2012), notably residing along arteriolar capillaries 
(Murfee et al., 2005; Stefanska et al., 2015); PDGFR-β is considered a pan pericyte 
marker, and, like NG2 (Smirkin et al., 2009; Prazeres et al., 2017) has reported co-
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expression of MΦ identifying markers (Inaba et al., 1993). Anti-PDGFR-β was used in 
conjunction with Alexa Fluor-488 conjugated IB4 determine locale along the IB4-
labelled vasculature. 
To ascertain the basal cellular spatial relationships and any degree of co-staining 
between pericytes and resident MΦ in both C57 and SD: anti-NG2 and anti- PDGFR-
β to stain for pericytes in both SD (Crawford et al., 2012)  and C57; anti-F4/80 was 
used to stain residential MΦ in C57; and anti-CD163 was used to stain residential MΦ 
in SD, having both been used to characterise these cells in the respective species 
previously (Hume, and Gordon, 1983; Kaissling, and Le Hir, 1994), and previously 
reported overlap in these markers in the CNS (Balabanov et al., 1996; Yamazaki et al., 
2017; Komuro et al., 2017).  Slices were also stained with Hoechst 33342 (Hoechst; 
Invitrogen Ltd. UK), to accurately quantify and elucidate any overlap between pericyte 
and MΦ cells by correlation of their blue nuclei in images. 
Table 2.2 Antibody dilutions table. 
Antibody Dilution Reference  Antibody Dilution Reference 
























































11º = Primary antibody 22º = Secondary antibody  
For the basal characteristics of healthy tissue, fresh live kidney slices from C57 and 
SD were incubated with 5 µM Hoechst made is PSS, bubbled with 95% O2/ 5% CO2, 
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for 20-minutes. After incubations, slices were washed with PSS for three 5-minute 
intervals, and then subsequently fixed for 15-minutes with 4% paraformaldehyde (PFA) 
made in 0.1 M phosphate buffered saline (PBS, Sigma-Aldrich Ltd.). Post fixation, 
immmunohistochemical staining was conducted as described in Section 2.3, with the 
respective primary antibody concentrations as listed above in Table 2.2  For the MΦ: 
to probe the anti-CD163, donkey-anti-mouse Alexa Fluor-488 (donkey, 1:200, A-
21202, Invitrogen Ltd.) secondary antibody was used; to probe the anti-F4/80, donkey-
anti-rat Alexa Fluor-488 (donkey, 1:200, A-21208, Invitrogen) secondary antibody was 
used; and to probe the anti-CD68, donkey-anti-rabbit Alexa Fluor-555 secondary 
antibody was used, which was also used to probe NG2 and PDGFR-β as described in 
Section 2.3.  
Given reported low cell numbers of CD163+ MΦ in the rat (Kaissling, and Le Hir, 1994), 
and the possible dormant state of residential immune cells,  SD and C57 slices were 
also incubated in pro-inflammatory cytokines TNF-α and IL-1β (R&D Systems, 
Abingdon Science Park) at a concentration of 10 ng/mL, made in PSS, to activate the 
MΦ, and possibly pericytes with MΦ functions. These slices were incubated for 4 hours 
with either; TNF-α, IL-1β, or PSS alone for 4 hours. In the experimental group of tissue 
slices that were incubated with inflammatory compounds as described above, these 
tissue slices were incubated with 5 μM Hoechst 33342 for the last 20-minutes of that 
incubation, prior to processing as described above in section 2.2. 
andwere excited and detected as described above in section 2.3 33342 excited 
anddetected as described in section 2.2performed  At least four regions of interest 
(ROI) were randomly selected for both the IM and OM, after which 10 μm deep z-
stacks were acquired, with an optical plane area of 214.21 μm x 214.21 μm per slice 
of the stack, each plane 1 μm apart.  
As measurement per μm2 would overlook stereology of pericytes and MΦ for this 
analysis, the acquisition of a z-stack and reconstruction of the 3-D distribution allows 
for morphological heterogeneity in the cell counts. In a 2-D image the ratio of large 
nuclear profiles to small nuclear profiles in sections almost certainly does not equate 
to the actual ratio in the three-dimensional tissue (Bertram, 2001). ROI were 
determined by showing presence of both positively labelled MΦ and pericytes as these 
were my cells of interest, and ≥ 35 pericytes per ROI in the OM and ≥ 10 pericytes in 
the IM, due to differences in regional pericyte density, and influences of stimulation on 
pericyte densities (Crawford et al., 2012). ROI were determined by pericytes as the 
object of study. This number of pericytes allows for 200 counting events per animal in 
the OM and IM combined which ensures observed variation within a group is 
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dominated by the biological variation between experiments and not by the variation 
due to stereological sampling (Weibel et al., 2007; Bertram, 2001). Only whole cells 
were included in analysis, as determined by a non-bisected Hoechst 33342+ cell nuclei 
in frame. This depth of render balanced resolution of the structural and spatial 
arrangements of both pericytes and MΦ in the medulla, without influencing the 
fluorophores fluorescent signal. 
 
Figure 2.1 Distribution of NG2+ pericytes in a region of interest (ROI) from mouse tissue. 
Images are a representative confocal acquired ROI from murine tissue incubated for 4-hours 
in control physiological saline solution (PSS), fluorescently showing anti-neural-glial-2 (NG2; 
a;red) and Hoechst 33342 (H342;blue) fluorescence. On the left is the maximal intensity z-
projection where cell counts were performed. Individual cell bodies can be identified by NG2+ 
immunofluorescence surrounding a Hoechst 33342+ nucleus, indicated by numbers in the 
reconstruction (left) and white arrows in the non-reconstructed images (right). As can be seen 
in the non-reconsctructed images, pericytes occur across multiple planes and as such these 
were used in tandem to ensure accurate cell counts. 52 pericytes were counted for this ROI 
projection, though for clarity only 5 are shown. 
 
Images acquired were processed off-line using FIJI software (Schindelin et al., 2012). 
In both SD and C57 for NG2+ experiments, dual channel images were used to quantify 
the number of pericytes or MΦ cells present individually, determined by red or green 
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staining surrounding a Hoechst 33342 (blue) stained nucleus from maximal intensity 
reconstructed z-stacks, so cell counts were not duplicate (Figure 2.1). As F4/80+-
labelled MΦ were abundant and clearly defined these were counted in the same 
manner as NG2+-labelled pericytes, whilst CD163+ MΦ were scarce and did not require 
such extensive counting. After cell counts, tri-channel images were used to determine 
if any nuclei were positive for both red and green staining to establish if co-expression 
of receptors around the same nuclei occurred and therefore demonstrate co-labelling. 
For examples of co-labelling see Figure 3.9. 
In the mouse, but not the rat spatial distance between between F4/80+-labelled and 
NG2+-labelled cell bodies. Subsequently, the percentage of the total F4/80+-labelled 
and NG2+-labelled cells per render that had cell-cell contact was calculated. Use of 
spectrally separated fluorophores for MΦ and pericytes allowed detection of 
independent cell populations as well as co-labelling. Cell-cell contact was defined as 
non-co-labelled, “oppositely” labelled Hoechst 33342+ nuclei that had no measurable 
space between the fluorescent soma, no pseudopodia or pericyte processes. The 10 
μm depths of field of the renders allowed for greater resolution of this phenomena and 
allowed distinguishing of true contacts from instances in which pericytes and MΦ co-
localized in the x-y plane but were in fact separated in the z dimension (Figure 3.3 and 
Figure 5.5 and 5.6). For cells not in direct cell-cell contact, minimal distance between 
oppositely labelled soma were measured. This distance was measured in the same 
slice of the z-stack render where both the NG2+ and F4/80+ cells soma were visible. 
Distance was calculated with both the NG2+-labelled pericytes as the loci of 
measurement, and F4/80+-labelled MΦ as the loci of measurement because distances 
may vary as vascular-resident NG2+ pericytes, unlike F4/80+ MΦ, are not motile in 
control conditions. 
NG2+ pericyte density per 100µ2, and pericyte size for both PDGFR-β and NG2+ 
pericytes was calculated as described above in section 2.3. vasa recta diameter 
encircled by PDGFR-β+ or NG2+ pericytes was measured as described in section 
2.3.For PDGFR-β+ experiments,  maximal intensity z-stacks of the 10 μm-deep z-
projections (214.21 μm x 214.21 μm)  were reconstructed in order to calculate the 
percentage of the render area positive (%area)  for PDGFR-β to quantify these 
pericytes, as reported in the literature previously (Ikeda et al., 2018; Craggs et al., 
2015). NG2+ density has also been calculated this way (Nakano et al., 2017; Hesp et 
al., 2017), so for comparison between the two pericyte markers this was another way 
NG2+-pericyte density was calculated.  The %area is not the same as an objective cell 
count and is a limitation of this method for quantification, and inter-sample variability 
of staining influences results, as observed in section 3.3.4. This technique is not as 
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readily reproducible, objective, nor comparable with studies that provide a cell count. 
However, there was no practical way of counting PDGFR-β+ cells given the expansive 
nature of PDGFR-β staining (Figure 3.1 and 5.1), and has been reported as a difficulty 
for this marker previously (Floege et al., 2008). The use of the %area was deemed 
necessary here. All other measurements taken for PDGFR-β+ pericytes and 
experiments involving this marker were the same as described above. Limitations to 




Values are presented as the mean ± standard error mean (SEM), n numbers are 
presented as the number of animals used then the number of kidney slices. The 
number of animals, not slices, was used for calculation of the SEM. At least 3 animals 
were used per final series of experiments. SEM, not confidence intervals (CI) were 
used as n numbers of animals, not slices, were used to calculate the SEM. SEM falls 
as n increases, yet in this study n values were small and thus SEM here would not 
erroneously imply a small spread of data. Statistical significance was calculated using 
a two-tailed Student’s t-test, paired or unpaired when relevant. For statistical analysis 
between differing concentrations of the same vasoactive agent used in the murine 
functional experiments, a one-way ANOVA with post-hoc Bonferroni correction. For 
statistical analysis between IL-1β-stimulated, TNF-α-stimulated, and PSS control 
experiments, a one-way ANOVA with post-hoc Dunnett’s tests were performed to 
compare treatment groups. Values were calculated using GraphPad PRISM 5.0 
software (La Jolla, California).  A value of p < 0.05 was considered statistically 




3 A RODENT LIVE KIDNEY SLICE MODEL TO INVESTIGATE THE 




Pericytes are a vascular-resident cell present throughout all tissues, and are 
responsible for providing structural support to the microvasculature and regulating 
capillary blood flow (Shaw et al., 2018), at the microcirculatory level. Functional 
evidence from isolated outer medullary descending vasa recta (OMDVR) (Silldorff et 
al., 1995; Pallone et al., 2000; Pallone, and Silldorff, 2001), and more recently the “live” 
rodent kidney slice technique (Crawford et al., 2011; Crawford et al., 2012), provides 
compelling evidence of renal pericytes responding to locally synthesized vasoactive 
agents, and can thereby independently regulate medullary blood flow (MBF).  Loss of 
pericytes leads to renal dysfunction (Kramann et al., 2017), and their role in MBF 
regulation shows how integral pericytes are in maintaining homeostasis in the kidney.   
However, emerging evidence suggests the quiescent activity of pericytes goes beyond 
haemodynamic regulation and can vary in an organ specific manner (for more detail 
see Chapter 1 Section 1.2.2). Yet, recent work has shown a cross-organ and cross-
species, interactive role for pericytes in the innate immune system (Proebstl et al., 
2012; Stark et al., 2012; Hung et al., 2017; Balabanov et al., 1996; Schreiner, 1992; 
Winau et al., 2007; Yang et al., 2016; Navarro et al., 2016). The perivascular position 
of pericytes is of strategic advantage for surveillance in both the intra- and 
extravascular space, as well as co-ordinating the immune response (chapter 1 
section 1.3) (Navarro et al., 2016; Alon, and Nourshargh, 2013). In rats, humans, and 
mice inflammation is co-ordinated at the DVR (Kielar et al., 2005; Ysebaert et al., 
2004), this pericyte multifunctionality is a cross species behaviour in the kidney (Liu et 
al., 2018; Xavier et al., 2017) (see Chapter 1 section 1.4 for limitations). 
This trans-species trend in function suggests a conserved activity of pericytes, much 
like pericyte-mediated regulation of vasa recta diameter (Sendeski et al., 2013). 
However, some early findings demonstrating immunoactivity of pericytes have been 
contested, highlighting the importance of accurate identification of cell types (Krueger, 
and Bechmann, 2010). There are multiple reasons why confusion exists over which 
populations of cell, residential macrophage (MΦ) or pericytes, are responsible for 
immunoactivity (see chapter 1 section 1.3.3).  Much data on immunoactivity has been 
generated in vitro (section 1.3). Ex vivo analysis of extracted cell suspensions 
oversimplifies both MΦ and pericyte populations, and does not reflect their in vivo  
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morphology, distribution (Gordon, and Plüddemann, 2017; Gordon et al., 2014) or 
functionality (Stapor et al., 2014). Results can be further confounded by overlapping 
expression of classical resident MΦ markers CD68 (Rustenhoven et al., 2016) and 
CD163 (Balabanov et al., 1996; Honda et al., 1990), and commonly used pericyte 
markers NG2 (Moransard et al., 2011; Komuro et al., 2017) and PDGFR-β (Inaba et 
al., 1993; de Parseval et al., 1993). Objective cell quantification and 
immunohistochemical techniques are ideally used together to determine cell 
populations.  
The use of the rodent “live” kidney slice model is beneficial for studying cellular 
diversity, and by preserving the renal architecture cellular communications are 
maintained (Stribos et al., 2016), and show exclusively residential MΦ with no source 
of circulating leukocytes (Stribos et al., 2016). The rodent slices in this technique are 
200 μm thick (Peppiatt-Wildman et al., 2012), which will allow for visualisation of the 
complex arrangement of renal MΦ and pericytes, and how that may change over time 
within the same animal; multiple slices mean an animal can act as its own time-point 
control.  Immunohistochemical analysis of α-SMA expressing pericytes encouraged 
investigations into pericytes contractile capabilities, identifying renal pericytes co-
expressing MΦ receptors,  with consideration for the notable pericyte morphology 
(Attwell et al., 2016), may encourage more accurate investigation in pericyte 
multifunctionality.  
As such, the primary aim here is to determine if the rodent kidney slice model is 
suitable for investigations into the multifunctional nature of renal pericytes, by i) 
validating the use of anti-PDGFR-β, -CD68, and -CD163 as identifying markers of 
pericytes and MΦ in the live slice preparation, ii) co-immunostaining with antibodies 
that reportedly identify both pericytes (anti-NG2 and anti-PDGFR-β) and MΦ (anti-
CD68 and anti-CD163), and iii) seeing if co-expression is either basally present, or can 
be induced by emulating pro-inflammatory environments using TNF-α and IL-1β, 
cytokines previously shown to encourage immune activities of pericytes (Proebstl et 






Intact live kidney slices from Sprague-Dawley rats were obtained as described in the 
general methodology chapter and processed as described in chapter 2 section 2.1. 
 
3.2.1  Immunohistochemical staining of Sprague-Dawley kidney slices. 
 
See Chapter 2 for more detail, but in brief, initial exploratory immunohistochemical 
experiments to identify whether antibodies are appropriate markers for identifying 
residential cell types were performed. Anti-CD68 (rabbit, 1:100; Abcam) and anti-
CD163 (mouse; 1:100; Bio-Rad), were used to determine the presence of MΦ cells in 
the rodent kidney slices. To assess suitability of anti-PDGFR-β as a pericyte marker 
in the rodent slice preparation, immunohistochemical experiments were performed 
using Alexa Fluor 488-conjugated IB4 (Invitrogen) to label capillaries and anti-PDGFR-
β (rabbit, 1:500; William Stallcup) used to label associated pericytes. Markers were 
deemed suitable if positive immunofluorescence was identified combined with 
appropriate morphology. 
For subsequent co-expression experiments, slices were incubated with anti-CD163 to 
identify MΦ and either anti-PDGFR-β or anti-NG2 (1:200, Merck-Millipore) to identify 
pericytes. Nuclear stain Hoechst 33342 5 μM (Invitrogen) was included for positive 
identification for a cell body to enable identification of any overlap between the nuclei 
of pericyte and MΦ cells by correlation of their blue nuclei in images. Inclusion of rodent 
MΦ marker anti-CD163 was to also provide clarity as to whether anti-NG2 and anti-
PDGFR-β exclusively stain renal pericytes and not MΦ. Experiments where kidney 
slices were fixed with 4% paraformaldehyde (PFA) immediately post Hoechst 33342 
incubation were performed to see if under homeostatic conditions any co-expression 
of pericyte and macrophage markers occurred. These tissues that were freshly slices 
were classified as the “0-hour” experimental group. To stimulate co-expression of MΦ 
and pericyte markers, slices were stimulated with pro-inflammatory cytokines TNF-α 
and IL-1β. The PSS controls in the cytokine stimulation experiments are referred to as 
the “4-hour” control. 
Kidney slices were incubated in Hoechst 33342, and then washed with PSS, slices 
were then fixed in 4% PFA then washed in 0.1 M phosphate buffered saline (PBS). 
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Tissue then underwent permeabilisation in 0.1% Triton X-100, and a step to block non-
specific antibody binding with 10% donkey serum solution, before an overnight 
incubation with primary antibodies. Subsequently, slices were washed with 0.1 M PBS 
and the primary antibodies were probed with fluorescent secondary antibodies donkey-
anti-rabbit Alexa Fluor 555 (donkey, 1:200; Invitrogen), and donkey-anti-mouse Alexa 
Fluor 488 (donkey, 1:200; Invitrogen). Slices were then washed a final time using PBS, 
then mounted using Citifluor (Agar Scientific) and stored at 4°C in the dark. Unless 
otherwise specified, reagents are from Sigma-Aldrich. 
Tissue sections stimulated with pro-inflammatory cytokines TNF-α, and IL-1β (10 
ng/mL; R&D Systems) were incubated for 4 hours prior to be processed as described 
above. Cytokine stimulations have a corresponding “4-hour” PSS-time control. Data 
acquisition and analysis was conducted as described in chapter 2 section 2.5. 
 
3.2.2 Statistics.  
 
All data is presented as mean values ± standard error mean (SEM), n numbers are 
presented as the number of animals used, then the number of kidney slices. The SEM 
is calculated with the number of animals used in the IHC experiments. Statistical 
significance was calculated using a two-tailed Student’s unpaired t-test for superfusion 
and “0 hour” PSS background experiments, and a one-way ANOVA with post-hoc 
Dunnett’s test was used for cytokine-stimulated and control tissue that was incubated 
for 4-hours. Values were calculated using GraphPad PRISM 5.0 software (La Jolla, 




3.3.1  Vasa recta pericytes are identifiable via immunohistochemical staining 
with PDGFR-β. 
 
The suitability of anti-PDGFR-β for labelling vasa recta pericytes was determined by 
the presence of Alexa-555 2° fluorescence (used to probe anti-PDGFR-β) adjacent to 
IB4 labelled vasa recta capillaries, and by brightfield images used to confirm 
morphology. A positive pericyte identification required PDGFR-β+ cells to present the 
notable morphology (Figure 3.1(aii-iii)); namely large, round cell bodies (Armulik et 
al., 2005) with branched cytoplasmic processes (Smith et al., 2012; Peppiatt-Wildman, 
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2013). PDGFR-β+-labelled cells were extensive throughout the rodent kidney, present 
in all regions, and closely associated with IB4 stained vessels (Figure 3.1(a)). In the 
cortex, comparative to NG2, there is extensive expression throughout the interstitial 
zone of the cortical labyrinth, and from mesangial cells of the glomerular tuft. It is 
reportedly not expressed by smooth muscle cells of the arteries or podocytes in healthy 
tissue (Floege et al., 2008), corroborated by observations here (n=1 animal and 2 
slices; Figure 3.1(ai)). Use of PDGFR-β in murine tissue concurrently (section 5.3.2) 
showed comparable staining and as such it was deemed that further validation of 
PDGFR-β was not needed and this antibody could be used for further study. Capillaries 
were distinguished based on linearity, as the medullary capillary plexus is extensively 
tortuous (Ren et al., 2014) , whereas vasa recta capillaries are organised into straight 
vascular bundles (Pallone et al., 1998b).  In the medulla, it is greatly expressed on 
pericytes around the vasa recta (Figure 3.1(aii-iii)). 
These cells have a preponderance in the renal medulla, and it is likely not all the cells 
positively identified with PDGFR-β fluorescent stain are pericytes. Yet, on the vascular 
bundles PDGFR-β+-labelled pericytes show the notable large soma and “bump-on-a-
log” pericyte-identifying morphology (Peppiatt et al., 2006). It is important to note, 
however, in the inner medulla anti-PDGFR-β stains interstitial fibroblasts (Figure 
3.1(c)), as demonstrated by their “rung on a ladder” elongated morphology (Kriz, and 
Kaissling, 2013), yet these are still distinguishable from true pericytes. Interestingly, 
unlike with NG2+ pericytes, PDGFR-β+ pericytes are occasionally paired along the 
vasa recta capillaries (Figure 3.1(b)) and PDGFR-β+-labelling does not reduce deep 
into the inner medulla (IM). Direct like-for-like comparisons of PDGFR-β+ and NG2+ 
pericytes are presented below in section 3.3.3. 
 
3.3.2 CD68 and CD163 expression is regionally specific in rodent kidney slices. 
 
In this study, known rodent residential macrophage (MΦ) receptors CD68 and CD163 
were targeted for their expression by both rat and human MΦ (Lee et al., 2008), as 
well as reported presence on pericytes (Balabanov et al., 1996; Pieper et al., 2014). 
Prior to co-labelling experiments with pericyte markers anti-NG2 and anti-PDGFR-β, 
these antibodies were trialled alone to determine their proximity to the medullary 
vasculature as no comment has previously been made for regional presence of 
CD163+ or CD68+ MΦ in a slice preparation. Usefulness for potential future 
identification of perivascular cells co-expressing MΦ and pericyte proteins could first 
be assessed by using the morphology and both the regional and perivascular location 
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of CD68+-fluorescently labelled or CD163+-fluorescently labelled cells. If no medullary 
presence of these markers were present, it is unlikely rodent vasa recta pericytes 
would express these cell surface proteins. 
 
Figure 3.1 Platelet derived growth factor receptor-β (PDGFR-β)+, CD68+, and CD163+ 
positive staining in the Sprague-Dawley rat. 
Representative regional images of PDGFR-β+ staining (red) in the (ai) cortex, (aii) outer 
medulla (OM), and (aiii) inner medulla (IM) along IB4+ capillaries. PDGFR-β+ cells are 
extensively present throughout the rodent kidney. (b) PDGFR-β+ pericytes were occasionally 
paired along vasa recta capillaries. (bi) PDGFR-β alone, (bii) bright field (BF), and (bii) 
composite image (biii; n = 2 animals and 5 slices). (ci) Shows IM PDGFR-β+ cells that have 
“rung-on-a-ladder” fibroblast morphology (*)(Kriz, and Kaissling, 2013). White arrow heads 
indicate pericyte and mesangial cell bodies, determined by glomerular or medullary location 
(diii) CD68 (red; n=1 animal and 3 slices) staining was perivascular and localised to arterioles, 
with comparable morphology to PDGFR-β+ (di), and neural-glial 2+ (dii; NG2+; red; n=4 animals 
and 9 slices). (ei-iii) Representative images of CD163+ macrophage (MΦ; green; highlighted 
with blue dashed circles). When present, CD163+ MΦ were closely apposite the vasculature 
(white dashed lines) and pericytes (yellow dashed circles). (ei) CD163, (eii) BF and (eiii) 
composite image (n=1 animal, and 1 slice). Structures (dashed lines); G = glomerulus, vr = 
vasa recta, T = tubule. Scale bars are 5 μm or 10 μm. 
 
After preliminary experiments with anti-CD68 it was observed there were few cells 
positively expressing this receptor all of which were found in the cortex of the slice, 
perivascular to the arterioles as shown in Figure 3.1(diii), Morphological and location-
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dependent discrimination meant anti-CD68 was not used in subsequent experiments, 
not fitting criteria set out in the above paragraph (n=1 animal, and 1 slice). As murine 
experiments with CD68 were performed concurrently, and showed only cortical 
staining in a similar fashion (Figure 5.2(c)) CD68 is reported as a pan-MΦ marker 
(Davies et al., 2013), but also used to quantify infiltrating MΦ (Rubio-Navarro et al., 
2016; Ysebaert et al., 2004; Mattson et al., 2006). In the context of this experimental 
model, there are no means by which infiltrating MΦ can be recruited as there are no 
circulating leukocytes (Stribos et al., 2016). Any circulating cells in the vasculature are 
likely to have been washed out during the slicing procedure as evidenced by the 
complete absence of red blood cells in the capillary in Figure 3.1(e). Positively stained 
CD68 cells were morphologically similar to NG2+ and PDGFR-β+ fluorescently labelled 
cells surrounding the arterioles (Figure 3.1(d)). However, data suggests these 
arteriolar cells form a complete muscular wall (Gattone et al., 1984; Molema, and Aird, 
2012), and are therefore not spatially separated pericytes (Attwell et al., 2016). 
Summatively, morphological and location-dependent discrimination excluded CD68 
from subsequent experiments. 
Initial experiments with anti-CD163, like anti-CD68, showed expression by few cells 
(n=1 slice, 1 animal), yet CD163+ fluorescently-labelled cells were present primarily in 
the renal medulla, closely apposite the vasculature (Figure 3.1(e)). Some of these 
CD163+ MΦ had comparable large, ovoid cell bodies, as determined by bright-field 
images (Figure 3.1(eii) and Figure 3.2(a-b), (d)), to the pericytes identified residing 
along the vasa recta capillaries. The non-ovoid CD163+ MΦ were fusiform, with short 
processes (Figure 3.2(c-e); images in Figure 3.2 taken from the control 0-hour PSS 
experiments). Unlike pericytes, the CD163+ MΦ shape was spread along the vessel, it 
did not resemble staining shown in Figure 3.2 for PDGFR-β+ pericytes, or for NG2-
identified pericytes (Figure 3.3; taken from the control 0-hour PSS experiments). 
The CD163+ MΦ were interspersed throughout tissue sections, with cell bodies 
separated by microns in the z-plane. As such, to visualise the medullary CD163+ MΦ 
z-stack acquisition was deemed necessary for more accurate identification of co-
labelling of cell soma with pericyte markers and CD163, and the spatial relationship 
between CD163+ MΦ and pericytes. A 2D rendition could also deceptively show co-
staining when in-fact the cells reside side-by-side in the optical plane, as well as an 
underestimation of their total cell number, hence the need for a deeper render. Adding 
the third dimension, in the form of a 10 μm-deep z-stack would enable accurate 
determination of co-expression around a Hoechst 33342-identified nuclei as CD163+ 
was sparse this better reflected their presence in the interstitium, illustrated in Figure 
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3.3.  Given the proximity the vasculature of the CD163-identified MΦ, and residence 
in the medulla, anti-CD163 was used to co-stain with anti-NG2 and anti-PDGFR-β. 
 
 
Figure 3.2 Morphologies of CD163+ macrophage (MΦ). 
Images show renal CD163+ MΦ morphology, with brightfield (BF; i), CD163 (green; ii), Hoechst 
33342 (H342; blue; iii) channels and the corresponding composite (iv) shown (a-e). CD163+ 
MΦ typically had ovoid morphology with no ramifications (a-b) or fusiform with short processes 
(c-e). Proximity to the vasa recta capillaries (yellow dashed lines) is demonstrated for MΦ (light 




3.3.3 PDGFR-β+ pericytes are larger and more abundant than NG2+ pericytes. 
 
Rodent kidney slices were co-immunostained with either: anti-NG2, anti-CD163 and 
Hoechst 33342; or anti-PDGFR-β, anti-CD163, and Hoechst 33342, to investigate any 
co-labelling of pericyte-identifying and MΦ-identifying markers around individual 
Hoechst 33342+ nuclei, and the spatial relationship between these cell-types. In other 
tissues the abundance of PDGFR-β-labelled and NG2-labelled pericytes vary 
dependent to where upon the vascular tree they reside (Murfee et al., 2005; Dore-
duffy, and Esen, 2018); in the kidney this was established as approximately 3:1 
PDGFR-β+ to NG2+ pericytes (LeBleu et al., 2013). Anti-PDGFR-β had not been used 
as a pericyte identifying marker with the slice technique, so PDGFR-β+ pericyte 
density, along with the pericyte size and the diameters of the vasa recta vessels on 
which they reside, were calculated, as staining with these antibodies outlines the  
 
Figure 3.3 Features of neural-glial-2 (NG2)+ pericyte and CD163+ macrophage (MΦ) 
distribution. 
Images (i-ix) are a composite montage of an 8 μm section from a 10 μm z-projection of 
fluorescent staining with anti-NG2 (red), anti-CD163 (green), and Hoechst 33342 (H342; blue). 
Pericyte cell bodies are highlighted with blue dashed circles, whilst MΦ are highlighted with 
yellow dashes around the entirety of the cell. White arrow indicates MΦ cell body, only present 
in the first 4 images. Of note is the regular, round morphology of pericytes throughout the 
render compared with the ramified, MΦ spread. n= 3 animals and 9. Scale bars are 10 μm. 
 71 
shape of the capillaries (Minocha et al., 2015). NG2+ pericyte density for rat kidney 
slices has been characterised as the number of NG2+-fluorescently labelled cell bodies 
per 100 μm2, and here in the rat was quantified to be 11.9±0.9 cells per 100 μm2 in 
theouter medulla (OM; Table 3.1), significantly greater than in the rat IM (7.2±0.6 cells 
per 100 μm2, p<0.0001; n = 3 animals and 9 slices; Table 3.1), non-significantly 
different with what was previously reported (Crawford et al., 2012). 
As seen in Section 3.3.1, PDGFR-β+-labelling is not wholly pericyte-specific and made 
accurate cell quantification impractical. Therefore, PDGFR-β+ and NG2+ pericyte 
density was calculated as described in section 2.5, the percentage of the area in the 
ROI occupied by positive immunolabelling. In healthy kidney sections, PDGFR-β+ 
density was significantly greater in the OM than the IM (32.6±1.2%, vs 21.7±1.2%, 
p<0.0001; n= 3 animals and 9 slices), and significantly greater than the NG2+ density 
in both the OM (10.1±1.0%, p<0.0001; Figure 3.4(ei)) and IM (4.8±0.6%, p<0.0001; 
Figure 3.4(ei)) as might be expected from previous reports on PDGFR-β; NG2 density 
in the kidney (LeBleu et al., 2013), and the expansive nature of PDGFR-β fluorescent 
labelling.  
Table 3.1 Characteristics of platelet derived growth factor receptor-β (PDGFR-β)+ and 
neural-glial 2 (NG2)+ pericytes in the renal medulla. 
 PDGFR-β NG2 OM1 IM2 OM IM 
Pericyte Density   
Area3 32.6±1.2*** 21.7±1.2***$ 10.1±1.0 4.8±0.6$ 
#4 N/A 11.9±0.9 7.2±0.6# 
Pericyte size, μm   
Height  5.6±0.2 5.2±0.3 4.8±0.2** 4.3±0.2** 
Width 6.8±0.3 6.2±0.4 7.2±0.3 6.8±0.3 
Vessel diameter, μm  
P5 site 7.9±0.3 7.2±0.2* 
NP6 site 10.0±0.3% 9.0±0.2%* 
Data presented are the mean±SEM. n = 3 animals and 9 slices, ≥ 200 pericytes per animal 
1OM= outer medulla, 2IM = inner medulla 
3Area calculated as the average percentage of area occupied with fluorescent stain per 10 μm 
deep (214.2 μm2) z-projection, 4# =Number of cells per 100 μm2 
5P = Pericyte, 6NP= non-pericyte 
*p<0.05; **p<0.01; and ***p<0.0001 between NG2+ and PDGFR-β+ pericytes  
%p<0.001 P vs NP. 
$p<0.01; #p<0.0001 between the OM and IM.  
 
Pericyte soma size was quantified as describe in section 2.4. PDGFR-β+ pericytes, 
identified by positive fluorescent labelling and BF morphology and location on vasa 
recta capillaries, are significantly larger in height than NG2+ pericytes in the OM 
(5.6±0.2 μm vs 4.8±0.2 μm, p<0.01; Table 3.1), and in the IM (5.2±0.3 μm vs 4.3±0.2 
μm, p<0.01; Table 3.1). However, there is no significant difference between PDGFR-
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β+ and NG2+ pericyte width in the OM (6.8±0.3 μm vs 7.2±0.3 μm, p>0.05), or IM 
(6.2±0.4 μm vs 6.8±0.3 μm, p>0.05). NG2+ pericyte characteristics here are consistent 
published NG2 pericyte characteristics (Crawford et al., 2012). Considering pericyte 
markers separately, there were no significant differences found between the OM and 
IM pericyte size for either stain (p>0.05). 
Considering pericyte markers separately with regards to vasa recta diameter; pericyte 
sites, the site where the pericyte soma resides, were significantly narrower than non-
pericyte sites, the section of vessel without pericyte cell coverage. The average vessel 
diameter covered with NG2+-labelled pericytes reside was 7.2±0.2 μm at pericyte sites, 
and 9.0±0.2 μm at non-pericyte sites (p<0.001; Figure 3.4(eii), Table 3.1). For 
PDGFR-β+ pericyte covered vasa recta, the average pericyte site diameter was 
7.9±0.3 μm, significantly narrower than non-pericyte sites (10.0±0.3 μm; p<0.001; 
Figure 3.4(eii); Table 3.1). The average vessel diameter measured for NG2+ pericyte 
covered vessels was significantly narrower than PDGFR-β+ pericyte covered vessels 
at both pericyte sites (p<0.005) and non-pericyte sites (p<0.05; Figure 3.4(eii); Table 
3.1). 
 
3.3.4  In control tissue, few CD163+ macrophages are present spatially close to 
vasa recta NG2+ and PDGFR-β+ pericytes. 
 
CD163+ MΦ were scarce in healthy rodent kidney slices, which has been previously 
reported (Kaissling, and Le Hir, 1994). As such, determining the regions of interest 
(ROI) was limited to, where possible, the definite presence of CD163 staining in order 
to investigate co-labelling and pericyte-MΦ spatial relationships and, the following data 
may overestimate CD163+ MΦ presence in the rat kidney (Table 3.2). When present, 
CD163+ cells were primarily located in the renal medulla, with no significant differences 
observed between the outer medulla (OM; Figure 3.4(a), (c)), and inner medulla (IM; 
Figure 3.4(b), (d)) and associated with the vasculature, interwoven throughout the 
tissue (Figure 3.3). The CD163+ MΦ present had two distinctive morphologies: very 
round without ramifications, or fusiform with processes (Figure 3.2). CD163+ MΦ 
reportedly have large cell bodies (Kaissling, and Le Hir, 1994), yet a degree of variation 
was observed, with the ovular CD163+ MΦ(Figure 3.1(e) and Figure 3.2(a-b), (d)) 
larger than fusiform CD163+ MΦ (Figure 3.2(c)&(e)).  
 73 
 
Figure 3.4 Both platelet derived growth factor receptor-β (PDGFR-β)+ vessel diameter, 
and fluorescent staining is significantly greater than neural-glial-2 (NG2)+ staining in the 
outer and inner medulla. 
(a-d) are representative maximal intensity z-projections of 10 μm deep z-stack, confocal 
acquired images of outer (OM;a,c) and inner medullary (IM;b,d) staining with NG2 (ai-ii, bi-
ii;red) or PDGFR-beta (aiii-iv, biii-iv; red), CD163 (green), and Hoechst 33342 (H342; blue). 





 staining, whilst blue dashed circles indicate CD163
+
 MΦ. The respective pericyte 
densities, determined by the percentage of the reconstructed render occupied by positive 
staining for PDGFR-β (orange bar) and NG2 (blue bar) can be seen in (ei) The average vasa 
recta diameter at a pericyte site (P) or non-pericyte site (NP), and comparative pericyte sites 
with (MΦ) or without CD163
+
 MΦ contact can be seen in (eii) All bar graph values represent 
means±SEM.  Scale bars = 5 or 10 µm. n= 3 animals, and 9 slices. 
$




 p<0.001, and 
&




In rodent kidney sections CD163+ MΦ were present, yet infrequent such that it was not 
possible to acquire images with CD163+ MΦ present in every render. However, as a 
subjective metric from all z-stacks acquired, when present there were 1-4 cells per 
acquisition in ~41% of OM renders from PDGFR-β experiments in the OM, and ~46% 
of IM renders; and ~46% of OM renders from NG2 experiments, and 58% of IM renders. 
This is not a true density of MΦ, and values are approximations only for ROI identified 
as described in Section 2.5 and is a limitation of this study. On average, the number 
of CD163+ cells present were not significantly different between the IM and OM of NG2 
(0.6±0.5 cells in the OM, 0.8±0.5 in the IM, p>0.05; Table 3.2) or PDGFR-β (0.7±0.6 
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cells in the OM, 0.7±0.5 in the IM, p>0.05; Table 3.2) groups. The averaging above 
likely overestimates their abundance in healthy tissue sections due to the infrequency 
of CD163+ MΦ and is not a cellular density. 
Table 3.2 Characteristics of renal platelet derived growth factor receptor-β (PDGFR-β)+ 
and neural-glial 2 (NG2)+ pericytes in contact with CD163+ macrophages (MΦ). 
Data presented are the mean±SEM. n = 3 animals and 9 slices, ≥ 200 pericytes per animal. 
The number of CD163+ MΦ (CD163+ MΦ (#)) are calculated as the average number of cells in the 
regions of interest identified here. This is not a cellular density. 
1OM= outer medulla, 2IM = inner medulla,3P = Pericyte, 4 NP= non-pericyte    
* p<0.05; **p<0.01 for comparisons between NG2+ and PDGFR-β+ pericytes 
$p<0.05; %p<0.001 for comparisons between values presented here and corresponding values in 
Table 3.1. 
 
PDGFR-β+ fluorescent labelling was extensive and showed a sustained association 
with CD163+ MΦ, when present (Figure 3.4(c-d)), and as such direct measurements 
were not calculated for the spatial relationship between cell-types. In the NG2-labelled 
tissue, NG2 staining was not so prolific and cell soma are clearly distinguishable so 
the spatial relationship could be calculated specifically regarding the cell soma. 
Distance between NG2+ pericytes and CD163+ MΦ was measured in the same slice of 
the z-stack render, with the locus of measurement being CD163+ MΦ, where both the 
NG2+ and CD163+ cell soma were visible. Subsequently, the percentage of the total 
CD163+-labelled cells per render that had cell-cell contact was calculated. This was 
not performed with NG2+ pericytes as the focus of measurement due to limited 
numbers of MΦ. 
There was approximately 75% contact between CD163+ MΦ and NG2+ pericytes in the 
OM, with cells 34.1±5.4 µm apart if not in contact on average; and approximately 73% 
of CD163+ MΦ had contact in the IM, with cells 41.3±13.3 µm apart, on average, when 
not in contact (Figure 3.5). In a solitary cell mathematical model (Francis, and Palsson, 
1997),  and whole drosophilia wing sections (Bollenbach et al., 2008); as a realistic in 
vivo estimation, local cytokine signalling has been calculated to span a maximal 
effective distance of ~200-250 µm, or ~20-25 cell diameters, within 10-30-minutes 
(Francis, and Palsson, 1997; Bollenbach et al., 2008). This means communication is 
 PDGFR-β NG2 OM1 IM2 OM IM 
Number of CD163+ MΦ    
 0.7±0.6 0.7±0.5 0.6±0.5 0.8±0.5 
Pericyte size, μm   
Height  5.4±0.4* 4.7±0.5 4.3±0.2 4.1±0.2 
Width 6.8±0.4 5.9±0.8 7.0±0.7 6.6±0.4 
Vessel diameter, μm  
P3 site 6.7±0.4$ 5.0±0.3**% 
NP4 site 9.0±0.5 7.3±0.5*% 
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possible between these separate MΦ and NG2+ pericytes. Both distance and the 
degree of contact were not significantly different for the OM or the IM (>0.05; Figure 
3.5). 
 
3.3.5 Pericytes in contact with CD163+ macrophages are constricted in healthy 
tissue. 
 
As shown in Section 3.3.3, vasa recta diameter was significantly narrower at pericyte 
sites the non-pericyte sites, for PDGFR-β+ and NG2+ pericyte covered vessels. Given 
the extent of MΦ-pericyte contact, characteristics of vasa recta diameter and pericyte 
soma with CD163+ MΦ contact were measured to determine if MΦ-pericyte contact 
had any influence on pericyte characteristics. It is not solely the pericyte cell body that 
is involved in communications, but pericyte processes that extend along the 
vasculature allow direct chemical communications between pericytes and 
neighbouring cells (Armulik et al., 2011). Their lack of inclusion here (and in chapter 
5) is a limitation of this study as it understates any potential involvement the process 
may have in pericyte-MΦ communications or process-mediated communications. It 
may also mean the degree of pericyte-MΦ contact is greater than stated here. 
However, given the difficulty in discriminating between the pericyte soma associated 
with individual processes (section 4.3.2) versus the clarity of cell-cell contact (Figure 
3.3, 5.5, and 5.6) their involvement was not commented upon. 
Vasa recta where pericytes were in direct cellular-contact with CD163+ MΦ were 
significantly constricted at the pericyte sites comparative to those pericyte sites with 
no MΦ contact; 5.0±0.3 μm at NG2+ pericyte sites (vs 7.2±0.2 μm, p<0.001; Figure 
3.4(eii); Table 3.2) and 6.7±0.4 μm at PDGFR-β+ pericyte sites (vs 7.9±0.3 μm, 
p<0.05; Figure 3.4(eii); Table 3.2). There was a significant difference (p<0.001) 
between the corresponding non-pericyte sites for NG2+ pericyte covered vessels 
(7.3±0.5 μm vs 9.0±0.2 μm; Figure 3.4(eii); Table 3.2), but not for PDGFR-β+ pericyte 
covered vessels (9.0±0.5 μm vs 10.0±0.3 μm; p>0.05; Figure 3.4(eii); Table 3.2). 
No statistically significant differences in pericyte soma size were measured 
irrespective of MΦ contact. PDGFR-β+ pericytes in contact with CD163+ MΦ were: 
5.4±0.4 μm (vs 5.6±0.2 μm, p>0.05) in height, and 6.8±0.4 μm (vs 6.8±0.3 μm, p>0.05;) 
wide in the OM; and 4.7±0.5 μm (vs 5.2±0.3 μm, p>0.05) in height, and 5.9±0.8 μm (vs 
6.2±0.4 μm) wide in the IM (Table 3.2). NG2+ pericytes in contact with CD163+ MΦ 
were: 4.3±0.2 μm (vs 4.8±0.2 μm; p>0.05) in height, and 7.0±0.7 μm (vs 7.2±0.3 μm, 
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p>0.05) wide in the OM; and 4.1±0.2 μm (vs 4.3±0.2 μm, p>0.05) in height, and 6.6±0.4 
μm (6.8±0.3 μm, p>0.05; Table 3.2) wide in the IM. In the OM, NG2+ pericytes in 
contact with CD163+ MΦ were significantly smaller (p<0.05) than their PDGFR-β 
counterparts (Table 3.2). 
 
3.3.6 Exposure of live tissue to cytokines, and duration of incubation in control 
tissue sections, influences CD163+ macrophage presence in the renal medulla. 
 
CD163 is considered to label mature resident MΦ, whilst some resident monocytes are 
considered dormant (Fabriek et al., 2005a; Polfliet et al., 2006). Maturation of MΦ 
occurs with cytokine stimulation. As pericytes have shown to acquire immune activity 
and upregulate expression of immune receptors upon stimulation with cytokines 
(Matsumoto et al., 2014; Takata et al., 2011; Pieper et al., 2014). The primary aim of 
cytokine stimulation of rat kidney slices here was to observe if NG2+-labelled or 
PDGFR-β+-labelled medullary pericytes were “dormant” and express MΦ markers 
when activated in an emulated inflammatory state. No co-labelling of MΦ-identifying 
and pericyte-identifying markers occurred in the 0-hour experiments yet did in 
stimulated PDGFR-β tissue. This is discussed below in section 3.3.10. 
Slices that were kept in PSS control solution (n= 3 animals and 3 slices for both NG2 
and PDGFR-β experiments) or incubated with either TNF-α (10 ng/mL; n= 3 animals 
and 5 slices for both NG2 and PDGFR-β experiments) or IL-1β (10 ng/mL, n= 3 animals 
and 5 slices for both NG2 and PDGFR-β experiments) for 4-hours had an increased 
presence of CD163+ MΦ. In the PSS time-matched control conditions after 4-hours, 
there were 1-3 MΦ in approximately 70% of renders in the OM (an average of 1.3±0.3 
MΦ, and 2.1±0.6 MΦ in NG2 and PDGFR-β experiments respectively; Table 3.3), and 
80% of renders from the IM (an average of 1.8±0.4 MΦ, and 2.6±0.5 MΦ in NG2 and 
PDGFR-β experiments respectively; Table 3.3). This represented a 1.5-fold increase 
in CD163+ MΦ presence in NG2 experiments, and 1.7-fold increase in PDGFR-β 
experiments under control conditions at 4-hours compared to the 0-hour PSS 
experiments.  An important note is that whilst MΦ were present at a frequency that 
enabled selection of 3-4 ROI in cytokine stimulated tissue, the image acquisition area 
was still limited to where there was CD163+ fluorescent stain and as such, as discussed 
in Section 3.3.4, values here likely overestimate CD163+ MΦ presence in the renal 
medulla.  
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Table 3.3 CD163+ Macrophage (MΦ), platelet derived growth factor receptor-β (PDGFR-
β)+, and neural-glial-2 (NG2)+ pericyte quantification after TNF-α and IL-1β stimulation. 
 PDGFR-β  NG2 
 PSS TNF-α IL-1β  PSS TNF-α IL-1β 
Number of CD163+ MΦ     
OM1 2.1±0.6 3.4±0.5 4.4±0.6*  1.3±0.3 3.4±0.4* 3.7±0.6** 
IM2 2.6±0.5 3.1±0.4 3.6±0.5  1.8±0.4 4.9±0.8* 3.8±0.5 
Normalised CD163+ MΦ numbers, %     
OM 100.0±29.7 164.0±23.5 209.0±30.4*  100.0±25.8 257.9±27.9* 296.3±42.6** 
IM 100.0±17.4 119.7±14.9 139.4±17.5  100.0±23.1 274.7±47.2* 212.4±29.8 
Normalised pericyte area density, %     
OM 100.0±13.2 135.0±7.6* 121.6±6.4  100.0±18.8 51.9±3.6** 62.1±8.0* IM 100.0±6.5 86.5±3.5 75.7±4.1* 100.0±7.9 59.9±4.6 62.1±5.4 
Data presented as mean±SEM, n = 3 animals and 3-5 slices, ≥ 200 pericytes per animal. 
(%) Values are the percent of the PSS control mean and are calculated as the percent of the 
10 μm z-stack (214.2 μm2) occupied with positive stain. 
1OM = Outer medulla, 2IM = Inner medulla. 
*p<0.05; **p<0.01 for comparisons between cytokine stimulation and PSS  
 
After cytokine stimulation, the number of CD163+ MΦ present in the medullary regions 
ranged from 1-13 cells per field of view. Upon stimulation of rodent kidney slices with 
TNF-α, there was a 2.6-2.7-fold increase in the abundance of MΦ in both NG2 
(257.9±27.9% in the OM, p<0.05, and 274.7±47.2% in the IM, p<0.05; (Figure 3.6(d)); 
Table 3.3) and 1.2-1.6-fold increase in PDGFR-β experiments (164.0±23.9% in the 
OM, p>0.05, and 119.7±14.9% in the IM, p>0.05; (Figure 3.7(d); Table 3.3), although 
this increase was only significant (p<0.05) for NG2 experiments. Incubations with IL-
1β caused 1 2.1-2.9-fold increase in MΦ in NG2 experiments (286.3±42.6% in the OM, 
p<0.01, and 212.4±29.8% in the IM, p>0.05; (Figure 3.6(d); Table 3.3) and 1.4-2.1-
fold increase in PDGFR-β experiments (209.0±30.4% in the OM control, p<0.05, and 
139.4±17.5 % in the IM, p>0.05; (Figure 3.7(d)); Table 3.3). In both NG2 and PDGFR-
β experiments, the increase of MΦ was only significant in the OM, although there 
tended to be more MΦ in the IM. The difference between PDGFR-β and NG2 
experimental groups likely related to a higher average of MΦ in the PSS 4-hour control 
in the PDGFR-β group (Table 3.3); total cell numbers were low, so the relative 
increases observed were greater. Direct cell counts can be seen in Table 3.3. Together 
these show pro-inflammatory cytokines activate dormant MΦ in the renal medulla, as 
does the slicing procedure itself given the increase in occurrence of CD163+ MΦ 
observed in the 4-hour PSS time-matched control sections. See above section 




3.3.6.1 Cytokine stimulation did not influence contact between CD163+ 
macrophage and NG2+ pericytes. 
 
As discussed below, cytokine stimulation significantly reduces NG2+-pericyte density 
so it is possible that the emulated pro-inflammatory environment encourages increased 
MΦ-pericyte communications but cannot be commented upon further here. Cytokine 
stimulation did not significantly influence the degree of CD163+ MΦ-NG2+ pericyte cell-
cell contact with direct cellular-contact (Figure 3.5(i)), nor alter the distance of MΦ to 
the nearest NG2+ pericyte when not in contact from the time-matched PSS control in 
the IM. However, in the time-matched 4-hour PSS control OM values showed a 
significant 4.5-fold reduction in distance between MΦ and NG2+ pericytes comparative 
to the 0-hour PSS experiment 7.5±3.4 μm (34.10±5.4 μm; p<0.01; Figure 3.5(ii)), 
although the percentage of OM CD163+ MΦ with NG2+ pericyte cellular-contact did not 
significantly change (p>0.05). 
 
 
Figure 3.5 The effect of pro-inflammatory cytokines TNF-α and IL-1β on the spatial 
arrangement of neural-glial-2 (NG2)+ pericytes and CD163+ macrophages (MΦ). 
In (i) bars represent the average percentage of total CD163+ MΦ present with NG2+ pericyte 
contact per 10 μm deep z-stack (214.2 μm2) (Contact %), in the outer (OM; dark green) and 
inner medulla (IM; light green). (ii) shows the corresponding distance for CD163+ MΦ without 
direct cell contact with an NG2+ pericyte to the nearest NG2+ pericyte. “PSS 0” are values 
from the basal experiments, “PSS” is data from the time-matched 4-hour PSS control. Data 
presented as mean±SEM. * p<0.05, ** p<0.01, ns p>0.05 when compared with “PSS”. n= 3 
animals and 5 slices for TNF-α and IL-1β treatment groups, and n= 3 animals and 3 slices for 
PSS treatment group. 
 
In the 4-hour PSS control, 78.0±14.9% of OM CD163+ MΦ had direct contact with an 
NG2+ pericyte, and when not in contact MΦ were 7.5±3.4 μm apart on average. After 
TNF-α stimulation, 79.8±5.8% of OM MΦ had contact with an NG2+ pericyte (Figure 
3.5(i)), and 77.3±7.4% of OM MΦ had contact with a pericyte upon IL-1β stimulation 
(Figure 3.5(i)). The corresponding distance between OM CD163+ MΦ and NG2+-
labelled pericytes that did not have contact was a non-significant 1.9-fold increase with 
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TNF-α (14.2±2.9 μm; p>0.05; Figure 3.5(ii)), yet after IL-1β incubation it was a 
significant increase with cells 2.6-times further apart (19.5±2.5 μm; p<0.05; Figure 
3.5(ii)). 
The degree of CD163+ MΦ-NG2+ pericyte contact in the OM tended to be greater than 
that observed in the IM, and the corresponding distance between cells not in contact 
tended to be larger in the IM than the OM, across all treatment groups. However, within 
the measurements taken from the IM, there was no significant difference (p>0.05) in 
any of the treatment groups. The percentage of CD163+ MΦ in contact with an NG2+ 
pericyte was; 58.3±15.1% in PSS, 48.1±17.3% in TNF-α, and 46.32±9.2% in IL-1β, 
although there was an approximately 1.2-fold reduction in direct cellular-contact after 
cytokine stimulation (Figure 3.5(i)). Whilst not significantly reduced, there tended to 
be a higher degrree of IM CD163+ MΦ-NG2+ pericyte contact in the 0-hour PSS control 
comparative to the time-matched 4-hour PSS treatment group (73.3±10.8%; p>0.05; 
Figure 3.5(i))). 
The corresponding distances between of IM CD163+ MΦ not in contact with an NG2+ 
pericyte was also not significantly different (p>0.05). In the time-matched PSS control, 
IM CD163+ MΦ were, on average, 24.2±7.8 μm apart from NG2+ pericytes (Figure 
3.5(ii)). Upon TNF-α and IL-1β stimulation this distance between cells was 
approximately 1.3-times greater at 30.6±3.8 μm (p>0.05) and 30.3±3.1 μm (p>0.05) 
respectively (Figure 3.5(ii)). In the 4-hour PSS time-matched control, the distance 
between CD163+ MΦ and NG2+ pericytes was, on average, approximately halved in 
the IM after 4-hours comparative to the 0-hour PSS experiments (24.2±7.8 μm vs 
41.3±13.3 μm), although this change was not significant (p>0.05; Figure 3.5(ii)). 
The CD163+ MΦ-NG2+ pericyte close spatial arrangement, as discussed above in 
section 3.3.4, means that cell-cell signalling is possible within the distances 
measured. Cell-cell contact forms part of neutrophil-pericyte communication (Wang et 
al., 2012) and  the high degree of contact between MΦ and pericytes, whilst CD163+ 
total cell numbers are low, is suggestive of communication between these cell types. 
It also suggests that such communication is a feature of CD163+ MΦ activities 
regardless of pro-inflammatory states, seeing as there was not a significant difference 




3.3.7 Cytokine stimulation differentially altered PDGFR-β+ and NG2+-labelled 
pericyte densities. 
 
In kidney slices exposed only to control PSS solution, there were 14.5±5.0 
NG2+_labelled pericytes per 100 μm2 in the OM, and 8.9±1.3 pericytes per 100 μm2 in 
the IM. Cytokine stimulation significantly reduced NG2+ pericyte density in both the 
OM and IM. Stimulation of kidney slices with TNF-α resulted in a significant 48% 
reduction of pericyte density versus the time-matched control in the OM (7.5±1.2 
pericytes per 100μm2, p<0.01), and 40% in the IM (5.3±1.0 pericytes per 100 μm2, 
p<0.001; Figure 3.6(c); Table 3.3). Stimulation with IL-1β caused less of a reduction 
in NG2+ pericyte density, yet it was still a significant decrease of 38% in the OM 
(8.9±2.7 pericytes per 100 μm2, p<0.05), and 38% in the IM (5.5±1.1 pericytes per 100 
μm2, p<0.001; Figure 3.6(c); Table 3.3). 
Interestingly, when NG2+ pericyte density was calculated as the percentage area of 
the render occupied by positive fluorescent stain, as described in section 3.3.3, there 
was a non-significant reduction (p>0.05) in the OM after incubation with either TNF-α 
(6.2±0.9%) or IL-1β (8.1±0.9%) compared with the time-matched PSS control 
(9.2±1.6%; p>0.05). In the IM, TNF-α stimulation caused a non-significant reduction in 
NG2+ pericyte density (3.2±0.5% vs 4.7% density in PSS; p>0.05), yet IL-1β 
significantly reduced the IM NG2+ pericyte density by 40% (2.8±0.3%; p<0.05). This 
could be suggestive of a localised reduction of NG2+ pericyte density around the vasa 
recta capillaries as opposed to an overall reduction of NG2+ pericytes in the medulla. 
Contrastingly, with PDGFR-β experiments there was an apparent reduction of in the 
area occupied by PDGFR-β+ fluorescent labelling in the PSS time-matched control 
experiments. Comparative to the 0-hour area density of PDGFR-β+-labelling in PSS, 
there was an apparent, significant 45% reduction (17.6±2.3%; p<0.05) in the OM, and 
a non-significant reduction of 13% in the IM (21.7±1.4%; p>0.05) in the 4-hour PSS 
time-matched experiments. This could possibly relate to observations that CD163+ MΦ 
were located near the surface of the tissue in PSS 4-hour experiments demonstrated 
by the lower density of Hoechst 33342+ stain (Figure 3.6(aiii) and Figure 3.7(aiii)). 
CD163+ have been reported as a “wound-healing” (Martinez et al., 2011) or 
“remodelling” phenotype of MΦ (Olmes et al., 2015)  so in control sections CD163+ are 




Figure 3.6 Effects of pro-inflammatory cytokine stimulation on CD163+ macrophage (MΦ) 
and neural-glial-2 (NG2)+ pericyte density in the outer (OM) and inner (IM) medulla. 
Representative reconstructed maximal intensity z-projections of confocal-acquired images in 
(a-b) showing the effect of stimulation with TNF-α (10 ng/mL; i), IL-1β (10 ng/mL; ii) and the 
PSS control (iii) on NG2+-labelled pericytes (red) CD163+-labelled MΦ (green) in the OM (a) 
and IM (b). Cell nuclei were identified using Hoechst 33342 (H342; blue). The respective 
changes in pericyte density (c) and the MΦ abundance (d) are presented as the percent 
change from the PSS control. Data presented as mean±SEM. n= 3 animals and 3 slices for all 
but NG2 PSS, where n=4 animals and 4 slices. * p<0.05, ** p<0.01, *** p<0.001, ns p>0.05. 
 
Comparatively, in cytokine stimulated tissue sections there was a greater abundance 
of CD163+ MΦ distributed throughout the tissue. Subsequently, changes of PDGFR-
β+ pericyte density induced by cytokine stimulation presented here may not be 
representative of actual changes in density. TNF-α stimulated kidney slices showed a 
significant increase of pericyte density of 1.4-times that of the time-matched control 
(23.8±1.3%; p<0.05) in the OM, and a 1.2-times reduction of PDGFR-β+-labelled 
pericyte density (18.7±0.8%; p>0.05 Figure 3.7(c); Table 3.3) in the IM. With IL-1β 
treated sections, there was a non-significant 1.2-fold increase in PDGFR-β+ pericyte 
density in the OM (21.4±1.3; p>0.05), and a significant 1.3-fold reduction in the IM 
(16.4±0.9%; p<0.05; Figure 3.7(c) Table 3.3). 
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Figure 3.7 Effects of pro-inflammatory cytokine stimulation on CD163+ macrophage (MΦ) 
and platelet derived growth factor receptor-β (PDGFR-β)+ pericyte density in the outer 
(OM) and inner (IM) medulla. 
Representative reconstructed maximal intensity z-projections of confocal-acquired images in 
(a-b) showing the effect of stimulation with TNF-α (10 ng/mL; i), IL-1β (10 ng/mL; ii) and the 
PSS control (iii) on NG2+-labelled pericytes (red) CD163+-labelled MΦ (green) in the OM (a) 
and IM (b). Cell nuclei were identified using Hoechst 33342 (H342; blue). The respective 
changes in pericyte density (c) and the MΦ abundance (d) are presented as the percent change 
from the PSS control. Data presented as mean±SEM. n= 3 animals and 3 slices * p<0.05, ** 
p<0.01, ns p>0.05. 
 
3.3.8 Cytokine stimulation differentially altered PDGFR-β+-labelled and NG2+-
labelled pericyte covered vasa recta diameters. 
 
From initial experimentation (section 3.3.5), it was observed the vasa recta diameter 
was significantly narrower at pericyte sites than non-pericyte sites (Table 3.1; 
p<0.0001), for both PDGFR-β+ and NG2+ pericytes. Further to this, vasa recta where 
pericytes had cell-cell contact with CD163+ MΦ were constricted to a significantly 
greater degree than pericytes without MΦ contact (Table 3.2; p<0.0001). 
Subsequently, after cytokine stimulation, measurements of vasa recta diameter were 
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also taken from both vessels where pericytes had MΦ contact, and from vessels where 
pericytes had no MΦ contact in all treatment groups.  In time-matched 4-hour PSS 
control tissue sections, much like the initial experiments, NG2+ pericytes with direct 
cellular contact with CD163+ MΦ were significantly more constricted than pericytes 
without; the average vasa recta diameter was 5.9±0.7 μm at pericyte sites where 
CD163+ MΦ were in contact with NG2+ pericytes, significantly narrower than vessels 
without NG2+ pericyte-MΦ contact (7.2±0.3 μm; p<0.05; Table 3.4).Vasa recta covered 
with PDGFR-β+ pericytes measured 6.0±0.5 μm in width at pericyte sites in contact 
with MΦ, compared to 7.5±0.5 μm (p<0.05; Table 3.4) at pericyte sites without MΦ 
contact. No significant difference was measured at non-pericyte sites (p>0.05; Table 
3.4).   
In TNF-α treated tissue sections, when NG2+ pericytes had cell-cell contact with 
CD163+ MΦ the pericyte site diameter was significantly narrower than the PSS control 
pericyte sites with NG2+ pericyte-CD163+ MΦ contact (5.9±0.7 μm vs 4.8±0.3 μm; 
p<0.01; Figure 3.8(i)), but this was not the case for IL-1β treated sections (5.9±0.5 
μm; p>0.05; Figure 3.8(i)). There was no significant difference observed in vessel 
diameters at the corresponding non-pericyte sites, regardless of treatment with TNF-
α (8.4±0.6 μm in PSS vs 7.2±0.4 μm; p>0.05) or IL-1β (8.3±0.4 μm; p>0.05). At NG2+ 
pericyte sites without MΦ contact, vessels exposed only to PSS were significantly 
wider than TNF-α (7.2±0.4 μm vs 5.7±0.2 μm; p<0.01; Figure 3.8(i)), and IL-1β 
(5.9±0.3 μm; p<0.01; Figure 3.8(i)) stimulated vessels. Again, there was no significant 
difference in diameter at the corresponding non-pericyte sites for PSS (8.8±0.6 μm), 
IL-1β (8.3±0.3 μm; p>0.05) or TNF-α (7.8±0.2 μm; p>0.05) treatment groups. All values 
shown in Table 3.4. 
Table 3.4 Effect of TNF-α and IL-1β stimulation, and CD163+ macrophage (MΦ) presence 
on vasa recta diameter encircled by neural-glial-2 (NG2)+ or platelet derived growth 
factor receptor-β  (PDGFR-β)+ pericytes. 
Data shown as mean±SEM in μm, n = 3 animals and 3-5 slices, ≥ 200 pericytes per animal. 
1P = pericyte  site 2NP = non-pericyte site 
*p<0.05; **p<0.01 compared with PSS  
£p<0.05 comparison between MΦ contact and no contact 
 
Interestingly, unlike with NG2+ pericyte-covered vasa recta, cytokine stimulation did 
not significantly influence PDGFR-β+ pericyte covered vessel diameter, whilst CD163+ 
 PDGFR-β   NG2 
 PSS TNF-α IL-1β  PSS TNF-α IL-1β 
CD163+ MΦ contact     
P1 6.0±0.5£ 6.5±0.3 5.6±0.3£  5.9±0.7£ 4.8±0.3£ 5.9±0.5 
NP2 8.6±0.6 9.1±0.3 8.9±0.4  8.4±0.6 7.2±0.4 8.3±0.4 
No CD163+ MΦ contact     
P 7.5±0.5 7.1±0.3 6.6±0.4  7.2±0.3 5.7±0.2** 5.9±0.3** 
NP 9.5±0.7 10.0±0.4 10.1±0.4  8.8±0.4 7.8±0.2 8.3±0.3 
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MΦ cell-cell contact did. Reportedly renal PDGFR-β+/NG2- pericytes do not express 
contractile protein α-SMA (Wang et al., 2017), so this population may not be 
contractile. TNF-α stimulated PDGFR-β+ pericyte-covered vessels were 7.1±0.3 μm at 
pericyte sites (vs 7.5±0.5 μm in PSS, p>0.05; Figure 3.8(ii)), and IL-1β stimulated 
vessels were 6.6±0.4 μm (p>0.05; Figure 3.8(ii)) at pericyte sites. No significant 
difference in diameter was seen when comparing data for vessel diameter at non-
pericyte sites in PSS (9.5±0.7 μm) with that measured in in TNF-α (10.0±0.4 μm; 
p>0.05; Figure 3.8(ii)), and in IL-1β (10.1±0.4 μm; p>0.05; Figure 3.8(ii)). The vessel 
diameters measured for PDGFR-β+ pericyte sites when the corresponding pericyte had 
CD163+ MΦ contact also showed no difference between treatment groups. In the PSS 
treatment group, the pericyte site with MΦ contact measured 6.0±0.5 μm, non-
significantly different from measurements taken from IL-1β stimulated PDGFR-β+ 
pericyte-sites with MΦ contact (5.6±0.3 μm, p>0.05; Figure 3.8(ii)), or TNF-α 
stimulated sections (6.5±0.3 μm, p>0.05; Figure 3.8(ii)). There was no significant 
difference in the corresponding non-pericyte sites between PSS (8.6±0.6 μm), and 
TNF-α (9.1±0.3 μm; p>0.05) or IL-1β (8.9±0.4 μm; p.0.05; Figure 3.8(ii)). Interestingly, 
when considering the constricted nature of PDGFR-β+ pericytes with CD163+ cell 
contact, both PSS (p<0.05; as mentioned above) and IL-1β (p<0.05), but not TNF-α 
(p>0.05) showed a significant difference between the vasa recta diameters measured 
for PDGFR-β+ pericyte sites with and without CD163+ MΦ contact (p>0.05; Table 3.4). 
However, this data from IL-1β may be reflective of NG2+/PDGFR-β+ pericytes given 
this measured vessel diameter, and pericyte soma size presented below. All values 




Figure 3.8 The effect of pro-inflammatory cytokines TNF-α and IL-1β and CD163+ 
macrophage (MΦ) presence on neural-glial-2 (NG2)+ or platelet derived growth factor 
receptor-β  (PDGFR-β)+ pericyte-regulated vasa recta diameter. 
(a-b) Show the effect of TNF-α (10 ng/mL; hatched bars) and IL-1β (10 ng/mL; checked bars) 
on vasa recta diameter, encircled by either PDGFR-β+ (a; orange bars) or NG2+ (b; blue bars) 
at a pericyte site (P) and corresponding non-pericyte site (NP). Also shown is the diameter at 
a pericyte in contact with an MΦ (P-MΦ) and its corresponding non-pericyte site (MΦ-NP). 
Data presented as mean±SEM. n= 3 animals and 5 slices for TNF-α and IL-1β, and 3 animals 
and 3 slices for PSS incubations for both NG2 and PDGFR-β. ** p<0.01 for comparison to PSS 
control; £ p<0.05 for comparison between sites with or without MΦ contact. See colour key for 
treatment groups. 
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3.3.9 Cytokine stimulation, but not CD163+ macrophage cellular contact, 
influenced NG2+ pericyte soma size. 
 
It was noted in Section 3.3.3 that whilst direct cellular contact of either PDGFR-β+-
labelled or NG2+-labelled pericytes with CD163+ MΦ influences vasa recta diameter 
(Table 3.2), there was no significant influence on pericyte soma size. However, for 
consistency, measurements were taken for both pericytes with and without MΦ contact 
in all treatment groups. In PSS, NG2+ pericytes in contact with CD163+ MΦ were: 
3.8±0.4 μm in height, and 5.4±0.5 μm wide in the OM; and 3.8±0.3 μm by 5.9±0.8 μm 
in the IM. Without MΦ contact, they were 4.4±0.3 μm in height by 6.4±0.4 μm in width 
in the OM, and 4.4±0.2 μm in height by 7.2±0.4 μm in width in the IM (Table 3.5).  
Table 3.5 Effect of TNF-α and IL-1β stimulation, and CD163+ macrophage (MΦ) presence 
neural-glial-2 (NG2)+ or platelet derived growth factor receptor-β  (PDGFR-β)+ pericyte 
soma size. 
  PDGFR-β  NG2 
  PSS TNF-α IL-1β  PSS TNF-α IL-1β 
CD163+ MΦ contact     
OM1 H3 5.4±0.5 4.9±0.5 3.8±0.4*  3.8±0.4 3.9±0.2 3.5±0.3 
 W4 6.4±0.4 6.3±0.6 6.5±0.5  5.4±0.5 6.4±0.4 6.4±0.5 
IM2 H 5.2±0.7 5.5±0.3 5.2±0.3  3.8±0.3 3.8±0.2 4.0±0.3 
 W 7.5±0.3 6.2±0.4 6.6±0.4  5.9±0.8 5.5±0.3 6.5±0.5 
No CD163+ MΦ contact      
OM H 5.6±0.3 5.4±0.4 4.7±0.4  4.4±0.3 3.7±0.1* 3.6±0.2** 
 W 7.3±0.4 6.5±0.4 7.3±0.4  6.4±0.4 6.6±0.2 6.0±0.3 
IM H 5.1±0.4 4.5±0.4 5.0±0.3  4.4±0.2 3.5±0.1*** 3.4±0.2*** 
 W 7.0±0.5 6.5±0.4 6.7±0.6  7.2±0.4 6.1±0.3 6.4±0.4 
Data shown as mean±SEM in μm, n = 3 animals and 3-5 slices, ≥ 200 pericytes per animal.  
1OM = outer medulla; 2IM = inner medulla 
3H = height; 4W = width. 
*p<0.05; ** p<0.01; *** P<0.001 for comparison with PSS 
 
NG2+ pericyte height, but not width, was significantly altered upon exposure to both 
TNF-α and IL-1β. However, when NG2+ pericytes had cell-cell contact with a MΦ, there 
was no significant difference in height or width observed between all treatment groups, 
suggesting that in the 4-hour PSS experiments these NG2+ pericytes tended to be 
smaller in both height and width than those without an adjacent CD163+ MΦ. 
Stimulation with either TNF-α or IL-1β caused an approximately 16-18% reduction in 
NG2+ pericyte soma height, with no significant change in width in both the OM and IM 
(p<0.05). There was no significant difference in pericyte soma width (Table 3.5). TNF-
α stimulated NG2+ pericytes without MΦ contact measured 3.7±0.1 μm in height 
(p<0.05) by 6.6±0.2 μm in width (p>0.05) in the OM, and 3.5±0.1 μm in height 
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(p<0.001) by 6.1±0.3 μm in width (p>0.05) in the IM (Table 3.5). IL-1β stimulated 
pericytes without MΦ contact were 3.6±0.2 μm in height (p<0.01) by 6.0±0.3 μm in 
width (p>0.05) in the OM, and 3.4±0.2 μm in height (p<0.001) by 6.4±0.4 μm in the IM 
(p>0.05; Table 3.5). All other measurements for NG2+ pericyte soma are in Table 3.5. 
Much like the 0-hour PSS experiments, there was no difference in size of the time-
matched PSS PDGFR-β+ pericytes with CD163+ MΦ contact (5.4±0.5 μm in height, 
6.4±0.4 μm wide) or without  CD163+ MΦ contact (5.6±0.3 μm in height, 7.3±0.4 μm 
wide, p>0.05; Table 3.5)  in the OM,  or IM (5.2±0.7 μm in height and 7.5±0.3 μm wide 
vs 5.1±0.4 μm in height and 7.0±0.5 μm wide, with or without CD163+ MΦ contact in 
the IM respectively, p>0.05; Table 3.5). Interestingly, unlike with NG2+-labelled 
pericytes, PDGFR-β+ pericyte soma size was not significantly (p>0.05) influenced by 
cytokine stimulation, yet IL-1β stimulated, PDGFR-β+ pericytes with CD163+ MΦ 
contact were approximately 30% smaller in height in the OM (3.8±0.4 μm vs 5.4±0.5 
μm; p<0.05) but not the IM (5.2±0.3 μm; p>0.05) with no significant difference in 
pericyte soma width (Table 3.5). TNF-α stimulation caused no significant change in 
pericyte soma size with or without CD163+ MΦ cell-cell contact (Table 3.5). All other 
measurements for PDGFR-β+ pericyte soma are in Table 3.5. 
Interestingly, as mentioned in the above section, IL-1β-stimulated PDGFR-β+ pericytes 
with MΦ contact were constricted and shown here to be significantly smaller in height. 
This may reflect an IL-1β-stimulated CD163+ MΦ migratory preference to 
NG2+/PDGFR-β+ pericytes and TNF-α showed no such effect, and this difference was 
only measured for IL-1β when MΦ were present. However, as experiments were not 
conducted with both pericyte markers in tandem, it cannot be commented upon 
whether these smaller pericytes with MΦ contact are PDGFR-β+/ NG2+ or PDGFR-β+/ 
NG2-. Overall, this data suggests that cytokine stimulation with TNF-α and IL-1β, but 
not CD163+ MΦ presence, exerts a cell-surface protein specific reduction in pericyte 
soma size of NG2+, but not PDGFR-β+ pericytes. 
 
3.3.10 Stimulation of kidney slices with pro-inflammatory cytokines TNF-α and 
IL-1β does not induce CD163 expression in NG2+ pericytes but does in few 
PDGFR-β+ pericytes.  
 
The primary question that co-immunostaining was utilised to address was “is there any 
overlap in cellular expression of MΦ-identifying and pericyte-identifying markers?” as 
has been demonstrated in other studies (Rustenhoven et al., 2016; Balabanov et al., 
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1996; Honda et al., 1990; Moransard et al., 2011; Komuro et al., 2017; Inaba et al., 
1993; de Parseval et al., 1993) and “does such co-expression co-label perivascular 
cells in the kidney?”. A positive identification included red pericyte (Alexa-555) and 
green MΦ (Alexa-488) fluorescent staining around an individual Hoechst 33342+-
identified cell nuclei. Prior to experimentation, to ensure any potential co-staining 
observed would not be due to overlap of primary antibodies binding to similar protein 
sequences, the target sequences of anti-NG2 primary antibody (GENBANK: Q00657), 
anti-PDGFR-β primary antibody (GENBANK: NP_001139740), and anti-CD163 
primary antibody (GENBANK: NP_001101357.1) antibodies were aligned using the 
UniProt online alignment tool (available at: https://www.uniprot.org/align/) to determine 
sequence homology. After alignment, it was determined that anti-CD163 and anti-NG2 
sequence homology was less than 10%, and anti-CD163 and anti-PDGFR-β sequence 
homology was less than 13%. As such any observations of a Hoechst 33342+ cell body 
co-expressing MΦ and pericyte markers is not likely caused by cross-reactivity of the 
primary antibodies for pericytes (NG2 and PDGFR-β) or CD163 at the same antigenic 
sites. 
For the purpose of identifying co-staining, 2D images could limit perspective and lead 
to potential false positives by not providing the opportunity to distinguish 2 cells 
adjacent to each other in the z-plane. By adding the third dimension in the form if a 10 
μm deep z-stack (step size of 1 μm, 212.4 μm2), accurate determination of co-
expression of MΦ and pericyte markers around an individual Hoechst 33342+ cell 
nucleus is possible. Another consideration was determination of co-localisation. This 
method was chosen over a co-localisation assay because both pericytes and MΦ have 
processes and filopodia, if a computational method to determine co-localisation was 
employed it would give an overestimation of how frequently this occurs due to physical 
contact between cells not true co-localisation. A limitation in selecting regions of 
interest (ROI) was the very limited presence of CD163+ MΦ, as described in Section 
3.3.4; as these MΦ were not evenly distributed throughout the kidney image acquisition 
was restricted to where there was CD163+ cellular presence. For determination of cell 
type, i.e. would these cells be co-labelled pericytes or co-labelled MΦ, pericyte 
morphology and perivascular location would be used in tandem with co-labelling to 
determine if it was pericytic expression of MΦ CD163. 
In the 0-hour PSS experiments, neither PDGFR-β+ nor NG2+-labelled pericytes 
expressed CD163. CD163 is selectively expressed by mature tissue MΦ (Polfliet et al., 
2006), so to observe if renal NG2+ or PDGFR-β+-labelled pericytes were “dormant” 
monocytes, and could be stimulated to express CD163, kidney slices were 
subsequently incubated with pro-inflammatory cytokines TNF-α and IL-1β to determine  
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Figure 3.9 Co-expression of platelet derived growth factor receptor-β (PDGFR-β)+ with 
CD163+ on vascular resident cells in the renal medulla bearing morphological similarities 
to PDGFR-β+ pericytes. 
Representative images from experiments where tissue was incubated with either TNF-α (a-c) 
or IL-1β (d-f), showing positive staining with anti-PDGFR-β (i; red), anti-CD163 (iii; green), 
and Hoechst 33342 (H342; iv; blue) with the corresponding composite render (iv). Scale bars 
are 5 μm. 
if this phenomenon may be inducible. Simulation with cytokines could also activate 
tissue resident immature monocytes for an increased CD163+ MΦ cellular presence, 
better depicting their spatial relationship and cellular interactions with pericyte. 
No co-staining of MΦ marker CD163 and pericyte marker NG2 occurred, irrespective 
of TNF-α or IL-1β stimulation in either the IM or the OM.  Contrastingly to NG2 
experiments, there was CD163+/PDGFR-β+ co-staining observed after cytokine 
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stimulation in the medulla of rat kidney sections. Representative images can be seen 
in Figure 3.9 for TNF-α (Figure 3.9(a-c)) and IL-1β (Figure 3.8(d-f)). Further to this, 
co-expressing cells bore  morphology of  pericytes e.g. the “bump-on-a-log” 
characteristic shape (Peppiatt et al., 2006) (Figure 3.9(a)), suggesting that these are 
pericytes expressing CD163; this morphology is notable different from the morphology 
of CD163+ MΦ presented in Figure 3.2.  
Whilst a more objective approach would have been fluorescence automated cell 
sorting (FACS) to accurately identify co-expression of pericyte and MΦ markers on the 
cell surface. This has been reported as performed in the mouse previously for 
determining PDGFR-β and CD11b, co-expression (Xavier et al., 2017), where no co-
positive cells were detected. However, what was observed here is that PDGFR-
β+/CD163+ cells would be a “rare event” i.e. total cell numbers are markedly low, due 
to their infrequency and as such not readily identifiable using FACS (Rundberg Nilsson 
et al., 2013; Hedley, and Keeney, 2013), meaning they could be overlooked. However, 
the data here shows (Figure 3.9) that co-expression can be encouraged in a pro-
inflammatory environment. Further still, FACS would not provide opportunity to use 
cellular in situ morphology to observe if these are co-labelled pericytes or MΦ. Overall 
this data suggests that rodent renal PDGFR-β+ pericytes can express MΦ-identifying 





The aim of this study was to determine, using the rodent live slice model, if renal 
pericytes express MΦ-identifying markers, which could be suggestive of an immune-
phenotype. What was found here were morphological and responsive differences 
between renal neural-glial-2 (NG2)+-labelled and platelet derived growth factor 
receptor-β (PDGFR-β)+-labelled pericytes. PDGFR-β+ pericytes were significantly 
larger than NG2+ pericytes, and the vasa recta PDGFR-β+ pericytes covered were 
significantly wider in diameter. Pericyte populations also had differing responsiveness 
to pro-inflammatory cytokines TNF-α and IL-1β, with PDGFR-β+ pericytes being less 
vasoresponsive in response to stimulation, yet PDGFR-β+ pericytes, not NG2+ 
pericytes, showed co-labelling with CD163. Further still, despite limitations with a small 
population of CD163+ MΦ, data here is suggestive of pericyte-MΦ communication; 
when correlating vasa recta diameter with incidence of direct cellular-contact between 
MΦ and pericytes, it was noted that vessels encircled by both PDGFR-β+ and NG2+ 
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pericytes were significantly more constricted when in contact with CD163+ MΦ, 
indicating that a cellular communication may be occurring to alter the vessel diameter 
comparative to when these two cells types did not have cell-cell contact. 
 
3.4.1 PDGFR-β+ pericyte covered vasa recta have larger diameters and are more 
numerous than those covered by NG2+ pericytes. 
  
This study considered rodent pericytes expressing the receptor PDGFR-β and the cell 
surface proteoglycan NG2 as separate populations while investigating any possible 
differences in their characteristics. Whilst these pericyte-identifying markers have been 
used to identify functional roles of pericytes in inflammation (Xavier et al., 2017; Lemos 
et al., 2016; Proebstl et al., 2012) and fibrogenesis (Xavier et al., 2017; Chen et al., 
2011; Birbrair et al., 2014), how pericytes with differing cell surface proteins may be 
functionally and morphologically different remains unclear. Measurements of vasa 
recta diameter, soma size, and pericyte densities were calculated separately for 
PDGFR-β+-labelled and NG2+-labelled pericytes. 
The standard approach for calculating medullary NG2+ pericyte density is to calculate 
the cellular density per 100 μm2 (Crawford et al., 2012). Yet, the established approach 
for calculating PDGFR-β+ pericyte density is to calculate the percentage of the area 
positively immunolabelled for this receptor (Ikeda et al., 2018; Craggs et al., 2015). 
Further to this, PDGFR-β+ staining is extensive (Figure 3.1(a), 3.4(c-d) & 3.7(c-d)) 
and meant quantification of cell number would not have been accurate and therefore 
was not calculated. For direct comparison between pericyte groupings, NG2+ pericyte 
density was calculated was also calculated as %area. 
PDGFR-β+ is reportedly expressed by all pericytes and by numerous non-pericyte cells 
(Bergers, and Song, 2005; Díaz-Flores et al., 2009; Chen et al., 2011). Therefore, it 
would be expected to have a greater percentage of area occupied by staining than that 
measured for NG2, representing a smaller population of pericytes (Díaz-Flores et al., 
2009), restricted to the arteriolar DVR (Pallone et al., 2003b; Murfee et al., 2005).  
Much like has been previously reported with NG2+ pericytes (Crawford et al., 2012), in 
the rat pericyte “drop off”; the reduction of pericyte density between the OM and IM 
(Park et al., 1997a); was observed with a significant difference in PDGFR-β+ stain 
(Figure 3.4(eii)). Regardless of the method of measurement of NG2+ pericyte; per 100 
μm2, or the corresponding percentage of area occupied by NG2+ positive fluorescent 
staining, there was also significant reduction in density in the IM comparative to the 
OM (Figure 3.4e(ii); Table 3.1).  
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Given limitations with calculating the PDGFR-β+ / NG2+ pericyte density as %area 
here, these values are not directly comparable with published studies, which tend to 
be either 2-dimensional calculations of %area (Ikeda et al., 2018; Craggs et al., 2015; 
Nakano et al., 2017; Hesp et al., 2017), or a direct cell count per 2D ROI (LeBleu et 
al., 2013).  However, the ratio of the amount of staining for anti-NG2 and anti-PDGFR-
β correlates with ratios between cell counts for these renal pericytes, and ratios of DVR 
to AVR. There was a significant difference between the abundance of PDGFR-β+-
labelled and NG2+-labelled pericytes. In both the OM and IM, there were 3-4 fold more 
PDGFR-β+ pericytes than NG2+ pericytes, a ratio that has been previously reported for 
murine kidneys (LeBleu et al., 2013).  Literature suggests NG2+ pericytes are restricted 
to the arteriolar end of capillaries (Murfee et al., 2005). Assuming this were true for the 
kidney, the stark difference in density of NG2+ and PDGFR-β+ pericytes could 
correspond to the ratio of venular ascending (AVR) to arteriolar descending vasa recta 
(DVR), with a comparable 4-fold difference measured in the rat previously (Holliger et 
al., 1983).  However, as PDGFR-β was also present on other interstitial cells (Figure 
3.1(c)) the density calculated likely overestimates the total abundance of PDGFR-β+ 
pericytes but cannot be commented upon here.  
The diameters of vessels of the medullary capillary plexus, whilst also populated with 
NG2+ and PDGFR-β+ pericytes, were not measured because in any given plane of the 
z-stack renders capillaries had no consistently suitable length of vessel to measure, 
hence all measurements were from vasa recta capillaries. Rodent vasa recta encircled 
by PDGFR-β+ pericytes were approximately 10% larger in diameter than NG2+ pericyte 
covered vessels at both the pericyte and non-pericyte sites. It has been previously 
reported that rodent AVR are approximately 30% larger than the DVR (Holliger et al., 
1983), with postcapillary venules known to be larger vessels (Pober, and Sessa, 2014). 
If the difference in the area of positive fluorescent staining for PDGFR-β and NG2 
related to coverage of the AVR by PDGFR-β+/NG2- pericytes, it could explain why 
PDGFR-β+ vasa recta were significantly wider in diameter (p<0.05). It is also possible 
that the PDGFR-β+ measurements taken are comprised of both NG2+ and NG2- 
populations, influencing measurements for PDGFR-β+ vessels and reflect the lower 
magnitude of size difference of vessel diameters presented here. Unfortunately, co-
staining with both pericyte-identifying markers was not conducted so further 
commentary cannot be made. 
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3.4.1.1 Vasa recta PDGFR-β+ pericytes bear morphological differences to NG2+ 
pericytes. 
 
In the rodent ureteric vascular bed pre-capillary arteriolar pericytes and pericytes on 
the collecting venules (Borysova et al., 2013) bear visual morphological similarity to 
NG2+ (arteriolar) and PDGFR-β+ (venular) pericytes here. Whilst anecdotal, the larger 
soma of venular pericytes in the ureteric vascular bed reflects observations here of 
PDGFR-β+ pericyte soma being approximately 20% larger in height than NG2+ 
pericytes, and therefore potentially representing a venular population. Pericyte sizes, 
when reported, are more often presented as a combined measurement their soma and 
process coverage over the vasculature (Borysova et al., 2013). In the murine brain, 
where they measured total cell length (soma and processes), it was found contractile 
α-SMA+ “ensheathing pericytes” (EP) on the pre-capillary arteriole were approximately 
1/3rd the size of non-contractile capillary α-SMA- “mesh pericytes” (MP). Further still, 
the vessels on which EP reside were 30% larger in diameter (Grant et al., 2017). These 
differences are comparable to those presented here and suggest pericyte function may 
be inferable from both morphological differences and cell surface protein expression. 
However, whilst pericyte processes were not measured here it makes direct 
comparison difficult and is a limitation of this study, pericyte soma size also correlates 
with these differences.  
The likelihood is that the NG2+-labelled pericytes also express PDGFR-β as a pan-
pericyte marker (Chen et al., 2011), and not co-labelling for these markers is a 
limitation of this study. Whilst significant differences have been observed, it would be 
beneficial to measure pericytes that are NG2+ and NG2- separately; the average values 
presented here for PDGFR-β+ pericytes likely contain measurements from both NG2+ 
and NG2- pericytes. These experiments were not conducted because the PDGFR-β 
and NG2 primary antibodies were both raised in rabbit. The PDGFR-β was kindly 
donated by William Stallcup, with no other validated alternative anti-NG2 accessible at 
the time. A future experiment needed is to co-stain with anti-PDGFR-β and anti-NG2 
to ascertain whether the morphological differences presented above remain 
significantly different between PDGFR-β+/NG2+ and PDGFR-β+/NG2- pericytes 
separately. Overall this data, in line with that presented in the literature strongly 
suggests identifying which morphology belongs to which subtype of pericyte could be 
another tool for the identification of a known heterogeneous population of cells (Dore-
Duffy, and Cleary, 2011; Attwell et al., 2016). 
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3.4.2 In control kidney tissue there are few CD163+ macrophages, which 
primarily reside in the medulla. 
 
As only MΦ are reportedly perivascular (Lapenna et al., 2018), certain markers that 
identify multiple immune cell types e.g. MHC-II, were not deemed suitable for use here 
despite reported pericyte expression (Pieper et al., 2014; Winau et al., 2007). Two 
separate rodent MΦ-identifying markers were assessed for suitability in the rodent 
slice model, and whilst both CD68 and CD163 had positive staining, only CD163 was 
present in the renal medulla and as such this was used for further experimentation. 
CD68 is considered a pan-MΦ marker (Gordon et al., 2014; Gordon, and Plüddemann, 
2017) and is used frequently in the rodent kidney  (Rubio-Navarro et al., 2016; 
Ysebaert et al., 2004; Mattson et al., 2006). However, data here suggests that a more 
accurate description of CD68 would be of a non-residential MΦ marker given the low 
occurrence of CD68+ MΦ. The restriction to CD68 to arteriolar SMC in the cortex 
corroborates views of other authors that CD68 expression is an indicator of phagocytic 
capability instead of MΦ (Beranek, 2005). 
In healthy human kidney sections, CD163+ MΦ reside apposite the vascular bundles 
(Colvin, 2019), and an increase in CD163+ MΦ correlates with the severity of renal 
disease in; IgA nephropathy,  glomerular sclerosis, and diabetic kidney disease. 
CD163+ MΦ infiltration also correlates with the degree of interstitial fibrosis (O’Reilly 
et al., 2016; Rubio-Navarro et al., 2016; Olmes et al., 2015; Tang et al., 2019), 
accumulating at sites where α-SMA+ myofibroblasts reside (Ikezumi et al., 2011), 
suggestive of a highly pathogenic role in human renal disease. Despite the 
perivascular locale of CD163+ MΦ in human kidneys, no current studies have looked 
at their relationship with pericytes. In the rat, renal CD163+ MΦ have previously been 
noted to be few in number and almost exclusively perivascular (Kaissling, and Le Hir, 
1994), which was reflected in observations here; CD163+ MΦ maintained a high degree 
of direct cellular-contact with NG2+ pericytes. Interestingly, this remained constant 
regardless of stimulation with TNF-α or IL-1β with over 70% of MΦ contacting an NG2+ 
pericyte in all treatment groups. In an isolated cell culture model with neutrophils and 
α-SMA- porcine CNS pericytes, TNF-α stimulation encourages cell-cell contact with an 
increased adhesion between the two cell types (Pieper, and Galla, 2014), yet in this 
model, stimulation with the same pro-inflammatory cytokines does not induce a greater 
degree of cell-cell contact between CD163+ MΦs and NG2+ pericytes.  
The limited presence of CD163+ MΦ reported in control tissue sections could relate to 
numerous factors: the removal of the renal capsule, where many of these MΦ reside 
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(Kaissling, and Le Hir, 1994); a lack of residential MΦ maturity (Polfliet et al., 2006); 
CD163 identifying a niche subpopulation of MΦ, M2c MΦ (Kim et al., 2015b; Chavez-
Galan et al., 2015); or the lack of a source of circulating leukocytes to infiltrate into the 
renal interstitium (Stribos et al., 2016). When present, CD163+ MΦ had a varied 
morphology with regards to size, yet some consistencies in shape were observed with 
MΦ being ovular or fusiform in shape with processes, reported previously for CD163+ 
MΦ in embryonic rat kidneys (Matsuyama et al., 2018). It would be interesting to probe 
further if CD163+ MΦ morphology relates to subtypes, as it appeared to with pericytes.  
 
3.4.3 CD163+ macrophage and pericytes may actively communicate to regulate 
vasa recta diameter. 
 
Human renal PDGFR-β+ pericytes with cell-cell contact with CD163+ MΦ show fibrotic 
activation, however what specifically occurs remains unclear (Campanholle et al., 
2013). Over 70% of MΦ had cell-cell contact with a pericyte, it raised the question of 
“is there a reason, when present, CD163+ MΦ are preferentially next to pericytes? And 
was there a functional consequence from this association?”. No signalling mechanisms 
could be elucidated here; whilst immunohistochemistry can identify the location of 
signalling proteins it would require the inclusion of  antibodies against the active 
proteins or antibodies against phosphorylated amino acids to demonstrate the pathway 
is active (Svoboda, and Reenstra, 2002). In place of identifying specific signalling 
pathways, vessel diameter was used as a proxy to determine if there was a 
physiological outcome from direct cell-cell contact, a mechanism of MΦ communication 
(Nitta, and Orlando, 2013; Arrevillaga-Boni et al., 2014; Rodriguez et al., 2016).  What 
was found was comparative to pericytes with no MΦ contact, when either PDGFR-β+-
labelled or NG2+-labelled pericytes were in contact with an MΦ the vasa recta were 
significantly constricted.  
The DVR and AVR have a counter-current arrangement, and it has been proposed that 
circulating leukocytes migrate out from the circulation at the venular end (NG2-) of the 
capillary bed and their trajectory towards the inflammatory foci is then co-ordinated by 
the arteriolar (NG2+) pericytes (Figure 1.9) (Alon, and Nourshargh, 2013). 
Furthermore, in vivo reports in the murine cremaster muscle and ear demonstrated 
that NG2+ pericytes instructed the migration of leukocytes out of the vasculature after 
TNF-α or IL-1β stimulation (Proebstl et al., 2012; Stark et al., 2012). Leukocyte and 
platelet adherence in the postcapillary venules has been proposed to induce 
constriction of the closely paired arterioles via diffusion of vasoactive mediators in the 
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mesenteric vascular bed (Harris et al., 2005), authors were unable to determine for 
what purpose but this would increase chances of leukocyte adherence and subsequent 
extravasation in the venules by reducing the flow rate (Muller, 2013). In the medulla 
CD68+ infiltrating MΦ accumulate in the AVR post ischaemia-reperfusion injury 
(Ysebaert et al., 2004), which could potentially result in NG2+-pericyte covered DVR 
vasoconstriction. CD163+ MΦ produce TNF-α and IL-1β (Polfliet et al., 2006) and 
promote leukocyte infiltration (Guo et al., 2018); they could co-ordinate this activity 
with renal pericytes and induce the subsequent vasoconstriction. Further work is 
needed to tease out if it is pericyte sites on the AVR or DVR which have constricted 
when in contact with MΦ. There is an absence of antibodies used to identify these 
vessels, yet could involve the use of UT-B and plasmalemmal vesicle-1 which have 
been used previously to identify DVR and AVR respectively in mice and rats (Dantzler 
et al., 2011; Pannabecker, and Dantzler, 2006; Ko et al., 2010). 
Interestingly, CD163+ MΦ are reportedly involved in angiogenesis, increasing the 
permeability of the microvasculature via HIF-1α/VEGF-A signalling and weakening of 
the endothelial VE-cadherin (Guo et al., 2018), via CD163-dependent cell-cell 
interactions (Kobori et al., 2018). This would subsequently enable endothelial cell 
proliferation and generation of the angiogenic sprout (Wallez et al., 2006). However, 
in an inflammatory bowel disease model, whilst CD163+ MΦ depletion improves 
vasomotor response in the mesenteric arteries i.e. reduces the reduces vessel 
permeability, it does so in an endothelial-independent fashion (Grunz-Borgmann et al., 
2019). This suggests it is communications with a non-endothelial vascular cell type 
that are responsible for this activity, possibly pericytes. Data presented here suggests 
that this cell-cell communication could be MΦ-pericyte mediated as it was the pericyte 
site where the vessel diameter was significantly altered, regardless of cytokine 
stimulation. In the murine cochlear duct pericytes, endothelial cells and MΦ maintain 
vascular stability of the stria vascularis (Neng et al., 2013), therefore MΦ- pericyte 
communications could potentially be a homeostatic mechanism in the kidney to 
regulate vessel diameter. 
 
3.4.4  Stimulation of tissue with TNF-α and IL-1β increase the number of CD163+ 
macrophages in the medulla. 
 
There are contradictory reports regarding the activation of CD163+ MΦ by pro-
inflammatory cytokines. IL-1β has been shown to upregulate CD163 expression in 
monocytes (Darrieutort-Laffite et al., 2014; Schenk et al., 2014) whereas TNF-α 
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supresses it (Buechler et al., 2000). As the primary focus of this study was pericyte 
activation, and TNF-α and IL-1β are known to encourage immune functionality for 
pericytes (Proebstl et al., 2012; Pieper et al., 2013; Nehmé, and Edelman, 2008) these 
cytokines were deemed suitable for use in experimentation here. However, it is 
important to note these values are not objective and the quantification of MΦ here is a 
limitation of this study. However, selection of ROI was restricted to where both CD163+ 
MΦ and pericytes were present and as such quantification for the ROI were performed.  
Following the 4-hour incubations there was an apparent activation of dormant 
residential monocytes given the semi-quantitative 1.5-fold increase in CD163+ MΦ in 
the time-matched 4-hour PSS experiments comparative to the 0-hour PSS 
experiments. In precision cut lung slices of Fischer 344, there was an increase 200-
1400 pg/mg increase in IL-1β and TNF-α present, followed by an increase of CD68+ 
MΦ in tissue sections by approximately 1.3-fold in was observed control conditions 
after a period of 7 days, and that within 3 hours of slice incubation there was a 
(Behrsing et al., 2013). A comparable upregulation of TNF-α, IL-6, and IL-1β mRNA 
was observed in C57BL/6 brain (Schroeter et al., 2003) and both precision cut murine 
(Poosti et al., 2015) and human (Stribos et al., 2016) kidney slices within 3 hours. TNF-
α and IL-1β stimulation resulted in a 1.2-2.7-fold increase in CD163+ MΦ and shows 
dormant residential MΦ can be activated by TNF-α and IL-1β to express CD163 
(Figure 3.6 and 3.7). The degree of MΦ-pericyte contact was higher in the OM than 
in the IM, regardless of cytokine treatment, despite no significant difference in the total 
number of CD163+ MΦ present in the fields of view between the OM and IM regions 
(Table 3.3), possibly suggesting a regional preference for CD163+ MΦ activity with 
NG2+ pericytes but more work is needed. Whilst the data present ed regarding the 
regional differences in CD163 MΦ is not strong, the effect of their presence on vasa 
recta diameter (3.4.3) is an objective quantification and a beneficial finding.  
 
3.4.5 TNF-α and IL-1β stimulation significantly reduce NG2+ pericyte density in 
both medullary regions. 
 
Following 4-hour incubations with pro-inflammatory cytokines TNF-α and IL-1β, NG2+ 
pericyte density was significantly reduced. TNF-α and IL-1β stimulation reduce 
pericytic expression of α-SMA and PDGFR-β (Persidsky et al., 2016; Jansson et al., 
2016),  and TNF-α (Tigges et al., 2013) and IL-1β (Rustenhoven et al., 2018) reportedly 
activate a proliferatory and migratory pericyte phenotype. It has also been suggested 
LPS-induced IL-1β reduces the proliferation of NG2+ cells in the rodent brain and also 
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encourages the shedding of NG2 (Wennström et al., 2014). This raises an interesting 
question that just because a molecule is no longer expressed by a cell does not 
necessarily mean that cell is no longer present. In the circumventricular organs  salt 
loading alters pericyte expression of NG2 and PDGFR-β (Morita et al., 2014). This 
data indicates cell-surface molecule expression is dynamic and influenced by the 
microenvironment, with shed molecules indicative of activity.  
PDGFR-β+ pericyte density measured in the PSS 4-hour control was significantly less 
than the TNF-α and IL-1β treated sections. After 4-hours there was approximately 
double the number of CD163+ MΦ in the PDGFR-β PSS 4-hour time-matched 
experiment compared to the NG2 4-hour PSS control (Table 3.3), which may suggest 
the PDGFR-β PSS experiments were performed in unhealthy tissue sections. As there 
was doubt with regards to the accuracy of staining in PDGFR-β+ time-matched control 
experiments, the effects of cytokine stimulation on the PDGFR-β+ pericyte density will 
not be commented upon further. As other measurements could be taken using the 
bright-field images those measurements were not excluded from the discussion below. 
Accumulation of diffuse NG2 protein is correlated with leukocyte infiltration (Moransard 
et al., 2011), and a reduction in NG2+ pericyte density correlates with infiltration of 
immune cells in the murine heart and lung (Zeng et al., 2016). In the SHR kidney a 
reduction of NG2+ pericytes correlates with vascular congestion in the vasa recta post-
IRI (Crislip et al., 2017), with further evidence showing CD68+ MΦ and CD28+ T cells 
accumulating in the AVR of humans and rats post ischaemic injury (Ysebaert et al., 
2004). The constriction and loss of NG2+ pericytes, or at least loss of the NG2 protein, 
could lead to destabilisation of the pericyte-endothelial network (You et al., 2014). This 
cytokine induced reduction of NG2 pericyte density could be a component of enabling 
extravasation of circulating immune cells, even in the absence of circulating leukocytes 
as they are not present in the slices (Stribos et al., 2016). 
3.4.6 TNF-α and IL-1β differentially affect PDGFR-β+ and NG2+ pericyte 
contractility and morphology. 
 
In the murine cremaster muscle, α-SMA+ pericytes expressed TNFRI, TNFRII, and IL-
1R (Proebstl et al., 2012), and human placental NG2+/ α-SMA+ pericytes express 
TNFRI and various pattern recognition receptors (Stark et al., 2012). Excluding 
instances of pericyte-MΦ cell contact, in the rat cytokines elicit a significant pericyte-
mediated constriction of vasa recta capillaries. However, whether the vessels 
constricted depended on the expression pattern of the pericyte. Rodent vasa recta 
covered with NG2+ pericytes, but not PDGFR-β+ pericytes, were significantly 
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constricted after cytokine exposure, specifically at pericyte sites. The lack of 
contractility of PDGFR-β+ pericytes in response to IL-1β exposure may relate to its 
inhibitory activity of PDGFR-β-induced actin cytoskeleton reorganisation (Sundberg et 
al., 2009), inhibiting pericyte contractility (Durham et al., 2014).  PDGFR-β+/NG2- 
pericytes may be a non-contractile population. In the renal medulla NG2+/PDGFR-β+ 
pericytes express α-SMA (Stefanska et al., 2015) whilst PDGFR-β+/NG2- pericytes 
show minimal expression of this contractile protein (Wang et al., 2017) indicating A 
differential activity of NG2+ and NG2- pericytes. These contractile differences are 
possibly reflected here in the smaller renal NG2+ pericyte morphology as RhoGTPases 
are required for pericyte contractility (Kolyada et al., 2003; Kutcher et al., 2007). 
Pericytes where these are activated are significantly smaller in size than pericytes 
where they remain dormant (Kolyada et al., 2003).  
Following a similar trend in responsiveness, cytokine stimulation caused a significant 
reduction in NG2+ pericyte size whereas no morphological changes were observed 
with PDGFR-β+ pericytes. Proebstl et al 2012 (Proebstl et al., 2012) reported a 
morphological change in in vivo murine α-SMA+ pericytes upon exposure to TNF-α and 
IL-1β, and morphological changes have been reported in cultured rodent lung pericytes 
(Kerkar et al., 2006), and murine CN2 pericytes in vitro (Tigges et al., 2013; Kim et al., 
2015a; Persidsky et al., 2016). An expression pattern-dependent difference in pericyte 
activity is not new, and has been previously reported; PDGFR-β+/NG2- are fibrogenic 
whilst PDGFR-β+/NG2- are not (Stefanska et al., 2015). The evidence here 
demonstrates NG2+ pericytes being markedly influenced by pro-inflammatory 
cytokines and suggests perhaps they are key regulators in the inflammatory process. 
As described in section 3.4.1, as co-staining with PDGFR-β and NG2 was not 
performed, further commentary on potential subpopulations of pericytes cannot be 
made. However, these functional differences, in line with the morphological 
differences, are indicative of subtypes being present. Knowing if residential MΦ 
preferentially go to PDGFR-β+/NG2+ but not PDGFR-β+/NG2- pericytes could be 
informative regarding propagation of the immune response in the renal medulla and 
warrants further investigation.  
 
3.4.7 A small number of PDGFR-β+ pericytes were co-labelled with anti-CD163. 
 
Recent evidence has suggested an immune role for renal pericytes (Liu et al., 2018; 
Xavier et al., 2017; Lemos et al., 2016; Kielar et al., 2005; Ysebaert et al., 2004), but 
the question of “are these pericytes or perivascular MΦ” had not been visually probed, 
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utilising the characteristic pericyte morphology, and potentially confusing activities of 
differing cell types. Although basally no rodent pericytes expressed CD163, after 
stimulation with pro-inflammatory cytokines TNF-α and IL-1β, few cells were positively 
fluorescently labelled by both anti-CD163 and anti-PDGFR-β, but not with anti-NG2. 
These cells co-labelled bore morphological similarities to the criteria used for 
identifying pericytes (Bergers, and Song, 2005), and PDGFR-β reportedly labels 
human immune cells (Inaba et al., 1993; de Parseval et al., 1993), yet as these 
PDGFR-β+/CD163+ cells were so infrequent any further commentary is difficult.  
Data here is strongly indicative of active communication between renal pericytes and 
residential CD163+ MΦ. However, use of a pan-MΦ marker might be more informative. 
Whilst pericyte-MΦ mediated vasoconstrictions were significant as a measured 
physiological outcome from cell-cell contact, low CD163+ cell numbers may not be 
reflective of the residential MΦ population. Subsequent questions arising from this 
investigation are is MΦ-pericyte contact a regular occurrence, do these cells 
communicate in basal conditions, and do pericytes co-express MΦ- identifying markers 
or do MΦ express pericyte-associated proteins. The scope of anti-CD163 is finite for 
these questions in rodent kidneys, and would also be limited in murine kidneys (Rubio-
Navarro et al., 2016; Bi et al., 2018) despite abundance in the human renal medulla 
(Colvin, 2019), where it appears to behave as a pan-marker for human renal MΦ.  
Ultimately, experiments showed interesting early findings but did not sufficiently 
address the primary aim of the investigation. As there is a lack of pan-MΦ identifying 
markers in the rat, this species has limited usefulness in the application here so a more 
suitable model would be beneficial. Mice are a suitable candidate given numerous 
studies investigating pericyte immune functionality were conducted in this species 
(Kovac et al., 2011; Olson, and Soriano, 2011; Xavier et al., 2017; Lemos et al., 2016).  
Further still, the murine pan-MΦ F4/80 antigen which also has reported co-labelling 
with NG2  (Komuro et al., 2017; Rajantie et al., 2004; Pieper et al., 2014) which would 
overcome the issue of using a subpopulation marker. 
The establishment and validation of known pericyte behaviours was first characterised 
in the rodent kidney slice model (Crawford et al., 2012), prior to its use here to 
investigate renal pericyte multipotency. As such the development of the murine live 
slice would enable an informed cross-species comparison of models as well as access 
the murine pan-MΦ marker F4/80 to further address questions regarding the 








As described in Section 1.1.3.2, descending vasa recta (DVR) pericytes are 
responsible for regulating renal medullary blood flow (MBF) (Silldorff et al., 1995; 
Crawford et al., 2012; Crawford et al., 2011; Zhang et al., 2005). These studies, and 
those from other vascular beds (Peppiatt et al., 2006; Almaça et al., 2018; Hall et al., 
2014) characterised pericytes upon: NG2-expression; morphology; vascular 
residence; and their contractile responses upon exposure to a panel of vasoactive 
agonists  including angiotensin-II (Ang-II), endothelin-1 (ET-1), and noradrenaline (NA)  
(Crawford et al., 2012; Almaça et al., 2018; Peppiatt et al., 2006). Whilst all NG2+ 
pericytes are considered to co-express PDGFR-β (Dore-duffy, and Esen, 2018), in the 
renal medulla NG2+/PDGFR-β+ pericytes express α-SMA (Stefanska et al., 2015) 
whereas NG2-/ PDGFR-β+ pericytes show minimal expression of this contractile 
protein (Wang et al., 2017). With the expression of NG2 restricted to the arteriolar end 
of the vascular bed (Murfee et al., 2005) together these support the notion that the 
pericyte subpopulations which regulate MBF are likely NG2+. Renal NG2+ pericyte 
morphology, regional distribution, and vasoactivity has been characterised for the 
rodent kidney slice model (Crawford et al., 2012). The functional and morphological 
features of murine renal pericytes have yet to be characterised. 
However, the translation of models between species is not quite so straightforward. 
Data generated in differing rat and mouse models are often used to corroborate 
findings with the assumption that physiology is similar, if not equivalent, between rats 
and mice (Downs, 2011). However species-related differences in pathogenesis (Natoli 
et al., 2013; Ellenbroek, and Youn, 2016), and the use of inconsistent experimental 
methods and poorly characterised models (Steven et al., 2017), can make 
interpretation of data difficult. C57BL/6J are known to be resistant to hypertension 
(Neuhofer, and Beck, 2005; Hartner et al., 2003). In isolated tissue preparations from 
the liver (Zhao et al., 2009), mesentery (Hedemann et al., 2004), and abdominal aorta 
(Russell, and Watts, 2000) the vasoactive response of C57BL/6J mouse tissue 
comparative to Sprague-Dawley  rat tissue is markedly reduced when all experimental 
parameters, aside from the species used, are identical. As a characteristic example, 
with systemic administration of exogenous Ang-II, in mice the duration of the pressor 
response was 25% less than in the rat, and the magnitude of the response i.e. the 
degree of vasoconstriction, was up to 50% lower in the mouse, depending on the Ang-
II concentration (Cholewa et al., 2005).  
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Chapter 3, whilst showing interesting pre-liminary findings with regards to pericyte-
multipotency, was limited in usefulness for addressing the question “do renal pericytes 
show potential for multipotency”, so a more suitable model is needed. Establishment 
of a murine model would enable the use of the pan-macrophage identifying antigen 
F4/80, which is extensively expressed in murine kidneys (Hume, and Gordon, 1983) 
and has reported pericyte and macrophage (MΦ) expression (Discussed in section 
1.3.3). There is also a definitive benefit to having the same model developed in multiple 
species, looking for trends in behaviour whilst being knowledgeable on their respective 
differences (Cunningham, 2002; Boswell et al., 2014), offering predictive validity of the 
model in a translatable fashion (Denayer et al., 2014). Application of vasoactive agents 
to murine kidney slices should demonstrate the known responsive differences between 
C57BL/6J mice and SD rats, reflected by the vasoactivity of murine pericytes.  
As such, the aim of this chapter is to; i) Use the anti-NG2 antibody in the mouse, that 
was used in the rat, to identify pericytes on IB4-labelled vasa recta capillaries, as was 
performed in the original rat model iii) characterise the murine NG2+-labelled pericytes 
distribution and morphology objectively, and iii) characterise the responsiveness to 
vasoactive agents used to initially to validate the rodent kidney slice model (Crawford 
et al., 2012), and thus translate the rat live slice kidney preparation into a viable 




Experiments using animals were conducted in accordance with UK Home Office 
Scientific Procedures Act (1986). 
 
4.2.1  C57BL/6J tissue slicing. 
 
Murine kidneys were retrieved, prepared and sliced as described in Chapter 2 Section 
2.1. Prior to experimentation slices were kept in a slice hold chamber kept for up to 4 





4.2.2 Viability of C57BL/6J live kidney slices. 
 
See Chapter 2 section 2.2, but in brief; to determine the viability of the murine kidney 
slices, incubations were conducted with 5 µM Hoechst 33342 (Hoechst, Sigma-Aldrich, 
UK), and 20 µM propidium iodide (PI, Sigma-Aldrich, UK), in bubbled (95% O2/5% CO2) 
PSS. Post incubation slices were washed three times in PSS (95% O2/5% CO2) for 5-
minutes, then fixed with 4% paraformaldehyde (PFA; Sigma-Aldrich, UK) for 15-
minutes. After fixation, slices were washed with 0.1 M phosphate buffered saline (PBS, 
Sigma-Aldrich) and mounted using Citifluor (Agar Scientific Ltd, Essex, UK). Slices 
were imaged using a Zeiss LSM 800 confocal microscope (Carl Zeiss Ltd, Welwyn 
Garden City, UK) and analysed using FIJI, a public domain software (Schindelin et al., 
2012), to calculate the ratio of live:dead cells  using the cell counter plugin, and 
Equation 2.1. 
 
4.2.3 Determination of C57BL/6J NG2+ pericyte density and pericyte 
characteristics. 
 
For more detail please see Chapter 2 section 2.3, but in brief; prior to fixation, live 
kidney slices were incubated with 50 µg/mL Alexa Fluor-488-conjugated isolectin B4 
(IB4; Invitrogen Ltd), prepared in bubbled (95% O2/5% CO2) PSS for 45-minutes. 
Subsequently, slices were washed with PSS for 15-minutes, followed by a 15-minute 
fixation period using 4% PFA. Fixed slices were washed three times for 10-minutes 
with 0.1 M PBS, before permeabilisation with 0.1% Triton X-100 (Sigma-Aldrich, 
Dorset, UK) made in 0.1 M PBS, and blocked with 10% donkey serum (Sigma-Aldrich, 
Dorset, UK). Post blocking, slices were incubated with anti-nerual-glial (NG2) rabbit 
polyclonal primary antibody (Ab; Millipore UK Ltd, Watford, UK) to identify pericytes for 
16-hours overnight. This Ab was then probed with an Alexa Fluor 555-conjugated 
donkey-anti-rabbit secondary Ab (Invitrogen Ltd) for 2-hours, washed with PBS and 
then mounted using Citifluor. Slices were kept at 4°C in the dark prior to imaging using 
a Carl Zeiss LSM 880 confocal microscope (Carl Zeiss Ltd, Oberkochen, Germany) as 




4.2.4 Functional experiments and video analysis 
 
Differential interference contrast (DIC) images of pericytes on subsurface vasa recta 
capillaries and their functional responses were conducted and measured as described 
in Chapter 2 section 2.4. The vasoactive agents that were chosen  are important 
endogenous mediators of MBF (Neuhofer, and Beck, 2005; Pallone, and Silldorff, 
2001; Cowley et al., 1995), and trialled in the rat (Crawford et al., 2012; Crawford et 
al., 2011). These agents were adenosine 5’-triphosphate (ATP; Sigma-Aldrich, Dorset, 
UK); angiotensin II (Ang-II; Sigma-Aldrich, Dorset, UK.); endothelin-1 (ET-1; Tocris, 
Bristol, UK); bradykinin (BK; Sigma-Aldrich, Dorset, UK); prostaglandin E2 (PGE2; 
Tocris, Bristol, UK); noradrenaline (NA; Tocris, Bristol, UK); 3'-O-(4-Benzoyl)benzoyl 
adenosine5'-triphosphate (BzATP ;Sigma-Aldrich, Dorset, UK); S-Nitroso-N-Acetyl-
D,L-Penicillamine  (SNAP, Tocris, Bristol, UK); Indomethacin (Sigma-Aldritch); and 
Tyramine (Sigma-Aldrich). Control superfusion experiments with PSS alone, followed 
by exposure to 10 nM ET-1. Concentrations used can be seen in Table 2.1 in Chapter 
2. Time-Series was conducted using FIJI software as previously described (Crawford 
et al., 2012). In brief, measurements were taken from an identified pericyte and non-
pericyte site every 5s for the duration of the experiment. Each capillary acted as its 
own control. The first 5 measurements were used to determine the baseline diameter, 
and represented the resting value, expressed as 100%. All subsequent measurements 




For all experiments, statistical analysis was conducted using GraphPad PRISM 5.0 
software (La Jolla, California) using a Student’s t-test, paired or unpaired where 
relevant. ANOVA and Bonferroni post-hoc tests were used to compare responses 
when tissue was exposed to differing concentrations of the same agonist if they elicited 
a vasoactive response. A value of p<0.05 was considered significant. All experiments 
where the change in vessel diameter is <5% of the baseline diameter were considered 
non-significant and discounted from statistical analysis. Values are expressed as 
mean±SEM. SEM is calculated with animal number. Sample size (n) represents the 
number of pericytes (with 1 pericyte site and non-pericyte site per live kidney slice), as 
variation in response was found between pericytes and not animals (Crawford et al., 
2011). 
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4.3  Results 
 
4.3.1  C57BL/6J kidney slices are viable, with pericytes clearly identifiable. 
 
The slicing depth to expose the entirety of the medulla was approximately 1.7 mm with 
3-5 usable slices obtained per pair of murine kidneys. To determine viability of these 
slices, kidney sections were stained with the fluorophores Hoechst 33342 (H342) and 
propidium iodide (PI) to calculate the proportion of live (H342): dead (H342 and PI) 
cells present. From the stained tissue sections, areas of 100 µm2 were analysed and 
79.0±2.4% of cells were alive, corresponding to a live: dead cell ratio of 4:1. This 
reflects observations in the rodent model (Crawford et al., 2012), and from other murine 
kidney slices (Brähler et al., 2016) (n= 4 animals, and 9 slices).  
 
 
Figure 4.1 Viability of kidney slices from C57BL/6J mice 
Live kidney slices were stained with Hoechst 33342 (blue) and propidium iodide (PI; red) and 
imaged using confocal microscopy. Hoechst 33342 (ai) labelled all nuclei, and PI (aii) labelled 
dead cells, with the composite (aiii) of both showing the majority of cells in the field of view are 
alive. The corresponding DIC image for (ai-aiii) shows a vasa recta capillary (aiv, white dotted 
lines) with surrounding pericytes (yellow dashed circle). The composite image of all channels 
(av) shows that the pericytes on this capillary are viable. Scale bars are 10 μm n= 4 animals 
and 9 slices. 
10 μm 10 μm 10 μm
10 μm 10 μm
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Importantly, from Figure 4.1(av), comprised of a bright field image overlaid with 
Hoechst and PI fluorescence, it can be seen that not only are the pericytes identifiable 
via the ‘bump-on-a-long’ morphology (Peppiatt et al., 2006), but that they constitute 
part of the surviving parenchyma in this preparation, with cells of the tubules and 
interstitium also viable. 
 
4.3.2 NG2+ pericytes are clearly labelled in C57BL/6J kidney slices. 
 
 
Figure 4.2 Identification of NG2+ pericytes in the C57BL/6J renal medulla. 
Vasa recta capillaries (green) were identified using Alexa-488 conjugated Isolectin-B4 (IB4), 
and pericytes (red) with anti-neural-glial 2 (NG2) primary antibody and probed with Alexa-555. 
Pericyte density was calculated per 100 µm2, and a representative image from the renal outer 
medulla (OM; a), as indicated by a white-dashed box. The yellow dashed circle highlights an 
individual pericyte cell with its processes, which is shown magnified in (bi-iii). (biii) is the 
corresponding composite of (bi) and (bii), which demonstrate identification of the pericyte soma 
(blue circle), and measurements of pericyte primary processes (blue lines) around the vasa 
recta wall (µm). The white dashed lines in highlight the vasa recta walls. (bii) shows the 
fluorescently labelled IB4 on the vasa recta (vr), and where a corresponding diameter 
measurement would be obtained (double ended yellow arrow). All scale bars are 10 µm. n=4 
animals and 9 slices. 
 
Pericytes were labelled with anti-NG2, probed with Alexa-555 and co-localised to vasa 
recta that were stained with Alexa-488- conjugated IB4 (Figure 4.2). Pericyte 
characteristics were determined by analysis of randomly selected 100µm2 regions in 










processes were measured, which can be seen emanating from the cell body running 
both along (longitudinal) and around (circumferential) the abluminal surface of the 
capillary (Figure 4.2(biii)). A summary of murine pericyte characteristics can be seen 
in Table 4.1. For the rest of this section, the pericyte characteristics discussed are 
specifically for NG2+-labelled pericytes. 
The average pericyte density per 100 µm2 in the mouse is 4.3±0.3 in the IM, 
significantly lower than the 9.4±0.6 pericytes per 100 µm2 in the OM (p<0.0001; n=4 
animals and 8 slices, Table 4.1). Comparatively, in the rat the average pericyte density 
is 9.1±0.5 per 100 µm2  in the IM and 12.4±1.2per 100 µm2  in the OM (Crawford et al., 
2012),. The distance between pericytes in the mouse was not significantly different 
between the IM and OM (n; p>0.05), averaging to be 26.8±1.4 µm apart, and 
correspondingly almost double the distance than observed in the rat (16.0±1.2 µm; 
p<0.05). Correspondingly to the increased distance between pericyte soma, the 
primary processes protruding from pericytes along the vasa recta (longitudinal) in the 
mouse were 19.2±0.8 μm, and 9.7±0.6 μm around (circumferential). The longitudinal 
processes are significantly longer than those in the rat (8.3±0.4 μm, 
p<0.0001)(Crawford et al., 2012).  The primary process lengths measured here would 
ensure complete coverage of the vasa recta. However, due to difficulties with 
identifying the end of pericyte processes, measurements of process length were not 
taken for data in chapter 3 or 5 (section 3.3.5). 
Table 4.1 Summary of C57BL/6J NG2+ pericyte characteristics. 
 OM1 IM2 Average 
Pericyte Density  
#3 9.4±0.6 4.3±0.3*** 7.3±0.4 
Pericyte soma size, μm  
Height 4.9±0.2 4.9±0.2 4.9±0.2 
Width 9.0±0.4 9.4±0.4 9.3±0.3 
Distance between pericytes on vasa recta, μm 
 24.4±1.8 28.±2.0 26.8±1.4 
Pericyte processes, μm 
Longitudinal 17.8±1.2 20.4±1.1 19.2±0.8 
Circumferential 9.8±1.1 9.7±0.6 9.7±0.6 
IB4-labelled vasa recta diameter, µm 
Pericyte site 6.15±0.3 
Non-pericyte site 7.9±0.4*** 
Data presented are the mean±SEM. n= 4 animals and 98slices, ≥ 200 pericytes per animal. 
1OM= outer medulla, 2IM = inner medulla 
3# =Number of cells per 100 μm2 
***p<0.0001  
 
There was no significant difference in cell body size between the OM or IM (9.0±0.4 
µm vs 9.4±0.4 µm in length respectively, p>0.05, Table 4.1), and the same size as 
pericytes in the rat which were 9.0±0.2 µm along (p>0.05). In Chapter 3, SD NG2+ 
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pericytes measured 4.6±0.2 μm in height on average, non-significantly different from 
the mouse here (4.9±0.2; p>0.05). 
 
4.3.3 C57BL/6J renal pericytes are functionally responsive, and vasoactive 
agents affect vasa recta diameter in situ. 
 
Vasa recta capillary diameter was measured at a pericyte and corresponding non-
pericyte site along the same vasa recta capillary in DIC superfusion experiments. The 
average resting vessel diameter was calculated as 6.5±0.2 μm at pericyte sites and 
8.0±0.2 μm at non-pericyte sites (p<0.001; n>40). This was not significantly different 
(p>0.05) from values obtained for vasa recta from IB4 and NG2 experiments; 6.1±0.3 
µm at pericyte and 7.0±0.4 µm at non-pericyte sites (p<0.001; Table 4.1; n>30 vessel 
measured), therefore DIC measurements accurately reflect vasa recta capillary 
diameter. These values are significantly different from those observed in the rat 
(7.5±0.4 μm at p and 9.5±0.4 μm at np sites, p<0.0001) (Crawford et al., 2012). For 
functional experiments, capillary diameter was measured every 5 s before, during, and 
after superfusion with agonist of choice, and normalised as a percentage of the 
average “baseline” diameter of the first 120s of the experiment. This was calculated 
for a paired pericyte and non-pericyte site per experiment, and the values are 
represented as a percentage change of the original baseline diameter.  
To demonstrate that any alterations in vasa recta diameter observed were due to the 
presence of agonist, PSS control experiments were conducted. These demonstrated 
that in the absence of an agonist there was no significant alteration in vessel diameter 
at pericyte sites (change in vessel diameter <5 % of baseline), and that there was no 
significant difference between changes at pericyte sites and non-pericyte sites 
(2.1±0.8% at p and 2.0±1.0 % at np sites, p>0.05, n= 7 slices and 7 animals). To further 
validate this finding, that these slices possessed the capability to respond, but were 
unresponsive due to lack of agonist, after PSS control experiments ET-1 (10 nM) was 
applied as an additional 1200s experiment. This agonist and concentration were 
chosen as it demonstrated the highest response rate (67%). An representative trace 
for a PSS + ET-1 control can be seen in Figure 4.3(c). As can be seen in Figure 4.3(a-
b) there are two adjacent vessels that are unresponsive during superfusion with PSS 
alone (figure 4.3(a)), yet upon exposure to ET-1 (10 nM; Figure 4.b(b); n=7 slices, 
and 7 animals) while one vessel does not respond, the adjacent vasa recta capillary 
forcibly constricts, demonstrating the viability of the kidney slice. This variability of 
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pericyte responsiveness as has been observed in similar CNS studies and by Crawford 
et al (Peppiatt et al., 2006; Crawford et al., 2012). 
 
 
Figure 4.3 Pericytes in the C57BL/6J preparation only constrict in the presence of an 
agonist. 
A standard differential interference contrast (DIC) field of view of in situ vasa recta for a time 
series experiment is shown in (ai-biii). (ai-iii) show a physiological saline solution (PSS) 
control experiment at: 75s (ai); 300s, where emulated experimental conditions have been 
replicated with PSS (aii); and1000s, during a “wash out” period (aiii). Subsequently, (bi-iii) 
show the same capillary upon exposure to endothelin-1 (ET-1) in an identical setting before 
(bi), during (bii), and after (biii) at the same time points of the experiment. Pericyte cell bodies 
are indicated by a yellow dashed circle, pericyte sites by black or blue dashed lines, and non-
pericyte sites by red dashed lines. What can be seen is that the vessel in the foreground does 
not rspond in the presence of ET-1 (black and red dashed lines) but the vessel in the 
background (blue and orange dashed lines) is responsive. (c) In the responsive vessel, 
measurements were obtained from a pericyte site (c; black line) and corresponding non-
pericyte site (red line) every 5s for the first 100s to establish the baseline diameter, then all 
subsequent measurements were expressed as the percentage change of that width. 
Experiments were 1200s long, and exposure to PSS is indicated by the 1st black bar (n=4 
slices, and 3 animals). Afterwards, endothelin-1 (ET-1; 10 nM, 2nd black bar). The average 
change in vessel diameter upon exposure to PSS alone is presented in (d) at pericyte (black 
bar) and non-pericyte (red bar) sites (n=7 slices, and 7 animals). Values presented are 











































The overall response rate observed in the rat was, on average, 51% of pericytes 
(Crawford et al., 2012) whereas in the mouse model the overall average response rate 
is 30-40%,  with individual agonist-induced responses varying from 14-67% depending 
on the agonist used. Also noted was the majority of vasoactive responses were of a 
lower magnitude than that observed in the rat This is discussed in greater detail below 
for each agonist individually (Section 4.3.3).  On occasions where more than one slice 
per animal were used for the same experiment, some pericytes were responsive whilst 
others were not, further demonstrating that responsiveness is dependent upon the 
pericyte as opposed to the animal. This lower overall response rate and magnitude of 
responses is likely related to the known resistance of C57BL/6J mice to renal 
hypertension, and a strain related phenomenon of reduces vascular reactivity (Hartner 
et al., 2003). 
 
4.3.3.1 Responsiveness of murine pericytes in situ to endogenous vasoactive 
compounds varies from those in the rat. 
 
To characterise the vasoreactivity of the murine kidney slice model, and enable 
comparison with the rat model, slices were exposed to the same panel of well-known 
and functionally important vasoactive agents (Neuhofer, and Beck, 2005; Pallone, and 
Silldorff, 2001), that the Sprague-Dawley model had also been exposed to (Crawford 
et al., 2012; Crawford et al., 2011; Kennedy-Lydon et al., 2015). Values of pericyte-
mediated changes in vessel diameter were not limited to the window of superfusion, 
as some agonists, such as ET-1, are known to have a lag before any vasoactivity 
occurs (Potts et al., 2012). Like-for-like concentrations of agonists were initially used 
on the murine slices, and dependent upon the responsiveness of the murine tissue 




Upon exposure of naïve vessels to angiotensin-II (Ang-II;100 nM), a significantly 
greater constriction occurred at pericyte sites (10.1±2.6%) compared to non-pericyte 
sites (3.3±1.0%, n = 5 slices and 5 animals, p<0.05; Figure 4.4(d)), yet significantly 
lower than that observed in the rat (29.3±4.7% at pericyte sites, p<0.05)(Crawford et 
al., 2012). As the response rate was moderately low at 100 nM (~35.7%), Ang-II 
concentration was moderated to determine if response rate could be improved. Ang-II 
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concentrations of; 1 nM, 10 nm, and 300 nM were assessed.  Ang-II at 300 nM 
significantly reduced vessel diameter by 13.6±2.5% at pericyte sites compared with 




Figure 4.4  Angiotensin-II (Ang-II) evoked constriction of in situ vasa recta is of a lower 
magnitude than in the Sprague-Dawley (SD) model. 
Representative differential interference contrast (DIC) images of time-series experiment of 
superfusion of a vasa recta capillary with either 10 nM (a) or 300 nM (b) of Ang-II: before (i); 
during exposure to the agonist (ii); and during a washout period from the agonist (iii). Pericyte 
cell bodies are indicated with yellow dashed circles, and corresponding pericyte (black dashed 
bars) and non-pericyte sites (red dashed bars) are indicated. 300 nM Ang-II (b) evokes a 
reversible response during superfusion, but 10 nM (a) evokes a sustained constriction; 
illustrated by representative traces for 10 nM (ci) and 300 nM (cii). These traces represent the 
% change over time at a paired pericyte site (black line) and non-pericyte site (red line), 
exposure to agonist is indicated by a black bar. Average data for superfusion experiments in 
the C57 with: 10 nM(n=11 slices and 11 animals); 100 nM (n=5 slices and 5 animals); and 300 
nM (n=8 slices and 8 animals) of Ang-II show a significantly greater constriction at pericyte 
sites (black bar) than non-pericyte sites (red bar). The equivalent experiment with 100 nM Ang-
II in the Sprague-Dawley rat model (SD; blue bar) shows the pericyte-mediated constriction is 
more significant in the SD model. The pericyte-mediated constriction was not significantly 
different between the varying concentrations of Ang-II in the C57 model. Values show mean 











































































Despite the magnitude of the vasoconstriction not significantly differing between Ang-
II 100 nM or 300 nM (p>0.05), 300 nM yielded a higher response rate (60%). Of note 
is that both these constrictions were reversible; where diameter returned to within 10% 
of the baseline, as previously defined by Crawford et al (Crawford et al., 2012).  Ang-
II 10 nM also induced a pericyte-mediated constriction, of 12.0±1.3% at p sites (vs 
1.8±1.0% at np sites, p<0.0001; n= 11 slices, and 11 animals), with a 46% response 
rate. However, this constriction was sustained until the end of the 20-min experimental 
window, reaching maximal constriction during the washout period (Figure 4.4(cii)). 
Ang-II 1 nM failed to reliably elicit a response (<15% response rate; n=8 slices, and 8 
animals used in total). 
 
4.3.3.1.2 Adenosine-5’-triphosphate and noradrenaline. 
 
Superfusion with 100 µM adenosine-5’-triphosphate (ATP) failed to elicit any 
vasoactive response (n=13 slices and 12 animals), with an average reduction of 
1.6±0.6% at pericyte sites and 0.9±0.5% and non-pericyte sites (p>0.05). Unlike with 
Ang-II, where it was response rate needed optimisation from the initial experimental 
concentration, 100 μM of ATP elicited no response. Given a reported resistance of the 
C57 strain to ATP (Donnelly-Roberts et al., 2009),  the concentration was increased. 
1 mM ATP caused a significant pericyte-mediated constriction (9.6±1.0% vs 1.1±0.7% 
at non-pericyte sites; n= 5 slices and 5 animals, p<0.005; Figure 4.5c). Much like with 
100 μM Ang-II, this response rate was low (31.3%), so for a more reliable model a 
higher concentration of ATP (2 mM) was tested. This yielded a vasoconstriction that 
was significantly larger at pericyte sites than non-pericyte sites (13.4±1.3% vs 
1.8±1.3%, n=5 slices and 5 animals, p<0.005; Figure 4.5a-c) and, a significantly larger 
constriction than that elicited by 1 mM (p<0.05). Tissue was more responsive to 2 mM 
than 1 mM, with a response rate of 45.5%. The magnitude of the pericyte-mediated 
constrictions elicited by 1 mM and 2 mM ATP were however significantly lower than 
those elicited by 100 µM ATP in the rat (19.4±2.8%, p<0.01)(Crawford et al., 2011). 
Like ATP, the initial concentration Noradrenaline (NA) used in the rodent slice 
technique (10 nM) was ineffective in the C57 model, with an average constriction of 
2.2±0.7% at pericyte sites and 0.8±0.4 at non-pericyte sites measured (p<0.05, n=8 
slices and 8 animals; Figure 4.5(f)); not within the >5% threshold. Subsequently 
concentrations of 30 nM, 100 nM, and 300 nM were tested, with only 300 nM inducing 
a vasoactive response. 30 nM (n = 7 slices and 7 animals) and 100 nM (n= 3 slices 
and 3 animals) yielded pericyte-mediated constrictions of 1.5±1.0% and 0.6±0.6% at 
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pericyte sites respectively. NA 300 nM had a low response rate of 36.4%, but elicited 
an average vasoconstriction of 15.4±2.7% at pericyte sites, vs 1.3±0.6% at non-
pericyte sites (p<0.05, n= 4 slices and 4 animals; Figure 4.5(c-f)). Interestingly, upon 
optimisation of the concentration; the magnitude of response isn’t significantly different 
between species (20.8±5.1%; p>0.05) (Crawford et al., 2012) but the concentration is 
30-times greater ( 10 nM vs 300 nM). 
 
 
Figure 4.5  Adenosine-5’-triphosphate (ATP) and noradrenaline (NA) needed marked 
increase in concentration to stimulate vasoactivity of C57BL/6J in situ vasa recta 
capillaries. 
Representative differential interference contrast (DIC) images of time-series experiment of 
superfusion of a vasa recta capillary with either ATP (a) ot NA (d) before (i), during exposure 
to the agonist (ii), and during a washout period from the agonist (iii). Pericyte cell bodies are 
indicated with a yellow dashed circle, and corresponding pericyte (black dashed bars) and non-
pericyte (red dashed bars) sites are indicated. A corresponding representative trace of the % 
change in diameter over time for ATP (b) and NA (e) at pericyte (black) and non-pericyte (red) 
sites, with exposure to agonist indicated by a black bar. Average superfusion data for: ATP (c) 
at concentrations of 100 µM (n=13 slices and 12 animals), 1 mM (n= 5 slices and 5 animals), 
and 2 mM (n=5 slices and 5 animals); and NA (f) at concentrations of 10 nM (n=8 slices and 8 
animals) and 300 nM (n=7 slices and 7 animals) show a significantly greater constriction at 
pericyte sites (black bars) than non-pericyte sites (red bars) The equivalent experiment with 
100µM ATP (c) in the Sprague-Dawley rat model (SD; blue bars) shows the pericyte-mediated 
constriction is more significant in the SD model but not with 10 nM NA (f) . Values are 









































































































Figure 4.6 Endothelin-1 (ET-1) evoked a significantly greater, pericyte-mediate, 
constriction in the C57BL/6J mouse. 
Representative differential interference contrast (DIC) images of time-series experiment of 
superfusion of a vasa recta capillary with either 10 nM (a) or 3 nM (d) of ET-1 before (i), during 
exposure to the agonist (ii), and during a washout period from the agonist (iii). Pericyte cell 
bodies are indicated with yellow dashed circles, and corresponding pericyte (black dashed 
bars) and non-pericyte sites (red dashed bars) are indicated. It can be seen with both 10 nM 
(a) and 3 nM (b) that a vasoactive response begins towards the end of superfusion and is 
sustained; illustrated by representative traces for 10 nM (ci) and 3 nM (cii). These traces 
represent the % change over time at a paired pericyte site (black line) and non-pericyte site 
(red line), exposure to agonist is indicated by a black bar. Average data for superfusion 
experiments in the C57 with 1 nM (n=4 slices and 4 animals), 3 nM (n=4 slices and 4 animals), 
5 nM (n=5 slices and 5 animals), and 10 nm (n=7 slices and 7 animals) of ET-1 show a 
significantly greater constriction at pericyte sites (black bar) than non-pericyte sites (red bar). 
The equivalent experiment with 10 nM ET-1 in the Sprague-Dawley rat model (SD; blue bar) 
shows the pericyte-mediated constriction is more significant in the C57 model. Values are 
mean±SEM. * = p<0.05, ** = p<0.005, *** = p<0.0001. Scale bars are 10 μm. 
 
ET-1 10 nM significantly decreased vasa recta diameter by 30.0±3.7% at pericyte sites 














































































Figure 4.6(d)). This is significantly larger (~3 fold) than the vasoconstriction elicited 
by ET-1 10 nM in the rat (10.3±1.9, p<0.001)(Crawford et al., 2012). Despite having 
the highest response rate of any agonist assessed (66.7%), this concentration resulted 
in severe endothelial swelling (Figure 4.6(a)) and so the concentration was lowered 
for optimisation.  ET-1 1 nM, elicited a non-significant response (12.2±2.5% at pericyte 
sites vs 2.0±1.1% non-pericyte sites, p>0.05, n=4 slices and 4 animals; Figure 4.6d). 
ET-1 5 nM induced a significant, pericyte-mediated constriction of 48.7.4±11.0% at 
pericytes sites (vs 9.4±3.5% at non-pericyte sites, p<0.05, n= 5 slices and 5 animals; 
Figure 4.6(d)) with a lower response rate of 50%. Superfusion with 3 nM ET-1 also 
induced a significant constriction of 25±5% at pericyte sites (vs 4.1±2.5% at non-
pericyte sites, p<0.05, n=4 slices and 4 animals), with a pericyte-response rate of 50%. 
There was no significant difference between the pericyte-meditated constriction at 
differing concentrations of ET-1 (p>0.05; Figure 4.6(d)). For all concentrations, 
constriction began during the end of drug exposure, with maximal values not observed 
until approximately 600s after removal and sustained until the end of the 1200s 
experiment (Figure 4.6(c)). 
 
4.3.3.1.4 Prostaglandin E2 and bradykinin 
 
Prostaglandin E2 (PGE2) 10 μM caused a significant, irreversible dilation that was 
significantly greater at pericyte sites (6.5±0.4%) than non-pericyte sites (0.6±0.3%; n= 
6 slices and 4 animals, p<0.001; Figure 4.7(a)). This pericyte-mediated dilation is not 
significantly different than that observed in the rat (8.6±1.6%, p>0.05)(Kennedy-Lydon 
et al., 2015; Crawford et al., 2012), with a 60% pericyte-response rate. In 2 of the 6 
responders, there was an observed constriction before the dilation (Figure 4.7(b)). To 
determine if the concentration of PGE2 could be further optimised, 1 μM and 100 μM 
were also applied. 1 μM was ineffective, with an increase in diameter of 4.6±0.9% at 
pericyte sites and 1.3±1.3% at non-pericyte sites (n=4 slices and 2 animals, p>0.05). 
100 μM of PGE2 induced a significant response, causing an average dilation of 
11.0±3.3% at pericyte-sites and 1.1±0.5% at non-pericyte sites (n = 5 slices and 5 
animals, p<0.05), with a 36.4% response rate. 
Due to experimental error not noted until post-experimentation and optimisation, a 
concentration of 10 μM as opposed to 10 nM was used in the murine model. Bradykinin 
(BK) 10 µM failed to elicit a significant response (n=10 slices and 8 animals), so both 
1 µM and 100 µM were tested. 100 µM failed to elicit a response in the murine model 
(n= 8 slices and 5 animals), yet  1 µM (n=6 slices and 6 animals) elicited a significant 
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pericyte-mediated vasoconstriction of vasa recta capillaries of 13.8±2.4% compared to 
non-pericyte sites (2.4±0.8%, p<0.05), with a response rate of ~50%, whereas in the 
rat a concentration of 10 nM resulted in a pericyte-mediated vasodilation of 8.3±1.6% 
(Kennedy-Lydon et al., 2015) 
 
 
Figure 4.7 Prostaglandin E2 (PGE2) and Bradykinin (BK) needed marked increase in 
concentration to stimulate vasoactivity of C57BL/6J in situ vasa recta capillaries. 
Representative differential interference contrast (DIC) images of time-series experiment of 
superfusion of a vasa recta capillary with either PGE2 (a) or BK (d) before (i), during exposure 
to the agonist (ii), and during a washout period from the agonist (iii). Pericyte cell bodies are 
indicated with a yellow dashed circle, and corresponding pericyte (black dashed bars) and non-
pericyte (red dashed bars) sites are indicated. A corresponding representative trace of the % 
change in diameter over time for PGE2 (b) and BK (e) at pericyte (black) and non-pericyte (red) 
sites, with exposure to agonist indicated by a black bar. Average superfusion data for: PGE2 
(c) at concentrations of 10 µM (n=6 slices and 4 animals), and 100 µM (n= 5 slices and 5 
animals) ; and BK (f) at concentrations of 1 µM (n=6 slices and 6 animals) and 10 µM (n=10 
slices and 8 animals) show a significantly greater constriction at pericyte sites (black bars) than 
non-pericyte sites (red bars) The equivalent experiment with 10 µM PGE2 (c) in the Sprague-
Dawley rat model (SD; blue bars) shows a pericyte-mediated of comparable magnitude in the 
SD model,  but with 10 nM BK (f) a vasodilation is observed, not a pericyte-mediated 
constriction. Values are mean±SEM. *** = p<0.005, ****=p<0.0001 ns = p>0.05. Scale bars are 
10 μm. 
 
4.3.3.2 Superfusion of C57BL/6J slices with exogenous compounds 
demonstrates pericyte-mediated vasoactivity. 
 
After establishing the behavioural profile of murine vasa recta pericytes in response to 
endogenous key regulators of blood flow, it was then appropriate to investigate how 
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diameter. To investigate: Tyramine,  affecting NA and ATP release from varicosities 
(Kirkpatrick, and Burnstock, 1994); and Indomethacin, attenuating the local production 
of PGE2 were used, as they had been in the rat (Crawford et al., 2012). The NO donor 
S-Nitroso-N-Acetyl-D,L-Penicillamine (SNAP) was also administered. As the high 
concentration of ATP required to elicit a response in the mouse is indicative of P2X7-
receptor activation (Donnelly-Roberts et al., 2009), the competitive agonist 3'-O-(4-
Benzoyl)benzoyl adenosine5'-triphosphate (BzATP) was superfused for comparison . 
Superfusion with SNAP 100 μM elicited a significant pericyte-mediated dilation of 
11.4±1.4% at pericyte sites (vs 1.5±0.8% at non-pericyte sites, p<0.0005, n=6 slices 
and 6 animals) with a 30% response rate, comparable to dilation achieved in the rat 
(12.6±2.9%, p>0.05; Figure 4.8(e)) (Crawford et al., 2012), consequently no 
optimisation of this agent was performed. 
Indomethacin 30 μM elicited a reversible pericyte mediated constriction of 14.4±2.4% 
(vs 2.4±1.9% at non-pericyte sites, p<0.0005, n=6 slices and 6 animals), with a 38% 
response rate in the murine kidney slice model. This constriction was not significantly 
different from the constriction observed in the rat (9.9±0.5%, p>0.05; Figure 4.8(f)) 
(Crawford et al., 2012), correlating with the observations for PGE2 above (section 
4.3.3.1.4) that there was no significant differences in the vasoactive repsonse between 
the species.  
Superfusion of murine kidney slices with 10 μM of BzATP resulted in a significantly 
greater constriction at pericyte sites than non-pericyte sites (9.1±1.7% vs 1.8±0.9% 
respectively, p<0.005, n= 6 slices and 6 animals; Figure 4.8(i)) BzATP is 
approximately is 10-30x more potent than ATP at P2X7-(Sugiyama et al., 2005; 
Crawford et al., 2011; Donnelly-Roberts et al., 2009), and this constriction was not 
significantly different from that elicited by either 1 mM or 2 mM ATP in the mouse 
(p>0.05).  With a response rate of 33%, this is comparable to the response rate 
observed with 1 mM ATP (section 4.3.3.1.2). Much like with ATP, the constriction 
elicited by BzATP in the mouse is significantly less than that observed in the rat 
(20.2±2.5%, p<0.0001). Given the expense of BzATP, higher concentrations were not 
assessed as they were with ATP. 
Interestingly, whilst SNAP, BzATP, and indomethacin data correlate with observations 
in the rat, application of 1 μM tyramine caused a pericyte-mediated dilation. The 
dilation  was significantly greater at pericyte sites than non-pericyte sites (10.7±1.7% 
and 3.2±1.1% respectively, p<0.005, n= 4 slices and 4 animals), with a 36% response 
rate, significantly different from the tyramine-evoked constriction (11.9±2.5%, 
p<0.0001; Figure 4.8(L)) observed in the rat (Crawford et al., 2012).  Whilst 1 μM 
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Tyramine induced a pericyte-mediated vasodilation, it has been reported that low 
concentration ATP is vasodilatory (Crawford et al., 2011). Given the insensitivity to NA 
observed in the model, it is possible that the neurotransmitter release was such to 
favour dilation. Superfusion with other concentrations of tyramine were ineffective, not 
breaching the >5% change in vessel baseline diameter threshold. 100 nM of tyramine 
elicited a non-significant response (-4.4±2.0% at pericyte sites vs -0.4±0.2% at non-
pericyte sites respectively (n=4 slices and 4 animals), as did 10 μM, 30 μM (n>3 slices 
and 3 animals). 
 
Figure 4.8 Simulating or attenuating the release of endogenous compounds in C57BL/6J 
kidney slices. 
Representative differential interference contrast (DIC) images of time-series experiment of 
superfusion of a vasa recta capillary with either SNAP 100 μm (a), Indomethacin 30 μm (Indo; 
d), BzATP 10 μm (g) or Tyramine 1 μm (j) before exposure (i), during exposure to the agonist 
(ii), and during a washout period from the agonist (iii). Pericyte cell bodies are indicated with 
a yellow dashed circle, and corresponding pericyte (black dashed bars) and non-pericyte (red 
dashed bars) sites are indicated. A corresponding representative trace of the % change in 
diameter over time for SNAP (b), Indo (e), BzATP (h) and Tyramine (k) at pericyte (black) and 
non-pericyte (red) sites, with exposure to agonist indicated by a black bar. Average superfusion 
data for C57BL/6J are shown (c,f,i and L) comparative to the Sprague-Dawley (SD; blue bars) 
model at the corresponding concentrations. Values are mean±SEM. ** = p<0.05, ***=p<0.0001 
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As a heterogeneous population of cells, establishing the baseline vasoactive behaviour 
of murine pericytes, in line with the known vasoactive physiology of the species, was 
necessary to validate the C57BL/6J (C57) kidney slice model. What has been shown 
in this chapter is that murine NG2+ pericytes have comparable renal distribution and 
morphology to those of the rat (Crawford et al., 2012), they are vasoactive in response 
to locally important regulators of blood flow such as Ang-II and PGE2 (Crawford et al., 
2012; Almaça et al., 2018; Peppiatt et al., 2006), and the magnitude of pericyte-
mediated regulation of vasa recta diameter reflects the known differences in vascular  
physiology between  C57 mice and Sprague-Dawley (SD) rats (Russell, and Watts, 
2000; Cholewa et al., 2005; Hedemann et al., 2004; Zhao et al., 2009). Further still, 
characterising NG2+ pericyte morphological characteristics highlighted other cross-
species consistencies in their size and showed the pericyte-mediated regulation of 
medullary blood flow is a conserved behaviour of renal pericytes across 
species(Cunningham, 2002; Boswell et al., 2014), and validated the murine as an 
investigative tool for establishing renal pericyte characteristics with the data generated 
offering predictive validity in a translatable fashion (Denayer et al., 2014). 
 
4.4.1 C57BL/6J kidney slices are viable. 
 
Upon slicing the C57 kidneys, slicing both together provided 3-5 usable slices whereas 
the SD model provided approximately 5-6 usable slices per kidney (unpublished data). 
Given that murine kidneys are approximately 10 times smaller than rat kidneys 
(Becker, and Hewitson, 2013), this suggests murine kidneys have a larger medulla, 
possibly facilitating a more concentrated urine (Sands, and Layton, 2009). Further still, 
the slices obtained were viable with  ~79% of cells alive, as was reported in the SD 
model (Crawford et al., 2012). A different C57BL/6J kidney slice preparation, using the 
same method of H342 and PI co-labelling, had comparable viability at 90-minutes 
(Brähler et al., 2016)  with another lab assessing ATP content of C57 kidney slices 
determining they were viable up to 72-hours (Poosti et al., 2015). The window for use 




4.4.2 C57BL/6J NG2+ pericyte morphology is comparable to the rat whilst vasa 
recta capillaries are smaller. 
 
Antibodies against NG2 and IB4 were used for fluorescent identification and co-
localisation of pericytes to vasa recta. Vasa recta capillaries were approximately 13% 
and 16% smaller in diameter in the mouse than the rat at pericyte sites and non-
pericyte sites respectively. Murine red blood cells (RBCs) are 6.0 μm in diameter 
comparative to rat RBC measuring 6.5 μm in diameter, (Unekawa et al., 2010) hence 
the capillary diameter also being comparably smaller between species. Much like the 
rat, a greater density of pericytes in the OM than the IM was observed (Table 4.1) 
(Crawford et al., 2012; Park et al., 1997b). This reduced density in the IM is likely 
reflective of the reduced density of the DVR (Pallone et al., 2003b; Park et al., 1997a). 
There were significantly fewer NG2+ pericytes in both the OM and the IM of the 
C57BL/6J slices comparative to the rat, but pericyte soma were not significantly 
different in size. There are differences in arrangements of the vasa recta in mice, being 
more interwoven with medullary tubules in the mouse (Fazan et al., 2002; Kriz, and 
Kaissling, 2013), which might obfuscate some pericytes. However, given the size 
difference between rats and mice, with rats being larger (Becker, and Hewitson, 2013) 
and having a significantly larger vascular volume (Boswell et al., 2014), this lower 
density is likely reflective of fewer vasa recta overall. It also implies there would be 
less NG2+/α-SMA+ DVR pericytes available to constrict, potentially why the response 
rate was lower in C57 than SD (section 4.4.2). 
Interestingly, whilst pericyte soma size was not different, murine pericytes had 
significantly longer longitudinal primary processes than in the rat (Section 4.3.2). 
However, in both species the length of longitudinal processes ensured the endothelium 
was covered. This could suggest that pericytes ensure vascular stability with their 
process length supporting the vessel (Bergers, and Song, 2005) with the 
circumferential processes enacting their contractility (Courtoy, and Boyles, 1983), 
demonstrated by constrictions and dilations remaining localised to the pericyte soma 
where these circumferential processes reside and not further along with the 
longitudinal processes.  
Overall, given the difference in process length, this consistency in pericyte soma size 
could be used as a consistent objective metric for identification of pericytes across 
species. As there was no difference between OM and IM NG2+ pericyte measurements 
in the mouse, they are not considered separately. 
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Figure 4.9 Interspecies differences between SD (a) and C57 (b) pericyte density.  
Vasa recta capillaries were labelled with Alexa-488-conjugated IB 4 (green). The cell body 
(arrows) of pericytes in the renal medulla were labelled with anti-NG2 and Alexa-555-
conjugated secondary antibody (red). It can be seen there are more pericytes in rodent tissue 
(a) than murine tissuse (n). Image (a) adapted from (Crawford et al., 2012). 
 
4.4.3 C57BL/6J renal pericyte-mediated responsiveness is less frequent than 
the SD model. 
 
After the murine kidney slices were deemed viable and the structural environment was 
established, functional experiments were conducted. The vasoactive agents that were 
chosen are considered to be the most relevant autocrine or paracrine factors 
modulating medullary O2 supply (Neuhofer, and Beck, 2005; Pallone, and Silldorff, 
2001; Cowley et al., 1995), and had been used in the rat previously (Crawford et al., 
2012; Crawford et al., 2011; Kennedy-Lydon et al., 2015). Overall, the observation that 
not all pericytes respond in the mouse is in line with other models investigating 
pericyte-mediated regulation of capillary diameter. When reported, rodent pericyte 
models often demonstrate a moderate response rate; 10-37% of depending on the 
vasoactive agent  and tissue (Kawamura et al., 2003; Peppiatt et al., 2006). A notable 
difference between the two species for the kidney slice models was the reduced 
responsiveness of the murine vessels. In the rat, on average, 50-60% of pericytes 
identified respond to superfusion with vasoactive agents with a significant, measurable 
response (Crawford et al., 2012). In the mouse, however, even upon optimisation of 
the concentration, the average response rate is lower at approximately 30-40% of 
pericytes, and the alterations in vessel diameter are, bar the exception of ET-1, of a 
lesser magnitude (discussed below in section 4.4.4.5).  In the C57BL/6J strain 
10 µm 10 µm
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specifically, it has been observed that they are less prone to hypertension (Hartner et 
al., 2003) , and other vascular models in this strain have shown vasoactivity of a lower 
magnitude comparative to the SD rat (Russell, and Watts, 2000; Cholewa et al., 2005; 
Hedemann et al., 2004; Zhao et al., 2009).The alterations of vasa recta diameter 
measured were localised to the pericyte site in the presence of all of these agents 
known to endogenously regulate MBF. Whilst it is likely endothelial cells (EdC) might 
influence vasoactivitity (McCarron et al., 2017), if all pericytes were to respond it would 
not reflect the refined control (Crawford et al., 2012) that is necessary for MBF to be 
physiologically regulated. The OM tubules are not perfused by capillaries that arise 
from their parent glomerulus and as such a global change in perfusion would lead to a 
perfusion-metabolism mismatch (Chou et al., 1990). This reduced response rate in 
both species also likely reflects that not all pericytes will respond due to their myriad 
of functions (Harrell et al., 2018), reports of pericyte-mediated vasoactivity from other 
tissues (Kawamura et al., 2003; Peppiatt et al., 2006), and the additional resistance 
observed in the mouse due to their known vascular physiology.  
 
4.4.4 C57BL/6J renal pericytes are vasoactive, and contractility reflects known 
species differences in vascular reactivity 
 
For any model, predictive functionality e.g. the model reliably responding,  is a 
necessary requisite for generating valid data (Astashkina et al., 2012). As such, 
concentrations were optimised to produce the maximal response possible at the lowest 
concentration of agonist for a set exposure timeframe. Initial concentrations trialled 
matched those used in the rat preparation for like-for-like comparisons, which were 
then adjusted with respect to the measured contractile response and the pericyte 
response rate in the mouse. Interestingly, for all agonists bar ET-1, the magnitude of 
the contractile pericyte-mediated response of the C57 model was significantly lower 
than those even the rat post-optimisation, and reflects reported interspecies 
differences in isolated liver (Zhao et al., 2009), mesentery (Hedemann et al., 2004), 
and abdominal aorta (Russell, and Watts, 2000) vascular models, as well as 
systemically (Billet et al., 2007; Cassis et al., 2004) and in cell culture models 
(Donnelly-Roberts et al., 2009). However, vasodilatory agents were comparable 
between the two species. 
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4.4.4.1 Angiotensin II-mediated constriction of DVR-pericytes is conserved 
across species.  
 
Angiotensin-II (Ang-II) is a key regulator of MBF (Dickhout et al., 2002; Cowley Jr, and 
O’connor, 2013; Fan et al., 2019), with systemic administration resulting in a more 
pronounced reduction of MBF than cortical perfusion (Fan et al., 2019), and its 
contractility attenuated within the medulla via mTAL-produced nitric oxide (NO)-
mediated tubulovascular feedback to the vasa recta (Dickhout et al., 2002). Whilst 
Ang-II binding is most significant in the kidney for both rats and mice, SD rat kidneys 
have approximately double the Ang-II receptor density. Further still, contractile actions 
of Ang-II are primarily mediated by the AT1A receptor (Billet et al., 2007; Cassis et al., 
2004; Rodrigues et al., 2009), yet radiolabelling has shown AT2 predominates in the 
murine medulla, with markedly less expression of AT1 [48]. What AT1-R are present 
could have their activity limited by AT2-R-dependent NO and prostacyclin release 
(AbdAlla et al., 2001; Russell, and Watts, 2000). Further still, AT1-R dimerizes with B2-
R and results in a more potent activity of Ang-II in the SD (AbdAlla et al., 2000) which 
might not occur as readily in the C57 medulla. 
Yet, whilst being a key agonist in both species the action of Ang-II is markedly different. 
Ex vivo in the liver and thoracic aorta (Zhao et al., 2009; Russell, and Watts, 2000), 
and via in vivo administration (Cassis et al., 2004; Cholewa et al., 2005) the vascular 
response of the mouse is reduced compared to the rat. In vivo, 10-times the 
concentration of Ang-II was needed systemically to elicit a modest increase in blood 
pressure in C57 eliciting approximately 50 % of the reduction of blood pressure 
measured for the rat (Cholewa et al., 2005; Cassis et al., 2004). This was reflected 
here in the pericyte-mediated vasoactive response in the kidney. The magnitude of the 
constriction in the mouse in here for 300 nM was approximately half that of the rat 
elicited by 100 nM Ang-II, and 2/3rds that elicited by 10 nM  Ang-II (Crawford et al., 
2012), reflecting the findings in the literature above.  
Whilst the constriction measured was not significantly different between 100 nM and 
300 nM in C57, the response rate was far more reliable at 60% versus 37%, hence the 
selection of this concentration as optimal for this preparation. Interestingly, the shape 
of the 300 nM Ang-II-induced constriction; the rapid onset and gradual return to 
baseline, matches observations in mice (Ruan et al., 1999; Cassis et al., 2004; Outzen 
et al., 2015), in the rodent live slice model (Crawford et al., 2012), and in isolated 
human  outer medullary DVR (Sendeski et al., 2013), showing a conserved behaviour 
 123 
between the animal models and humans upon concentration optimisation, whilst 
reflecting the reported sensitivities of these different species to Ang-II. 
 
4.4.4.2 Bradykinin is contractile at high concentrations at C57 DVR pericytes. 
 
Whilst still not fully elucidated BK may also play a role in the control of medullary 
oxygenation, dependent upon the constitutively expressed  B2-R (Kakoki et al., 2007), 
which is involved in Na+/K+ homeostasis (Zhang et al., 2018) . Blockade of B2-R 
selectively reduces MBF without affecting the GFR in rats  (Mattson, and Cowley, 
1993; Fenoy, and Roman, 1992), whilst perfusion with bradykinin selectively increases 
MBF in rodent isolated (I) outer medullary DVR, in part due to stimulation of by activity 
at this receptor  (Pallone et al., 1998a; Rhinehart et al., 2002; Pallone et al., 2003b) as 
well as its effect on local PGE2 production (Mattson, 2003). Due to conserved similarity 
between rats and mice in expression of the B2R (Ma et al., 1994), and BK’s known 
pharmacology it could be assumed that the pericyte-mediated dilatory responses 
observed in rats would be comparable in mice. Due to experimental error, a 
concentration of 100-1000-times that used in the SD model  (Kennedy-Lydon et al., 
2015) was used here and interestingly induced a significant pericyte-mediated 
vasoconstriction.  
On smooth muscle cells, BK is contractile via B2-R as opposed to dilatory (Wong, 
2016), with dilatory functions being endothelium-dependent (Wong, 2016). Activation 
of B2-R in the rat leads to afferent arteriolar dilation yet it constricts mesangial cells 
(Bascands et al., 1994) suggesting BK can be contractile at subpopulations of 
pericytes in the kidney (Am et al., 2013). However, even though the concentrations are 
not comparable here this species difference in contractility to BK has been noted 
previously. In an aortic smooth muscle model, BK caused vasoconstriction in C57 mice 
(Felipe et al., 2007), whereas in the SD rat model BK produces a vasodilation of aortic 
smooth muscle at the same concentration (Benetos et al., 1997). Due to experimental 
error, further comment cannot be made on the interspecies differences in a like-for-
like manner. Yet some evidence exists to suggests an indirect mechanism could be 
responsible for this BK-induced constriction. 
In the C57 mouse, 1-10 μM BK-B2-R signalling, as well as Ang-II-AT2-R signalling (Wu 
et al., 2018), inhibitis K+ channel Kir4.1 and thereby downregulates the sodium-
chloride symporter (NCC) on the distal convoluted tubule (DCT) (Zhang et al., 2018), 
As discussed below in section 4.4.4.6, inhibition of the mTAL Na-K-2Cl results in a 
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secondary constriction of DVR as a response to reduced metabolic demand (Fan et 
al., 2019), this may be true for other salt transporters. Further still, there are species 
related differences to NCC downregulation; acute Ang-II infusion reduces DCT 
expression of NCC in C57 (Zhao, and Navar, 2008). In SD rats, NCC expression only 
reduces once acute circulating Ang-II levels fall (Lee et al., 2009). Ang-II activity and 
BK activity are interrelated (Rodrigues et al., 2009; AbdAlla et al., 2000) and it is 
therefore possible that BK in murine kidneys would not perform the same as in the rat. 
As kidney slices retain all the functional architecture of the kidney, it is possible that 
compensatory mechanisms are activated by BK-stimulation to constrict pericytes on 
the DVR in response to downregulation of NCC in mice via tubulovascular crosstalk. 
 
4.4.4.3 Adenosine-5’-triphosphate and BzATP suggest DVR pericytes-
contractility is mediated at least in part by P2X7. 
 
ATP is the signalling molecule for the autoregulatory tubuloglomerular feedback 
mechanism (Peti-Peterdi, and Harris, 2010; Marsh et al., 2019; Bell et al., 2003), with 
further evidence for autoregulatory activity of purinergic signalling in the medulla, 
involved in tubulovascular crosstalk between the medullary thick ascending limb 
(mTAL) and  DVR pericytes (Cowley Jr, and O’connor, 2013; Crawford et al., 2011; 
Crawford et al., 2013; Dickhout et al., 2002). Both rat renal and CNS pericytes have 
shown to express P2 receptors which are responsible for the vasoactivity of ATP, with 
both pericyte-mediated constriction and dilation measured (Crawford et al., 2011; Cai 
et al., 2018; Methner et al., 2019). 
The ATP concentration required to elicit a significant response in the mouse was 10-
20-fold that of the rat, which has been reported previously (Donnelly-Roberts et al., 
2009; Li et al., 2012). Superfusion with 1-2 mM of ATP was required to elicit a response 
in C57 mouse kidney slices, which has been reported for the  C57 brain (Cai et al., 
2018) and muscle vasculature (Cai et al., 2018). Conversely, in the SD kidney slice 
model 100 μM of ATP was sufficient, with a constriction approximately double the 
magnitude of the mouse, showing as a species it is more sensitive to ATP-induced 
vasoconstriction. However, responsiveness to ATP may vary between organs as both  
C57 (Cai et al., 2018) and SD (Peppiatt et al., 2006) brain preparations responding to 
1 mM ATP. However,  whilst 100 μM has shown efficacy in rat pericyte models for the 
retina and kidney (Sugiyama et al., 2005; Crawford et al., 2011), it is ineffective at C57 
pericytes in the pancreas (Almaça et al., 2018), renal pericytes here, and with 
concentrations of 1-10 mM used in the skeletal muscle and brain (Cai et al., 2018; 
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Methner et al., 2019), so it is likely the mouse as a species is less responsive to ATP 
than the rat. Interestingly, in murine  muscle fibres, 100 μM of ATP is dilatory whereas 
in the rat it is contractile  (Ziganshina et al., 2019), suggesting a concentration of 100 
μm ATP in the kidney slice model may be insufficient to induce a constriction, yet too 
high a concentration for dilation. 
This considered, these concentrations of ATP used to induce constriction in both C57 
and SD models are high, for the respective species, which suggests activation of the 
P2X7 receptor (P2X7-R) (Vonend et al., 2005; Donnelly-Roberts et al., 2009; Crawford 
et al., 2011). The resistance of C57 to ATP-induced contractility, and lower magnitude 
of response, may reflect the strain specific loss of function mutation in the P2X7-R  
(Adriouch et al., 2002), and possibly facilitates some of the species resistance to 
hypertension (Neuhofer, and Beck, 2005; Hartner et al., 2003). BzATP is 10-30x more 
potent than ATP at P2X7-(Sugiyama et al., 2005; Crawford et al., 2011; Donnelly-
Roberts et al., 2009), and this was also reflected in the mouse. The C57 mouse model 
did not require the concentration of BzATP to be adjusted (10 μM) and the constrictions 
measured was not significantly different to that obtained by ATP (1-2 mM). BzATP was 
notably potent in the SD kidney slice model, with detectable pericyte-expression of 
P2X7 mRNA (Crawford et al., 2011).  With the pericyte-mediated contractility 
efficacious to superfusion with BzATP in both species, this further suggests DVR 
pericytes express and can exert contractility through P2X7-receptor activation.  
In vivo, high concentrations of ATP occur in response to extreme cellular damage 
(North, 2002) so it is possible that ATP-induced constriction is pathological, whereas 
ATP-induced pericyte-mediated dilation is a homeostatic mechanism that maintain 
medullary perfusion to the mTAL (Cowley Jr, and O’connor, 2013). Dilation of DVR 
pericytes in response to low ATP concentrations and the interspecies vasoactive 
differences to ATP may be further reflected by the murine response to tyramine and 
NA, discussed in more detail below in section 4.4.4.4, but further work is needed to 
fully understand this. 
 
4.4.4.4 The activity of noradrenaline (NA) and tyramine in the mouse further 
suggest species-related differences to both NA and ATP 
 
The sympathetic nervous system is involved in the regulation of renovascular 
resistance by release of ATP and NA (Vonend et al., 2005). Blood flow in the cortex is 
seemingly more sensitive to NA stimulation than the medulla, primarily due to the α2 
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receptor (α2-R) presence in the medulla which can attenuate NA-mediated 
vasoconstriction via α2-mediated release of NO (Mattson, 2003; Vonend et al., 2009). 
However, there is a notable renal medullary presence of varicosities (Yang et al., 1995; 
Crawford et al., 2012), within 2 μm of NG2+ pericytes in the rat kidney (Crawford et al., 
2013), suggesting innervation is involved in MBF regulation. Further still, denervation 
markedly influences MBF more than CBF in the rat, with renal nerve stimulation having 
a significantly greater impact on MBF (Hermansson et al., 1984). Together these are 
suggestive of sympathetic involvement in maintaining tonicity of the DVR. However, in 
line with other vasoconstrictors, the C57 model model was resistant to NA. 
NA enacts its contractile effects via α1-R which have noted differential activity in murine 
and rodent aorta (Russell, and Watts, 2000), with comparable findings here. To induce 
a comparable vasoconstriction of vasa recta in the C57 mouse model, 30-times the 
concentration of NA was required (Crawford et al., 2012). Interestingly the inherent 
resistance of mice to NA may also relate to architecture of the murine kidney; with ¼ 
of the myelinated nerve presence that is present in the rodent kidney (Fazan et al., 
2002). In an isolated-perfused kidney (IPK) preparation in the C57 mouse, a 
concentration ≥300 nM of NA was necessary to cause a resultant reduction in renal 
perfusion pressure (Vonend et al., 2005), further corroborating the use of 300 nM here. 
Interestingly, the efficacy of NA can be related to that of Ang-II, where Ang-II is a 
secretagogue of NA via neuronal AT1-R (Bernier, and Perry, 1999; Nakamura et al., 
2014; Ma et al., 2001). One study investigating renal sympathetic nerve activity found 
mice needed 10-times the concentration of NA comparative to Ang-II to achieve the 
same increase in mean arterial pressure (MAP) (Ma et al., 2001), meaning a 
concentration with a higher response rate ,whilst remaining physiologically relevant, 
could be 3 μM of NA, but was not trialled here. Interestingly, in the SD rat Ang-II-
induced reduction in MBF is more potent than NA, at approximately 1.5-times the 
magnitude (Bądzyńska, and Sadowski, 2011; Crawford et al., 2012), yet in C57 there 
was not difference between the NA and Ang-II induced pericyte-mediated 
vasoconstriction, possibly reflective of differences in AT1-R expression present in the 
kidneys between the species.  
As mentioned above in section 4.4.4.3, dilation of DVR pericytes in response to low 
ATP concentrations mat be reflected in the C57 models dilatory, not contractile, 
response to tyramine. It was noted in the SD model that 1 μM of tyramine seemed to 
preferentially stimulate ATP release, demonstrated by the effectiveness of P2-
antagonist suramin (Crawford et al., 2013). Tyramine stimulates sympathetic nerves 
to release NA and ATP, and is comparable to the effect of nerve stimulation, which 
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also produces these co-transmitters (Vonend et al., 2009; Farmer, 1966). The time 
until maximal change in vasa recta diameter for both species occurred during washout 
of tyramine (Figure 4.8(k)), which likely reflects time taken to release of NA and ATP 
from varicosities.  
In the mouse kidney (Vonend et al., 2005) and other tissues (Burnstock, and Novak, 
2012) it has also been observed that in certain conditions ATP, not NA, is the 
predominant neurotransmitter released. As noted above in section 4.4.4.3, the C57 is 
notably resistant to ATP, and perhaps whilst stimulation with tyramine evokes 
comparable ATP release in both species, in the C57 model this is a dilatory 
physiological concentration. As a dilatory concentration of ATP in the C57 model has 
yet to be ascertained, further commentary is not possible. However, provides further 
evidence for purinergic signalling in the regulation of MBF.  
 
4.4.4.5 In the mouse, the DVR pericyte responsiveness to endothelin-1 differs 
from that described in the literature. 
 
Endothelin-1 (ET-1) is synthesized in the IM by CD and interstitial cells, and a key local 
mediator of MBF, with a high local concentration in the medulla (Silldorff et al., 1995; 
Neuhofer, and Beck, 2006). ET-1 is a potent vasoconstrictor of the DVR, noted to 
cause focal, long lasting constrictions along the capillary (Scherer et al., 2005; Pallone 
et al., 2003b; Pallone, and Silldorff, 2001), localised to pericyte-sites  (Silldorff et al., 
1995; Crawford et al., 2012). Interestingly as a potential feed-forward mechanism, ET-
1 stimulates production of PGE2 by medullary interstitial cells (Wilkes et al., 1991) 
further suggesting there are autoregulatory mechanisms innate to the medulla.  
Endothelin pharmacology has been compared between rats, humans and mice (Wiley, 
and Davenport, 2004), showing similar potency, despite a lesser magnitude of 
vasoactive response in C57 mice in the aorta (Russell, and Watts, 2000), brain (Horie 
et al., 2008), and cavernosum  (Carneiro et al., 2008) comparative to rats. However, 
in the kidney slice model, a 10-fold reduction of the concentration in the mouse (10 nM 
to 1 nM) resulted in a comparable pericyte-mediated vasoconstriction to that measured 
in the rat for 10 nM; which opposes what the literature would otherwise suggest of the 
rat exhibiting a larger vasoconstriction. The notable interspecies difference in 
constriction observed here may relate to overexpression expression of ET-1A receptors 
(-R) over ET-1b-R in the murine DVR, as ET-1b has demonstrated its vasodilatory 
properties (Carneiro et al., 2008; Schildroth et al., 2011; Inscho et al., 2005). In the 
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mouse heart there is a reported 9:1 ratio or ET1A:ET1B, whereas in the rat this ratio is 
4:1[69]. The literature suggests ET-1 should have a greater magnitude of response in 
the rodent kidneys. In afferent arterioles, it was found that both ETA-R and ETb-R 
contribute to vasoconstriction in the rat juxtamedullary vessels (Endlich et al., 1996)  
whereas in murine AA only ET-1a-R contributes (Schildroth et al., 2011). 
Data acquired from different species demonstrates a conserved contractile profile in 
response to ET-1, where vessels had a lag in onset of constriction and did not return 
to baseline diameter within the experimental window, even after washout of ET-1. 
Much like in this preparation (Figure 4.6(c)), porcine microvessels exposed to ET-1 
take ~600s to reach maximal contractility and vessels remained constricted (Potts et 
al., 2012). This sustained constriction in both mice and rats has also been observed 
hepatically in vivo; at >600s post ET-1 injection with portal venous pressure remained 
elevated (Zhao et al., 2009), and another group who were also looking at pericyte-
mediated regulation of IOMDVR observed it took approximately >600-seconds to reach 
the maximal constriction in the rat (Silldorff et al., 1995), with constriction only 
moderately reversed 10-minutes once infusion had stopped. Interestingly, in the 
IOMDVR preparation the constriction measured in response to ET-1 was 
approximately double the magnitude of the mouse response here, whilst the pericyte-
mediated constriction reported by Crawford et al (Crawford et al., 2012) of SD kidney 
slice DVR pericytes to ET-1 was approximately 4-times smaller than the magnitude of 
the mouse pericyte-mediated response. In light of the literature and measurements 
here, it suggests there was error in how the ET-1-mediated vasoconstriction in the 
original rat model was measured (Crawford et al., 2012), and as such those values are 
not accurate or in fitting with other vascular models. 
 
4.4.4.6 Prostaglandin E2, and associated exogenous drugs, have comparable 
pericyte-mediated activity in both species.  
 
Prostaglandin E2 (PGE2) is formed by cyclooxygenases-1 and -2 (COX- 1, COX-2 
which are abundantly expressed in the medulla (Kennedy-Lydon et al., 2015), and acts 
as another key regulator of MBF. PGE2 has direct and indirect vasoactivity: both 
directly at DVR pericytes via prostaglandin receptors EP2 and EP4 (Silldorff et al., 1995; 
Meurer et al., 2018); and indirectly by potentiating dilation of peptides like interleukin-
1 (IL-1) and  atrial natriuretic peptide (ANP), whilst buffering vasoconstriction of 
antidiuretic hormone (ADH), Ang-II, ET-1 and NA (Silldorff et al., 1995; Neuhofer, and 
Beck, 2005; Kennedy-Lydon et al., 2015; Wilkes et al., 1991; Mattson, 2003). Without 
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this complex dilatory-profile PGE2 could potentially reduce IMBF; in furosemide treated 
rats and dogs inhibition of the mTAL Na-K-2Cl cotransporter results in a secondary 
constriction of DVR as a response to reduced metabolic demand (Fan et al., 2019). 
PGE2 also inhibits the Na-K-ATPase-mediated NaCl reabsorption in the mTAL and 
collecting duct (CD) thereby reducing metabolic demand, which could constrict DVR 
thus reducing MBF (Neuhofer, and Beck, 2006). Thus, PGE2 can reduce medullary 
metabolic demand, yet feed-forward mechanisms mean maintenance of medullary 
perfusion and thus oxygenation. 
PGE2 was not luminally perfused in this study, it needed to penetrate ~50 μm below 
the slice surface where vasa recta capillaries are visualised, and actual concentration 
reaching pericytes could not be determined and is possibly lower than the 
concentration applied. This may suggest DVR pericytes are more resistant to higher 
concentrations that afferent arterioles (Meurer et al., 2018), which would be important 
in preserving MBF as stated above. Interestingly, 1 μM the SD (Kennedy-Lydon et al., 
2015) and C57 kidney slice models was an ineffective concentration. The magnitude 
of the response in both species was also not significantly different at 10 μM (Crawford 
et al., 2012; Kennedy-Lydon et al., 2015), which has been reported for the species in 
the parenchymal arterioles, with a concentration-dependent vasoactivity of PGE2 
(Dabertrand et al., 2013).  
PGE2 at high concentrations in rodent and murine vascular beds acts as a 
vasoconstrictor at  non-preconstricted  arterioles (Dabertrand et al., 2013; Meurer et 
al., 2018; Ohno et al., 1999). Interestingly, a constriction of the naïve vasa recta was 
observed with PGE2 before dilation in some experiments. As can be seen in Figure 
4.7(b), PGE2 10 μM caused a small constriction during superfusion, and during 
washout the subsequent vasodilation occurred. This could possibly occur due to 
dilution of the PGE2 concentration upon washout. In murine isolated perfused kidneys 
(IPK), 1 μM/L of PGE2 cause an increase in renal vascular resistance, where 10 nM/L 
was dilatory (Meurer et al., 2018), so reduction in the concentration of PGE2 in the 
perfusion bath during washout could have resulted in a dilatory concentration.  
Correspondingly, perfusion with nonselective COX-inhibitor indomethacin resulted in 
a pericyte-mediated constriction that was also not significantly different between 
species (Crawford et al., 2012; Kennedy-Lydon et al., 2015), and this subsequent 
reduction in MBF could constitute a pathomechanism behind NSAID-induced 
nephrotoxicity. Given the comparable magnitude of response between the species, 
which has been observed in other tissues (Dabertrand et al., 2013), data here suggests 
prostaglandins have comparable vasoactive action in rats and mice. As medullary 
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PGE2 both potentiates vasodilators and inhibits vasoconstrictors, there are multiple 
downstream pathways that may be affected by its inhibition, but are beyond the scope 
of this study, and is potentially why superfusion in the SD kidney slices with SNAP or 
bradykinin (BK) did not attenuate indomethacin contractility at DVR pericytes 
(Kennedy-Lydon et al., 2015) 
Further still, there’s potential vasodilators have similar efficacy across species as NO-
donor S-Nitroso-N-Acetyl-D,L-Penicillamine (SNAP), resulted in a comparable 
vasodilation at 100 μM. This comparable efficacy of vasodilators suggests potentially 
mice are protected from renovascular diseases from resistance to vasoconstrictors as 
opposed to dilatory agents being more effective. An NO-donor having similar efficacy 
between models, whilst other endogenous agonists do not, is further suggestive of 
species-difference in both receptor functionalities and/or receptor expression profiles, 
as NO does not act via a receptor instead diffusing through biological membranes 
(Mohaupt et al., 1994). Bioavailability of NO in the kidney of each species would need 
to be established also. 
 
4.4.5 There is benefit to developing and characterising a cross-species model. 
 
As discussed above there are known differences in receptor expression and agonist 
potencies, and indeed bioavailability that are reflected in the vasoactivity in the two 
kidney slice models here. These findings further demonstrate there is risk in using a 
defined experimental model in different species to corroborate findings. This is based 
on an assumption that behaviour profiles will be equivalent between rats and mice  
(Downs, 2011). However, it also demonstrates how useful it is to use the same model 
in different species to observe how functionality might be conserved. Pericyte-
mediated regulation of the DVR in mouse and rat is conserved, given the general 
observation that agonist evoked diameter changes are seen to specifically occur at 
pericyte sites on vasa recta. 
Importantly however, it should be noted that responses measured in the rat are not 
predictive of what would occur in the mouse version of the same model. Nevertheless, 
upon assessment of the literature the differences in pericyte-mediated activity 
observed here reflect what is known about 1) the individual species and 2) how the 
vasoactive behaviour relates between the species. The C57 mouse vascular reactivity 
is markedly less pronounced than that measured in the rat (Russell, and Watts, 2000; 
Cholewa et al., 2005; Hedemann et al., 2004; Zhao et al., 2009), and as such this 
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reduced responsiveness demonstrates predictive validity of the C57 mouse model. 
Data here demonstrate the need for important for benchmarking of responses of 
vessels in each animal model and are indicate these experiments are critical part of 
validating a mouse live kidney slice model (Denayer et al., 2014). Not only this, the 
behaviour of the vasculature in the C57 mouse model corroborates other evidence 
provided for the two models. Notably that the C57 mouse model has reduced 
vasoactivity comparative to the SD rat.  
The aim with animal models is translatability and to generate knowledge around human 
physiology that is otherwise impractical or unethical to determine. It is important not 
only to notice differences between species, but to also try and probe why these 
differences exist and subsequently interpreting data in the context of these species-
specific differences in physiology (Cunningham, 2002; Boswell et al., 2014; Martignoni 
et al., 2006; Radermacher, and Haouzi, 2013). It is also important to consider what is 
conserved. Mentioned briefly in section 4.4.4.1; humans, rats and mice all show 
pericyte-mediated contractility in response to Ang-II on the DVR. Upon exposure to the 
same concentration of Ang-II (10 nM), both rats and human outer medullary DVR reach 
an approximately 25% constriction at t = 5 mins post bolus of Ang-II, and slowly 
desensitize (Sendeski et al., 2013; Zhang et al., 2004). The magnitude of constriction 
for a concentration matched concentration of Ang-II (10 nM) was smaller in the SD 
kidney slice model, with a constriction of 18.0±2.7% at pericyte sites (Crawford et al., 
2012).  Whilst the constriction observed in the C57 mouse slices was considerably 
lower than both SD rats and humans at comparative concentrations, all species show 
that regulation of DVR diameter is pericyte-mediated and thus a conserved 
functionality of this cell type. Further still, it may be demonstrative that  live kidney 
slices are a suitable in situ in-between model that demonstrates functionality of the 
vasculature in tissue thus bridging in vitro and in vivo models (Crawford et al., 2012). 
This present study underlines the importance of using companion models across 
species given the species-related differences in physiology. It also demonstrates how 
the C57 kidney slice model is: i) representative of the species; ii) representative of 
known pericyte behaviour (contractile cells that regulate vasa recta diameter) and thus 
MBF; and iii) the C57 slice model is viable and suitable for further investigations into 
the multipotency of renal pericytes, as will be addressed in the next chapter. 
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5 THE USE OF A MURINE LIVE SLICE MODEL TO INVESTIGATE THE 




Data presented in Chapter 3 showed CD163+ macrophages (MΦ) were spatially close 
to NG2+ and PDGFR-β+ pericytes when present, and their cell-cell contact with 
pericytes induced a constriction of vasa recta capillaries. Further still, in line with 
reports suggesting that rodent CNS pericytes express the CD163 receptor (Balabanov 
et al., 1996), after stimulation with pro-inflammatory cytokines TNF-α and IL-1β, few 
cells were fluorescently labelled with both anti-CD163 and anti-PDGFR-β. Importantly, 
these cells bore morphological similarities to the criteria used for identifying pericytes 
(Bergers, and Song, 2005). However, in the Sprague-Dawley (SD) model, anti-CD163 
was only able to identify a very small population of resident renal MΦ, as demonstrated 
by the low number of cells expressing the CD163 receptor in the rat (Kaissling, and Le 
Hir, 1994) and the mouse (Rubio-Navarro et al., 2016; Bi et al., 2018), despite its 
abundance in human kidneys (Colvin, 2019). Consequently, these findings may not be 
generalisable to renal pericytes and would be difficult to further probe using anti-
CD163.   
Currently in the field, rodent MΦ have few identifying-receptors that would be 
considered “pan-MΦ”. It is also important that these MΦ markers identify residential 
populations, as circulating immune cells are not present in tissue slices (Stribos et al., 
2016).  CD68 is used as a pan-MΦ marker in other models (Damoiseaux et al., 1994; 
Ysebaert et al., 2004) yet there was no medullary presence, and therefore no pericyte-
expression in the rodent kidney slices (Chapter 3), despite reported expression on 
pericytes in other tissues (Rustenhoven et al., 2016; Pieper et al., 2014; Thomas, 
1999). The literature has reported pericyte expression of immune receptors can require 
stimulation, e.g. MHC-II has been found expressed by  porcine brain capillary pericytes 
after interferon-γ stimulation (Pieper et al., 2014). Whilst MHC-II is a MΦ marker 
successfully used in the rat, it is not specific to residential MΦ and is expressed by 
other immune cells in the interstitium including immature monocytes, lymphocytes, and 
B-cells (Rimsza et al., 2003; Muhlethaler-Mottet, 1997; Landsman et al., 2009).  
Therefore, given the lack of a suitable pan-MΦ identifying receptor in the rat, use of 
the SD model to further investigate the relationship of pericytes and MΦ in the kidney 
was limited. 
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In Chapter 4, it was established that the murine kidney slice model is a viable tool for 
the study of pericytes, contractile behaviour of pericytes appeared to be conserved in 
a species-specific manner. As a model, the mouse is extensively used in the field of 
immunology (Mestas, and Hughes, 2004), and access to a murine kidney slice model 
circumvents the issue of a small number of residential identifiable MΦ population in 
the rat, as was observed in Chapter 3. It enables uses of the residential pan-MΦ 
antigen F4/80, abundantly expressed throughout the murine kidney (Hume, and 
Gordon, 1983; Cao et al., 2015), and reported co-expression on pericytes (Section 
1.1.3.1). Therefore, given the F4/80+ receptor is considered exclusive to murine MΦ 
and abundant in the kidney, this allows a more extensive investigation into the pericyte-
MΦ relationship than that observed in Chapter 3. 
Much of the current data on the immune functionality pericytes are generated from 
murine models (Section 1.3-4) This immune activation of renal pericytes is an 
investigative avenue worth exploring, especially given the novel interaction identified 
between renal pericytes and CD163+ MΦ in this thesis. With the extensive presence 
of F4/80+ MΦ in the medulla (Hume, and Gordon, 1983), a better randomised 
visualisation of these MΦ  with  pericytes within the tissue is an advantage over the rat 
model.  
Ultimately, the aim of this chapter is to conduct like-for-like experiments to those 
performed in the SD rat but using anti-F4/80 to label MΦ. This will enable the 
characterisation of i) the vasoreactive responsiveness of vasa recta pericytes to short-
term stimulation with pro-inflammatory cytokines TNF-α and IL-1β (acute superfusion 
experiments), as previously described in the SD rat model Chapter 4 section 4.2.3, 
(Data provided by Kirsti Taylor); ii) determine the influence that MΦ contact has on 
pericyte characteristics, their spatial relationship, and the possibility of any cells being 
positive for both pericytic (PDGFR-β and NG2) and MΦ (F4/80) markers, as was 
observed in Chapter 3 with the rat; and iii) determine how these characteristics might 
be influenced by cytokine stimulation with TNF-α and IL-1β.  
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5.2 5.2 Methods: 
 
Intact live kidney slices from 9-week-old C57BL/6J mice (Charles River Laboratories, 
Manston) were obtained and processed as described in Chapter 2. 
 
5.2.1 5.2.1 DIC video analysis.  
 
Real time video images were collected of live murine kidney slices superfused with 
either TNF-α (10 ng/mL; R&D Systems) or IL-1β (10 ng/mL; R&D Systems) as 
described in chapter 2 section 2.5.  
 
5.2.2 5.2.2 Immunohistochemical experiments. 
 
In brief, initial exploratory immunohistochemical experiments to ascertain appropriate 
markers for identifying residential MΦ were performed with anti-CD68 (rabbit, 1:100; 
Abcam) and anti-F4/80 (rat; 1:1000; Bio-Rad), to determine the presence of cells 
positive for these receptors in the murine kidney slices. Suitability of anti-PDGFR-β 
was determined as described in chapter 3 section 3.2.1 
For subsequent co-expression experiments, slices were incubated with anti-F4/80 to 
identify MΦ and either anti-PDGFR-β or anti-NG2 (1:200, Merck-Millipore) to identify 
pericytes. Nuclear stain Hoechst 33342 5 μM (Invitrogen) was included for positive 
identification for a cell body to accurately quantify and elucidate any overlap between 
pericyte and MΦ cells by correlation of their blue nuclei in images. Inclusion of rodent 
MΦ marker anti-F4/80 was to also provide clarity as to whether anti-NG2 and anti-
PDGFR-β exclusively stain renal pericytes. Experiments where kidney slices were 
fixed with 4% paraformaldehyde (PFA) immediately post Hoechst 33342 incubation 
were performed to see if under homeostatic conditions any co-expression of pericyte 
and macrophage markers occurred. These tissues that were freshly slices were 
classified as the “0-hour” experimental group. To stimulate co-expression of MΦ and 
pericyte markers, slices were stimulated with pro-inflammatory cytokines TNF-α and 
IL-1β. The PSS control in the cytokine stimulation experiments are referred to as the 
“4-hour” control. 
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Kidney slices were incubated in Hoechst 33342, and then washed with PSS, slices 
were then fixed in 4% PFA then washed in 0.1 M phosphate buffered saline (PBS). 
Tissue then underwent permeabilisation in 0.1% Triton X-100, and a step to block non-
specific antibody binding with 10% donkey serum solution, before an overnight 
incubation with primary antibodies. Subsequently, slices were washed with 0.1 M PBS 
and the primary antibodies were probed with fluorescent secondary antibodies donkey-
anti-rabbit Alexa Fluor 555 (donkey, 1:200; Invitrogen), and donkey-anti-rat Alexa Fluor 
488 (donkey, 1:200; Invitrogen). Slices were then washed a final time using PBS, then 
mounted using Citifluor (Agar Scientific) and stored at 4°C in the dark. Unless 
otherwise specified, reagents are from Sigma-Aldrich. 
Tissue sections stimulated with pro-inflammatory cytokines TNF-α, and IL-1β (10 
ng/mL; R&D Systems) were incubated for 4 hours prior to be processed as described 
above. Cytokine stimulations have a corresponding “4-hour” PSS-time control. Data 




All data is presented as mean values ± standard error mean (SEM), n numbers are 
presented as the number of animals used, then the number of kidney slices. The SEM 
is calculated with the number of animals used in the IHC experiments. Statistical 
significance was calculated using a two-tailed Student’s unpaired t-test for superfusion 
and “0 hour” PSS background experiments, and a one-way ANOVA with post-hoc 
Dunnett’s test was used for cytokine-stimulated and control tissue that was incubated 
for 4-hours. Values were calculated using GraphPad PRISM 5.0 software (La Jolla, 





5.3.1 TNF-α, but not IL-1β induces a significant pericyte-mediated 
vasoconstriction of vasa recta. 
 
To assess if pro-inflammatory cytokines have any acute actions on murine pericytes, 
live kidney slices were superfused with either 10 ng/mL TNF-α or IL-1β for a time period 
of 600s, followed by a “wash-out” period of approximately 600s frames to determine 
whether any cytokine-induced changes in vessel diameter were reversible. These 
experiments have previously been conducted in Sprague-Dawley (SD) rats, and data 
here will be compared against previously obtained data (data provided by Dr. Kirsti 
Taylor). Exposure of naïve vasa recta capillaries in murine kidney slices to 10 ng/mL 
of TNF-α resulted in a constriction of vessel diameter that was significantly greater at 
pericyte sites than non-pericyte sites (8.9±0.8% vs 2.5±1.2% respectively, p<0.05, n=3 
slices and 3 animals; Figure 5.1(a)). This was significantly less than the pericyte-
mediated constriction previously observed in the SD rat (-11.9±1.4%; p<0.0001). This 
constriction began during superfusion of the tissue with TNF-α and continued 
throughout the washout period (Figure 5.1(b)), with reversal to baseline observed in 
only 1/3 experiments. Superfusion with 10 ng/mL IL-1β failed to elicit any significant 
change in vasa recta diameter in the murine preparation (-4.0±0.6% at pericyte sites 
vs -3.2±1.3% at non-pericyte sites; p>0.05, n=4 animals, 4 slices; Figure 5.1(d)) in the 
timeframe investigated. Superfusion of SD kidney slices with IL-1β also failed to elicit 
any pericyte-mediated alteration of vasa recta diameter (-2.6±0.8%).  
 
5.3.2 PDGFR-β and CD68 expression in the C57BL/6J mouse kidney is similar 
to that observed in the Sprague-Dawley rat model. 
 
The suitability of anti-PDGFR-β in labelling renal pericytes was determined by the 
presence of Alexa-555 2° fluorescence (used to probe anti-PDGFR-β) adjacent to IB4 
labelled vasa recta capillaries, and by brightfield images used to confirm structures. 
Data for murine kidney slices show comparable patterns of staining for PDGFR-β (see 
section 3.3.1 for description) (n=2 animals, 5 slices;(Figure 5.2(ai-aiii))). Some 
PDGFR-β+ pericytes are seemingly paired (Figure 5.2(b)), with adjacent PDGFR-β+ 
cells showing pericyte-identifying morphology, the large cell body and association with 
the vascular wall. PDGFR-β+-labelled pericytes are more numerous than those labelled  
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Figure 5.1 Superfusion of C57BL/6J murine kidney slices with TNF-α, but not IL-1β, 
caused a pericyte-mediated constriction of vasa recta capillaries.  
Representative DIC images of a time-series experiment of superfusion of a vasa recta capillary 
with TNF-α (a) and IL-1β (d) (i) before exposure, (ii) during exposure, and (iii) during washout 
from agonist. Pericytes are indicated with yellow dashed circles, as are a pericyte site (black 
dashed line) and corresponding non-pericyte site (red dashed line). The percentage change of 
vessel diameter of both sites was plotted against time (b) at a pericyte (black) and 
corresponding non-pericyte site (red) site, with exposure to agonist indicated by the black line 
above the trace. Average data for TNF-α (c; n= 3 animals and 3 slices), and IL-1β (n=4 animals 
and 4 slices; f) at concentrations of 10 ng/mL show TNF-α induced a significantly greater 
constriction at the pericyte site (black bar), whereas IL-1β was not significantly different from 
the non-pericyte (red bar) value. The average data for equivalent experiments performed in the 
Sprague-Dawley (SD) rat are shown by the blue bar and show the pericyte-mediated 
constriction in response to TNF-α is significantly greater than that observed in the mouse, and 
that there was no significant pericyte-mediated response to IL-β. * p<0.05, *** p<0.005, **** 
<0.0001, 
ns
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with NG2, yet anti-PDGFR-β does not exclusively label medullary pericytes, as 
interstitial fibroblasts in the medulla were also identified by immunofluorescence. 
Unlike NG2+ pericytes, PDGFR-β+ labelling does not drop off in the IM, with PDGFR-
β+ staining present throughout the entirety of the kidney slices. Direct like-for-like 
comparisons of pericyte morphological characteristics are presented below in section 
5.3.3. To exclude interspecies variability, anti-CD68 antibody was also used in the 
murine model (n=1 animal and 3 slices). CD68 had no presence in the murine medulla, 
primarily located in the cortex of the slice, around arterioles as shown in Figure 5.2(c). 
As an infiltrating MΦ marker in the kidney (Mattson et al., 2006), with no recruitment 
possible, this marker was not used for further study. Again, as described in section 
3.3.2, the morphology of CD68+ MΦ was similar to that of both PDGFR-β and NG2 
labelling these cells (Figure 5.2(c)). 
 
Figure 5.2 Platelet derived growth factor receptor-β (PDGFR-β)+ and CD68+ positive staining in the 
C57BL/6J mouse. 
PDGFR-β+ (red) pericytes (aii-iii) and mesangial cells (ai) reside along isolectin B4 (IB4; green) stained 
vasculature, with PDGFR-β+ cells extensively present throughout the rodent kidney. Representative 
regional images of PDGFR-β+ fluorescent staining in the (ai) cortex, (aii) outer medulla (OM), and (aiii) 
inner medulla (IM). Observed with PDGFR-β+ pericytes was occasional pairing of cell bodies along vasa 
recta capillaries, with; (bi) showing the brightfield image of paired cells indicated in (aii), (bii) showing 
the PDGFR-β+ staining, and the corresponding composite (biii; n = 2 animals and 5 slices). As observed 
in the Sprague-Dawley rat in chapter 3, when slices were probed with IB4 (green) and anti-CD68 (ciii; 
red; n=1 animal and 3 slices), staining was perivascular and localised to arterioles in the cortex, with 
morphology comparable that PDGFR-β+ (ci), and neural-glial 2+ (NG2+; red; n=4 animals and 9 slices) 
cell bodies which co-localise to arterioles. Structures are highlighted with dashed lines and are labelled;, 
G = glomerulus, A.A = afferent arteriole, PCT = proximal convoluted tubule, DCT = distal convoluted 
tubule, T = tubule, vr = vasa recta. White arrow heads indicate pericyte and mesangial cell bodies, whilst 































5.3.3 Vasa recta capillaries where pericytes are in contact with F4/80+ 
macrophages are constricted. 
 
Live murine kidney slices were co-immunostained with either anti-NG2 and anti-F4/80, 
or anti-PDGFR-β and anti-F4/80, to investigate the spatial relationships between these 
cell types and to observe if any co-labelling of these receptors on an individual Hoechst 
33342+ nuclei occurred. For PDGFR-β+ pericyte density, 10 μm deep (214.2 μm2; step 
size of 1 μm) maximal intensity z-stacks were reconstructed, and density was 
quantified by the percentage of the area occupied by PDGFR-β+-labelled 
immunofluorescence. This has been previously reported for quantification of PDGFR-
β+ pericyte density in other tissues where immunohistochemical experiments were 
performed (Ikeda et al., 2018; Craggs et al., 2015). Limitations of this technique are 
described in Chapter 2, and section 3.4.1. Whole renders were used irrespective of  
Table 5.1 Characteristics of platelet derived growth factor receptor-β (PDGFR-β)+ and 
neural-glial 2 (NG2)+ pericytes in the renal medulla. 
Data presented are the mean±SEM. n= 3 animals and 9 slices, ≥ 200 pericytes per animal  
1OM= outer medulla, 2IM = inner medulla 
3Area calculated as the average percentage of area occupied with fluorescent stain per 10 μm 
deep (214.2 μm2) z-projection, 4# =Number of cells per 100 μm2 
5P = Pericyte, 6NP= non-pericyte 
* p<0.05; **p<0.0001 for comparisons between NG2+ and PDGFR-β+ pericytes 
% p<0.0001 for comparisons between the OM and IM 
 
 
the presence of fibroblasts as removal would lead to inaccurate, subjective analysis. 
For comparison between pericytes, this quantification method was also used for NG2+-
labelled pericytes, as well per 100 μm2 as described in chapter 4. In healthy tissue 
sections, PDGFR-β+ labelled pericytes, as determined by their residence on vascular 
walls, were more abundant in the outer medulla (OM) than the inner medulla (IM; 
20.6±1.6% vs 16.0±1.1% respectively, p<0.0001, n=3 animals and 9 slices), as were 
NG2+ pericytes (10.9±1.1% vs 4.7±0.4% (Figure 5.3(c)); 9.0±0.6 cells/ 100 μm2 vs 
4.9±0.3 / 100 μm2 respectively, p<0.0001, n=3 animals and 9 slices; Table 5.1. The 
total PDGFR-β+ presence was significantly larger than NG2+ presence in both the OM 
 PDGFR-β NG2 OM1 IM2 OM IM 
Pericyte Density   
Area3 20.6±1.6** 16.0±1.1%** 10.9±1.1% 4.7±0.4 
#4 N/A 9.0±0.6  4.9±0.3% 
Pericyte size, μm   
Height  5.6±0.2** 5.7±0.2** 4.5±0.2 4.0±0.2 
Width 7.6±0.4 6.8±0.3* 7.5±0.3 8.0±0.4 
Vessel diameter, μm  
P5 site 6.7±0.2% 6.4 ±0.2% 
NP6 site 8.9±0.3** 8.3±0.2 
 140 
 
Figure 5.3 The regional densities of pericytes and macrophage (MΦ) in the outer (OM) 
and inner medulla (IM). 
(ai-ii, and bi-ii) are representative confocal acquired images of OM (ai and bi) and IM (aii and 
bii) fluorescently stained with anti-neural-glial-2 (NG2; a;red) or anti-platelet derived growth 
factor receptor-β (PDGFR-β; b;red), anti-F4/80 (green), and Hoechst 33342 (H342;blue). 
Individual cell bodies can be identified by NG2, PDGFR-β, or F4/80 positive 
immunofluorescence surround a Hoechst 33342+ nucleus, indicated by white arrows. The 
respective pericyte densities, as determined by the percentage of the render area (10 μm deep, 
214.2 μm2 standard deviation-projected z-stack) occupied by positive fluorescent staining can 
be seen in (c) for PDGFR-β+-labelled (orange bar) and NG2+-labelled (blue bar) pericytes in 
the OM and IM. The respective cellular density of F4/80+ MΦ can be seen in (d). All data 
presented as mean±SEM. n= 3 animals and 9 slices. ** p<0.0005, *** p<0.0001, ns = p<0.05. 
































(p<0.0001) and IM (p<0.0001). The average number of MΦ present per ROI of the OM 
was 19.1±1.9 cells, and 10.3±1.1 in the IM in NG2 experiments; and 17.4±2.2 and 
6.2±1.0 in PDGFR-β experiments in the OM and IM respectively. The average 
presence of MΦ in the OM is significantly greater in both NG2 (p<0.0005) and PDGFR-
β labelled tissue (p<0.0001) than that in the IM (Figure 5.3(c)), which has been 
reported previously (Hume, and Gordon, 1983; Soos et al., 2006).  
Pericyte size measured as described in section 2.3. The average size of NG2+-
labelled pericytes was 4.5±0.2 μm tall and 7.5±0.3 μm wide in the OM, and 4.0±0.2 μm 
tall and 8.0±0.4 μm wide in the IM, with an average combined size (OM + IM) of 4.3±0.1 
μm in height and 7.9±0.3 μm in width. PDGFR-β+-labelled pericytes were 5.6±0.2 μm 
tall and 7.6±0.4 μm wide in the OM, and 5.7±0.2 μm tall and 6.8±0.3 μm wide in the 
IM, with an average size of 5.5±0.1 μm in height and 7.2±0.2 μm in width. There were 
no significant differences found between the OM and IM size for both PDGFR-β+ and 
NG2+ pericytes (p>0.05). PDGFR-β+ pericytes were significantly larger in height 
(p<0.001) on average and tended to be narrower (significant in the IM; p<0.05).  
 
Table 5.2 Characteristics of renal platelet derived growth factor receptor-β (PDGFR-β)+ 
and neural-glial 2 (NG2)+ pericytes in contact with F4/80+ macrophages (MΦ). 
Data presented as the mean±SEM, n= 3 animals and 9 slices, ≥ 200 pericytes per animal 
The number of F4/80+ MΦ are calculated as the number of cells per 10 μm (214.2 μm2) z-stack 
1OM= outer medulla, 2IM = inner medulla, 3P = Pericyte, 4NP= non-pericyte 
*p<0.05; **p<0.01; ***p<0.0001 for comparisons between NG2+ and PDGFR-β+ pericytes  
£p<0.0005; %p<0.0001 for comparisons between the OM and IM 
#p<0.0001 for comparisons between values presented here and corresponding values in 
Table.5.1 
 
The average vessel diameter covered with NG2+-labelled pericytes reside is 6.4±0.2 
μm at the site where the pericyte soma resides (termed “pericyte site”), and 8.3±0.2 
μm at the section of vessel without pericyte cell coverage (non-pericyte site). Vasa 
recta covered with PDGFR-β+-labelled pericytes tended to be marginally, although not 
significantly (p>0.05), wider at pericyte sites (6.7±0.2 μm) and significantly wider at 
non-pericyte sites (8.9±0.3 μm; p<0.05) than vasa recta covered with NG2+-labelled 
 PDGFR-β NG2 OM1 IM2 OM IM 
Number of F4/80+ MΦ    
 17.4±2.2% 6.2±1.0 19.1±1.9 10.3±1.1 
Pericyte size, μm   
Height  5.1±0.2*** 5.5±0.2*** 4.0±0.1  3.9±0.2 
Width 7.2±0.3  6.4±0.3** 7.5±0.3  8.0±0.4, 
Vessel diameter, μm  
P3 site 5.1±0.3%, # 5.1±0.2%, # 
NP4 site 8.3±0.3* 7.5±0.3 
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pericytes. For vasa recta covered with either PDGFR-β+ and NG2+-labelled pericytes, 
vessel diameter at pericyte sites was significantly narrower than the vessel width at 
the corresponding non-pericyte sites (p<0.0001; Figure 5.4(a): Table 5.1).  
 
 
Figure 5.4 The effect of F4/80+ MΦ on vasa recta diameter and their spatial relationship 
with neural-glial-2 (NG2)+ pericytes.  
Bar chart (a) shows the average vasa recta diameter when encircled by NG2+ pericytes (blue 
bar) or PDGFR-β
+
 pericytes (orange bar) at a pericyte site (P) and corresponding non-pericyte 
site (NP), and the average vessel diameter when the pericyte has cell-cell contact with a F4/80
+
 
MΦ (MΦ-P) with associated non-pericyte site (MΦ-NP). In (bi) bars represent the percentage 
of total cells present in the render in contact (Contact %) with the locus from either a NG2
+
 
pericyte (P-MΦ; blue bar) or MΦ (MΦ-P; green bar), in the outer (OM) and inner medulla (IM). 
(bii) shows the corresponding distance for cells not in contact. Data presented as mean±SEM. 
* p<0.05, *** p<0.001, **** p<0.0001, 
ns
 p>0.05. n= 3 animals and 9 slices for both PDGFR-β 
and NG2.  
 
F4/80+-labelled MΦ primarily resided in the interstitial space and were distributed 
around the vascular and tubular compartments; spread over the outer surfaces of 
tubular segments and the vasculature, as has been previously reported (Hume, and 
























filopedia varying from long and spindly to short “hair-like” processes. The interwoven 
nature of residential MΦ in tissue (Gordon, and Plüddemann, 2017) was observed 
throughout the planes of renders generated; F4/80+-labelled MΦ were present across 
multiple planes in the 10 μm deep renders.  Contrastingly to F4/80+-labelled cells, both 
NG2+-labelled pericytes (Figure 5.5) and PDGFR-β+-labelled pericytes (Figure 5.6) 
were large and ovular in shape, restricted to their perivascular location. The 
morphology observed is characteristic for MΦ and pericytes respectively, which will be 
used for determination of any co-staining. 
 
5.3.4 NG2+-labelled pericytes and F4/80+-labelled macrophages have a close 
spatial relationship in the OM.  
 
As discussed in chapter 3, section 3.3.4, fluorescent PDGFR-β+-labelling was also 
expansive in the mouse. As such, direct quantification of the total cellular abundance 
of PDGFR-β-labelled cells in the render (10 μm deep z-stack, 214.2 μm2) was not 
feasible. This extensive PDGFR-β+ staining showed a sustained association with MΦ, 
but direct measurements were not calculated as those would be inaccurate. However, 
NG2+-labelling is less abundant (see Figure 5.3) and the degree of cell contact and 
the corresponding distance between cells not in contact was measured as described 
in section 2.5. 
In the OM, on average, 38.6±4.7% of NG2+-labelled pericytes in the render had cell-
cell contact with an F4/80-labelled MΦ, yet the proportion of F4/80+ MΦ with cell 
contact with NG2+-labelled pericytes was on average 54.6±4.5% of the total MΦ 
present in the field of view, a significantly greater (p<0.05) percentage. In the IM, the 
average percentage of NG2+-labelled pericytes with cell-cell contact with F4/80+-
labelled MΦ was marginally lower at 28.9±3.5% of pericyte, which was not-significantly 
different from the average percentage of IM F4/80+-labelled MΦ with contact with 
NG2+-labelled pericyte at 32.6±4.0% of F4/80+ MΦ (p>0.05; Figure 5.4(bi)). The 
percentage of F4/80+-labelled MΦ with NG2+-labelled pericyte contact was significantly 
greater in the OM (p<0.05), but there is no significant difference in the percentage of 




Figure 5.5 Features of neural-glial 2 (NG2)+ pericyte and F4/80+ macrophage (MΦ) 
morphology 
Images (i-ix) are a composite montage of a section from a 10 μm z-projection (214.2 μm2; 1 
μm step size) of fluorescent staining with anti-NG2 (red), anti-F4/80 (green), and Hoechst 
33342 (H342; blue). Pericyte cell bodies are highlighted with blue dashed circles, whilst MΦ 
are highlighted with white dashes around the entirety of the cell. Of note is the regular, round 
morphology of pericytes throughout the render compared with the ramified, MΦ spread. n= 3 
animals and 9. Scale bars are 10 μm. 
 
As stated above, when not in contact, the distance between cell bodies with a 
differential focus on both MΦ and pericytes was also measured. This measurement 
was taken between F4/80+-labelled and NG2+-labelled cell bodies in the same plane 
of the z-stack and involved focusing on either a NG2+ pericyte or F4/80+ MΦ, not both 
for the same measurement, then measuring the distance to the closest “oppositely”-
labelled cell body. When not in contact, the average distance between NG2-labelled 
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and the distance between MΦ (loci of measurement) and pericytes was 28.2±2.5μm 
on average (p>0.05). In the IM the average distance was 36.1±2.6 μm with the loci of 
measurement F4/80+-labelled MΦ, and 36.1±2.6 μm for NG2+-labelled pericytes 
(p>0.05; Figure 5.4(bii)). 
 
Figure 5.6 Features of platelet derived growth factor receptor-β (PDGFR-β)+ pericyte 
and F4/80+ macrophage (MΦ) morphology. 
Images (i-ix) are a composite montage of a section from a 10 μm z-projection of fluorescent 
staining with anti-PDGFR-β (red), anti-F4/80 (green), and Hoechst 33342 (H342; blue). 
Pericyte cell bodies are highlighted with blue dashed circles, whilst MΦ are highlighted with 
white dashes around the entirety of the cell. Of note is the regular, round morphology of 
pericytes throughout the render compared with the ramified, MΦ spread. White arrow indicates 












5.3.5 A small population of cells were positive for both F4/80 and either PDGFR-
β or NG2. 
 
Another question co-immunostaining was used to address was co-expression of NG2 
or PDGFR-β and F4/80 in murine kidney sections, as described in chapter 3 section 
3.3.10 for the rat, by a Hoechst 33342+ identified cell nucleus being positively labelled 
by both the red pericyte and green MΦ fluorescent stain. Prior to experimentation, to 
ensure any potential co-staining observed would not be due to overlap of primary 
antibodies binding to similar protein sequences, the sequences of primary antibodies 
against anti-NG2 (GENBANK: Q00657), anti-PDGFR-β (GENBANK: NP_001139740) 
and anti-F4/80 (GENBANK: Q61549-1) were aligned using the UniProt online 
alignment tool (available at: https://www.uniprot.org/align/) to determine sequence 
homology. After alignment, it was determined that Anti-F4/80 and Anti-NG2 sequence 
homology was less than 10%, and less than 12% homology between anti-F4/80 and 
anti-PDGFR-β. As such any observations of a Hoechst 33342+ cell body co-expressing 
MΦ and pericyte markers is not likely caused by cross-reactivity of the primary 
antibodies at the same antigenic sites. 
In Immunostained sections, a small proportion Hoechst 33342+ nuclei were seemingly 
positively labelled by anti-F4/80 immunofluorescence, and either NG2+ or PDGFR-β+ 
immunofluorescence. These cells that appeared to co-express pericyte and MΦ 
identifying markers had the ovular morphology that is characteristic of pericytes and 
were located along the vasculature as determined by brightfield images (Figure 5.7).  
An observation of at least one cell co-expressing F4/80+-fluorescent labelling with 
pericyte staining occurred in approximately 35% of NG2 and 57% of PDGFR-β 
experiments. (Figure 5.8). Mentioned in section 5.3.2 of this chapter was an 
occurrence of paired perivascular PDGFR-β+-labelled cells; co-labelling PDGFR-β and 
F4/80 occurred within these pairs (Figure 5.8(c-d)). Of note is the majority of F4/80+ 
MΦ in the renal medulla did not reside along the vasculature, so these cells co-
expressing pericyte and MΦ receptors are a possible sub-population of either MΦ or 
pericytes.  These double positive cells were so infrequent that objective quantification 
of their occurrence was not possible, however, some residential immune cells are 
dormant until activation (Fabriek et al., 2005a; Polfliet et al., 2006). Therefore, as in 
chapter 3, incubations with potent pro-inflammatory cytokines TNF-α and IL-1β were 
used to see if it would encourage more cells positive for PDGFR-β or NG2 labelling to 




Figure 5.7 Co-expression of neural-glial-2 (NG2) and F4/80 on perivascular cells. 
(a-c) show representative images of anti-NG2+ (red) and anti-F4/80+ labelling (green) around 
Hoechst 33342 (H342; blue) identified nuclei, that bears the morphology characteristic of 
pericytes. Images labelled with (i) show the composite of; (ii; NG2), (iii; F4/80), (iv; H342), and 
the bright field image (v; BF). Images in (a-b) show co-labelling of anti-NG2 and anti-F4/80. 
Images in (c) show a perivascular F4/80+, NG2- cell that also demonstrates the characteristic 
ovular morphology of pericytes. Cell bodies in the bright field images are indicated by white 
dashed circles. Scale bars are 5 μm. 
 
5.3.6 Incubations with cytokines increased the outer medullary (OM) F4/80+ 
macrophages presence and reduced both PDGFR-β+ and NG2+ pericyte density. 
 
Slices were either incubated in TNF-α (10 ng/mL, n= 3 animals and 3 slices) or IL-1β 
(10 ng/mL, n = 3 animals and 3 slices), or kept in control PSS conditions (n= 3 animals 
and 3 slices for PDGFR-β; n= 4 animals and 4 slices for NG2) for 4 hours. In PSS time-
matched control experiments, the total number of MΦ present per 10 μm deep render 
were, on average, 26.5±2.1 in the OM in NG2 experiments, and 24.2±2.6 in PDGFR-
β experiments (p>0.05). This was significantly more (p<0.0001) than in the IM, with on 
average 7.4±1.8 and 8.5±1.4 F4/80+-labelled MΦ inNG2 and PDGFR-β+ experiments 
respectively (p>0.05). This is an increase from the baseline cellular abundance of MΦ 
in the OM, but only significant in NG2 experiments (p<0.05). Representative images 
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Accounting for the increase in the PSS control, in tissue slices that were stimulated 
with TNF-α, the number of MΦ present increased by 1.4-fold in the OM to 141.8±12.1% 
(p<0.05) and 137±9.0% (p<0.05), and 2.2-fold in the IM to 217.8±40.0% (p<0.05) in 
NG2 experiments. Interestingly, there was a non-significant decrease in PDGFR-β 
experiments 65.3±15.1% (p>0.05). This stark difference is likely to relate to the 
regional distribution of PDGFR-β+-labelled pericytes compared with NG2+-labelled 
pericytes as described in section 5.3.2; PDGFR-β is present throughout the entirety of 
the IM whereas there is a known drop-off of NG2+ pericytes deep in the IM, which 
limited acquiring renders from the regions where NG2+ staining is located and 
increased the odds of MΦ cellular presence being larger as it was closer to the OM. 
 
Figure 5.8 Co-expression of platelet derived growth factor receptor-β (PDGFR-β) and 
F4/80 on perivascular cells. 
(a-d) show representative images of anti-PDGFR-β+ (red; i) and anti-F4/80+ fluorescent 
labelling (green; ii) around Hoechst 33342 (H342; blue; iii) identified nuclei, that bears the 
morphology characteristic of pericytes, seen in the brightfield images (BF; iv). The 
corresponding composite of the four different channels can be seen in (v). (a-b) Show 
individual perivascular co-expression of F4/80 and PDGFR-β. (c-d) show co-expression of 
F4/80 by one cell in a pair of PDGFR-β+-labelled pericytes. Cell bodies in the bright field images 
are indicated by white dashed circles. Scale bars are 5 μm. 
 
Incubations of kidney slices with IL-1β resulted in an OM increase of 1.2-1.4 times the 
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123.0±11.1% (ns) and 137.1±7.6% (p<0.05) of those obtained from tissue exposed 
only to PSS. In the IM a non-significant 1.4-1.6-fold increase was observed, 
corresponding to 163.6±16.3% (ns) and 136.5±30.3% (ns) of values obtained from the 
PSS control for NG2 and PDGFR-β respectively (Table 5.3; Figure 5.9(d) and 5.10(d) 
respectively). The presence of MΦ observed here, as in the previous “0 hour” 
experiments presented in section 5.3.3 and as previously reported (Hume, and 
Gordon, 1983; Soos et al., 2006), was a significantly larger presence of MΦ  in the OM 
than in the IM for PSS (p<0.0001), TNF-α (p<0.0001), and IL-1β (p<0.001). 
 
Table 5.3 F4/80+ Macrophage (MΦ), platelet derived growth factor receptor-β (PDGFR-
β)+, and neural-glial-2 (NG2)+ pericyte quantification after TNF-α and IL-1β stimulation 
Data presented as mean±SEM, n= 3 animals and 3-4 slices, ≥ 200 pericytes per animal 
(%) Values are the percent of the PSS control mean and are calculated as the percent of the 10 
μm z-stack (214.2 μm2) occupied with positive stain. 
1OM = Outer medulla, 2IM = Inner medulla. 
*p<0.05; **p<0.01 for comparisons between cytokine stimulation and PSS. 
 
In kidney sections only exposed to PSS, the average pericyte density measured in the 
renders for PDGFR-β+ was 30.0±2.4% in the OM and 19.3±1.3% in the IM. NG2+ 
pericytes had a density of 20.5±1.8% in the OM and 5.3±0.7% in the IM; pericyte 
density is significantly greater in the OM for both groups of pericytes (p<0.0001). TNF-
α stimulation caused a reduction of pericytes to 81.2±4.6% (p<0.05) of control PDGFR-
β+ in the OM, but not in the IM (107.3±5.4%; p>0.05; Figure 5.10(c)). This reduction 
of density in the OM was larger with NG2+ pericytes (66.6±6.0%; p<0.01; Figure 
5.9(c)), and also insignificant in the IM (114.7±19.5%; p>0.05, Table 5.3). A similar 
trend was observed with IL-1β, with significant reductions in OM pericytes for both 
PDGFR-β (77.9±3.1; p<0.05) and NG2 (69.8±7.8%; p<0.05) experiments, but not in 
the IM (103±3.6% and 99.7±7.8% for PDGFR-β+ and NG2+ pericytes respectively; 
p>0.05). These reductions are not significantly different between NG2+ or PDGFR-β+ 
pericytes. 
 PDGFR-β  NG2 
 PSS TNF-α IL-1β  PSS TNF-α IL-1β 
Number of F4/80+ MΦ     
OM1 24.2±2.6 33.3±2.2* 33.1±1.8*  26.5±2.1 37.6±3.2* 32.6±2.9 
IM2 8.5±1.4 5.6±1.3 11.7±2.6  7.4±1.8 16.1±2.9* 9.4±1.2 
Normalised F4/80+ MΦ numbers, %     
OM 100±10.8 137.1±9.0* 137.1±7.6*  100±8.1 141.8±12.1* 123.0±11.1 
IM 100±16.7 65.3±15.1 136.5±30.3  100±23.9 217.8±40.0* 163.6±16.3 
Normalised pericyte area density, %     
OM 100±20.21 81.2±4.6* 77.9±3.1*  100±7.7 63.6±6.3** 69.8±7.8* IM 100±6.7 107.3±5.4 103.5±3.6 100±7.1 114.7±19.5 99.7±7.8 
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Figure 5.9 Effects of pro-inflammatory cytokine stimulation on F4/80+ macrophage (MΦ) 
and neural-glial 2 (NG2)+-labelled pericyte density in the outer (OM) and inner (IM) 
medulla 
Representative confocal-acquired images in (a-b) showing the effect of stimulation with TNF-
α (10 ng/mL; i), IL-1β (10 ng/mL; ii) and the PSS control (iii) on NG2+-labelled pericytes (red) 
F4/80+-labelled MΦ (green) in the OM (a) and IM (b). Cell nuclei were identified using Hoechst 
33342 (H342; blue). The respective changes in pericyte density (c) and the MΦ abundance (d) 
are presented as the percent change from the PSS control. Data presented as mean±SEM. n= 
3 animals and 3 slices for all but NG2 PSS, where n=4 animals and 4 slices. * p<0.05, ns p>0.05. 
 
Due to the expansive nature of PDGFR-β (Figure 5.1(a)), direct quantification of cell 
numbers was not feasible or accurate. The standard, as shown above, is to present 
the percentage of space occupied by positive stain (Ikeda et al., 2018; Craggs et al., 
2015). However in the kidney the density of NG2+ pericyte cell bodies per 100 μm2 has 
previously been reported; both in chapter 4 and as published by Crawford et al 
(Crawford et al., 2012). Hence this was also calculated here, along with the total 
number of cell bodies present in the renders acquired. Total numbers of NG2+ pericytes 
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densities per 100 μm2 of 12.6±1.0 cells in the OM and 4.1±0.3 in the IM. In the OM, 
TNF-α significantly reduced OM NG2+ pericyte vascular bundle density per 100 μm2 
(8.8±1.0; p<0.05) and the total quantity to 38.8±3.0 pericytes (p<0.05), but not in the 
IM (13.1±2.0 total and 3.5±0.5 pericytes per 100 μm2; p>0.05). IL-1β significantly 
reduced total NG2+ pericyte cell numbers (40.5±5.0; p<0.05) in the OM and the 
pericyte density per 100 μm2 (9.3±1.1; p<0.05). IL-1β had no significant effect on the 
IM pericyte densities overall (15.8±1.3) or per 100 μm2 (4.3±0.4; p>0.05). 
 
Figure 5.10 Effects of pro-inflammatory cytokine stimulation on F4/80+ macrophage (MΦ) 
and platelet derived growth factor receptor-β (PDGFR-β)+-labelled pericyte density in the 
outer (OM) and inner (IM) medulla. 
Representative confocal-acquired images in (a-b) showing the effect of stimulation with TNF-
α (10 ng/mL; i), IL-1β (10 ng/mL; ii) and the PSS control (iii) on PDGFR-β+-labelled pericytes 
(red) F4/80+-labelled MΦ (green) in the OM (a) and IM (b). Cell nuclei were identified using 
Hoechst 33342 (H342; blue). The respective changes in pericyte density (c) and the MΦ 
abundance (d) are presented as the percent change from the PSS control. Data presented as 















































5.3.7 IL-1β, not TNF-α, retained F4/80+ macrophages near NG2+ pericytes in both 
the OM and IM.  
 
Due to lack of cell quantification, the percentage of cell-cell F4/80+ MΦ-PDGFR-β+ 
contact was not possible to calculate, nor the distance between those cells without 
contact, as described in section 5.3.3. However, as NG2+ pericyte cellular density per 
10 μm-deep (214.2 μm2) render was calculated such analysis could be performed in 
these experiments.  Cytokine stimulation significantly increased the percentage of OM 
NG2+ pericytes with cell-cell contact to a F4/80+ MΦ; 70.9±2.2% upon treatment with 
TNF-α (p<0.001), 63.0±3.2% with IL-1β (p<0.05), compared with 50.6±3.7% in slices 
exposed to PSS. Interestingly, the percentage of NG2+ pericytes with direct cell-cell 
contact to F4/80+ MΦ significantly increased after the incubation time-period of 4-hours 
in the OM, compared with the “0 hour” PSS experiments showing 38.6±4.7% of 
pericytes having contact (p<0.05; Figure 5.11(ai)). 
Table 5.4 The spatial relationship between F4/80+ Macrophage (MΦ) and neural-glial-2 
(NG2)+ pericytes after TNF-α and IL-1β stimulation 
 Contact  Distance 
 PSS TNF-α IL-1β  PSS TNF-α IL-1β 
NG2+ Pericyte–F4/80+ MΦ     
OM1 52.6±3.7$ 70.9±2.2*** 63.0±3.2*  100±10.9 94.4±8.2 82.7±10.8 
IM2 24.7±6.8 35.5±7.6 25.2±3.2  100±9.0 60.8±11.7* 61.8±7.6* 
F4/80+ MΦ–NG2+ Pericyte      
OM 65.6±5.1$ 58.9±3.3 59.4±1.8  100±9.4 89.7±7.5 73.2±4.6* 
IM 38.7±6.7 22.3±5.3 38.4±3.6  100±9.2 89.1±11.0 60.3±6.2** 
Data are shown as mean±SEM, n= 3 animals and 3-4 slices, ≥ 200 pericytes per animal. 
For contact, measurements are shown as the percentage of cells per 10 μm z-stack (214.2 μm2) 
with cell-cell contact, % 
For distance, values are shown as percentage of the PSS control value, % 
1OM = Outer medulla, 2IM = Inner medulla. 
Pericyte-MΦ means the focus of measurement is dependent upon location of the NG2+ pericyte 
MΦ-pericyte means the focus of measurement is dependent upon location of the MΦ 
*p<0.05; ** p<0.01; ***p<0.001 for comparison with PSS control 
$p<0.05 for comparison between OM and IM 
 
There was no such significant increase (p>0.05) in the IM; with 35.5±7.8% of pericytes 
with contact upon TNF-α stimulation, and 25.5±3.2% of pericytes with IL-1β 
stimulation, compared to 24.7±6.8% of pericytes in tissue sections kept in PSS. With 
regards to the percentage of total MΦ present that were in contact with NG2+ pericytes, 
there is no significant difference between cytokine and PSS exposure: 38.7±6.7%, 
22.3±5.3%, and 38.4±3.6% in the IM; and 65.6±5.1%, 58.9±3.3, and 59.4±1.8% in the 
OM for PSS, TNF-α, and IL-1β exposure respectively in the IM (p>0.05; Table 5.4; 
Figure 5.11(bi)). However, whilst not significant, in the OM compared to the 0-hour 
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PSS experiments, in time-matched 4-hour control there was an approximately 20% 
increase in the percentage of F4/80+ MΦ in contact with NG2+ pericytes. The degree 
of contact for both pericytes to MΦ (p<0.0001), and MΦ to pericytes (p<0.0001) was 
significantly larger in the OM than the IM. 
For those cells not in contact, the distances between them were measured. The loci of 
measurements were either from a NG2+ pericyte cell body, or a F4/80+ MΦ cell body 
to the nearest oppositely labelled cell. The average distance of pericytes to MΦ did not 
significantly differ in the OM upon cytokine stimulation. In PSS the OM distance from 
pericytes to the nearest MΦ was 20.9±2.3 μm, which TNF-α and IL-1β stimulation did 
not significantly reduce (94.4±8.2% and 82.7±10.8% of the PSS control respectively; 
p>0.05; Figure 5.11(aii)). In the IM, upon exposure to PSS only the distance from 
NG2+ pericytes to the nearest F4/80+ MΦ was 40.7±3.7 μm. TNF-α stimulation reduced 
this distance 1.6-fold to 60.8±11.7% (p<0.05) of that observed with PSS alone. This 
relative change was comparable after stimulation with IL-1β, reducing the distance to 
61.8±7.6% (p<0.05; Figure 5.11(aii)) of that observed in PSS experiments.  
 
Figure 5.11 The effect of pro-inflammatory cytokines TNF-α and IL-1β on the spatial 
arrangement between neural-glial-2 (NG2)+ pericytes and F4/80+ macrophage (MΦ). 
In (ai) and (bi) bars represent the average percentage of total cells present with cell-cell contact 
per 10 μm deep z-stack (214.2 μm2) (Contact %). with the locus from either a NG2
+
 pericyte 
cell body (ai; blue bars) or F4/80+ MΦ cell body (bi; green bars), in the outer (OM) and inner 
medulla (IM). (aii) and (bii) show the corresponding distance for cells not in contact as a 
percentage of the distance observed the PSS control (% distance). In (ai) “PSS” is the time-
matched control experiment with the cytokine stimulations, “PSS 0” are values taken from 
slices processed immediately post-slicing. Data presented as mean±SEM. * p<0.05, *** 
p<0.001, 
ns
 p>0.05. n= 3 animals and 3 slices for TNF-α and IL-1β treatment groups, and n= 4 






























































The average distance from pericytes to MΦ in PSS was significantly greater in the IM 
than the OM (p<0.0001), with no regional difference observed for the distance in slices 
treated with either TNF-α or IL-1β (p>0.05). With MΦ as the locus, the average 
distance to the nearest pericyte in the OM was 33.1±3.1 μm. TNF-α stimulation did not 
significantly reduce this distance (89.7±7.5%; p>0.05), but IL-1β did to 73.2±4.6% 
(p<0.05) of the distance observed in PSS. A similar trend was observed in the IM; on 
average in slices incubated in PSS, MΦ were 41.1±3.8 μm away from pericytes. TNF-
α stimulation did not significantly reduce this distance (89.1±11.0%; p>0.05), yet IL-1β 
stimulation caused a significant reduction in distance from MΦ to pericytes to 
60.3±6.2% of that in PSS (p<0.01; Figure 5.11(bii)). 
5.3.8  
5.3.9 TNF-α- and IL-1β-induced, pericyte-mediated vasoconstriction, is 
potentiated by macrophage contact in NG2+, but not PDGFR-β+ pericytes 
 
The vasa recta diameter was significantly narrower at pericyte sites than non-pericyte 
sites (Table 5.1; p<0.0001), for both PDGFR-β+ and NG2+ pericytes. Further to this, 
vasa recta where pericytes that had cell-cell contact with F4/80+ MΦ were significantly 
constricted, specifically at pericyte sites (Table 5.2; p<0.0001).  In cytokine treated 
tissue, vasa recta at both NG2+ pericyte sites and non-pericyte sites are significantly 
narrower than in PSS; in TNF-α stimulated tissue pericyte sites measured 5.0±0.2 μm, 
and 7.2±0.3 μm at non-pericyte sites on average (p<0.05 vs 5.6±0.2 μm and 7.9±0.2 
μm for vasa recta exposed to PSS at pericyte and non-pericyte sites respectively). 
Vasa recta exposed to IL-1β, measured 4.9±0.2 μm and 6.9±0.2 μm at pericyte and 
non-pericyte sites respectively on average (p<0.01). 
There was no significant difference in vasa recta diameters at pericyte sites when MΦ 
were present. The average vessel diameter measured was 5.2±0.3 μm in PSS alone, 
5.3±0.3 μm in TNF-α treated tissue (p>0.05), and 5.6±0.3 μm in IL-1β treated tissue 
(p>0.05) at pericyte sites. There was also no significant difference (p>0.05) of vessel 
diameters at non-pericyte sites when the corresponding pericyte had F4/80+ MΦ 
contact which were on average; 7.2±0.3 μm in PSS, 7.2±0.3 μm in TNF-α, and 7.4±0.3 
μm in IL-1β. However, when vessel diameters where pericytes with F4/80 MΦ contact 
were excluded, TNF-α stimulation caused a significant constriction at PDGFR-β+ 
pericyte sites; 5.7±0.2 μm (p<0.05) at the pericyte site and 7.7±0.3 μm (p>0.05) at the 
corresponding non-pericyte site compared with a capillary diameter of 6.5±0.2 μm at 
pericyte sites and 8.2±0.3 μm at the corresponding non-pericyte site in PSS 
incubations.  
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IL-1β stimulation did not significantly change vasa recta diameter at pericyte (6.0±0.2 
μm; p>0.05) or non-pericyte sites (8.2±0.2 μm; p>0.05). Both the PDGFR-β+ pericyte 
site (p<0.0005) and corresponding non-pericyte site (p<0.05) on vasa recta in PSS 
were significantly narrower when in contact with MΦ, as was the non-pericyte site in 
IL-1β (p<0.05) incubations when the PDGFR-β+ had MΦ contact (Table 5.5; Figure 
5.12(b)). However, in section 5.3.3 it was observed that when pericytes were in direct 
cellular contact with F4/80+ MΦ, vasa recta were significantly narrower, specifically at 
pericyte sites (Table 5.2) suggesting those pericytes were constricted. Subsequently, 
values were categorised based upon whether the corresponding pericyte had cellular 
contact with a MΦ.   
Table 5.5 Effect of TNF-α and IL-1β stimulation, and F4/80+ macrophage (MΦ) presence 
on vasa recta diameter encircled by neural-glial-2 (NG2)+ or platelet derived growth 
factor receptor-β  (PDGFR-β)+ pericytes. 
Data shown as mean±SEM in μm, n= 3 animals and 3-4 slices, ≥ 200 pericytes per animal. 
1P = pericyte  site 2NP = non-pericyte site 
*p<0.05 compared with PSS  
£p<0.05; @p<0.005; %p<0.0005 comparison between MΦ contact and no contact 
 
 
When in contact with MΦ, there was no significant difference (p>0.05) in vasa recta 
diameter at NG2+ pericyte sites (4.9±0.3 μm, 4.7±0.2 μm, and 4.4±0.2 μm for PSS, 
TNF-α, and IL-1β respectively) between the treatment groups. There was a significant 
difference in the IL-1β non-pericyte site diameter compared to that exposed to PSS 
(6.3±0.3 μm vs 7.4±0.3 μm; p<0.01), but not with TNF-α (7.0±0.3; p>0.05). Conversely, 
when comparing vessel diameter measurements between stimulation groups without 
F4/80+ MΦ contact, there is a significant difference in TNF-α (5.3±0.2 μm vs 6.2±0.2 
μm for PSS; p<0.05) and IL-1β (5.4±0.3 μm; p<0.05) stimulated pericyte sites 
compared with PSS, and a significant difference in the TNF-α stimulated non-pericyte 
site (7.2±0.3 μm vs 8.3±0.3 μm in PSS; p<0.05) but not with IL-1β (7.5±0.3 μm; p>0.05; 
Table 5.5; Figure 5.12(a)). Interestingly, much like was observed in PSS, vasa recta 
encircled by NG2+ pericytes with F4/80+ MΦ contact in IL-1β stimulated tissue are 
significantly narrower at both the pericyte and non-pericyte sire (p<0.005). This did not 
occur with TNF-α exposure (p>0.05). 
 PDGFR-β  NG2 
 PSS TNF-α IL-1β  PSS TNF-α IL-1β 
F4/80+ MΦ contact     
P1 5.2±0.3% 5.3±0.3 5.6±0.3  4.9±0.3% 4.7±0.2 4.4±0.2@ 
NP2 7.2±0.3£ 7.2±0.3 7.4±0.3£  7.4±0.3£ 7.0±0.3 6.3±0.3*@ 
No F4/80+ MΦ contact     
P 6.5±0.2 5.7±0.2* 6.0±0.2  6.2±0.2 5.3±0.2* 5.4±0.3* 
NP 8.2±0.3 7.7±0.3 8.2±0.2  8.3±0.3 7.2±0.3* 7.5±0.3 
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On capillaries encircled with PDGFR-β+ pericytes, there was no significant difference 
between PSS control and cytokine treated tissue. Diameters measured were on 
average: 5.7±0.2 μm in PSS, 5.5±0.2 μm (p>0.05) and 5.6±0.2 μm (p>0.05) for TNF-α 
and IL-1β respectively at pericyte sites; and 7.7±0.2 μm in PSS, and 7.5±0.3 μm 
(p>0.05) and 7.8±0.2 (p>0.05) for TNF-α and IL-1β respectively at non-pericyte sites 
(Table 5.6). As with NG2, in Table 5.2 it can be seen that MΦ presence influences 
vasa recta diameter at PDGFR-β+ pericyte sites, so again measurements were divided 
into with or without F4/80+ cell contact. 
 
 
Figure 5.12 The effect of pro-inflammatory cytokines TNF-α and IL-1β and MΦ presence 
on vasa recta diameter. 
Bar graphs show the effect of TNF-α (hatched bars) and IL-1β (checked bars) stimulation on 
the dimeter of vasa recta diameter encircled by either platelet derived growth factor receptor-
β (PDGFR-β+; a; orange bars) or neural-glial-2 (NG2+; b; blue bars) pericytes. Measurements 
were taken from a pericyte site (P) and corresponding non-pericyte site (NP). Also shown is 
the capillary diameter at a pericyte site in contact with an F4/80+ MΦ (P-MΦ) and its 
corresponding non-pericyte site (MΦ-NP). Data presented as mean±SEM. n= 3 animals and 3 
slices for all but the NG2 PSS experiments, where n=4 animals and 4 slices. * p<0.05, for 
comparison with PSS; £p<0.05; @p<0.005 for comparisons between sites with MΦ contact and 
no contact; ns p>0.05. 
 
There was no significant difference in vasa recta diameters at pericyte sites when MΦ 
were present. The average vessel diameter measured was 5.2±0.3 μm in PSS alone, 
5.3±0.3 μm in TNF-α treated tissue (p>0.05), and 5.6±0.3 μm in IL-1β treated tissue 
(p>0.05) at pericyte sites. There was also no significant difference (p>0.05) of vessel 
diameters at non-pericyte sites when the corresponding pericyte had F4/80+ MΦ 
contact which were on average; 7.2±0.3 μm in PSS, 7.2±0.3 μm in TNF-α, and 7.4±0.3 
μm in IL-1β. However, when vessel diameters where pericytes with F4/80 MΦ contact 
were excluded, TNF-α stimulation caused a significant constriction at PDGFR-β+ 
pericyte sites; 5.7±0.2 μm (p<0.05) at the pericyte site and 7.7±0.3 μm (p>0.05) at the 
corresponding non-pericyte site compared with a capillary diameter of 6.5±0.2 μm at 








































incubations. IL-1β stimulation did not significantly change vasa recta diameter at 
pericyte (6.0±0.2 μm; p>0.05) or non-pericyte sites (8.2±0.2 μm; p>0.05). Both the 
PDGFR-β+ pericyte site (p<0.0005) and corresponding non-pericyte site (p<0.05) on 
vasa recta in PSS were significantly narrower when in contact with MΦ, as was the 
non-pericyte site in IL-1β (p<0.05) incubations when the PDGFR-β+ had MΦ contact 
(Table 5.5; Figure 5.12(b)) 
Table 5.6 Effect of TNF-α and IL-1β stimulation, and F4/80+ macrophage (MΦ) presence 
on neural-glial-2 (NG2)+ or platelet derived growth factor receptor-β  (PDGFR-β)+ 
pericyte soma size. 
Data shown as mean±SEM in μm, n= 3 animals and 3-4 slices, ≥ 200 pericytes per animal. 
1H = height; 2W = width; 3OM = outer medulla; 4IM = inner medulla. 
*p<0.05 for comparison between pericytes with MΦ contact and pericytes with no MΦ contact. 
 
5.3.10 Presence of F4/80+ macrophages, not cytokine stimulation has potential 
to influence PDGFR-β+ pericyte morphology  
 
In section 5.3.3, it was observed that whilst F4/80+ MΦ contact caused a pericyte-
mediated constriction of vasa recta diameter, this contact did not influence the 
morphology of the pericyte soma for either PDGFR-β+ or NG2+-labelled pericytes 
(Table 5.2). NG2+ pericyte morphology was not altered upon to exposure to either 
TNF-α or IL-1β (p>0.05), and there was no significant difference, regardless of contact 
with F4/80+ MΦ, compared to PSS (p>0.05).  
In PSS: NG2+ pericytes in contact with MΦ were: 4.4±0.3 μm in height, and 7.4±0.4 
μm wide in the OM; and 4.0±0.2 μm by 6.9±0.4 μm in the IM. Without MΦ contact, they 
were 4.5±0.2 μm in height by 7.5±0.3 μm in width in the OM, and 4.2±0.2 μm in height 
by 7.9±0.4 μm in width in the IM. With regards to pericytes exposed only to PSS, this 
lack in morphological difference when MΦ were in contact was observed in the initial 
experiments for NG2+ pericytes (Table 5.2). 
  PDGFR-β  NG2 
  PSS TNF-α IL-1β  PSS TNF-α IL-1β 
F4/80+ MΦ contact     
OM1 H3 4.4±0.2* 4.8±0.2 5.0±0.2  4.4±0.3 4.6±0.2 4.3±0.3 
 W4 6.7±0.4 7.1±0.3 7.2±0.3  7.4±0.4 7.8±0.5 7.9±0.3 
IM2 H 5.0±0.2 4.8±0.3 4.9±0.2  4.0±0.2 3.5±0.2 3.8±0.3 
 W 6.9±0.4 6.2±0.4 7.0±0.4  6.9±0.4 6.2±0.4 7.0±0.4 
No F4/80+ MΦ contact      
OM H 5.2±0.2 4.8±0.1 5.2±0.2  4.5±0.2 4.3±0.3 4.1±0.2 
 W 7.4±0.3 7.9±0.3 6.8±0.4  7.5±0.3 7.4±0.5 7.1±0.3 
IM H 7.4±0.3 7.9±0.3 6.8±0.4  7.5±0.3 7.4±0.5 7.1±0.3 
 W 5.9±0.3 5.8±0.3 6.5±0.3  7.9±0.4 7.2±0.4 7.2±0.4 
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Upon TNF-α stimulation, NG2+ pericytes with MΦ contact were; 4.6±0.2 μm in height 
by 7.8±0.5 μm in width in the OM, and 3.5±0.2 μm in height by 6.2±0.4 μm wide in the 
IM. Pericytes without MΦ contact measured 4.1±0.2 μm in height by 7.1±0.3 μm in 
width in the OM, and 3.9±0.2 μm in height by 7.2±0.4 μm in width in the IM. IL-1β 
stimulated NG2+ pericytes that also had direct cellular contact with F4/80+ MΦ were; 
4.3±0.3 μm in height by 7.9±0.3 μm in width in the OM, and 3.8±0.3 μm in height by 
7.0±0.4 μm in width in the IM. Without this contact, IL-1β stimulated pericytes were 
4.1±0.2 μm in height by 7.1±0.3 μm in width in the OM, and 4.2±0.2 μm by 7.2±0.4 μm 
in the IM.  
Cytokine stimulation with either TNF-α or IL-1β also had no significant effect on 
PDGFR-β+ pericyte size (p>0.05). However, OM PDGFR-β+ pericytes with MΦ contact 
in PSS were significantly smaller than those without contact; 4.4±0.2 μm in height and 
6.7±0.4 μm in width with F4/80+ MΦ contact, and 5.2±0.2 μm in height by 7.4±0.3 μm 
in width without contact (Figure 5.13). In the IM there was no significant difference 
observed with MΦ- PDGFR-β+ pericyte contact in PSS. These pericyte with contact 
measure 5.0±0.2 μm tall by 6.9±0.4μm wide compared to 5.3±0.2 μm in height and 
5.9±0.3 μm in width without MΦ contact. For pericytes exposed only to PSS, this MΦ-
related PDGFR-β+ morphological change was a trend observed for pericytes in section 
5.3.3 (Table 5.2). However, this reduction in height was not significant in the pilot study 
(p>0.05), but interestingly is non-significantly different for the height of NG2+ OM 
pericytes. Unfortunately, as experiments were not conducted with both pericyte 
markers simultaneously, it cannot be commented upon whether these smaller 
pericytes with MΦ contact are PDGFR-β+/ NG2+ or PDGFR-β+/ NG2-.  
 
Figure 5.13 Differential effect of F4/80+ macrophage (MΦ) presence on neural-glial-2 
(NG2)+ or platelet derived growth factor receptor-β  (PDGFR-β)+  pericytes in the outer 
medulla (OM). 





-labelled (blue bar) pericytes when in direct cellular contact with F4/80
+
-labelled 
MΦ (MΦ) and without contact with MΦ (P) when exposed only to PSS. Data presented as 
mean±SEM. * p<0.05; 
ns
 p>0.05, n=3 slices and 3 animals for PDGFR-β and n=4 animals and 







With TNF-α stimulation, pericytes in contact with MΦ were 4.8±0.2 μm in height and 
7.1±0.3 μm in width in the OM; and 4.8±0.2 μm in height by 6.2±0.4 μm in width in the 
IM. Pericytes incubated in TNF-α with no direct contact to MΦ, pericytes measured 
5.2±0.2 μm in height by 7.4±0.3 μm in width the OM and 4.9±0.3 μm in height by 
5.8±0.3 μm in width in the IM. IL-1β stimulated PDGFR-β+ pericytes measured 5.0±0.2 
μm in height by 7.2±0.3 μm in width the OM, and 4.9±0.2 μm tall and 7.0±0.4 μm wide 
in the IM when they had direct cellular contact with a F4/80+ MΦ. IL-1β stimulated, 
PDGFR-β+ pericytes without MΦ contact were 5.2±0.2 μm in height and 6.8±0.4 μm in 
width in the OM, and 5.1±0.2 μm in height by 6.5±0.3 μm in width in the IM. 
 
5.3.11 Pro-inflammatory cytokine stimulation does not appear to encourage 
cellular co-expression of F4/80 and NG2+, but does for F4/80 and PDGFR-β. 
 
In section 5.3.5, it was observed that there was a small population of cells that were 
seemingly positively labelled for both the MΦ identifying marker anti-F4/80, and either 
pericyte identifying markers anti-NG2 or anti-PDGFR-β (Figure 5.7-8). This co-
expression was determined when there was co-staining with both pericyte (red) and 
MΦ (green) fluorescence localised around an individual Hoechst 33342+ nucleus. 
Computational calculation of the degree of co-localisation of fluorescent staining is not 
feasible in this study as it would likely include cell-cell contact in analysis, 
overestimating the degree of co-localisation.  As described in section 5.3.5, addition 
of the 3rd dimension by acquiring a 10 μm z-stack render (212.4 μm2) enabled exclusion 
of cells that were merely adjacent to one another in the z-plane from quantification of 
co-expression. Renders were generated by randomly selecting a ROI in both the OM 
and IM and co-expression was only assessed after images had been acquired. As 
F4/80+ expression is a sign of MΦ maturity (Lee et al., 1985), the aim here of cytokine 
stimulation of kidney slices was to observe if NG2+-labelled or PDGFR-β+-labelled 
pericytes were “dormant” and express MΦ markers when activated in an emulated 
inflammatory  state.  
Unlike in experiments presented in section 5.3.5, no co-staining of MΦ marker F4/80 
and pericyte marker NG2 occurred, irrespective of TNF-α or IL-1β stimulation in either 
the IM or the OM. From observations presented in section 5.3.3, the majority of F4/80+ 
MΦ resided in the interstitial space, yet, it was observed here that there was seemingly 
more perivascular F4/80+ NG2- cells than had been noted previously, having the ovular 
morphology characteristic of pericytes (Figure 5.14). These perivascular F4/80+ NG2- 
cells reside along capillaries lined with anti-NG2 staining, (Figure 5.14(b), (e)).  
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Figure 5.14 Morphology of perivascular neural-glial-2 (NG2)-, F4/80+ cells is comparable 
to NG2+ pericytes, irrespective of cytokine treatment in the renal medulla. 
Representative images where tissue was incubated with; PSS (a-b), TNF-α (c-d), and IL-1β 
(e-f) showing staining with anti-NG2 (i; red), anti-F4/80 (iii; green), and Hoechst 33342 (H342; 









ai) ii) iii) iv)
bi) ii) iii) iv)
ci) ii) iii) iv)
di) ii) iii) iv)
ei) ii) iii) iv)
ci) ii) iii) iv)
NG2 F4/80 H342 Composite
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Figure 5.15 Co-expression of platelet derived growth factor receptor-β (PDGFR-β) and 
F4/80 on non-vascular resident cells in the renal medulla. 
Exemplary images from experiments where tissue was incubated with either; PSS (a-b), TNF-
α (b), and IL-1β (c), showing positive staining with anti-PDGFR-β (i; red), anti-F4/80 (iii; green), 
and Hoechst 33342 (H342; iv; blue) with the corresponding composite render (iv). Scale bars 
are 5 μm. 
 
Contrastingly to NG2 experiments, there was frequent F4/80+/PDGFR-β+ co-staining 
observed, also independent of cytokine stimulation in both the IM and OM. 
Representative images can be seen in Figure 5.16. Given the nature of this study it 
was not possible to determine if there was an increase in the quantity of these cells, 
however, they appeared in more of the renders acquired than in section 5.3.5. Further 
to this, also observed were F4/80+, PDGFR-β+ cells that were not co-localised to a 
vasa recta capillary and also  lacked the distinct morphology of a pericytes e.g. the 
“bump-on-a-log” characteristic shape (Peppiatt et al., 2006) (Figure 5.15), suggesting 
that these may be F4/80+, PDGFR-β+ MΦ as opposed to pericytes. However, further 
experimentation would be needed to definitively say cells co-expressing these 
receptors were pericytes or MΦ. 
5 μm
5 μm
ai) ii) iii) iv)
bi) ii) iii) iv)
ci) ii) iii) iv)




Figure 5.16 Co-expression of platelet derived growth factor receptor-β (PDGFR-β)+ with 
F4/80+ on vascular resident cells in the renal medulla bearing morphological 
similarities to PDGFR-β+ pericytes. 
Representative images from experiments where tissue was incubated with either; PSS (a-b), 
TNF-α (c-d), and IL-1β (e-f), showing positive staining with anti-PDGFR-β (i; red), anti-F4/80 
(iii; green), and Hoechst 33342 (H342; iv; blue) with the corresponding composite render (iv). 
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The aim of this study was to repeat those experiments conducted in the rat kidney slice 
model in chapter 3, using the novel murine live kidney slice model, developed in 
chapter 4, to bypass the issue of a small population of residential CD163+ MΦ 
observed in experiments in rats. It was found that murine PDGFR-β+ and NG2+ 
pericytes show different characteristics and responsiveness, much like was observed 
with rat tissue (Chapter 3). Further still, vessels covered by PDGFR-β+ and NG2+ 
pericytes with MΦ-pericyte cell-cell contact were significantly constricted at the 
pericyte site compared to vessels without such cell-cell contact, suggesting a 
conserved consequence of residential MΦ-pericyte interaction across species is vasa 
recta constriction.  
Ultimately, the primary question of co-immunostaining aimed to address was “is there 
any overlap in cellular expression of MΦ-identifying and pericyte-identifying markers 
in renal perivascular cells?”. There were a small number of CD163+/PDGFR-β+ 
pericytes in rat tissue (Chapter 3 Figure 3.9) after stimulation with TNF-α and IL-1β. 
What was observed in the mouse is cells with both MΦ (Figure 5.15) and pericyte 
(Figure 5.16) morphology co-label with PDGFR-β and the F4/80 antigen consistently, 
regardless of cytokine stimulation. Those cells that are co-labelled with pericyte 
morphology are likely pericytes and suggests renal PDGFR-β+ pericytes are 
multifunctional, yet both NG2+ and PDGFR-β+ pericytes interact with residential MΦ. 
 
5.4.1 5.4.1 Murine PDGFR-β+ pericyte covered vasa recta have larger diameters 
and are more numerous than those covered by NG2+ pericytes. 
  
In both rat (Chapter 3) and murine kidney slices, the morphological difference, regional 
variation in pericyte densities, and the diameters of vasa recta on which of NG2+ and 
PDGFR-β+ pericytes reside are seemingly conserved across species. Please see 
Chapter 3 section 3.4.1-3.4.1.1 for detailed discussion, as it applies to the murine 




5.4.2 5.4.2 F4/80+ macrophages and pericytes may actively communicate to 
regulate vasa recta diameter. 
 
Prior to investigating the multifunctional nature of renal pericytes, it was necessary to 
identify whether perivascular cells that are positive for pericyte identifying markers 
NG2 and PDGFR-β also positively labelled for F4/80. There is a reported overlap in all 
the pericyte and MΦ-identifying markers, including F4/80 (Prazeres et al., 2017), NG2 
(Moransard et al., 2011), and PDGFR-β (Inaba et al., 1993; de Parseval et al., 1993), 
used in this study. Only MΦ are reportedly perivascular, so other immune cell 
populations are unlikely to overlap with pericytes and therefore not considered. 
Brightfield images and cell morphologies were used for categorising cells as pericytes 
and MΦ in tandem with immunolabelling. Co-labelling is discussed below in section 
5.4.7. Limitations with how MΦ and pericyte densities were calculated and the 
subsequent generalisability have been discussed in section 3.4.1. 
This study corroborates current knowledge for renal F4/80+ MΦ distribution in healthy 
tissue, these MΦ are interwoven throughout the interstitium and reside primarily in the 
OM, concentrated by the medullary rays (Hume, and Gordon, 1983; Berry et al., 2017; 
Kielar et al., 2005). The morphology of these interstitial F4/80+ MΦ is highly 
heterogenous and ramified comparative to the ovoid, regular morphology of the 
pericyte soma (Figure 5.3-5.4). It has been suggested that F4/80hi MΦ in the kidney 
are involved with the maintenance and restoration of tissue homeostasis (George et 
al., 2017), and their proximity to the medullary rays suggests active communication 
with cells of the microvasculature. This is supported by observations here that, on 
average, of the total number F4/80+ MΦ present in OM ROI, over 50% have direct 
contact with NG2+-labelled pericytes. With NG2+ pericytes as the loci of measurement, 
this was significantly less at approximately 39% of pericytes in the renders having 
cellular contact with MΦ. When not in contact, cells were on average 30 μm apart, well 
within the maximal spatial limits for effective paracrine signalling (chapter 3 section 
3.3.4) (Francis, and Palsson, 1997; Bollenbach et al., 2008).  Data published by 
another group has shown in the absence of PDGFR-β+ pericytes, the immune 
response is not propagated in the kidney by tubular injury (Lemos et al., 2016), 
suggesting active communication between pericytes and immune cells is required to 
trigger immune responses. Please see chapter 3 section 3.4.3 for detailed discussion 




5.4.3 The differential acute activity of TNF-α and IL-1β appears to be conserved 
between mice and rats, whilst reflecting species differences. 
 
Much like in the rat, acute superfusion of murine kidney slices with TNF-α elicited a 
pericyte-mediated vasoconstriction, and IL-1β failed to elicit any vasoactive response 
(rodent data provided by Kirsti Taylor). In the rat TNF-α induce a significantly greater 
vasoconstriction, approximately 30% larger than that measured in the mouse and 
further reflects a reduced magnitude of responsiveness of the C57BL/6J vasculature 
(Russell, and Watts, 2000). Whilst TNF-α has previously been shown to reduce renal 
blood flow and GFR in the murine kidney in an acute setting (Shahid et al., 2008),  
species differences in cytokine profiles may also influence the responses observed. In 
a cerebral ischaemia model in the SD rat there is a rapid, strong induction of TNF-α 
and IL-1β mRNA comparative to the weaker, delayed but protracted response in 
C57BL/6J mice to the same injury model (Schroeter et al., 2003). It is possible that 
longer exposure time to lower concentrations of TNF-α would have greater efficacy as 
it would better mimic the murine inflammatory response.  
IL-1β activity reportedly peaks at 4-hours, whereas TNF-α has a reduced latency 
period (Proebstl et al., 2012) meaning the acute nature of the superfusion experiments 
could offer an alternate explanation as to why no constriction was observed with short-
term exposure IL-1β in the slice preparations. However, unlike TNF-α, IL-1β has limited 
evidence for being directly vasoactive in the kidney and other tissues, instead seeming 
to augment the vasoactive response of other agonists. In hypertensive rats, 
endothelium denuded aortic rings incubated in IL-1β had a potentiated contractile 
response to phenylepherine (Dorrance, 2007). In a similar fashion, IL-β reduced the 
potency of vasoconstriction in rat cremaster arteriole to noradrenaline whereas TNF-α 
alone induced a vasodilation (Baudry et al., 1996). Together this suggests 
observations in both models are reflective of the different responses observed between 
the species in response to various cytokines, whilst reflecting the differential short-
term vasoactivity of TNF-α and IL-1β. 
 
5.4.3.1 In the mouse, TNF-α and IL-1β differentially affect PDGFR-β+ and NG2+ 
pericyte contractility, whilst not affecting the morphology of either. 
 
Following 4-hour incubations in the murine model with both cytokines, a significant 
pericyte-mediated constriction of vasa recta capillaries was elicited in comparison to 
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the time-matched PSS control in which no pericyte-mediated change in vasa recta 
diameter was measured, as described in section 3.4,6. Interestingly, as observed in 
the rat, whether murine vasa recta constricted depended on the surface protein 
expression of the pericyte. Vasa recta covered with NG2+ pericytes were significantly 
constricted, specifically at pericyte sites yet PDGFR-β+ pericytes show minimal 
cytokine-induced contractility in both the mouse and rat kidney slices.  
Interestingly, unlike in the rat TNF-α and IL-1β stimulation did not affect murine NG2+ 
or PDGFR-β+ pericyte soma size. The rodent cytokine stimulated renal NG2+ pericytes 
were approximately 20% smaller in soma height, as discussed in section 3.4.6. It is 
that process length was not measured here and is a limitation of this study (section 
3.3.5). In vitro pericytes do not have the dynamic morphology of pericytes in situ, and 
the morphological change reported by Proebstl et al  (Proebstl et al., 2012) in murine 
pericytes may not have involve a change in soma size. Conversely here in the murine 
kidney slices there may have been a reduction in total NG2+ glycoprotein coverage 
over the vessel as the total area covered by pericytes reduces as they constrict 
(Kolyada et al., 2003), which would correlate with a total morphological change. As 
there is no universal consensus on measuring pericyte size, comparison is difficult. 
Yet, observations here reflect further interspecies functional differences in PDGFR-β+ 
and NG2+ pericytes, whilst illustrating a conserved behaviour with the differential 
activity of cytokines on NG2+ and PDGFR-β+ pericytes and their associated vessels. 
This is discussed in more detail in chapter 3 section 3.4.6    
 
5.4.4 Dormant monocytes when activated migrate towards NG2+ pericytes in 
the outer medulla. 
 
Unlike in chapter 3 with the rat having few CD163+ MΦ present, F4/80+ MΦ in the 
mouse were abundant and as such the spatial relationship was readily quantifiable, 
though limited (section 3.4.1). F4/80+ MΦ remain motile in the slice preparation whilst 
NG2+ pericytes identified in this technique are vascular resident, so measurements 
were taken regarding F4/80+ MΦ and NG2+ pericytes separately to determine if there 
were differences between the cell types. However, as observed in the rat, a significant 
increase in the number of F4/80+ MΦ was observed in the time-matched PSS control, 
which needed accounting for when taking measurements from the incubation 
experiments. Other murine models show that residential MΦ proliferate independently 
from the recruitment of monocyte precursors (Jenkins et al., 2011), and tissue slices 
shown a marked upregulation of pro-inflammatory cytokines which would activate 
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residential monocytes (section 3.4.4), reflected in both the murine and rodent kidney 
slices with an increase in the number of MΦ within 4 hours. 
Accounting for the approximately 25% increase of MΦ observed in the PSS 4-hour 
control, TNF-α and IL-1β stimulate maturation of  F4/80+ MΦ  from a local monocyte 
precursor population, given there is no source of circulating leukocytes (Stribos et al., 
2016). Interestingly, in the inner medulla (IM) for PDGFR-β and NG2 experiments, the 
average number of MΦ quantified after stimulation of TNF-α were starkly different. 
These discrepancies in the IM are likely from the NG2+ pericyte drop-off (Shaw et al., 
2018) limiting the available ROI selection to the upper portion of the IM where MΦ cell 
numbers are likely higher from proximity to the outer medulla (OM). Conversely, 
PDGFR-β+ stain is expressed throughout the entirety of the IM resulting in sections of 
the lower portions of the IM being randomly selected as the ROI and is subsequently 
a flaw in the methodology. This does suggest the regional differences persist past the 
OM/IM border and that there may be further regional differences in cell behaviour 
throughout the kidney. 
In the OM, cytokine stimulation increased MΦ cell number and decreased pericyte 
density and correspondingly the total number of pericytes present in the field of view. 
Migration of residential F4/80+ MΦ specifically to the vascular bundles has been 
observed post IRI (Kielar et al., 2005), and shown in Figure 5.11, this likely reflects 
F4/80+ MΦ migrating to NG2+ pericytes. For the percentage of F4/80+ MΦ with cell-cell 
contact with NG2+ pericytes to remain constant at 4-hours of incubation across all 
treatment groups, the newly activated monocytes would need to be migrating towards 
the NG2+ pericytes to maintain the degree of contact as the total cell numbers change. 
This is corroborated by the significant increase in the percentage NG2+ pericytes with 
cell-cell contact with an F4/80+ MΦ, despite the significant reduction in pericyte density 
by both cytokines. It is interesting to note even in the absence of cytokine stimulation, 
the percentage of OM NG2+ pericytes with cell-cell contact to an F4/80+ MΦ in PSS at 
4-hours increased by 36%, whilst MΦ cell number only increased by 25%. Together 
this suggests newly mature MΦ migrate towards OM NG2+ pericytes, indicating that 





5.4.5 IL-1β, but not TNF-α, significantly influences distances between NG2+ 
pericytes and F4/80+ macrophages. 
 
Interestingly, IL-1β, but not TNF-α, consistently reduced the distance between MΦ and 
NG2+ pericytes in both the OM and IM. In a matrigel plug model of sterile inflammation, 
it was observed post-hypoxia that whilst IL-1α was responsible for the recruitment of 
neutrophils, IL-1β was responsible for recruitment and retention of residential CD11b+, 
Ly6Cdull, F4/80hi MΦ (Rider et al., 2011), suggesting that in the murine kidney slice 
model that IL-1β retained MΦ in close proximity to the vasculature. IL-1β triggers this 
recruitment of MΦ via the MyD88 pathway (Babcock et al., 2008) and it has recently 
been demonstrated that activation of PDGFR-β+ pericyte MyD88 signalling amplifies 
inflammation (Leaf et al., 2016), suggesting IL-1β-mediated MΦ recruitment could be 
coordinated via pericytes. Conversely, data suggests that TNF-α recruits circulating 
monocytes; in the CNS of MCMV-infected neonatal mice, TNF-α neutralising Ab 
significantly reduced infiltration of Ly6C+ CCR2+ monocytes (Seleme et al., 2017). 
These reported differences in the roles of TNF-α and IL-1β may explain the differences 
observed here in the murine slice preparation, with IL-1β encouraging retention of 
F4/80+ MΦ near NG2+ pericytes. 
 
5.4.6 The pericyte-mediated constriction of vasa recta capillaries induced by 
macrophages may be orchestrated by NG2+ not NG2- pericytes.  
 
The cellular contact between pericytes and MΦ could have been an artefact from their 
respective high densities in the murine OM. However, much like in the rat, when murine 
renal pericytes had cell-cell contact with MΦ the vasa recta were significantly 
constricted at the pericyte site, comparative to vessels where pericytes had no MΦ 
contact, suggesting communication is occurring between MΦ and pericytes. This also 
demonstrates a cross-species physiological outcome from contact between these cell 
types. Interestingly, unlike in the initial exploratory experiments, after the 4-hour 
incubation period OM PDGFR-β+ pericytes, but not NG2+ pericytes, in PSS that had 
cell-cell contact with an F4/80+ MΦ had significantly smaller cell bodies. This event did 
not occur with rodent PDGFR-β+ pericytes in chapter 3. Conversely, rodent NG2+ 
pericytes with CD163+ MΦ contact in PSS were significantly smaller than those without 
contact, whereas murine NG2+ pericyte soma were not significantly different either 
way.  
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PDGFR-β+ soma measurements when in contact with MΦ were not significantly 
different in size for those of NG2+ pericyte soma, whilst PDGFR-β+ pericytes without 
MΦ contact were significantly larger than those in contact. Given the size discrepancy 
that was not noted in the initial exploratory experiments, these PDGFR-β+ pericytes 
with MΦ contact are potentially PDGFR-β+/NG2+. In control PSS conditions at 4-hours 
over half of the NG2+ pericytes in the renders were in direct cellular contact with MΦ 
compared to just over 1/3rd in tissue immediately fixed at “0-hours”, with over 60% of 
MΦ in contact with NG2+ cells. This increase in the number of NG2+ pericytes with MΦ 
contact could possibly explain why this difference was not observed in initial 
experimentation but it was after 4-hours; the odds of randomly selecting an 
NG2+/PDGFR-β+ pericyte were much greater because the degree of NG2+-F4/80+ cell-
cell contact was significantly increased (Figure 5.11). If true, this could further imply 
that F4/80+ MΦ preferentially migrate to the NG2+/PDGFR-β+ pericytes of the DVR 
upon activation.  In the mesentery, the corresponding paired arteriole constricts upon 
PMN and platelet adhesion in the venule (Harris et al., 2005). Data here may suggest 
there are potentially differing reasons why arteriolar NG2+ and venular PDGFR-β+ are 
encouraged to constrict with F4/80+ MΦ contact. Arteriolar constriction may be 
necessary to allow for the adhesion of PMN, which could then encourage dilation at 
the venular end of the capillary bed. 
Alternatively, this constriction of venular NG2-/PDGFR-β+ pericyte populated 
capillaries could be a functional requirement allowing circulating polymorphonuclear 
leukocytes (PMN) to extravasate out of venular NG2- capillaries. Circulating leukocytes 
move passively in the bloodstream, swept along by the laminar flow of blood. In 
postcapillary venules at sites of inflammation, local reduction in the flow of blood 
increases the chances that leukocytes will make contact with the endothelial cells lining 
the vessel (Muller, 2013). In tumour cells direct cellular contact with residential MΦ 
activates the RhoA/ROCK pathway (Roh-Johnson et al., 2014), whilst activated PMN 
encourage relaxation of the pericyte actin-myosin system when there is direct cell-cell 
contact between the cell types, communicating via inhibition of the RhoA/ROCK 
signalling pathway (Wang et al., 2012), leading to vasodilation.  In this model there is 
no source of circulating PMN (Stribos et al., 2016), and lack of such cell-cell contact 
with PDGFR-β+ pericytes could have resulted in these vessels remaining constricted. 
As mentioned in chapter 3, pericytes where Rho GTPases are activated are smaller 
in size (Kolyada et al., 2003) so these may be PDGFR-β+/NG2- pericytes with this 
signalling pathway activated. Alluded to above in section 5.4.1, experiments for co-
labelling tissue sections with anti-PDGFR-β and anti-NG2 were not performed at any 
point in this study and has shown to be a limitation due to the lack of clarity. 
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5.4.7 A small population of cells co-label with anti-PDGFR-β and anti-F4/80, 
with both pericyte and macrophage morphology 
 
Interestingly in the kidney it has been previously reported that co-expression of 
PDGFR-β and MΦ markers does not occur, whilst having a close spatial relationship 
(Ferland-McCollough et al., 2016), as discussed in Chapter 1 section 1.4.1.1. 
However, these pericytes were co-labelled with more niche identifying markers and 
subsequently expression did not wholly co-localise with PDGFR-β, meaning the 
populations of cells identified here were likely excluded from analysis. Observed here 
was a very small population of perivascular cells positive for either NG2 or PDGFR-β 
fluorescent labelling also appeared to co-express the F4/80 antigen, with staining 
surrounding a Hoechst 33342+ cell nuclei showing the characteristic ovoid morphology 
of pericytes. This occurred more frequently with PDGFR-β+ pericytes than NG2+ 
pericytes however, these populations were too small to accurately quantify. Pericytes 
may only acquire an inflammatory phenotype in a pathological setting, so tissue slices 
were exposed to pro-inflammatory cytokines TNF-α and IL-1β to see if co-expression 
of F4/80 and NG2 or PDGFR-β increased in frequency of occurrence. 
The importance of assessing co-labelling of pericyte and MΦ-identifying markers is 
described in section 5.4.2. Whilst data presented here showed limited evidence for co-
expression of NG2 and F4/80, PDGFR-β+ and F4/80 fluorescent staining was 
consistently found to regularly identify the same cell, as determined by the presence 
of a Hoechst 33342-identified cell nucleus, regardless of cytokine treatment. Unlike 
with NG2 experiments where no co-labelling was observed at 4 hours, the occurrences 
of apparent PDGFR-β and F4/80 double-labelled cells increased. Interestingly, and 
shown in Figure 5.15-16, the morphology of these cells varies between varied like MΦ, 
and the ovoid soma typical of pericytes. PDGFR-β is reportedly expressed on an array 
of haematopoietic cells, including both murine (Inaba et al., 1993) and human (de 
Parseval et al., 1993)  MΦ, along with T-cells (Daynes et al., 1991) and NK cells 
(Gersuk et al., 1991), despite not co-localising with CD11b in the mouse (Chen et al., 
2011).  The morphological differences observed between the “pericyte-like” and “MΦ-
like” PDGFR-β+/F4/80+ cells is suggestive that there may be differing populations that 
co-express these receptors, and further distinction is necessary. 
In summary, the use of a murine live kidney slice model has provided compelling 
evidence to suggest that residential F4/80+ MΦ and both NG2+ and PDGFR-β+ actively 
communicate, with a regional significance in the OM. This provides compelling 
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evidence to suggest: i) renal pericytes are multifunctional and actively communicate 
with residential immune cells; ii) this pericyte-MΦ communication is seemingly 
conserved cross-species, corroborating data available from the rodent slice 
preparation presented in Chapter 3; iii) a small population of perivascular cells co-
express F4/80 and an interstitial population express PDGFR-β; and iv) A receptor 
expression-dependent variation in multipotency; renal PDGFR-β+ pericytes exhibit 
multifunctionality co-expressing F4/80, a receptor involved in antigen presentation to 
T-cells (Lin et al., 2005), whilst residential MΦ-pericyte communications are 
orchestrated by NG2+ pericytes acting as immune co-ordinators in the renal OM in both 
rats and mice. 
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6 GENERAL DISCUSSION 
 
6.1 Pericytes as a multifunctional class of cell? 
 
A reduction in pericyte density is negatively associated with vascular congestion in the 
renal medulla following ischaemia reperfusion injury (IRI) in SHR, promoting red blood 
cell congestion in the vasa recta and peritubular capillaries (Crislip et al., 2017). It is 
the loss of the pericytes (Kramann et al., 2017) which potentiates capillary rarefaction. 
Further in situ evidence from human histological data from CKD biopsies show loss of 
interstitial capillaries correlates with increased interstitial CD68+ MΦ accumulation, 
with patients with the most reduced capillary density had the most unfavourable 
outcomes (Eardley et al., 2008). Post ischaemia-reperfusion injury (IRI) CD68+ 
macrophage (MΦ) and CD8+ T-cells occlude the AVR after ischaemia get trapped, 
leading to congestion resulting in no-reflow in both rats and humans (Ysebaert et al., 
2004). Together this is indicative that the renal medulla is where the inflammatory 
response is co-ordinated, with PDGFR-β+  pericytes of the vasa recta, not residential 
MΦ  being the source of other pro-inflammatory IL-6 (Kielar et al., 2005; Leaf et al., 
2016) being actively involved. The consequence of loss of pericytes and a reduction 
in capillary density is a disruption of medullary blood flow, renal function and damage 
to the kidney (Kennedy-Lydon et al., 2013; Peppiatt-Wildman, 2013). 
The most extensively researched role of pericytes across tissues is vascular 
stabilisation and the regulation of blood flow (Lemos et al., 2016; Stapor et al., 2014; 
Betsholtz et al., 2005; Bergers, and Song, 2005; Díaz-Flores et al., 2009), with 
involvement in pathophysiology mechanisms; where they can contribute directly to 
fibrogenesis (Birbrair et al., 2014; Iwaisako et al., 2014; Murray et al., 2017; Rojas et 
al., 2012; Kramann et al., 2017), tumorogenesis (Huang et al., 2011; You et al., 2014; 
Lu, and Shenoy, 2017), and irreversibly constrict causing localised ischaemia leading 
to vessel rarefaction in disease states (Kramann et al., 2017; Hall et al., 2014).  Given 
these extensive homeostatic and pathogenic roles, it is fitting there is plentiful evidence 
demonstrating pericytes are multifunctional (discussed in chapter 1 section 1.2.2). 
Inflammation is a key feature in the pathogenesis of renal disease, regardless of 
whether insult is primarily induced by the immune response (Weisheit et al., 2015) and 
inflammatory  pericytes would be heavily implicated in disease (Humphreys et al., 
2010; Navarro et al., 2016; Xavier et al., 2017; Sendeski et al., 2013; Crawford et al., 
2012; Zhang et al., 2004; Turner, and Pallone, 1997; Silldorff et al., 1995; Yang et al., 
1995; Pallone et al., 1998a; Crawford et al., 2011; Kennedy-Lydon et al., 2015; Colvin, 
2019) with human, mouse, and rat renal pericytes showing all showing inflammatory 
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involvement (Leaf et al., 2016; Navarro et al., 2016; Xavier et al., 2017; Crislip et al., 
2017), please see sections 1.3-4 for more detail on the current evidence . 
However, there is inherent difficulty in determining an activity as being pericyte-
mediated (section 1.3.3.1). The subsequent aim of this thesis was to assess the 
validity of the use of the live slice kidney models to further probe the multifunctional 
capabilities of renal pericytes (Chapter 3 and 5). This thesis has provided novel and 
compelling evidence to support the multifunctionality of renal pericytes. 
 
6.2 Renal pericytes are contractile in a species-specific manner. 
 
The aim with animal models is translatability and to generate knowledge around human 
physiology that is otherwise impractical or unethical to determine, and subsequently 
enable the extrapolation of data in the context of known species-specific differences 
in physiology (Cunningham, 2002; Boswell et al., 2014; Martignoni et al., 2006; 
Radermacher, and Haouzi, 2013). Pericytes cover the microcirculatory network in all 
vascularised tissues and possess the machinery to enact a vasoactive response in 
these vascular beds (Stefanska et al., 2015; Colvin, 2019; Shaw et al., 2018; Peppiatt-
Wildman, 2013; Hamilton et al., 2010; Park et al., 1997a; Sendeski et al., 2013; 
Crawford et al., 2012; Zhang et al., 2004; Turner, and Pallone, 1997; Silldorff et al., 
1995; Yang et al., 1995; Pallone et al., 1998a; Crawford et al., 2011; Kennedy-Lydon 
et al., 2015; Kerkar et al., 2006; Peppiatt et al., 2006; Almaça et al., 2018)  
It has been observed that human (Colvin, 2019; Wei et al., 2015) and rodent (Park et 
al., 1997a) isolated OM DVR (IOMDVR) pericytes express contractile α-SMA and 
respond to renally synthesized vasoactive agents, including Angiotensin-II and 
Prostaglandin E2 (Crawford et al., 2011; Crawford et al., 2012; Kennedy-Lydon et al., 
2015; Dickhout et al., 2002; Cowley Jr, and O’connor, 2013; Silldorff et al., 1995; Yang 
et al., 1995; Pallone et al., 1998a; Turner, and Pallone, 1997; Zhang et al., 2004; Fan 
et al., 2019; Sendeski et al., 2013). Whilst data shows pericyte contractility is 
translatable, in identical tissue preparations from the liver (Zhao et al., 2009), 
mesentery (Hedemann et al., 2004), and abdominal aorta (Russell, and Watts, 2000) 
the vasoactive response of C57BL/6J mouse is markedly lower than that of the 
Sprague-Dawley rat, so there are likely species differences in the characteristics of 
pericyte-mediated vasoactivity. Consequently, establishing the “like-for-like” kidney 
slice model in the mouse demonstrated exactly this;  C57BL/6J mouse vasoactivity is 
markedly less than that of the Sprague Dawley rat (Russell, and Watts, 2000; Cholewa 
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et al., 2005; Hedemann et al., 2004; Zhao et al., 2009), and as such the reduced 
responsiveness and magnitude of response of murine renal pericytes (section 4.3) 
demonstrated predictive validity of the murine model (Denayer et al., 2014), discussed 
in greater detail in section 4.4. Overall, findings in the mouse demonstrated that renal 
NG2+ pericyte morphology and regulation of DVR diameter by pericytes is conserved 
in mice, rats (Crawford et al., 2012; Zhang et al., 2004; Turner, and Pallone, 1997; 
Silldorff et al., 1995; Yang et al., 1995; Pallone et al., 1998a; Crawford et al., 2011; 
Kennedy-Lydon et al., 2015), and humans (Sendeski et al., 2013), and therefore use 
of the slice models to probe novel renal pericyte characteristics could translate to 
human tissue.  
 
6.3 The kidney slice models can be used to further investigate the 
multifunctionality of renal pericytes.  
 
In this study, kidney slice models (Crawford et al., 2012) were useful for investigating 
specifically residential cell populations (Stribos et al., 2016) whilst maintaining the 
internal architecture and cell-cell communication pathways reflective of in vivo renal 
behaviour. The use of 200 μm kidney slices also allowed visualisation of the 
differences in pericyte and MΦ morphology (Figure 3.3, 5.3 and 5.4), consideration of 
cell stereology, and the regional distribution in the kidney. Not only is pericyte 
morphology characteristic (Attwell et al., 2016) and possibly indicative of function 
(Kolyada et al., 2003), but MΦ morphology can also indicate functionality or ontogeny 
(Wang et al., 2013; Lee et al., 2013).  
Trans-species conserved cellular distribution, morphological trends, and behaviours 
suggest conserved activity, leading to better translatability of data from animal models 
as well as the ability of acknowledging species-specific differences. Knowing such 
species-specific differences, whilst also elucidating similarities, is beneficial in making 
an informative model. For example, GABA-A receptor subtype expression varies on T-
cells across humans, rats, and mice (Mendu et al., 2012), whilst GABA is 
immunomodulatory on T-cells across all species (Bjurström et al., 2009). The specific 
signalling pathways may not be identical, but an overall conserved behaviour across 
species is a better indication of a translatable finding.   
It has been argued that tissue slices are limited in experiment throughput because of 
the number of capillaries per slice and lack of clarity over signalling pathways 
(Neuhaus et al., 2017), yet maintaining such involvement of other cells/ pathways  
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better reflects in vivo behaviour; no physiological response is from one single, isolated 
pathway. When OMDVR are isolated with the adjacent tubular segment pericyte 
contractility is attenuated (Cowley Jr, and O’connor, 2013). In vivo, agonists cause a 
preferential reduction in IMBF (Fan et al., 2019; Neuhofer, and Beck, 2005; Nakanishi 
et al., 1995), suggesting a preferential constriction of central DVR, as tubules would 
communicate with peripheral DVR and moderate their responsiveness, as suggested 
by the ex vivo data.  Prior to investigating novel murine pericyte behaviours 
establishing the baseline characteristics was necessary for the murine kidney slices. 
The responsiveness of murine pericytes reflected the known species-specific 
differences in pericyte contractility and thus both slice models accurately model in vivo 
physiology. 
Chapter 3 showed an interesting interactive relationship of NG2+ and PDGFR-β+ 
pericytes with CD163+ MΦ, as well as co-labelling with anti-PDGFR-β and anti-CD163 
on cells with pericyte morphology. Yet low numbers of CD163+ MΦ, and lack of 
alternative residential MΦ markers in the rat necessitated the development of a more 
suitable model to further probe this relationship. Whilst CD163+ MΦ numbers are also 
low in the mouse kidney (Rubio-Navarro et al., 2016; Bi et al., 2018), this species 
enabled use of the F4/80 antigen, a pan-MΦ marker, that reflects the human cellular 
distribution of MΦ in the kidney. (Berry et al., 2017; Kielar et al., 2005; Hume, and 
Gordon, 1983; Colvin, 2019) Further still, F4/80+ cells communicate with pericytes (Shi, 
2009; Neng et al., 2013) and anti-F4/80 reportedly co-labels pericytes (Yamazaki et 
al., 2017; Komuro et al., 2017; Rajantie et al., 2004).  This was reflected in the murine 
data (Chapter 5) and showed usefulness of the slice models for visualising this 
behaviour in both species, but further work is needed to expand upon this interaction. 
 
6.4 PDGFR-β+ and NG2+ pericytes represent different renal populations of 
pericytes, likely correlating to AVR and DVR coverage. 
 
In other organs like the brain, PDGFR-β+ and NG2+ co-expression can range from 80-
90% (Cuervo et al., 2017; O’Farrel et al., 2017; Hung et al., 2017), whereas in the 
kidney slices it appears approximately 1/3rd of PDGFR-β+ pericytes co-express NG2, 
in line with published findings of these respective pericyte densities in the kidney 
(LeBleu et al., 2013; Holliger et al., 1983). It was proposed in section 3.4.1 that this 
difference correlates with the respective ratio of AVR:DVR (Holliger et al., 1983)  and 
reflect differences in AVR and DVR pericyte and capillary morphology. The larger size 
of PDGFR-β+ pericytes in both rats and mice may reflect lack of RhoA GTPase-
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dependent contractility (Kolyada et al., 2003; Kutcher et al., 2007) which is regulated 
by NG2 (Binamé et al., 2013; Binamé, 2014). This is supported by lack of contractility 
of PDGFR-β+ pericytes to TNF-α and IL-1β in both rats and mice. The venular pericytes 
of other tissues reportedly express α-SMA, yet the unique vascular architecture of the 
vasa recta may mean AVR pericytes do not need to be contractile. Loss of water from 
the DVR, and the high interstitial osmolality, and a slower perfusion rate of the DVR 
(Zimmerhackl et al., 1985) results in blood becoming viscous as it descends into the 
IM, which may itself prevent backflow.  
The inter-species discrepancies in PDGFR-β+ pericyte contractility may have 
highlighted a preference of NG2+ pericytes in communicating with residential MΦ. 
Interestingly, whilst most behaviours were conserved in a species-specific manner, 
PDGFR-β+ pericytes showed differences between response between species to TNF-
α and IL-1β. With differing cytokine release profiles (Schroeter et al., 2003), there may 
be differing activity of TNF-α and IL-1β between the species. However, all other 
findings correlated with published data. Instead, in the rat it was only PDGFR-β+ 
pericytes with CD163+ MΦ contact that constricted to IL-1β, being non-significantly 
different in size to NG2+ vessels and pericytes, unlike the other PDGFR-β 
measurements taken (Table 3.4 and 3.5). In the mouse, it was TNF-α that induced a 
PDGFR-β+ pericyte-mediated vasoconstriction, with morphology suggesting these 
pericytes were NG2+/PDGFR-β+ (Table 5.5).  At the 4-hour time point it was 
determined that the majority of newly activated F4/80+ MΦ migrated to NG2+ pericyte 
sites. In the comparative PDGFR-β experiments, the PDGFR-β+ pericytes with F4/80+ 
MΦ contact in the PSS group were the same size as NG2+ pericytes unlike the PDGFR-
β+ pericytes without F4/80+ MΦ contact. Together this suggests that the contradictory 
measurements for PDGFR-β in the rat and mouse may reflect PDGFR-β+/NG2+ 
pericyte behaviour and that residential MΦ-pericyte communications are preferentially 
co-ordinated in the OM by DVR NG2+, not AVR NG2- pericytes. However, this does 
need to be confirmed by tri-labelling with α-SMA, PDGFR-β and NG2 and is a future 
experiment to be conducted.   
 
6.5 Renal pericytes and macrophages seemingly communicate. 
 
Mentioned above in section 6.3, preliminary findings in the rat were that CD163+ MΦ 
and both NG2+ and PDGFR-β+ pericytes were possibly communicating as the net effect 
of cell-cell contact was that those vasa recta were constricted. This was further 
reflected by murine data showing pericytes with F4/80+ MΦ contact were also 
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constricted. Further still, as mentioned above (section 6.4), the increased cell-cell 
contact observed between NG2+ pericytes and MΦ suggests immune co-ordination 
may be preferentially orchestrated by NG2+ pericytes. Pericytes of the kidney recruit 
inflammatory MΦ (section 1.4.1).  In line with the data observed here for F4/80+ MΦ, 
it is possible PDGFR-β+/NG2+ are the population of “recruiter” pericytes in the kidney. 
This fits with recent work showing arteriolar NG2+ pericytes recruit circulating 
leukocytes (Stark et al., 2012; Proebstl et al., 2012) and instruct their transmigration 
towards the inflammatory foci post extravasation (Alon, and Nourshargh, 2013). It is 
possible that the residential MΦ-pericyte communication observed here is an initial 
step in co-ordinating the recruitment of these immune cells at the DVR, and therefore 
by NG2+ pericytes, and future work needed is to establish both this subpopulation of 
pericyte and thus the means to identify communication pathways between MΦ and 
pericytes. 
 
6.6 Macrophages and NG2+ pericytes may communicate via RhoA/ROCK 
signalling. 
 
A limitation of this study is not objectively determining that the pericytes with MΦ 
contact were not apoptotic (Díaz-Flores et al., 2009; Arroyo, and Iruela-Arispe, 2010), 
irreversibly-constricted pericytes causing a localised ischaemia being removed by 
residential MΦ (Neuhaus et al., 2017; Hall et al., 2014).  However, the literature 
strongly suggests that cell-cell interaction is a common key mechanism by which 
immune cells communicate. Immune cells across tissues are able to communicate via 
cell-cell contact with their pseudopodium (Kobori et al., 2018; Arrevillaga-Boni et al., 
2014) and tunnelling nanotubes (TNT) (Rodriguez et al., 2016; Onfelt et al., 2004; 
Watkins, and Salter, 2005) enabling the exchange of membrane lipids and particles. 
Pericytes are also able to communicate via their cytoplasmic process (Armulik et al., 
2011), and their lack of inclusion here is another limitation, though it does not discredit 
the influence of cell-cell contact. In the human kidney MΦ-pericyte contact has a 
physiological outcome (Dixon et al., 2014), and other renal cell lines show cell-cell 
communications facilitated by TNT (Rustom et al., 2004). In the brain porcine α-SMA- 
pericytes-neutrophils perform cell-cell interactions via pericyte-expressed ICAM-1 and 
TNT projections (Pieper, and Galla, 2014). Further still, the NG2 proteoglycan itself 
directs cells via direct cellular contact (Binamé et al., 2013; Binamé, 2014; Stark et al., 
2012); this data supports the MΦ-pericyte contact seen here being communicative. 
MΦ cell-cell contact with pericytes induces RhoA GTPase signalling (Roh-Johnson et 
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al., 2014), with the RhoA/ROCK pathway  necessary for PMN infiltration (Rao et al., 
2017) and pericyte contractility (Kutcher et al., 2007; Kolyada et al., 2003) and 
highlights a potential signalling pathway activated by this contact. 
The AVR is the site of immune cell extravasation in the kidney (Ysebaert et al., 2004) 
with vascular bundles showing marked upregulation of adhesion molecules ICAM-1, 
P-selectin, and MCP-1 within an hour post-IRI (Naruse et al., 2002; Kelly et al., 1994; 
De Greef et al., 2003). Upregulation of these molecules requires RhoA/ROCK 
signalling (Rao et al., 2017; Cernuda-Morollón, and Ridley, 2006). The upregulation of 
these, with a subsequent constriction of DVR NG2+ pericytes by MΦ-induced activation 
of RhoA GTPase could reduce AVR perfusion and enhance leukocyte extravasation 
after shear-dependent capture by these adhesion molecules (Kolaczkowska, and 
Kubes, 2013; Abtin et al., 2014).  Understanding this mechanism could highlight targets 
against the immune infiltrate and loss of vasa recta pericytes implicated in the 
progression of renal disease, but further commentary is beyond the scope of this study. 
 
6.7 PDGFR-β co-labels with CD163 and F4/80. 
 
Throughout renal organogenesis most kidney macrophages are perivascular (Munro 
et al., 2019) and whilst the developmental origin of these co-labelled calls could not be 
determined here, data has shown developmentally and in adult tissues that subsets of 
pericytes derive from  MΦ (Yamazaki et al., 2017; Dai et al., 2010; Komuro et al., 2017; 
Rajantie et al., 2004). It is possible that after co-ordinating development of the 
neovascular tubes (Munro et al., 2019), some of these PVM may differentiate into 
pericytes. In order for these MΦ-derived pericytes to invest into the endothelial tube 
they require PDGFR-β expression (Hellström et al., 1999) and MΦ expressing PDGFR-
β may represent a population that differentiate into pericytes to maintain vascular 
homeostasis  (Dai et al., 2010). Blockade of PDGFR-β reportedly inhibits recruitment 
of MΦ , demonstrating the importance of PDGFR-β signalling in inflammation (Chen et 
al., 2011; Lin et al., 2011), yet it could reflect either PDGFR-β+ pericyte-mediated or 
PDGFR-β+ MΦ-mediated recruitment of circulating leukocytes. The F4/80 antigen is 
not just an identifying marker, it is a functional receptor and its primary role is in antigen 
presentation to T-cells (Lin et al., 2005); pericytes of the kidney have been shown in 
humans and mice to be involved in regulation of T-cells (Liu et al., 2018) and could 
potentially explain pericyte-mediated expression of F4/80.  
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The overarching question of this thesis was “do renal pericytes show 
multifunctionality?”, and more specifically, the use of kidney slices in probing the role 
of renal pericytes in inflammation as demonstrated by other labs in the kidney 
described above. Interestingly, what was observed in both species was that PDGFR-
β+ cells co-labelled with CD163 and F4/80. Whilst the occurrences of co-labelling were 
much too scarce to draw conclusions from in the rat with CD163, in the mouse both 
control and cytokine stimulated tissue demonstrated that anti-F4/80 and anti-PDGFR-
β co-labelled the same Hoechst 33342+-identified cell nuclei. Further still, cells 
identified as co-labelled were seemingly different populations; some had morphology 
of pericytes (Figure 5.16), whilst others bore MΦ morphology (Figure 5.15). This 
indicates further work is needed to determine if PDGFR-β+ pericytes or PDGFR-β+ MΦ 
are responsible for the immunogenicity previously reported for renal PDGFR-β+ 
pericytes (Xavier et al., 2017; Tanaka et al., 2017). Use of immunohistochemical 
techniques (IHC) in this study; the brightfield images, as well as the depth of the 
renders, was what enabled identification of the notable pericyte “bump-on-a-log” 
morphology (Peppiatt et al., 2006) and subsequent distinction to be made between 
cells co-labelled with F4/80 and PDGFR-β. This study has explicitly shown that 
pericyte morphology can enable distinguishing between MΦ and pericytes and will 
hopefully inform future work to include an IHC component when characterising pericyte 
multifunctionality. 
 
6.8 Expression of NG2 by macrophage-derived pericytes may occur at a later 
stage of investment into the endothelial wall.  
 
Described in detail in Section 1.3.2 is the MΦ origin of subsets of NG2+ pericytes and 
suggests a shared lineage of F4/80+ MΦ and a subpopulation of NG2+ MΦ-derived 
pericytes. These MΦ-derived pericytes may not lose their immune-activities, and MΦ 
expressing PDGFR-β (Figure 5.15) may ultimately invest into the endothelium, 
differentiating into pericytes. As it was PDGFR-β, not NG2, that showed co-labelling 
reliably with F4/80, this possibly suggests if these F4/80+ pericytes were to become 
NG2+ that expression of NG2 by these MΦ derived pericytes may occur later into 
maturation, outside the 4-hour scope of this study. F4/80+ MΦ  in vitro (Moransard et 
al., 2011) and in the murine skin (Yamazaki et al., 2017) stimulated by TGF-β  are 
encouraged to express NG2. As inflammation increases the permeability of the 
vasculature (Arroyo, and Iruela-Arispe, 2010), and can encourage pericytes away from 
the capillary (Tanaka, and Nangaku, 2013), as TGF-β induces resolution of 
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inflammation (Gordon, and Martinez, 2010) it may also encourage F4/80+ 
differentiation and investment into the capillary wall, replacing lost pericytes. It was 
noted that some perivascular F4/80+ MΦ had pericyte morphology (Figure 5.14), yet 
at that point in time did not co-express NG2. F4/80 and NG2 expression is dynamic, 
and as raised in section 3.4.5, just because a cell does not in the moment express a 
molecule does not mean it is unable to or did not previously. Longer experimental 
timeframes, more time-points in data acquisition or stimulation of murine kidney slices 
with an anti-inflammatory cytokine like TGF-β may have shown co-labelling of F4/80 
and NG2 may have shown alternative findings. 
 
6.9 Future work. 
 
Translatability of animal data to human physiology is a current concern among 
research communities (Denayer et al., 2014; Rhrissorrakrai et al., 2015), yet discussed 
and presented in this thesis is the use of trying to ascertain conserved behaviour for 
translatability. Overall, data here demonstrates the behaviour characterised for renal 
pericytes in the kidney slice models is reproducible reflecting species differences 
(discussed extensively in section 4.4), whilst showing a conserved role for pericytes 
regulating MBF. This novel consequence of interaction between residential MΦ and 
pericytes here is also seemingly conserved across species (section 6.5), suggesting 
that this interaction is orchestrated in the OM by NG2+, not NG2- Also in this thesis is 
that PDGFR-β co-labels with MΦ markers as opposed to NG2, with use of the murine 
model provided better assessment of such overlap in pericyte and MΦ markers given 
the very small number of CD163+ MΦ in the rat. Expression and distribution of F4/80+ 
MΦ  in the mouse is reflective of human CD163 MΦ distribution; the high MΦ density 
in the OM, and their location primarily apposite the vascular bundles (Colvin, 2019; 
Hume, and Gordon, 1983)(Figure 1.10 and 5.5) as well as a conserved site for co-
ordination of the immune response in rats and humans (Ysebaert et al., 2004); the 
occurrence conserved behaviours across species aids in translatability to humans 
(Steven et al., 2017). 
This thesis provided extensive evidence for direct interaction between pericytes and 
MΦ, across species, having a physiological outcome. This is a translatable example, 
as noted in humans is a functional interaction between Mannose Receptor+ MΦ and 
PDGFR-β+ pericytes  (Dixon et al., 2014). However, the data in chapter 3 and 5 build 
upon this interaction to show that these pericytes are constricted upon interaction with  
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Figure 6.1 Proposed co-ordination of the immune response at the vasa recta capillaries 
by NG2+ and NG2- pericytes. 
The inflammatory foci stimulates both residential macrophage (MΦ; yellow) and NG2+/PDGFR-
β+ pericytes (blue) on the DVR to communicate (dark yellow arrow) secreting pro-inflammatory 
mediators IL-1β, TNF-α, IL-6, MIF, IL-33 and CCL2 (black arrows) to recruit immune cells 
including more MΦ, infiltrating MΦ (orange), T-cells (green) and polymorphonuclear leukocytes 
(peach). Subsequent cell-cell interaction between NG2+ pericytes and F4/80+ or CD163+ MΦ 
activates RhoA/ROCK signalling resulting in vasoconstriction, and a smaller soma comparative 
to NG2- pericytes. The recruited immune cells travel along the vasa recta and up a H2O2 
concentration gradient generated by NG2-/PDGFR-β+ pericytes (turquoise) on the AVR. PMN 
and other circulating leukocytes migrate out of the AVR via the fenestra in the endothelium 
(white spaces). The vasoconstriction of DVR NG2+ pericytes reduces flow rate to enable 
adherence, rolling and subsequent extravasation of recruited immune cells. Some immune 
cells amble to the inflammatory foci (peach dashed arrows), whereas a small population will 
be instructed by the NG2+ pericytes on the DVR expressing ICAM-1, MIF, MAC-1, and LFA-1 
(thick border), sensitising them and directing them directly to the inflammation (solid peach 
arrow) in an NG2-dependent manner. MΦ also express ICAM-1 (thick border) and are 
necessary for both recruitment (DVR; F4/80+ /CD163+) and enabling extravasation (AVR; 
CD169+). Gradients indicate a chemotactic gradient on the DVR (red), and expression of matrix 

















these pericytes and providing insight into this human data and highlights a potential 
target of future study and a novel cellular mechanism for renal pathology. The vascular 
reactivity in chapter 4 builds upon cross-species findings aiding in translatability as 
the murine and rodent models show a conserved contractility of DVR pericyte that 
reflects differences in known species gene expression and sensitivity to 
vasoconstrictors (section 4.4.3). For example, the difference in response to Ang-II can 
be explained by the relative receptor densities. The SD rodent kidney has 
approximately double the contractile AT1-R density of the C57BL/6J mouse (Cassis et 
al., 2004). This difference in magnitude that is species-specific could potentially relate 
to the capillary size difference (section 4.3.3); mice would need to be resistant to 
hypertensive agents to protect against marked blood pressure increases, which implies 
human tissue may be more sensitive given the size differences. investigating and 
understandings species-specific differences in physiology better aids the translatability 
of animal data to human disease (section 1.5), and data here supports the use of 
tandem models in answering biological questions. For future study into renal pericyte 
multifunctionality, for translatability both rodent and murine slice models will be utilised. 
 
This thesis has provided evidence to support the distribution of NG2+/NG2- pericytes 
in the kidney reflection arteriolar and venular locale, but future work identified by this 
study is a better characterisation NG2+ and NG2- pericytes in the kidney, to ascertain 
for certain the size differences between PDGFR-β+ and NG2+ correlate with the 
suggested NG2- population, as well as determining if the ratio of NG2: PDGFR-β does 
indeed reflect the respective DVR:AVR ratio. Use of UT-B and plasmalemmal vesicle 
protein 1 (PV-1) which have been used in mouse, rat, and human tissue (Kim, and 
Pannabecker, 2010; Yuan, and Pannabecker, 2010; Pannabecker, and Dantzler, 2006; 
Wei et al., 2015) to differentially label DVR and AVR respectively, in tandem with NG2 
and PDGFR-β in rat and mouse kidney slices could better determine the vascular 
location of renal pericyte subpopulations.  
Following on from this characterisation of NG2+ and NG2- pericytes, another necessary 
experiment is to perform IHC experiments anti-α-SMA antibodies to determine if indeed 
the NG2- pericytes do not express this marker.  Identifying the NG2+/α-SMA+ pericytes 
as the population of pericytes responsible for the MΦ-pericyte contractility observed 
will allow from their isolation from renal tissue using FACS and therefore their use in 
vitro to investigate the involvement of the RhoA/ROCK signalling pathway. What 
currently remains unclear is the cellular events leading the instigation of inflammation, 
though early on both pericytes and MΦ are involved (section 1.4). Upregulation of the 
adhesion molecules necessary for immune cell infiltration requires this pathway  (Rao 
et al., 2017; Cernuda-Morollón, and Ridley, 2006). The irreversible constriction 
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possibly elicited by MΦ-instigated pericyte RhoA activation could cause acute localised 
ischaemia, and sustained activation of this pathway could trigger apoptosis (Rao et al., 
2017), or their differentiation into myofibroblasts (Shi et al., 2020). This could be the 
instigator of the notable loss of pericytes, marked immune cell infiltrate, and capillary 
rarefaction notable in CKD (Eardley et al., 2008; Kramann et al., 2017) and offers a 
tantalising target to prevent inflammatory damage associated with the progression of 
kidney disease. It was also help expand upon the co-ordination mechanism proposed 
in Figure 6.1. 
Further to this, after ascertaining the arteriolar location of NG2+ pericytes by showing 
they are also α-SMA, the next step is to more accurately determine that the residential 
MΦ-pericyte interaction is in fact specifically co-ordinated at NG2+, not NG2- pericytes 
tri-staining with F4/80, NG2 and PDGFR-β is necessary, and potential subsequent 
staining of human tissue sections with PDGFR-β and CD163 for direct comparison. 
The specific identification of NG2+ pericytes as the subpopulation of pericytes 
responsible for propagation of the immune response would help in elucidating the 
inflammatory pathway, and may further reflect the known migratory sites of immune 
cells in rats and humans (Ysebaert et al., 2004), suggesting translatability of the slice 
models. Of benefit would also be to objectively quantify the co-labelling observed for 
PDGFR-β, as more work is needed to determine if the PDGFR-β+ cells identified in 
other labs as immunoactive (Xavier et al., 2017; Tanaka et al., 2017) are indeed 
pericytes and not PDGFR-β+ MΦ, especially as co-labelled cells bore both pericyte 
and MΦ morphology. It has been discussed elsewhere (section 3.3.5) but the 
exclusion of pericyte processes for PDGFR-β+ and NG2+ is a limitation of this study. 
Identifying a means of which to quantify pericyte processes accurately and thus their 
involvement in this MΦ-pericyte interaction could also help answer mechanistic 
questions behind this interaction.  
Establishment of the wild-type (WT) C57BL/6J model also opens up another venue; 
the use of transgenic (TG) mice. With the background characteristics well established 
in this thesis (chapter 4 and 5), using either NG2 or F4/80 TG mice could be used to 
investigate the multipotent, not multifunctional nature. Another interesting question 
raised by this study is, do renal pericytes upregulate NG2 post damage, and why might 
this occur? In NG2null mice, loss of NG2 reduces repair capabilities of microglia and 
the proliferative capabilities of pericytes and other NG2-expressing cells including 
microglia/macrophage (Kucharova et al., 2011). Observed here in both species is that 
the number of NG2+ pericytes per 100 μm2 increased by 4-hours. Whilst the NG2+ 
pericytes with F4/80+ MΦ contact with may be apoptotic and pre-constricted prior to 
MΦ presence, CD163+ MΦ with cell-cell contact to NG2+ pericytes in the rat also 
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induced a vasoconstriction. CD163+ MΦ communicate via their pseudopodia  (Kobori 
et al., 2018) and require direct cell-cell interaction with endothelia to direct 
vascularization (Kobori et al., 2018). The observed increase in NG2+ expression by 
pericytes, and the conserved contractility observed with both CD163+ and F4/80+ MΦ-
contact suggests that these cells are not apoptotic (Kucharova et al., 2011) and instead 
that they are potentially proliferatory (Kobori et al., 2018; Hesp et al., 2017) or even 
angiogenic (Guo et al., 2018; Puranik et al., 2018). Using the superfusion equipment 
with fluorescence enabled, the real-time activities of the cells in TG mice could be 
recorded in to measure how their protein expression may change, cellular interaction 
over time, and potentially their differentiation into other cell types.  
Overall, this thesis presents data to support kidney slices accurately modelling in vivo 
vascular physiology and renal pericytes exhibiting multifunctionality, notably in a cell-
surface molecule-specific manner that is conserved across species. Whilst more work 
is necessary to expand upon the above suggestions, this thesis provides a strong 
supporting argument to the multifunctional, inflammatory nature of renal pericytes. The 
kidney slice models provide an excellent platform for future experiments in the field. 
By ascertaining what occurs and the malfunction in the inflammatory renal repair cycle, 
it could lead to identification of therapeutic targets and interventions to protect patients 
from the deleterious outcomes that arise from the dysregulation of MBF and the 
multifunctional activities of renal pericytes. 
In conclusion, the data presented in this thesis supports a conserved contractile 
phenotype of DVR pericytes, that varies in a manner that reflects known species 
differences. This conserved nature of contractility is also suggestive that the novel 
observations of communication between renal residential MΦ and NG2+ pericytes may 
also be conserved, in a species-specific manner i.e., human NG2+ pericytes may also 
be constricted when in direct cellular contact with a CD163+ MΦ, as was observed in 
both rats and mice for the respective MΦ markers used in those species. This 
discussion suggests, with supporting evidence, that this cellular interaction reflects 
communication between residential MΦ and pericytes in the propagation of the innate 
immune response (Figure 6.1), that is co-ordinated at the level of the medullary vasa 
recta. The use of live kidney slice models is beneficial in understanding this 
inflammatory pathway and will hopefully lead to better therapeutic targets to prevent 
the capillary rarefaction, marked inflammation, and dysregulation of MBF and renal 
function characteristic of the progression of renal disease.   
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